data_1pfd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pfd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 121.612 0.72 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -97.36 159.59 14.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -171.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.95 90.15 6.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.305 1.842 . . . . 0.0 109.614 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.0 t -89.47 124.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -89.76 132.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.147 0.43 . . . . 0.0 110.836 165.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.4 mt -111.68 103.57 11.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 165.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.5 mt -71.62 95.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -92.79 156.75 40.53 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 124.145 0.978 . . . . 0.0 108.925 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.56 -35.3 76.38 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.2 3.267 . . . . 0.0 112.227 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.3 -30.97 52.8 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 127.376 2.27 . . . . 0.0 111.494 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.53 61.01 0.41 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 125.005 1.288 . . . . 0.0 110.73 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 71.95 142.72 0.06 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 127.768 2.427 . . . . 0.0 114.187 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.93 87.29 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.495 1.118 . . . . 0.0 108.148 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -66.71 132.18 47.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 109.746 167.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -153.38 166.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.133 0.573 . . . . 0.0 111.839 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.23 122.99 39.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.432 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -127.08 123.03 35.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.505 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 143.03 54.9 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.799 1.24 . . . . 0.0 110.099 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -24.99 47.73 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 127.333 2.253 . . . . 0.0 111.182 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -107.88 21.29 17.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.589 1.555 . . . . 0.0 111.462 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -134.55 158.31 41.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.757 1.162 . . . . 0.0 110.633 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -78.68 144.89 34.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.343 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.02 61.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.871 0.868 . . . . 0.0 111.098 173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 tp -169.11 -61.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.06 -55.95 12.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.057 0.943 . . . . 0.0 109.253 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -77.05 -13.76 59.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.876 0.87 . . . . 0.0 112.831 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.57 -50.46 15.51 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 120.945 -1.097 . . . . 0.0 108.603 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -53.38 -38.98 63.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.199 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.61 -38.8 56.26 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.59 -23.89 34.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.764 -0.585 . . . . 0.0 109.608 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.24 15.23 4.25 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.072 1.796 . . . . 0.0 111.473 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.2 mt -80.59 108.41 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.038 0.919 . . . . 0.0 112.445 -170.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.98 72.91 6.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.175 0.99 . . . . 0.0 110.398 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 O-C-N 120.921 -1.112 . . . . 0.0 109.651 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.319 0.58 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.56 164.46 27.01 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 125.942 1.734 . . . . 0.0 110.165 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -98.66 110.25 22.88 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.671 1.588 . . . . 0.0 110.502 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.49 115.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.63 -48.03 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.221 0.609 . . . . 0.0 109.505 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -160.87 173.99 14.51 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.067 -0.396 . . . . 0.0 110.223 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.49 -176.59 47.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.443 1.021 . . . . 0.0 110.742 -168.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -135.15 149.44 49.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -147.47 165.29 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.124 1.77 . . . . 0.0 107.54 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.12 113.54 21.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 108.748 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -110.86 31.77 5.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.023 170.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 p . . . . . 0 N--CA 1.467 0.423 0 CA-C-N 121.101 1.773 . . . . 0.0 111.191 -178.71 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.14 166.43 18.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 124.043 0.839 . . . . 0.0 109.85 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -53.56 -43.99 68.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.0 -61.52 2.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.126 0.97 . . . . 0.0 109.608 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -54.95 -50.08 69.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.269 0.627 . . . . 0.0 111.376 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mtt -51.95 -59.36 4.43 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.489 -0.757 . . . . 0.0 111.314 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.03 -42.28 76.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.45 1.1 . . . . 0.0 110.832 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.42 -20.72 65.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.683 1.593 . . . . 0.0 111.753 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.57 33.8 1.06 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 117.786 -1.564 . . . . 0.0 111.413 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.97 162.67 18.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.348 2.074 . . . . 0.0 113.297 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 125.061 1.344 . . . . 0.0 108.469 179.704 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.88 122.96 38.42 Favored Pre-proline 0 C--O 1.235 0.318 0 C-N-CA 125.537 1.535 . . . . 0.0 108.945 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -76.33 113.95 3.79 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.221 2.614 . . . . 0.0 111.284 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 p -89.52 -12.55 39.67 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.375 -0.828 . . . . 0.0 111.749 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.1 m -157.79 -177.88 6.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.634 1.574 . . . . 0.0 107.687 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.5 113.17 1.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 162.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.57 145.77 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.447 1.499 . . . . 0.0 108.595 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.71 125.63 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.03 155.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -102.87 128.42 49.66 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.28 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.0 p -86.4 178.73 7.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.045 1.293 . . . . 0.0 109.093 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.28 51.37 0.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.596 1.158 . . . . 0.0 111.178 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -127.62 37.62 4.18 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.584 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -70.08 0.25 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 165.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -72.92 33.16 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.737 -1.227 . . . . 0.0 113.803 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -121.97 -3.9 9.1 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.707 -1.245 . . . . 0.0 111.751 159.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.7 pt -111.75 -39.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.344 1.429 . . . . 0.0 111.694 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.253 1.275 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.436 175.712 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.101 0.477 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -104.81 156.02 18.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.278 0.561 . . . . 0.0 112.307 -167.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.34 104.39 2.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 127.835 2.454 . . . . 0.0 108.462 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.91 117.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -88.8 131.61 35.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.716 0.235 . . . . 0.0 111.283 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.5 mt -109.19 103.69 12.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.419 1.075 . . . . 0.0 109.105 167.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 53.9 mt -76.44 99.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -89.77 166.69 19.69 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 124.313 1.045 . . . . 0.0 109.48 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.18 -25.85 30.87 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.086 2.524 . . . . 0.0 111.182 166.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -46.11 78.7 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.169 0.988 . . . . 0.0 109.662 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.83 64.94 0.08 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 67.55 147.35 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.522 1.929 . . . . 0.0 113.643 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 p -154.43 105.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.398 165.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.99 142.35 41.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -152.41 169.24 23.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.182 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 123.5 44.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.4 124.72 50.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.734 0.646 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.03 151.55 45.7 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.524 1.63 . . . . 0.0 109.008 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -14.56 59.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 129.333 3.053 . . . . 0.0 110.566 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -114.4 20.04 15.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.533 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.58 148.91 29.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.087 0.858 . . . . 0.0 109.227 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -67.76 146.07 54.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.069 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.2 t -51.09 -51.53 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -57.32 12.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.305 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.94 -63.08 1.06 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.21 0.914 . . . . 0.0 110.611 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -69.69 -34.67 74.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.18 -57.4 8.87 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.676 -0.64 . . . . 0.0 110.911 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -55.39 -41.7 73.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.01 -38.59 65.28 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.22 -25.89 58.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.275 0.56 . . . . 0.0 109.794 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.63 13.65 6.09 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.385 1.469 . . . . 0.0 110.946 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.7 mt -75.63 121.6 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 117.624 0.712 . . . . 0.0 110.496 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.04 80.74 8.74 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.912 0.863 . . . . 0.0 113.069 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.04 165.78 25.58 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.151 1.834 . . . . 0.0 110.335 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -102.95 111.1 23.27 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.006 1.722 . . . . 0.0 110.977 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.27 117.38 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.938 0.79 . . . . 0.0 109.341 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.7 -47.68 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.294 1.038 . . . . 0.0 109.013 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -161.12 175.35 12.49 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 122.075 -0.391 . . . . 0.0 110.417 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.22 -160.83 52.72 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.559 1.076 . . . . 0.0 110.762 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 t -151.48 169.86 21.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.6 pt -161.46 160.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 127.234 2.214 . . . . 0.0 107.593 -167.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -114.82 110.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -106.58 37.16 2.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 111.264 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 CA--C 1.534 0.336 0 CA-C-N 118.951 0.796 . . . . 0.0 111.113 171.662 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.452 0.168 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.23 166.38 15.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 124.065 0.853 . . . . 0.0 109.893 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.95 -43.88 70.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.25 -61.97 1.91 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.234 1.014 . . . . 0.0 109.563 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -54.38 -50.95 66.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.979 0.511 . . . . 0.0 111.466 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mtm -53.98 -58.06 8.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.455 -0.778 . . . . 0.0 111.51 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.85 -44.33 70.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.714 1.206 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.64 67.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.811 1.645 . . . . 0.0 111.945 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.93 32.86 0.96 Allowed Glycine 0 C--O 1.223 -0.569 0 CA-C-O 117.601 -1.666 . . . . 0.0 111.774 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.438 ' CG ' HG21 ' A' ' 95' ' ' ILE . 95.8 m-85 -121.02 163.66 17.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.557 2.179 . . . . 0.0 113.635 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.452 -0.369 0 C-N-CA 123.759 0.824 . . . . 0.0 108.906 -179.052 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -106.66 131.46 21.68 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 126.558 1.943 . . . . 0.0 109.357 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -78.27 121.37 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.799 2.333 . . . . 0.0 111.725 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -97.29 -12.88 22.37 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.713 -0.617 . . . . 0.0 112.333 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -157.11 -175.23 5.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.563 1.545 . . . . 0.0 106.835 170.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -55.2 140.11 39.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 164.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 p -156.33 146.23 11.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.754 0.788 . . . . 0.0 110.311 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.84 126.8 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.14 147.93 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.878 0.871 . . . . 0.0 109.103 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -104.22 116.74 32.72 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.283 1.033 . . . . 0.0 110.813 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.1 p -79.11 176.25 9.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.244 0.929 . . . . 0.0 109.742 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 67.62 52.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.602 1.161 . . . . 0.0 111.082 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -123.6 43.98 2.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.683 0.793 . . . . 0.0 110.841 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.3 -71.6 0.2 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.82 50.64 1.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.696 -0.627 . . . . 0.0 111.846 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.73 -28.05 1.64 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.594 2.358 . . . . 0.0 111.618 165.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.438 HG21 ' CG ' ' A' ' 73' ' ' TYR . 26.0 pt -91.85 -42.19 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 119.184 0.902 . . . . 0.0 112.552 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 117.351 -1.309 . . . . 0.0 109.254 -177.396 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.422 0.154 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -128.81 156.1 44.13 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.195 0.598 . . . . 0.0 111.222 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.09 102.11 2.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.842 2.457 . . . . 0.0 108.469 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.64 120.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -90.53 131.94 35.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 123.165 0.291 . . . . 0.0 111.004 166.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.21 103.26 12.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 108.285 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mt -74.2 90.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -88.45 154.38 51.15 Favored Pre-proline 0 N--CA 1.444 -0.741 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -57.3 -31.95 92.36 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.87 3.046 . . . . 0.0 112.12 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.84 -33.76 37.49 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.916 2.086 . . . . 0.0 111.087 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.46 61.53 0.27 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 124.898 1.237 . . . . 0.0 110.145 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 68.57 153.79 0.1 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.152 2.181 . . . . 0.0 114.043 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.04 98.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.825 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.36 145.48 45.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.341 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -157.24 172.79 18.0 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.47 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.09 122.61 44.46 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t -122.94 127.86 49.47 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -69.32 141.88 54.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.738 1.256 . . . . 0.0 109.951 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -21.75 55.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 129.886 3.274 . . . . 0.0 111.52 173.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -107.6 12.85 27.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.809 1.644 . . . . 0.0 110.606 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.44 157.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.261 0.937 . . . . 0.0 110.61 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -76.12 149.07 37.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.219 0.608 . . . . 0.0 110.806 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.54 66.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.84 0.829 . . . . 0.0 111.226 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -163.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.583 1.553 . . . . 0.0 108.723 168.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.92 -57.76 11.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -63.08 -35.06 78.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.645 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.43 -56.73 17.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.637 -0.665 . . . . 0.0 109.713 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.86 -39.75 74.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 109.767 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -52.15 -42.15 63.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.869 0.759 . . . . 0.0 112.765 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.07 -23.26 55.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.048 0.451 . . . . 0.0 109.974 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.26 12.88 7.27 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.91 1.719 . . . . 0.0 111.369 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 64.2 mt -80.42 129.66 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.542 0.671 . . . . 0.0 111.1 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -93.32 127.6 38.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.132 0.973 . . . . 0.0 108.436 164.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.7 pt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 165.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.54 166.09 26.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.004 1.764 . . . . 0.0 110.99 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -102.73 110.2 22.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.761 2.024 . . . . 0.0 110.873 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.04 114.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 119.14 0.882 . . . . 0.0 109.062 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.98 -44.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.3 t -161.54 177.64 9.85 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.99 -168.77 43.93 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -142.71 151.2 41.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.7 pt -142.35 157.2 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -99.74 107.63 19.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.3 39.88 1.64 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.676 0.79 . . . . 0.0 111.442 170.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 119.492 1.042 . . . . 0.0 111.589 174.398 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.9 164.83 15.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.729 0.643 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.59 -43.19 68.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.163 0.985 . . . . 0.0 108.543 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -52.3 -61.63 2.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.089 0.956 . . . . 0.0 109.421 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -52.52 -52.28 55.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 111.332 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.7 mtt -52.33 -59.88 3.88 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 111.317 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.76 -44.0 73.26 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.954 1.302 . . . . 0.0 110.677 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.18 -20.84 64.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.744 1.618 . . . . 0.0 111.769 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.69 32.94 1.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-O 117.972 -1.46 . . . . 0.0 111.149 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.401 ' CG ' HG21 ' A' ' 95' ' ' ILE . 93.6 m-85 -118.35 165.88 13.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.963 1.882 . . . . 0.0 113.049 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -175.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.074 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.4 125.44 37.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.215 1.406 . . . . 0.0 109.416 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -74.25 114.99 4.17 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.858 2.372 . . . . 0.0 110.811 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.4 p -94.71 -9.8 33.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.144 0.884 . . . . 0.0 112.129 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -156.9 -177.7 6.81 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 107.491 169.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -55.58 139.25 44.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 163.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 p -157.56 146.43 10.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.483 -165.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.87 124.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.11 152.21 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.885 0.874 . . . . 0.0 108.86 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 17.0 mt-10 -103.99 117.23 33.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.138 0.975 . . . . 0.0 109.854 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 p -80.32 174.63 11.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.381 -0.824 . . . . 0.0 111.301 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.96 55.63 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.654 1.582 . . . . 0.0 111.281 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.425 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 20.6 mmtt -126.33 25.81 6.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.429 0.692 . . . . 0.0 112.668 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.13 -70.56 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.19 0.996 . . . . 0.0 108.725 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -79.77 39.12 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.557 -0.714 . . . . 0.0 112.373 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.92 -43.5 3.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.632 1.173 . . . . 0.0 109.275 161.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.401 HG21 ' CG ' ' A' ' 73' ' ' TYR . 21.3 pt -75.89 -41.48 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.314 -1.327 . . . . 0.0 109.559 -177.741 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 121.315 0.579 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -102.81 156.96 17.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.129 0.572 . . . . 0.0 112.394 -167.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -83.07 89.59 6.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.145 1.778 . . . . 0.0 109.8 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -87.31 127.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.69 131.32 43.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.139 0.427 . . . . 0.0 111.772 166.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.8 105.14 14.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.34 1.025 . . . . 0.0 108.396 166.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.19 94.0 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -93.16 155.24 41.31 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.083 0.953 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -56.5 -32.42 89.48 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.938 3.092 . . . . 0.0 112.147 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.91 48.95 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 126.541 1.936 . . . . 0.0 111.215 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.49 60.08 0.35 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 124.861 1.219 . . . . 0.0 110.935 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 67.89 141.68 0.04 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.263 2.225 . . . . 0.0 114.127 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.64 98.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.059 1.343 . . . . 0.0 107.864 169.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -82.18 133.31 35.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.696 1.599 . . . . 0.0 109.687 171.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.73 172.46 18.56 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 124.4 46.81 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 122.809 0.443 . . . . 0.0 110.224 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.6 t -125.43 128.21 47.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.98 140.06 50.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 123.832 1.777 . . . . 0.0 110.38 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -24.16 28.71 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 129.203 3.001 . . . . 0.0 111.335 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.36 7.24 38.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.574 1.549 . . . . 0.0 112.036 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.0 157.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-N 119.796 1.18 . . . . 0.0 110.302 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.53 147.35 41.89 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 122.013 -0.429 . . . . 0.0 110.804 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -53.96 -57.03 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.659 0.383 . . . . 0.0 110.137 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.54 -51.03 61.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.331 0.652 . . . . 0.0 111.089 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.28 -65.59 0.54 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.611 0.764 . . . . 0.0 110.64 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.57 -42.46 78.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.616 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.58 -59.92 3.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.965 -0.46 . . . . 0.0 111.176 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -58.87 -36.4 74.57 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.897 -0.573 . . . . 0.0 110.212 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -54.42 -38.31 66.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.959 0.799 . . . . 0.0 112.695 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.11 -26.53 53.39 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.807 -0.558 . . . . 0.0 109.991 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 12.64 8.36 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.747 1.641 . . . . 0.0 111.133 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.5 mt -74.34 125.53 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.602 0.701 . . . . 0.0 111.02 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.47 119.7 30.96 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.44 1.096 . . . . 0.0 109.041 167.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.2 pt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.402 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.98 161.59 27.54 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.65 1.595 . . . . 0.0 111.096 167.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -96.48 111.17 23.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.506 1.923 . . . . 0.0 110.728 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 19.8 t -61.06 111.01 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.211 1.405 . . . . 0.0 108.675 175.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -83.81 -47.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.015 0.926 . . . . 0.0 108.979 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -161.36 172.67 16.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.54 -162.38 50.24 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.374 0.988 . . . . 0.0 110.667 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -155.88 155.58 33.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.679 -0.895 . . . . 0.0 109.193 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.7 pt -135.3 165.95 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.99 1.716 . . . . 0.0 107.416 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.83 111.32 23.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.56 31.45 5.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.77 -0.633 . . . . 0.0 111.752 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 120.016 1.28 . . . . 0.0 112.175 -178.592 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 119.887 -0.101 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.66 164.35 17.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 124.092 0.87 . . . . 0.0 109.983 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.17 -44.11 64.48 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.613 1.165 . . . . 0.0 108.482 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.32 -62.43 1.63 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.538 1.135 . . . . 0.0 109.671 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -53.97 -50.18 67.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.283 0.633 . . . . 0.0 111.294 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 29.8 mtt -52.78 -59.98 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.933 -0.479 . . . . 0.0 111.343 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.63 -43.29 72.15 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.855 1.262 . . . . 0.0 110.618 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.63 -21.26 65.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.629 1.572 . . . . 0.0 111.948 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 33.66 1.32 Allowed Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.028 -1.429 . . . . 0.0 110.832 173.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.43 ' CG ' HG21 ' A' ' 95' ' ' ILE . 94.1 m-85 -118.75 166.43 12.79 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.965 1.882 . . . . 0.0 112.806 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -109.28 122.77 38.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 C-N-CA 124.522 1.129 . . . . 0.0 109.553 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -71.24 119.6 6.4 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.543 2.162 . . . . 0.0 111.102 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.9 p -93.7 -13.97 26.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.006 -0.434 . . . . 0.0 111.864 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.0 m -158.66 -177.69 6.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.803 1.641 . . . . 0.0 107.217 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.77 95.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.581 1.552 . . . . 0.0 109.337 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 p -99.24 148.75 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 110.236 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.38 125.97 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.77 144.39 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.756 0.822 . . . . 0.0 109.32 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -100.93 113.39 26.32 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.99 0.814 . . . . 0.0 110.538 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.2 p -79.46 175.69 10.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.979 0.809 . . . . 0.0 110.988 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.29 53.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.318 1.447 . . . . 0.0 111.326 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -124.73 24.67 7.68 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.528 0.731 . . . . 0.0 112.837 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -50.46 -70.17 0.09 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.197 0.999 . . . . 0.0 109.252 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.07 42.37 0.4 Allowed 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.854 -0.529 . . . . 0.0 112.037 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -130.33 -27.46 2.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.343 1.457 . . . . 0.0 111.29 163.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.43 HG21 ' CG ' ' A' ' 73' ' ' TYR . 25.0 pt -82.52 -42.89 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 119.468 1.031 . . . . 0.0 113.197 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.567 -1.206 . . . . 0.0 109.933 -176.057 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.02 157.74 15.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.305 0.642 . . . . 0.0 112.455 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -81.63 88.65 6.22 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.702 1.601 . . . . 0.0 109.737 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -86.85 123.55 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -95.03 131.82 40.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 117.714 0.234 . . . . 0.0 111.499 170.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.99 105.0 13.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 108.493 169.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 mt -75.55 87.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -83.52 154.77 65.88 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.423 1.089 . . . . 0.0 108.881 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.1 -27.33 78.91 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.716 2.944 . . . . 0.0 112.31 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.64 -31.55 57.56 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 125.666 1.586 . . . . 0.0 110.899 171.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.51 61.89 0.3 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 125.144 1.354 . . . . 0.0 110.571 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 65.82 163.15 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.692 1.997 . . . . 0.0 112.687 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.21 -67.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 75.9 128.58 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.438 1.895 . . . . 0.0 111.594 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -162.43 172.5 15.45 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.246 -0.284 . . . . 0.0 111.389 -170.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 127.47 45.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.7 t -124.75 124.99 43.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.277 0.631 . . . . 0.0 111.332 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -64.33 147.9 51.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.271 1.034 . . . . 0.0 110.588 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -65.35 -14.71 61.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.295 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -107.37 4.05 25.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.851 1.66 . . . . 0.0 111.652 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.59 156.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 119.27 0.941 . . . . 0.0 108.859 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.85 153.74 36.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.46 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -52.68 -53.87 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.361 172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -43.02 89.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.033 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -51.04 -66.54 0.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.57 1.176 . . . . 0.0 107.943 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -70.26 -34.11 72.42 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.941 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -59.3 4.65 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.98 -0.45 . . . . 0.0 111.961 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.7 -38.62 75.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.84 -39.34 68.49 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.75 -26.03 59.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.57 13.32 7.47 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.427 1.489 . . . . 0.0 110.936 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.4 mt -76.61 128.81 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 117.757 0.779 . . . . 0.0 110.173 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -90.83 119.48 31.07 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.996 1.318 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.5 pt . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 124.577 1.151 . . . . 0.0 107.946 173.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.789 0.804 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.91 170.98 24.68 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 126.041 1.781 . . . . 0.0 110.539 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -102.13 111.21 23.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 110.347 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.51 111.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 108.888 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -83.69 -47.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -161.94 175.79 11.47 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.076 -0.39 . . . . 0.0 110.707 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.97 -160.19 53.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 m -155.16 156.2 35.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.0 pt -140.21 166.21 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 107.85 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -104.29 109.16 20.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -113.43 58.7 0.66 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.997 0.919 . . . . 0.0 108.684 164.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.53 0.192 0 O-C-N 121.605 -0.684 . . . . 0.0 110.283 173.011 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -93.23 167.46 11.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.614 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.15 -43.22 74.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.633 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.9 -61.28 2.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 123.99 0.916 . . . . 0.0 109.423 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.45 -51.29 67.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.614 0.766 . . . . 0.0 111.011 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 63.1 mtt -50.54 -61.25 2.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.903 -0.498 . . . . 0.0 111.421 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.76 -44.24 73.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.709 1.204 . . . . 0.0 110.649 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.28 -22.84 65.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.872 1.669 . . . . 0.0 112.033 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.31 29.02 1.53 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-O 117.778 -1.568 . . . . 0.0 111.998 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.5 165.04 14.01 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 120.156 1.978 . . . . 0.0 112.85 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.09 0.956 . . . . 0.0 109.435 -177.25 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.09 125.72 30.47 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 125.145 1.378 . . . . 0.0 110.041 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -73.13 117.77 5.25 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.627 2.218 . . . . 0.0 111.323 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -89.56 -19.03 25.48 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.744 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 m -154.37 -176.21 5.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.474 1.91 . . . . 0.0 107.403 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.09 113.25 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 163.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 p -120.33 143.36 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.611 1.564 . . . . 0.0 109.134 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.82 155.31 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 124.641 1.176 . . . . 0.0 108.087 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.01 114.64 28.9 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.431 1.093 . . . . 0.0 109.268 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -75.18 176.94 6.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.211 0.914 . . . . 0.0 110.839 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 m80 68.95 53.4 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.96 1.304 . . . . 0.0 110.682 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -126.64 28.24 5.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 111.727 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.87 -64.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.73 14.14 0.53 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 -18.37 14.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.789 1.236 . . . . 0.0 109.782 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.7 pt -100.34 -40.49 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.419 0.554 . . . . 0.0 111.308 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.072 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -134.84 160.05 39.44 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.412 0.685 . . . . 0.0 111.169 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -87.88 87.21 7.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.842 1.657 . . . . 0.0 109.645 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.93 123.04 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -93.37 134.38 35.66 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 168.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.8 mt -113.61 105.89 13.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.884 1.274 . . . . 0.0 107.757 169.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.19 93.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -90.18 155.41 46.93 Favored Pre-proline 0 N--CA 1.443 -0.787 0 C-N-CA 125.215 1.406 . . . . 0.0 108.347 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.27 -30.22 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.687 2.925 . . . . 0.0 112.476 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.98 -32.02 61.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.439 1.896 . . . . 0.0 111.063 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.98 61.66 0.29 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.969 1.271 . . . . 0.0 110.782 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 66.42 162.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.015 2.126 . . . . 0.0 112.368 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.84 -63.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.184 0.593 . . . . 0.0 111.143 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 76.28 132.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.177 1.791 . . . . 0.0 112.04 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -162.27 173.83 13.67 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.29 126.81 41.76 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.0 t -129.26 130.87 46.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 139.29 41.3 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 123.571 1.653 . . . . 0.0 108.905 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.13 -27.65 9.02 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 130.019 3.328 . . . . 0.0 111.793 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -102.01 8.72 40.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.495 1.518 . . . . 0.0 111.569 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.74 158.05 43.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.488 1.04 . . . . 0.0 110.509 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -76.11 147.75 38.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.72 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.93 -54.36 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tt -78.9 46.4 0.68 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.569 1.148 . . . . 0.0 111.899 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -137.9 -68.73 0.46 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.352 1.461 . . . . 0.0 107.661 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.99 -10.27 47.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.845 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.64 -54.15 6.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.625 -1.297 . . . . 0.0 112.291 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.62 -39.15 67.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.158 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.333 0.3 OUTLIER -58.17 -30.18 66.2 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.87 -28.27 44.14 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.0 12.8 4.71 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.026 1.298 . . . . 0.0 111.293 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.0 mt -73.77 123.46 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.177 0.988 . . . . 0.0 110.139 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -89.34 115.24 26.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 124.114 0.965 . . . . 0.0 109.216 172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 123.133 1.444 . . . . 0.0 114.468 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.84 161.14 34.91 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -98.91 110.68 23.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.229 1.412 . . . . 0.0 110.302 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.69 109.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.935 0.894 . . . . 0.0 108.729 173.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.44 -49.26 17.37 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.043 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.9 t -160.35 173.07 16.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.67 -167.95 32.6 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -165.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -140.94 159.22 42.68 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 pt -146.07 166.82 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.239 1.416 . . . . 0.0 107.653 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -110.43 110.02 20.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.99 24.56 11.16 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.962 0.905 . . . . 0.0 112.135 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.54 0.565 0 CA-C-N 119.838 1.199 . . . . 0.0 112.634 -176.368 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.303 0.097 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.87 165.06 19.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.183 0.927 . . . . 0.0 109.65 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -42.79 72.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.061 0.944 . . . . 0.0 108.687 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.76 -61.13 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.11 0.964 . . . . 0.0 109.497 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.76 -51.43 63.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.342 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.1 mtt -51.19 -60.05 3.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.325 0.511 . . . . 0.0 111.402 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -54.92 -43.17 73.05 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.783 1.233 . . . . 0.0 110.652 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -20.25 64.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.672 1.589 . . . . 0.0 112.058 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.5 28.88 2.03 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.129 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -112.44 168.52 9.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.736 1.768 . . . . 0.0 112.931 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 125.307 1.443 . . . . 0.0 109.334 -177.309 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -105.53 125.3 33.75 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 109.492 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -76.05 115.63 4.19 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.742 2.294 . . . . 0.0 111.874 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 p -93.52 -9.57 37.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.279 0.945 . . . . 0.0 112.102 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -161.96 -177.06 5.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.204 1.802 . . . . 0.0 107.177 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.04 92.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.532 1.533 . . . . 0.0 109.696 168.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.42 146.76 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.963 1.305 . . . . 0.0 110.26 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.85 125.4 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.52 153.69 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 124.287 1.035 . . . . 0.0 108.222 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -103.74 125.73 50.41 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.073 0.949 . . . . 0.0 109.403 170.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 p -91.65 175.8 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.157 0.889 . . . . 0.0 110.7 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.13 60.39 0.65 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.292 1.037 . . . . 0.0 109.288 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -126.01 16.03 7.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.879 0.872 . . . . 0.0 112.499 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -41.31 -70.69 0.1 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.361 1.465 . . . . 0.0 109.777 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -80.99 32.85 0.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.22 -29.37 1.62 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.93 2.092 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.6 pt -81.7 -41.97 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.694 -0.669 . . . . 0.0 112.584 169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.486 -1.245 . . . . 0.0 110.007 -179.176 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -93.56 164.35 13.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.975 0.91 . . . . 0.0 111.443 -172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.56 89.33 7.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.145 1.378 . . . . 0.0 108.905 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.4 t -87.01 122.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -93.81 125.58 38.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.269 0.356 . . . . 0.0 110.668 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.1 mt -106.34 98.58 8.23 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 124.955 1.409 . . . . 0.0 108.022 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 mt -73.92 89.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -90.25 155.71 46.54 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 125.564 1.545 . . . . 0.0 108.316 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.96 -21.3 68.67 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.777 2.985 . . . . 0.0 112.681 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.54 -29.01 69.73 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.329 1.452 . . . . 0.0 110.862 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.8 61.95 0.35 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 65.6 173.16 0.22 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.505 1.522 . . . . 0.0 112.571 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 p -147.5 -55.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.651 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 71.1 132.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.718 1.607 . . . . 0.0 111.236 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -159.68 167.02 29.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.874 -0.516 . . . . 0.0 111.567 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 127.55 37.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.097 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.5 t -132.03 117.96 19.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.622 0.369 . . . . 0.0 110.696 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.76 148.88 19.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.629 1.972 . . . . 0.0 108.87 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -75.96 -6.79 52.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.769 -0.582 . . . . 0.0 112.328 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.26 36.25 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.457 1.503 . . . . 0.0 110.082 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.6 163.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 121.043 -1.035 . . . . 0.0 111.116 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -81.82 140.11 34.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.595 0.758 . . . . 0.0 111.894 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.84 -7.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.19 -34.93 10.93 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.604 1.161 . . . . 0.0 110.715 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -68.36 -69.46 0.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.17 0.986 . . . . 0.0 110.165 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.259 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.11 -62.16 1.68 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.775 0.83 . . . . 0.0 112.328 170.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -55.18 -40.69 71.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.064 -0.493 . . . . 0.0 109.727 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.3 -36.23 52.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.22 -30.32 34.26 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.508 0.595 . . . . 0.0 110.707 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.69 8.54 4.73 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.538 1.066 . . . . 0.0 112.076 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -70.02 118.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.732 1.266 . . . . 0.0 110.906 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -91.15 77.85 5.94 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.319 1.048 . . . . 0.0 109.634 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.566 0 O-C-N 120.764 -1.21 . . . . 0.0 108.837 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.39 169.54 24.25 Favored Glycine 0 N--CA 1.431 -1.645 0 C-N-CA 126.016 1.769 . . . . 0.0 109.547 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -98.76 110.65 23.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.476 1.511 . . . . 0.0 108.424 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.42 103.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 t -77.03 -44.49 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.0 t -163.46 172.3 14.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.64 -171.98 54.86 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.775 1.178 . . . . 0.0 111.151 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -137.38 157.61 46.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 pt -148.15 168.45 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.274 1.829 . . . . 0.0 107.417 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -111.43 110.43 20.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -104.52 35.29 2.78 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.074 0.55 . . . . 0.0 112.078 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.536 0.41 0 CA-C-N 119.623 1.101 . . . . 0.0 113.551 -179.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.391 0.138 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.19 168.61 11.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.031 0.832 . . . . 0.0 109.736 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.38 -42.48 70.43 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.71 -61.25 2.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.581 0.752 . . . . 0.0 109.521 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -55.66 -52.03 65.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.314 0.646 . . . . 0.0 111.283 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.2 mtm -51.81 -58.09 7.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.676 -0.64 . . . . 0.0 111.573 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.95 -42.93 76.97 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.332 1.053 . . . . 0.0 110.555 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.67 -21.27 64.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.56 1.544 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.58 2.23 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 118.355 -1.247 . . . . 0.0 110.859 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.423 ' CG ' HG23 ' A' ' 95' ' ' ILE . 95.0 m-85 -111.56 169.62 8.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.5 1.65 . . . . 0.0 111.564 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 123.657 0.783 . . . . 0.0 109.103 178.834 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -108.14 119.67 49.14 Favored Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 125.793 1.637 . . . . 0.0 108.863 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.51 116.72 4.37 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.855 2.37 . . . . 0.0 111.341 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 p -91.77 -12.96 32.38 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.002 -0.436 . . . . 0.0 111.404 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -160.82 -178.28 6.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.301 1.84 . . . . 0.0 107.474 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -57.17 96.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.875 1.67 . . . . 0.0 109.251 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.0 147.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.727 1.211 . . . . 0.0 110.163 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -116.92 119.46 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.93 142.36 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 16.4 mt-10 -98.34 119.51 37.15 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.047 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -80.15 177.34 9.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.209 1.368 . . . . 0.0 110.007 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.2 m80 67.61 47.94 1.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.847 1.259 . . . . 0.0 111.11 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 16.3 mmtt -121.38 41.1 3.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.124 0.57 . . . . 0.0 110.22 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -79.04 -60.06 2.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.31 51.86 0.73 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.427 0.691 . . . . 0.0 112.354 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.32 -12.03 0.05 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.443 1.497 . . . . 0.0 113.431 163.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.423 HG23 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -79.87 -40.56 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.916 1.235 . . . . 0.0 111.198 170.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.675 177.746 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -117.16 158.8 23.64 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.321 1.448 . . . . 0.0 111.526 -170.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.35 101.52 1.95 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.46 2.304 . . . . 0.0 108.833 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.25 124.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.3 0.375 . . . . 0.0 110.164 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.8 mt -108.86 106.48 16.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 108.848 167.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.15 99.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -99.27 155.24 36.76 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 124.929 1.291 . . . . 0.0 108.67 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.34 -34.54 89.1 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.995 3.13 . . . . 0.0 112.243 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.8 -34.75 28.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.438 2.295 . . . . 0.0 111.147 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.83 64.62 0.34 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 69.8 151.92 0.1 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.221 2.208 . . . . 0.0 114.045 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.94 111.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.176 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.03 138.19 31.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.705 1.202 . . . . 0.0 109.489 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.02 170.2 22.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.992 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.1 121.97 38.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 t -120.35 127.36 52.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.9 135.27 52.21 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -48.51 -39.45 23.33 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 123.183 1.468 . . . . 0.0 108.537 166.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -8.85 56.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.315 1.846 . . . . 0.0 111.954 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -128.62 155.68 40.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 124.11 0.964 . . . . 0.0 109.815 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -75.49 148.25 39.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.781 -0.575 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.11 50.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.945 0.898 . . . . 0.0 111.152 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.02 -47.65 0.13 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.97 -66.61 0.36 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.277 1.031 . . . . 0.0 111.019 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -69.03 -16.62 63.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.895 -0.503 . . . . 0.0 111.243 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.76 -51.32 35.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -56.6 -39.28 73.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.002 0.921 . . . . 0.0 109.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -50.87 -36.19 36.62 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.78 -28.73 27.94 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.966 -0.459 . . . . 0.0 110.214 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.83 12.89 4.76 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.518 1.532 . . . . 0.0 111.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 80.4 mt -73.81 112.18 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.334 1.067 . . . . 0.0 110.777 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.65 71.91 10.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.559 0.743 . . . . 0.0 110.414 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 O-C-N 120.76 -1.213 . . . . 0.0 109.469 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.14 165.72 27.71 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.554 2.026 . . . . 0.0 110.458 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -102.0 114.96 29.53 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.853 1.661 . . . . 0.0 110.704 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.5 112.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.1 0.96 . . . . 0.0 108.562 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -85.82 -42.37 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -157.02 -171.88 3.82 Favored 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.13 -155.21 22.51 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.71 1.148 . . . . 0.0 111.851 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.1 m -153.98 156.78 38.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.7 pt -136.29 149.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.8 112.73 24.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -107.84 42.11 1.41 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.468 0.707 . . . . 0.0 111.593 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 O-C-N 120.929 -1.107 . . . . 0.0 112.791 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 119.882 -0.104 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -85.92 168.54 14.11 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.086 0.866 . . . . 0.0 109.942 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -55.86 -42.66 76.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.358 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.1 -60.54 3.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.802 0.841 . . . . 0.0 109.614 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -54.62 -51.1 66.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.4 mtt -51.74 -59.68 4.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.26 0.482 . . . . 0.0 111.344 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.08 -42.12 72.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.916 1.286 . . . . 0.0 110.795 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.44 -20.2 64.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.412 1.485 . . . . 0.0 111.812 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.88 3.18 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-O 118.613 -1.104 . . . . 0.0 110.528 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.427 ' CG ' HG21 ' A' ' 95' ' ' ILE . 93.2 m-85 -109.76 169.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.077 1.439 . . . . 0.0 111.642 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 179.858 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -107.32 124.12 36.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.213 1.405 . . . . 0.0 111.126 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.49 100.78 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.943 3.095 . . . . 0.0 112.806 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.4 p -81.78 -18.06 45.46 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.06 -0.4 . . . . 0.0 110.89 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -151.98 179.59 8.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.304 . . . . 0.0 107.702 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.38 136.29 53.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.43 144.52 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.833 0.825 . . . . 0.0 111.662 -164.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.42 123.81 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 151.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -99.03 127.03 44.88 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 118.056 -0.973 . . . . 0.0 108.943 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.2 p -86.57 178.44 7.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.682 1.128 . . . . 0.0 109.073 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 65.5 53.9 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.436 1.094 . . . . 0.0 111.555 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -122.22 18.64 10.71 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.2 -67.19 0.3 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.001 0.92 . . . . 0.0 109.005 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -81.29 23.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.599 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.39 -21.37 9.87 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.541 1.136 . . . . 0.0 110.854 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.427 HG21 ' CG ' ' A' ' 73' ' ' TYR . 18.3 pt -88.47 -42.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 119.478 1.035 . . . . 0.0 112.562 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.879 -1.534 . . . . 0.0 110.068 -177.01 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 121.869 0.842 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.39 163.44 12.7 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.054 0.942 . . . . 0.0 112.853 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.44 81.87 8.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.98 2.112 . . . . 0.0 109.484 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -88.04 99.0 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -170.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.76 127.76 34.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.834 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -107.95 109.53 21.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.2 mt -78.58 91.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -88.29 155.07 51.87 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 124.023 0.929 . . . . 0.0 108.57 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.05 -37.03 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.468 3.446 . . . . 0.0 112.696 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.5 -36.63 15.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.852 2.461 . . . . 0.0 111.159 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.06 65.08 0.29 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 69.54 165.31 0.26 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 127.02 2.128 . . . . 0.0 112.765 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.87 -59.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.201 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 70.63 145.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.128 1.371 . . . . 0.0 110.966 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -169.54 158.94 8.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.93 0.892 . . . . 0.0 110.39 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 121.71 27.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.8 t -120.49 120.43 35.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.58 0.352 . . . . 0.0 110.427 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.57 141.97 58.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -31.1 61.47 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 125.531 1.532 . . . . 0.0 110.901 169.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -88.31 -5.32 58.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.257 1.023 . . . . 0.0 112.083 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -119.23 149.01 21.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 CA-C-N 119.725 1.148 . . . . 0.0 110.086 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -72.18 150.38 43.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.185 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 56.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.745 0.783 . . . . 0.0 111.528 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -163.9 -52.75 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -56.62 13.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.572 0.701 . . . . 0.0 110.159 -175.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -71.29 -23.58 61.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.16 -54.09 43.04 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.549 -0.719 . . . . 0.0 110.226 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -48.75 -46.87 41.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.901 0.88 . . . . 0.0 108.894 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -53.87 -38.74 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.3 -25.59 42.4 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.882 -0.511 . . . . 0.0 109.863 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.03 12.75 5.22 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.827 1.68 . . . . 0.0 111.529 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 98.7 mt -76.23 108.84 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.167 0.984 . . . . 0.0 111.318 -175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -78.87 68.61 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.742 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 O-C-N 120.944 -1.097 . . . . 0.0 108.247 173.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.554 0.692 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.68 167.33 25.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.135 1.826 . . . . 0.0 110.684 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -103.83 112.39 25.33 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.964 1.706 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.97 113.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.389 1.076 . . . . 0.0 109.132 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -85.78 -46.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 t -162.71 174.84 11.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.064 -0.398 . . . . 0.0 110.388 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.5 -173.2 54.44 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.599 1.095 . . . . 0.0 110.928 -170.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -141.44 147.7 38.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.7 pt -145.47 169.97 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.784 1.633 . . . . 0.0 107.408 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.24 111.72 22.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -114.09 48.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 109.56 168.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.536 0.422 0 O-C-N 120.526 -1.359 . . . . 0.0 109.585 174.447 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 CA--C 1.521 -0.16 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.81 167.49 13.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 124.05 0.844 . . . . 0.0 109.763 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.16 -43.37 64.05 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.926 1.29 . . . . 0.0 108.58 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.11 -60.81 2.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.45 1.1 . . . . 0.0 109.674 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -58.12 -48.34 80.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.211 0.604 . . . . 0.0 111.044 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtt -51.98 -60.57 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.912 -0.493 . . . . 0.0 110.839 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.97 -45.1 71.28 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.777 1.231 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.37 -20.96 63.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.019 1.728 . . . . 0.0 112.059 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.55 30.95 1.74 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 117.802 -1.554 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.491 ' CG ' HG21 ' A' ' 95' ' ' ILE . 94.6 m-85 -118.25 158.39 25.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.981 1.89 . . . . 0.0 113.747 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.446 -0.627 0 C-N-CA 123.536 0.734 . . . . 0.0 110.671 -175.09 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -116.96 118.65 36.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.768 1.627 . . . . 0.0 109.337 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -74.34 117.85 5.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.587 2.192 . . . . 0.0 111.666 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 p -89.88 -16.03 30.91 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.731 -0.606 . . . . 0.0 111.2 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 m -156.6 -177.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.877 1.671 . . . . 0.0 107.112 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.72 133.67 42.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 161.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.75 148.84 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 107.622 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.72 121.12 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 173.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.41 153.62 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -103.32 126.16 50.34 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 109.29 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.9 p -83.8 177.24 8.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.781 1.173 . . . . 0.0 109.263 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.2 m80 70.37 56.23 0.28 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.672 1.189 . . . . 0.0 111.54 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -129.04 31.47 4.89 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.614 0.765 . . . . 0.0 112.582 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -59.77 -66.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -80.23 47.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.649 0.738 . . . . 0.0 111.547 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -140.32 -41.29 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 131.453 3.901 . . . . 0.0 108.949 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.491 HG21 ' CG ' ' A' ' 73' ' ' TYR . 21.5 pt -75.49 -47.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.061 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.058 -1.448 . . . . 0.0 109.758 -173.616 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -118.68 154.93 31.92 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.552 0.691 . . . . 0.0 112.736 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.73 100.67 0.56 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 128.557 2.743 . . . . 0.0 108.65 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.04 125.67 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -97.18 135.72 38.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 165.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.5 mt -112.14 106.89 15.62 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 124.505 1.128 . . . . 0.0 108.447 169.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.1 mt -78.42 91.61 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.1 p -94.7 155.86 38.92 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.745 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 68.6 Cg_exo -53.43 -37.11 81.6 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 125.133 3.889 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.64 -38.06 9.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 128.444 2.698 . . . . 0.0 111.106 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.8 61.9 0.26 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 70.7 152.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 127.558 2.343 . . . . 0.0 112.905 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -152.65 90.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.861 1.315 . . . . 0.0 108.361 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -83.22 140.21 32.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.538 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.03 170.58 21.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.188 0.595 . . . . 0.0 112.224 -166.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.42 47.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.2 t -122.32 130.47 53.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.25 131.28 41.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.159 0.981 . . . . 0.0 108.988 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -44.48 -28.6 0.59 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.864 2.066 . . . . 0.0 111.833 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.57 -14.3 58.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.263 1.825 . . . . 0.0 112.489 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.9 154.4 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 0.0 110.078 -166.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -74.94 153.01 38.77 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.516 -1.365 . . . . 0.0 110.053 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -49.27 -51.3 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.815 -0.553 . . . . 0.0 110.866 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.75 72.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.82 -67.78 0.39 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -38.54 82.75 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.44 -61.88 1.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.33 -40.09 70.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.95 -40.27 72.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -19.9 56.73 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.481 -0.762 . . . . 0.0 109.039 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.26 15.08 7.3 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.237 1.399 . . . . 0.0 110.686 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.9 mt -81.81 133.12 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 117.302 0.551 . . . . 0.0 110.043 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -93.17 115.2 27.84 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.487 1.115 . . . . 0.0 108.832 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 pt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.619 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.11 167.12 27.9 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.546 1.546 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -105.23 112.57 25.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.516 1.926 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.9 110.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t -83.67 -45.48 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 t -160.96 174.41 13.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.977 -0.452 . . . . 0.0 110.292 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.39 -162.8 54.25 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -155.17 155.86 34.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.2 pt -144.22 160.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.724 1.61 . . . . 0.0 107.801 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -101.38 108.14 19.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -104.55 38.67 1.83 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.711 0.804 . . . . 0.0 111.463 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 119.328 0.967 . . . . 0.0 112.414 175.295 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -85.38 164.86 17.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 123.812 0.695 . . . . 0.0 109.548 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.48 -40.42 74.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 108.683 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.29 -61.64 2.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.947 0.899 . . . . 0.0 109.402 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.41 -53.11 31.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.628 0.771 . . . . 0.0 111.332 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.3 mtm -50.54 -62.15 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 0.0 111.857 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.94 -43.46 69.84 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.667 1.187 . . . . 0.0 110.72 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.53 64.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.766 1.626 . . . . 0.0 112.112 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.86 26.39 2.11 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-O 117.922 -1.488 . . . . 0.0 111.842 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.442 ' CG ' HG21 ' A' ' 95' ' ' ILE . 94.8 m-85 -113.68 166.25 11.73 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 120.018 1.909 . . . . 0.0 112.88 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.622 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -108.4 125.22 32.36 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 125.547 1.539 . . . . 0.0 109.678 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -71.98 119.36 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.194 1.93 . . . . 0.0 111.757 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -91.3 -17.19 26.33 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.257 -0.902 . . . . 0.0 112.039 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 m -156.21 -173.99 4.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.53 140.17 41.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.66 148.09 15.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.354 0.597 . . . . 0.0 109.853 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.54 124.2 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 151.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 123.795 0.838 . . . . 0.0 108.966 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -100.26 121.23 41.14 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.067 0.947 . . . . 0.0 108.605 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.431 ' HG1' ' CD2' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -74.34 179.81 4.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 119.163 0.892 . . . . 0.0 110.712 176.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.476 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 3.5 m-70 65.46 50.47 1.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.761 1.224 . . . . 0.0 112.86 169.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -122.01 15.5 10.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -172.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -45.39 -63.43 0.95 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.795 0.807 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -82.86 21.89 0.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.732 0.813 . . . . 0.0 113.142 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -110.2 -26.14 9.79 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.352 1.061 . . . . 0.0 110.495 162.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.442 HG21 ' CG ' ' A' ' 73' ' ' TYR . 34.6 pt -82.4 -48.85 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 119.478 1.035 . . . . 0.0 112.09 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.253 1.283 0 CA-C-O 117.498 -1.239 . . . . 0.0 109.693 -176.145 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.237 0.4 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -98.4 158.25 15.7 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 111.424 -168.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.82 90.21 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.837 1.655 . . . . 0.0 109.135 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.0 120.56 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -88.97 131.08 35.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.878 0.308 . . . . 0.0 111.346 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.8 mt -109.29 103.87 12.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.418 1.487 . . . . 0.0 107.508 166.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.4 mt -74.17 86.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -79.34 154.17 76.77 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.691 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.83 -32.43 94.93 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.949 3.1 . . . . 0.0 112.194 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -32.18 33.82 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 126.429 1.892 . . . . 0.0 110.907 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.01 62.62 0.32 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 125.255 1.407 . . . . 0.0 109.931 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 67.69 161.72 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.728 2.011 . . . . 0.0 112.883 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.4 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.072 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 73.67 129.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.121 1.768 . . . . 0.0 111.987 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -163.73 171.37 15.69 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.29 127.88 40.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.404 0.682 . . . . 0.0 111.524 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.6 t -131.51 130.27 42.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 175.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.3 150.99 39.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 110.108 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -7.38 46.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -115.26 21.01 14.51 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.767 1.627 . . . . 0.0 110.703 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.42 158.12 27.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 O-C-N 121.024 -1.048 . . . . 0.0 110.589 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -77.94 143.45 37.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.566 0.346 . . . . 0.0 110.99 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -49.07 -62.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 111.523 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tp -49.86 -52.5 32.21 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.537 0.735 . . . . 0.0 111.475 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -54.45 43.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -170.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -58.64 -44.91 90.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.581 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.87 -56.06 14.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.361 -0.837 . . . . 0.0 110.793 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.26 -38.95 81.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.674 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.7 -38.24 54.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.227 0.921 . . . . 0.0 112.301 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.96 -25.86 43.5 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.934 -0.479 . . . . 0.0 110.616 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.92 11.32 10.21 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.82 1.676 . . . . 0.0 111.31 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.24 123.41 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.7 0.75 . . . . 0.0 111.075 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.59 119.37 30.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.703 1.601 . . . . 0.0 109.986 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.59 160.68 28.45 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.175 1.845 . . . . 0.0 111.085 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -98.26 112.94 24.75 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.026 1.73 . . . . 0.0 111.166 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.16 116.2 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.073 0.851 . . . . 0.0 109.474 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.98 -48.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.998 0.519 . . . . 0.0 109.876 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -160.33 174.06 14.73 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.08 -169.37 43.14 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 m -142.54 149.48 39.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.071 0.948 . . . . 0.0 108.817 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 pt -132.89 165.52 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.027 1.731 . . . . 0.0 107.035 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -107.13 110.73 22.89 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.45 46.17 1.02 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.112 0.565 . . . . 0.0 110.168 168.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.533 0.301 0 O-C-N 121.539 -0.726 . . . . 0.0 109.751 169.737 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -85.85 160.62 19.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.966 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.36 -41.22 72.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.57 -61.01 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.981 0.912 . . . . 0.0 109.559 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -51.44 -51.07 57.99 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.0 111.202 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.1 mtt -52.18 -60.45 3.19 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.626 -0.671 . . . . 0.0 111.558 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.94 -42.68 76.54 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.379 1.072 . . . . 0.0 110.854 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.99 -19.93 63.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.8 1.64 . . . . 0.0 111.749 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.63 1.31 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 117.559 -1.689 . . . . 0.0 110.949 171.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -116.48 162.27 17.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.48 2.14 . . . . 0.0 113.802 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.729 -169.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -105.84 126.16 31.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 124.58 1.152 . . . . 0.0 109.215 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.87 119.1 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.659 2.24 . . . . 0.0 110.899 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 p -91.31 -15.04 29.72 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.099 -0.376 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -156.94 -174.71 5.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.49 134.81 40.58 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 p -151.87 148.04 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 109.769 -171.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.71 123.73 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 153.05 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -100.63 119.32 38.39 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.024 0.93 . . . . 0.0 109.477 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.7 p -79.91 175.89 10.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.411 1.005 . . . . 0.0 111.202 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 69.42 56.94 0.36 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.747 1.619 . . . . 0.0 111.814 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -126.96 12.68 7.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.84 -63.73 0.98 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.283 1.033 . . . . 0.0 109.075 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -79.87 26.63 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -110.12 -45.33 3.61 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 pt -71.62 -41.61 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -170.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.996 -1.478 . . . . 0.0 110.325 -178.583 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.819 0.342 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -109.17 158.98 17.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.591 0.756 . . . . 0.0 112.055 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.96 104.54 5.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.018 2.127 . . . . 0.0 109.123 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.19 111.77 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 122.898 0.479 . . . . 0.0 110.557 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -84.6 128.33 34.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 117.937 0.335 . . . . 0.0 111.456 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.1 mt -106.55 112.13 25.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mt -84.22 86.32 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p -83.32 153.69 65.9 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.097 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -36.92 69.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.654 3.569 . . . . 0.0 113.063 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -46.95 -38.68 11.0 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 127.526 2.33 . . . . 0.0 111.099 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.23 64.22 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.9 166.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 127.215 2.206 . . . . 0.0 112.158 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.72 -59.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.732 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 70.55 142.36 0.05 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.988 1.715 . . . . 0.0 113.086 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -164.34 178.93 7.13 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.811 0.844 . . . . 0.0 111.264 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.86 124.38 48.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.818 1.247 . . . . 0.0 109.086 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.5 t -121.05 128.3 52.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.51 0.324 . . . . 0.0 110.325 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.52 141.06 53.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.782 1.277 . . . . 0.0 108.23 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -18.83 65.63 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 128.895 2.878 . . . . 0.0 110.786 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.59 17.52 22.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.811 1.244 . . . . 0.0 111.292 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.35 151.78 32.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.59 1.086 . . . . 0.0 111.501 177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -65.05 138.74 58.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.905 0.882 . . . . 0.0 110.327 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.68 4.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.46 -52.07 2.81 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -45.8 -62.3 1.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.394 1.478 . . . . 0.0 111.246 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -65.07 -28.17 69.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.913 -0.492 . . . . 0.0 111.198 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.22 66.14 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 109.542 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -56.67 -41.4 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.037 0.935 . . . . 0.0 109.892 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -51.72 -37.72 52.17 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.73 -25.31 41.13 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.848 -0.532 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.15 11.34 9.04 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.805 1.669 . . . . 0.0 111.284 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.2 mt -82.16 126.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 118.208 1.004 . . . . 0.0 110.124 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -90.24 110.98 22.01 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.419 1.088 . . . . 0.0 109.447 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 170.278 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.39 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.4 156.05 26.36 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.092 1.806 . . . . 0.0 111.263 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.98 126.61 34.84 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.5 1.52 . . . . 0.0 110.028 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 17.3 t -73.73 128.34 36.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 120.11 1.323 . . . . 0.0 108.969 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -108.25 -44.21 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.297 0.639 . . . . 0.0 109.953 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 t -158.93 172.54 18.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.599 0.636 . . . . 0.0 109.715 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.97 -161.76 46.85 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.471 1.034 . . . . 0.0 111.407 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 m -156.24 158.55 37.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.65 -0.912 . . . . 0.0 108.757 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 pt -130.58 179.67 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.498 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.44 118.99 36.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -108.39 34.64 3.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.818 0.847 . . . . 0.0 111.721 169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 CA--C 1.538 0.504 0 O-C-N 120.631 -1.293 . . . . 0.0 113.173 -166.912 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.309 0.1 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.75 164.45 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 123.641 0.588 . . . . 0.0 110.253 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -52.6 -44.01 65.72 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.94 -61.2 2.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.286 1.034 . . . . 0.0 109.766 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -54.34 -49.53 69.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.227 0.611 . . . . 0.0 111.139 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 12.2 mtt -54.59 -58.55 7.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.635 -0.666 . . . . 0.0 111.66 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.33 -43.16 70.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.403 1.081 . . . . 0.0 110.697 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.82 65.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.842 1.657 . . . . 0.0 111.727 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.58 51.33 0.98 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -125.31 146.47 49.55 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.393 1.097 . . . . 0.0 111.915 169.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.08 123.01 40.43 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 125.277 1.431 . . . . 0.0 110.938 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -74.38 120.16 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.716 2.277 . . . . 0.0 111.29 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 p -99.34 -13.0 19.81 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.685 -0.635 . . . . 0.0 112.176 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.1 m -156.28 -173.52 4.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.35 143.85 32.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.89 151.9 10.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.281 0.562 . . . . 0.0 111.687 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.5 t -135.56 127.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -156.07 141.73 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -167.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.98 118.16 31.34 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.418 -0.801 . . . . 0.0 110.81 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 p -77.3 176.03 9.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.932 0.493 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.23 55.35 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.116 1.366 . . . . 0.0 111.472 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -123.28 33.29 5.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 122.939 0.496 . . . . 0.0 111.967 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.96 -71.93 0.08 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.35 45.0 0.72 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.498 0.666 . . . . 0.0 110.902 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.32 -46.13 2.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.134 1.374 . . . . 0.0 108.296 164.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.9 pt -72.5 -38.81 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.564 1.516 1 CA-C-O 81.463 -18.399 . . . . 0.0 111.435 -174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -99.8 155.4 17.67 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.03 101.74 0.42 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.309 2.244 . . . . 0.0 109.314 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.2 109.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -81.76 134.25 35.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.101 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -112.13 106.86 15.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 167.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.1 mt -76.66 96.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 156.23 41.69 Favored Pre-proline 0 N--CA 1.444 -0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 108.882 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.55 -36.85 81.94 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.49 3.46 . . . . 0.0 112.505 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.89 -34.84 21.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 127.423 2.289 . . . . 0.0 111.084 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.37 64.21 0.3 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 125.225 1.393 . . . . 0.0 109.693 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 67.9 161.59 0.18 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.996 2.118 . . . . 0.0 112.293 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.75 -58.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.786 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 72.21 143.46 0.06 Allowed 'General case' 0 C--O 1.229 0.017 0 C-N-CA 126.032 1.733 . . . . 0.0 112.79 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -163.43 169.95 18.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.998 0.519 . . . . 0.0 112.012 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 126.35 36.34 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.4 t -119.86 125.11 47.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.653 0.596 . . . . 0.0 110.531 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -69.11 146.27 52.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 123.003 1.383 . . . . 0.0 110.015 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.0 -1.65 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.257 1.023 . . . . 0.0 111.88 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.06 23.05 10.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.207 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -130.88 149.04 33.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-N 119.465 1.03 . . . . 0.0 110.367 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -64.25 142.83 58.27 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.9 t -49.12 -58.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.07 0.231 . . . . 0.0 110.554 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.6 -36.26 73.74 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -61.49 -62.15 2.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 122.398 1.094 . . . . 0.0 108.337 -169.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.12 -38.15 87.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.589 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.77 -58.21 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.203 -0.935 . . . . 0.0 112.084 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.88 -38.49 78.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 109.573 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.1 -40.81 61.8 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.886 0.766 . . . . 0.0 112.384 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.02 -24.07 55.24 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.886 -0.509 . . . . 0.0 109.948 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.31 15.34 7.73 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.386 1.47 . . . . 0.0 110.669 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.4 mt -77.88 125.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.557 0.678 . . . . 0.0 109.496 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.43 119.53 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.74 0.816 . . . . 0.0 109.166 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 pt . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 175.507 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.09 166.39 25.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.959 1.742 . . . . 0.0 109.977 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.24 114.27 27.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.63 1.572 . . . . 0.0 110.802 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.17 109.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.425 1.09 . . . . 0.0 108.519 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.47 -40.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 -169.74 3.19 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.24 -159.46 14.92 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.333 0.968 . . . . 0.0 112.012 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -155.25 151.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 pt -136.57 154.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.17 107.17 19.64 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.0 27.16 8.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.247 0.619 . . . . 0.0 111.772 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 120.074 1.307 . . . . 0.0 111.764 -177.805 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.54 164.81 14.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.044 0.84 . . . . 0.0 110.243 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.23 -44.4 64.81 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.968 1.307 . . . . 0.0 108.59 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -53.6 -60.97 2.62 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 109.41 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -53.96 -50.09 67.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.279 0.632 . . . . 0.0 111.431 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 64.4 mtt -50.38 -60.51 2.92 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.381 -0.825 . . . . 0.0 111.362 175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.04 -43.33 73.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.416 1.086 . . . . 0.0 110.759 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.69 64.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.725 1.61 . . . . 0.0 111.875 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.21 35.07 1.25 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.498 -1.168 . . . . 0.0 110.332 173.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -116.58 164.46 14.56 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.212 1.506 . . . . 0.0 111.476 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 123.796 0.839 . . . . 0.0 108.77 -178.108 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.85 126.52 28.14 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 124.811 1.244 . . . . 0.0 110.215 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -73.36 121.03 6.85 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.361 2.041 . . . . 0.0 111.648 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -95.68 -16.19 22.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.7 m -156.64 -173.97 4.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.5 142.58 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 165.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 p -152.74 149.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.857 0.837 . . . . 0.0 109.9 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.7 123.7 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.63 153.11 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -102.1 128.84 48.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.742 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.4 p -85.44 178.6 7.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.071 0.85 . . . . 0.0 110.04 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.8 m80 63.43 58.22 1.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.838 1.255 . . . . 0.0 110.877 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -126.51 6.15 6.89 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.914 0.885 . . . . 0.0 111.413 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -45.72 -55.53 6.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 127.867 2.467 . . . . 0.0 110.808 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -93.06 33.01 1.21 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 111.956 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.37 -39.59 2.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.615 1.166 . . . . 0.0 108.204 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.2 pt -67.92 -38.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.25 -177.567 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 122.19 0.995 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -107.09 158.84 16.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.553 1.141 . . . . 0.0 111.629 -159.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 102.8 2.08 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.058 2.143 . . . . 0.0 108.025 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.57 122.24 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -93.02 132.01 37.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.508 0.14 . . . . 0.0 110.691 168.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -108.17 104.64 14.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mt -73.71 95.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -94.85 152.94 40.03 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 124.934 1.293 . . . . 0.0 108.705 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -52.81 -37.33 76.52 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.461 3.441 . . . . 0.0 112.236 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.81 -39.57 8.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 128.819 2.848 . . . . 0.0 111.088 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.16 62.75 0.23 Allowed Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 125.348 1.451 . . . . 0.0 109.555 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.2 157.1 0.17 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 127.597 2.359 . . . . 0.0 114.669 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -159.22 108.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.826 163.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.67 143.53 42.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.073 0.549 . . . . 0.0 110.856 164.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.92 162.71 38.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.401 1.08 . . . . 0.0 110.443 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -84.14 131.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.0 t -127.4 129.35 47.38 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.385 -0.126 . . . . 0.0 111.019 170.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.76 136.71 47.25 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.669 0.747 . . . . 0.0 110.298 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.29 -32.75 11.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.655 1.582 . . . . 0.0 112.316 165.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.68 -10.99 59.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.84 1.256 . . . . 0.0 112.285 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.22 148.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 119.141 0.882 . . . . 0.0 109.172 -167.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -74.92 150.44 39.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.686 -1.258 . . . . 0.0 109.576 -174.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -49.96 -40.55 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.284 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.269 0.0 OUTLIER -66.12 -32.22 73.55 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -65.65 -66.71 0.51 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-O 121.458 0.647 . . . . 0.0 109.537 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -56.83 -36.16 69.64 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.956 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.96 -58.93 4.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 122.02 -0.425 . . . . 0.0 111.028 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.08 -36.68 75.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.642 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.82 -39.58 62.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.7 0.682 . . . . 0.0 111.961 171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.46 -29.17 33.84 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.2 14.35 7.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.977 1.751 . . . . 0.0 111.601 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.36 112.28 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 117.754 0.777 . . . . 0.0 109.588 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -84.7 98.09 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.032 1.333 . . . . 0.0 109.159 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 O-C-N 121.592 -0.692 . . . . 0.0 109.848 174.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.542 0.687 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -134.14 164.59 24.49 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 125.969 1.747 . . . . 0.0 109.208 162.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -98.24 109.25 22.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.796 1.638 . . . . 0.0 109.636 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.32 111.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.6 -42.08 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 122.852 0.461 . . . . 0.0 109.857 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.6 t -155.73 -166.75 2.3 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.48 -158.24 18.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.795 0.712 . . . . 0.0 111.929 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -145.58 154.91 42.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 168.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.3 pt -135.99 165.5 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -106.6 116.36 31.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -111.36 54.12 0.69 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 CA--C 1.534 0.333 0 O-C-N 121.509 -0.744 . . . . 0.0 109.494 169.75 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.05 165.34 15.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.992 0.808 . . . . 0.0 109.641 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.17 -39.49 69.6 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.924 0.89 . . . . 0.0 108.757 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.87 -62.38 1.69 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.654 0.782 . . . . 0.0 109.519 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -51.93 -51.41 57.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.215 0.606 . . . . 0.0 111.573 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.0 mtm -51.56 -60.39 3.2 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.711 -0.618 . . . . 0.0 111.487 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.1 -43.39 78.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.704 1.202 . . . . 0.0 110.708 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.13 66.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.733 1.613 . . . . 0.0 111.37 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.71 27.61 1.03 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 116.921 -2.044 . . . . 0.0 112.569 169.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.464 ' CG ' HG21 ' A' ' 95' ' ' ILE . 90.9 m-85 -120.44 167.02 12.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 121.245 2.523 . . . . 0.0 114.953 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -171.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -108.95 124.4 34.29 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 126.123 1.769 . . . . 0.0 109.603 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -74.3 111.39 3.3 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.726 2.284 . . . . 0.0 111.673 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 p -82.07 -18.93 41.38 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.354 -0.841 . . . . 0.0 110.93 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -155.8 -177.12 6.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.225 1.41 . . . . 0.0 107.736 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.48 140.55 45.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 163.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.61 140.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 121.648 0.737 . . . . 0.0 111.938 -166.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.12 127.28 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.87 153.09 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 124.233 1.013 . . . . 0.0 108.921 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -103.17 125.94 50.1 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.42 1.088 . . . . 0.0 109.232 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.1 p -83.56 177.14 8.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.536 1.516 . . . . 0.0 109.237 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 69.38 57.0 0.36 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 112.106 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -128.05 32.74 4.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -60.47 -68.66 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -81.75 52.64 1.96 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.669 0.747 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.52 -40.43 0.34 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 130.293 3.437 . . . . 0.0 109.363 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.464 HG21 ' CG ' ' A' ' 73' ' ' TYR . 35.1 pt -75.58 -43.28 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 119.007 -0.521 . . . . 0.0 112.278 175.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.076 -1.44 . . . . 0.0 109.569 176.164 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.773 0.796 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.8 158.48 15.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.518 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -81.21 84.65 6.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.982 1.713 . . . . 0.0 109.116 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -84.19 127.59 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -97.9 131.83 44.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 169.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.7 mt -109.41 110.93 22.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.732 1.27 . . . . 0.0 108.023 169.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -80.53 86.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.6 p -86.55 154.92 56.69 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.418 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.483 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 51.3 Cg_exo -55.07 -35.73 91.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.738 3.625 . . . . 0.0 112.411 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.39 -38.22 18.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.018 2.527 . . . . 0.0 111.212 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.34 61.86 0.21 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 125.593 1.568 . . . . 0.0 110.423 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 68.2 160.41 0.17 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.12 2.168 . . . . 0.0 111.997 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -129.18 -64.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.386 0.674 . . . . 0.0 111.53 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 75.54 127.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.068 1.747 . . . . 0.0 112.353 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -163.53 168.99 19.39 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.56 35.35 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.869 0.868 . . . . 0.0 112.12 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.0 t -125.98 129.42 49.19 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.743 0.817 . . . . 0.0 111.585 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.24 149.06 31.97 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.756 0.822 . . . . 0.0 110.284 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -65.34 -19.27 65.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.94 -0.475 . . . . 0.0 111.997 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.05 -3.28 58.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.615 1.166 . . . . 0.0 111.8 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 p -134.24 153.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.52 1.055 . . . . 0.0 110.667 -170.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -76.89 156.23 32.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.126 0.489 . . . . 0.0 112.001 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.78 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.954 0.902 . . . . 0.0 111.596 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.46 -51.14 0.1 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.59 -60.48 2.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.956 0.903 . . . . 0.0 110.929 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -72.22 -5.12 33.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.35 -49.07 6.93 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.396 -0.815 . . . . 0.0 109.618 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -53.63 -38.84 64.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.672 0.789 . . . . 0.0 110.541 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.258 0.4 OUTLIER -58.25 -35.52 71.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 176.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.89 -25.77 40.49 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.61 11.7 6.45 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 125.811 1.672 . . . . 0.0 111.24 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.44 121.35 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 118.279 1.039 . . . . 0.0 110.566 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -96.39 113.53 25.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 166.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.8 mt . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 163.724 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.25 27.66 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 124.834 1.207 . . . . 0.0 111.054 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -101.62 111.04 23.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.175 1.79 . . . . 0.0 110.308 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.2 t -58.8 116.91 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.016 0.927 . . . . 0.0 109.306 173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -93.05 -47.02 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t -158.31 170.71 21.62 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.26 -161.37 54.17 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -168.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -155.88 168.68 26.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.1 pt -147.08 162.26 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 127.581 2.352 . . . . 0.0 107.999 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -105.22 113.48 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.61 28.21 8.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.27 1.028 . . . . 0.0 111.772 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.1 p . . . . . 0 CA--C 1.539 0.521 0 O-C-N 121.323 -0.86 . . . . 0.0 113.17 -172.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.43 164.91 22.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.05 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.95 -44.44 67.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.6 -61.71 2.11 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.886 0.875 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -53.05 -52.09 59.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.346 0.658 . . . . 0.0 111.433 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.8 mtt -53.87 -58.17 8.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.566 -0.709 . . . . 0.0 111.665 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.79 -43.63 69.43 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.62 1.168 . . . . 0.0 110.557 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.97 65.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.17 28.75 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.913 -1.493 . . . . 0.0 111.072 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CG ' HG21 ' A' ' 95' ' ' ILE . 86.2 m-85 -110.79 163.57 13.64 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 120.067 1.934 . . . . 0.0 113.939 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.581 0 C-N-CA 125.683 1.593 . . . . 0.0 108.885 -168.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.15 123.68 36.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.822 1.649 . . . . 0.0 109.409 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.84 114.83 4.14 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.193 2.596 . . . . 0.0 111.063 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 p -88.34 -17.02 31.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.944 0.498 . . . . 0.0 110.834 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 m -157.08 -178.74 7.59 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.543 1.537 . . . . 0.0 108.116 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -53.58 121.4 7.68 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 161.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.25 144.51 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.995 -177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.59 125.28 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.17 154.02 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 123.999 0.92 . . . . 0.0 108.669 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.57 121.87 41.82 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.199 1.0 . . . . 0.0 108.643 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.442 ' HG1' ' CD2' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -74.52 -178.23 3.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.917 1.235 . . . . 0.0 110.999 176.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.483 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 5.1 m-70 65.88 48.45 1.83 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.968 1.307 . . . . 0.0 112.931 169.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -119.31 15.39 13.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -40.65 -68.44 0.18 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.116 0.967 . . . . 0.0 109.68 170.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.81 17.51 0.71 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.991 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.14 -17.48 12.37 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 117.888 -1.054 . . . . 0.0 110.904 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.419 HG21 ' CG ' ' A' ' 73' ' ' TYR . 28.8 pt -89.82 -45.48 15.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 119.98 1.264 . . . . 0.0 111.673 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.157 -176.905 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -98.39 158.75 15.39 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.56 0.744 . . . . 0.0 112.704 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -81.93 83.77 7.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.992 1.717 . . . . 0.0 109.181 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.66 121.68 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -89.55 132.34 35.13 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.675 167.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.8 mt -111.26 106.95 16.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.429 1.492 . . . . 0.0 107.238 170.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.1 mt -76.39 94.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 169.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -89.88 156.29 47.11 Favored Pre-proline 0 N--CA 1.444 -0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 108.689 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -52.12 -38.69 71.17 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.524 3.483 . . . . 0.0 112.422 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.69 -39.49 11.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 128.222 2.609 . . . . 0.0 111.237 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.05 66.19 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 125.585 1.564 . . . . 0.0 109.803 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.7 164.16 0.23 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.221 2.208 . . . . 0.0 112.565 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.71 -60.64 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.311 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 74.27 131.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.41 1.484 . . . . 0.0 111.598 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -162.44 167.86 22.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.54 124.44 39.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.4 t -131.78 123.99 28.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.187 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.79 138.7 56.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.41 1.484 . . . . 0.0 109.637 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -56.17 -27.29 53.85 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.691 1.597 . . . . 0.0 111.916 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -87.0 1.18 53.67 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 111.865 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.41 156.53 41.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.639 1.109 . . . . 0.0 110.677 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -78.42 149.07 33.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 121.83 -0.543 . . . . 0.0 111.241 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.23 63.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 122.073 0.94 . . . . 0.0 110.423 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -166.32 -51.87 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.44 -63.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.397 0.617 . . . . 0.0 110.98 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -58.02 -32.58 68.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.357 0.599 . . . . 0.0 110.243 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.06 -58.26 9.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.49 -41.51 63.44 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.87 -24.53 48.46 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.77 -0.581 . . . . 0.0 110.073 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.61 12.1 6.86 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.924 1.726 . . . . 0.0 111.736 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.24 111.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 117.826 0.813 . . . . 0.0 111.017 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -89.17 73.1 8.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.579 0 O-C-N 121.112 -0.992 . . . . 0.0 108.739 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 122.454 1.121 . . . . 0.0 113.206 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.51 27.34 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.737 1.637 . . . . 0.0 109.848 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -92.77 111.04 22.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.834 1.254 . . . . 0.0 109.965 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.93 110.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.46 -42.43 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 t -157.24 -167.88 2.45 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.65 -153.64 14.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.01 0.814 . . . . 0.0 111.644 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.6 m -157.28 154.99 29.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.9 pt -141.75 166.31 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.43 1.892 . . . . 0.0 106.381 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -109.44 119.71 40.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -108.36 46.31 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.678 0.791 . . . . 0.0 111.295 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.303 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.85 167.23 11.76 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.865 0.728 . . . . 0.0 109.67 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.88 -41.91 75.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.966 0.907 . . . . 0.0 109.029 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -60.16 3.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.853 0.861 . . . . 0.0 109.545 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -55.1 -50.32 69.49 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.647 0.779 . . . . 0.0 110.999 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 20.2 mtm -51.29 -59.83 3.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.829 -0.544 . . . . 0.0 112.182 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.04 -43.19 73.53 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.239 1.016 . . . . 0.0 110.511 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.03 -22.89 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.585 1.554 . . . . 0.0 111.797 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.42 35.55 0.8 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-O 118.33 -1.261 . . . . 0.0 111.019 170.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -116.46 161.77 18.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.789 1.794 . . . . 0.0 112.777 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.423 1.089 . . . . 0.0 108.74 -177.146 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.253 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -106.15 120.72 47.9 Favored Pre-proline 0 C--O 1.234 0.267 0 C-N-CA 126.105 1.762 . . . . 0.0 109.275 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -75.4 116.08 4.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.675 2.25 . . . . 0.0 112.031 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -90.41 -15.42 30.99 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.027 -0.421 . . . . 0.0 111.385 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.8 m -158.48 -177.31 6.45 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.088 1.355 . . . . 0.0 108.524 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -64.36 84.46 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.116 1.766 . . . . 0.0 109.941 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 p -85.82 155.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.822 1.249 . . . . 0.0 110.977 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.71 125.09 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.62 153.21 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.509 1.124 . . . . 0.0 108.642 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -101.39 129.09 47.34 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.787 170.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 p -88.51 176.89 6.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.083 1.311 . . . . 0.0 109.463 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 66.11 55.21 0.92 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 0.0 111.487 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -122.0 13.86 10.61 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -46.06 -62.76 1.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.794 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.99 28.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.306 0.642 . . . . 0.0 112.302 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -125.77 -12.35 6.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.819 1.248 . . . . 0.0 111.836 168.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.7 pt -91.21 -40.37 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 119.876 1.216 . . . . 0.0 111.924 172.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.964 -1.494 . . . . 0.0 110.173 178.096 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.4 155.21 37.83 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.75 0.82 . . . . 0.0 111.298 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -76.97 99.65 5.34 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.044 2.537 . . . . 0.0 108.038 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.89 118.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -85.94 129.95 34.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.126 0.266 . . . . 0.0 110.372 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.4 mt -108.92 102.88 11.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.0 mt -71.37 94.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 171.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -93.52 155.21 40.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.66 -32.61 76.25 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.745 2.963 . . . . 0.0 112.244 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.4 -33.91 45.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.679 2.392 . . . . 0.0 111.392 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.52 0.34 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 125.212 1.387 . . . . 0.0 110.489 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 71.47 145.27 0.07 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.868 2.467 . . . . 0.0 114.262 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.23 97.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -69.14 135.91 51.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.847 161.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -151.19 170.33 19.71 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.595 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 119.51 39.17 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.2 t -122.01 126.22 48.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.959 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.59 145.73 45.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.725 1.726 . . . . 0.0 110.936 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -56.74 -24.64 51.14 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 127.198 2.199 . . . . 0.0 112.119 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -103.78 10.06 36.75 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.456 1.502 . . . . 0.0 111.332 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 p -134.53 158.36 41.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.52 1.054 . . . . 0.0 110.943 -175.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -77.91 138.08 38.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 t -49.0 -48.93 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.612 0.244 . . . . 0.0 110.916 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -37.81 74.02 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.03 -64.07 0.93 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.718 0.77 . . . . 0.0 108.939 -167.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -57.17 -40.92 78.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.301 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.1 -59.54 3.81 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.753 -0.592 . . . . 0.0 111.454 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.69 -39.71 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.112 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -53.03 -40.95 64.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -75.22 -24.85 57.8 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 121.849 -0.532 . . . . 0.0 109.749 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.88 12.88 6.86 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.615 1.578 . . . . 0.0 111.057 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 89.1 mt -75.77 116.38 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.672 0.736 . . . . 0.0 110.785 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -80.38 63.93 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.382 0.61 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.22 166.0 26.16 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 125.478 1.513 . . . . 0.0 110.574 168.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -101.35 107.68 19.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.284 1.834 . . . . 0.0 110.087 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -59.56 109.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.19 -46.67 25.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -162.76 177.71 9.1 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.39 -161.96 23.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 m -156.71 144.83 19.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 168.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.1 pt -143.93 164.08 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.817 1.647 . . . . 0.0 106.741 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -108.96 109.9 21.07 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -104.75 25.08 10.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 0.0 111.928 170.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 CA--C 1.539 0.522 0 O-C-N 120.371 -1.456 . . . . 0.0 113.301 -177.868 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -83.94 169.06 15.43 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 124.424 1.078 . . . . 0.0 109.881 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.17 -44.86 71.85 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.64 -62.37 1.69 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.133 0.973 . . . . 0.0 109.482 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.39 -49.3 67.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.017 0.527 . . . . 0.0 111.359 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.18 -60.63 3.07 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.544 -0.722 . . . . 0.0 111.483 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.88 -42.19 68.39 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.248 1.019 . . . . 0.0 110.701 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.25 65.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.872 1.669 . . . . 0.0 112.32 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.83 30.64 1.93 Allowed Glycine 0 C--O 1.221 -0.715 0 CA-C-O 117.554 -1.692 . . . . 0.0 111.527 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.421 ' CG ' HG21 ' A' ' 95' ' ' ILE . 96.4 m-85 -118.12 161.44 19.85 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.52 2.16 . . . . 0.0 113.514 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.061 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 118.779 -0.629 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -112.19 123.01 35.25 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.222 1.809 . . . . 0.0 109.096 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -75.38 129.69 12.23 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.788 2.325 . . . . 0.0 111.595 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.3 p -104.05 -12.49 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.5 m -157.16 -174.93 5.14 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.13 127.77 33.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.1 t -135.91 153.76 32.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.674 0.79 . . . . 0.0 109.569 -173.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.63 121.15 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.27 152.83 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.418 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 21.6 mt-10 -101.13 131.2 47.18 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 124.347 1.059 . . . . 0.0 109.284 168.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -88.74 177.46 6.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.153 1.342 . . . . 0.0 109.434 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.1 54.46 0.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.915 1.286 . . . . 0.0 111.437 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.418 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 29.4 mmtt -125.32 22.37 7.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.74 0.816 . . . . 0.0 112.895 -174.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -45.75 -72.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 108.91 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.09 37.57 0.44 Allowed 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.935 -0.478 . . . . 0.0 111.812 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -122.06 -29.54 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.452 1.501 . . . . 0.0 110.647 163.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.421 HG21 ' CG ' ' A' ' 73' ' ' TYR . 26.1 pt -83.68 -45.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 119.347 0.976 . . . . 0.0 112.608 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.981 -1.485 . . . . 0.0 109.803 -175.662 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -131.63 155.61 47.26 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.97 0.908 . . . . 0.0 112.54 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.29 96.93 0.06 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.277 2.631 . . . . 0.0 109.651 169.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.38 118.59 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -85.82 130.24 34.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.471 0.176 . . . . 0.0 111.238 167.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.06 105.25 14.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 124.483 1.114 . . . . 0.0 108.603 169.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.5 mt -78.3 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -87.11 153.53 54.27 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.99 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.09 -35.05 89.56 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.951 3.101 . . . . 0.0 112.397 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.27 -38.8 13.13 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 127.485 2.314 . . . . 0.0 111.14 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.69 62.12 0.19 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 125.283 1.421 . . . . 0.0 110.197 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 67.43 162.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.111 2.164 . . . . 0.0 111.921 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.49 -59.85 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 123.438 0.695 . . . . 0.0 110.15 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.26 137.45 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 126.354 1.862 . . . . 0.0 112.464 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.64 174.65 11.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.725 0.41 . . . . 0.0 111.722 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 122.77 42.45 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.6 126.58 50.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.21 133.64 49.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.35 -30.87 30.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.315 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.1 -14.1 62.51 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.949 1.3 . . . . 0.0 112.136 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.52 160.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.34 147.05 42.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.032 -0.417 . . . . 0.0 111.86 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.2 62.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 122.174 0.987 . . . . 0.0 110.335 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.21 -60.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -49.59 -58.25 5.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.757 1.265 . . . . 0.0 109.823 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -74.93 -20.13 59.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.925 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.05 54.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.25 -40.86 68.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.213 0.605 . . . . 0.0 109.976 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.56 -39.61 64.9 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.42 -24.74 46.03 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.704 -0.622 . . . . 0.0 109.763 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.11 10.1 6.97 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.87 1.7 . . . . 0.0 111.37 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.4 mt -78.02 129.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.119 0.96 . . . . 0.0 111.012 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -87.2 125.41 34.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 164.509 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 122.803 1.287 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.01 158.31 27.6 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.001 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -95.43 109.81 21.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.074 1.35 . . . . 0.0 109.584 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 40.7 t -61.14 107.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.436 1.094 . . . . 0.0 108.225 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.29 -37.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -157.7 -163.21 1.3 Allowed 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.53 -171.28 51.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.033 0.349 . . . . 0.0 113.168 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.92 129.94 12.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 pt -139.1 152.28 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -100.72 112.97 25.47 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -105.68 41.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.249 0.62 . . . . 0.0 110.765 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 119.413 1.006 . . . . 0.0 111.495 176.225 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.231 0.111 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.19 165.58 14.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.618 0.723 . . . . 0.0 110.233 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.16 -41.35 71.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.818 1.247 . . . . 0.0 108.683 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.54 -60.63 2.93 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.129 0.972 . . . . 0.0 109.465 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -54.41 -48.26 71.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.462 0.705 . . . . 0.0 111.39 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.0 mtt -53.98 -60.18 3.67 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.521 -0.737 . . . . 0.0 111.106 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.67 -44.72 69.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.747 1.219 . . . . 0.0 110.558 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.18 64.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.741 1.617 . . . . 0.0 112.254 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.88 32.59 1.4 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.415 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.42 ' CG ' HG21 ' A' ' 95' ' ' ILE . 95.0 m-85 -120.24 159.38 25.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.343 2.072 . . . . 0.0 113.184 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.4 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.552 1.141 . . . . 0.0 108.73 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.66 118.44 45.08 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.006 1.723 . . . . 0.0 109.281 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -75.85 108.79 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.339 2.693 . . . . 0.0 112.707 -174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -88.43 -12.98 41.59 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.865 -0.522 . . . . 0.0 111.366 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.8 m -152.62 -177.27 6.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.167 1.387 . . . . 0.0 108.103 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.16 124.21 20.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 166.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.5 t -133.62 156.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.558 0.694 . . . . 0.0 111.282 -173.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.7 t -123.3 118.77 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.39 152.24 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.165 0.986 . . . . 0.0 108.939 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.53 127.55 46.86 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.077 0.951 . . . . 0.0 108.833 170.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -83.33 179.49 7.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.042 1.292 . . . . 0.0 110.139 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 69.73 55.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.153 1.381 . . . . 0.0 111.122 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.54 13.59 9.43 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -34.88 -76.29 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.855 2.062 . . . . 0.0 110.767 166.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.77 40.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.002 0.819 . . . . 0.0 112.426 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.37 -28.78 4.94 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.311 1.044 . . . . 0.0 111.047 158.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.42 HG21 ' CG ' ' A' ' 73' ' ' TYR . 34.8 pt -81.42 -48.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.296 0.953 . . . . 0.0 112.896 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.044 -173.306 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.7 m 58.78 78.25 0.26 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.536 0.735 . . . . 0.0 112.203 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -97.36 159.59 14.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -171.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.95 90.15 6.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.305 1.842 . . . . 0.0 109.614 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.0 t -89.47 124.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -89.76 132.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.147 0.43 . . . . 0.0 110.836 165.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.4 mt -111.68 103.57 11.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 165.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.5 mt -71.62 95.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -92.79 156.75 40.53 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 124.145 0.978 . . . . 0.0 108.925 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.56 -35.3 76.38 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.2 3.267 . . . . 0.0 112.227 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.3 -30.97 52.8 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 127.376 2.27 . . . . 0.0 111.494 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.53 61.01 0.41 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 125.005 1.288 . . . . 0.0 110.73 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 71.95 142.72 0.06 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 127.768 2.427 . . . . 0.0 114.187 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.93 87.29 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.495 1.118 . . . . 0.0 108.148 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -66.71 132.18 47.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 109.746 167.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -153.38 166.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.133 0.573 . . . . 0.0 111.839 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.23 122.99 39.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.432 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -127.08 123.03 35.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.505 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 143.03 54.9 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.799 1.24 . . . . 0.0 110.099 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -24.99 47.73 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 127.333 2.253 . . . . 0.0 111.182 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -107.88 21.29 17.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.589 1.555 . . . . 0.0 111.462 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -134.55 158.31 41.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.757 1.162 . . . . 0.0 110.633 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -78.68 144.89 34.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.343 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.02 61.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.871 0.868 . . . . 0.0 111.098 173.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 tp -169.11 -61.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.06 -55.95 12.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.057 0.943 . . . . 0.0 109.253 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -77.05 -13.76 59.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.876 0.87 . . . . 0.0 112.831 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.57 -50.46 15.51 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 120.945 -1.097 . . . . 0.0 108.603 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -53.38 -38.98 63.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.199 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.61 -38.8 56.26 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.59 -23.89 34.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.764 -0.585 . . . . 0.0 109.608 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.24 15.23 4.25 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.072 1.796 . . . . 0.0 111.473 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 82.2 mt -80.59 108.41 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.038 0.919 . . . . 0.0 112.445 -170.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.98 72.91 6.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.175 0.99 . . . . 0.0 110.398 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.53 156.25 91.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 120.921 -1.112 . . . . 0.0 109.651 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.43 71.06 6.03 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 124.034 3.156 . . . . 0.0 109.436 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.84 150.9 19.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.736 2.014 . . . . 0.0 108.926 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.7 m -128.37 -22.51 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.624 0.77 . . . . 0.0 112.765 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 170.36 10.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 126.237 1.815 . . . . 0.0 107.688 -171.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -135.12 83.86 2.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.623 0.647 . . . . 0.0 109.404 164.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.51 -47.5 0.89 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.647 1.579 . . . . 0.0 111.561 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.99 46.32 2.08 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.157 0.884 . . . . 0.0 111.934 172.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -154.14 69.21 0.77 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.8 m -131.27 -176.61 4.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.617 1.167 . . . . 0.0 109.986 -162.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.5 m -144.73 50.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -158.27 -152.56 0.34 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.438 1.495 . . . . 0.0 107.258 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.4 p 45.1 71.23 0.28 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.391 1.476 . . . . 0.0 114.504 165.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.09 25.68 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 120.49 -1.381 . . . . 0.0 112.387 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.56 164.46 27.01 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 125.942 1.734 . . . . 0.0 110.165 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -98.66 110.25 22.88 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.671 1.588 . . . . 0.0 110.502 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.49 115.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.63 -48.03 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.221 0.609 . . . . 0.0 109.505 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -160.87 173.99 14.51 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.067 -0.396 . . . . 0.0 110.223 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.49 -176.59 47.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.443 1.021 . . . . 0.0 110.742 -168.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -135.15 149.44 49.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 36.4 pt -147.47 165.29 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.124 1.77 . . . . 0.0 107.54 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.12 113.54 21.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 108.748 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -110.86 31.77 5.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.023 170.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 p -74.49 64.8 1.2 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.101 1.773 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -154.48 -42.37 0.09 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.714 1.205 . . . . 0.0 110.849 -165.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.55 178.58 1.98 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.193 0.997 . . . . 0.0 112.829 176.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 t -144.99 82.77 1.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 164.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -156.45 -73.16 0.1 Allowed 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.263 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.42 138.45 51.23 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.195 0.907 . . . . 0.0 111.456 -167.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.14 166.43 18.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 124.043 0.839 . . . . 0.0 109.85 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -53.56 -43.99 68.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.0 -61.52 2.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.126 0.97 . . . . 0.0 109.608 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -54.95 -50.08 69.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.269 0.627 . . . . 0.0 111.376 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mtt -51.95 -59.36 4.43 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.489 -0.757 . . . . 0.0 111.314 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.03 -42.28 76.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.45 1.1 . . . . 0.0 110.832 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.42 -20.72 65.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.683 1.593 . . . . 0.0 111.753 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.57 33.8 1.06 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 117.786 -1.564 . . . . 0.0 111.413 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.97 162.67 18.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.348 2.074 . . . . 0.0 113.297 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.0 p -152.52 147.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.061 1.344 . . . . 0.0 108.469 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.48 154.57 35.47 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -116.03 19.25 15.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.4 m -111.38 -48.36 3.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.122 1.369 . . . . 0.0 109.931 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -117.69 89.88 3.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.014 1.725 . . . . 0.0 108.515 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -152.05 131.87 13.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.88 122.96 38.42 Favored Pre-proline 0 C--O 1.235 0.318 0 C-N-CA 125.537 1.535 . . . . 0.0 108.945 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -76.33 113.95 3.79 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.221 2.614 . . . . 0.0 111.284 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 p -89.52 -12.55 39.67 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.375 -0.828 . . . . 0.0 111.749 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.1 m -157.79 -177.88 6.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.634 1.574 . . . . 0.0 107.687 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.5 113.17 1.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 162.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.57 145.77 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.447 1.499 . . . . 0.0 108.595 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.71 125.63 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.03 155.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -102.87 128.42 49.66 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.28 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.0 p -86.4 178.73 7.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.045 1.293 . . . . 0.0 109.093 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.28 51.37 0.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.596 1.158 . . . . 0.0 111.178 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -127.62 37.62 4.18 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.584 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -70.08 0.25 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 165.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -72.92 33.16 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.737 -1.227 . . . . 0.0 113.803 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -121.97 -3.9 9.1 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.707 -1.245 . . . . 0.0 111.751 159.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.7 pt -111.75 -39.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.344 1.429 . . . . 0.0 111.694 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.253 1.275 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.436 175.712 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.497 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m 78.8 89.57 0.06 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.7 0.8 . . . . 0.0 112.088 157.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -104.81 156.02 18.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.278 0.561 . . . . 0.0 112.307 -167.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.34 104.39 2.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 127.835 2.454 . . . . 0.0 108.462 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.91 117.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -88.8 131.61 35.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.716 0.235 . . . . 0.0 111.283 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.5 mt -109.19 103.69 12.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.419 1.075 . . . . 0.0 109.105 167.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 53.9 mt -76.44 99.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -89.77 166.69 19.69 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 124.313 1.045 . . . . 0.0 109.48 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.18 -25.85 30.87 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.086 2.524 . . . . 0.0 111.182 166.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -46.11 78.7 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.169 0.988 . . . . 0.0 109.662 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.83 64.94 0.08 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 67.55 147.35 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.522 1.929 . . . . 0.0 113.643 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 p -154.43 105.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.398 165.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.99 142.35 41.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -152.41 169.24 23.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.182 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 123.5 44.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.4 124.72 50.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.734 0.646 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.03 151.55 45.7 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.524 1.63 . . . . 0.0 109.008 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -76.99 -14.56 59.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 129.333 3.053 . . . . 0.0 110.566 -177.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -114.4 20.04 15.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.533 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.58 148.91 29.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.087 0.858 . . . . 0.0 109.227 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -67.76 146.07 54.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.069 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.2 t -51.09 -51.53 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -57.32 12.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.305 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.94 -63.08 1.06 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.21 0.914 . . . . 0.0 110.611 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -69.69 -34.67 74.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.18 -57.4 8.87 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.676 -0.64 . . . . 0.0 110.911 170.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -55.39 -41.7 73.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.01 -38.59 65.28 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.22 -25.89 58.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.275 0.56 . . . . 0.0 109.794 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.63 13.65 6.09 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.385 1.469 . . . . 0.0 110.946 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 93.7 mt -75.63 121.6 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 117.624 0.712 . . . . 0.0 110.496 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.04 80.74 8.74 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 155.33 86.59 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -64.81 133.69 37.36 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -169.19 156.8 7.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -168.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -168.75 -51.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.05 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 p -94.11 -150.17 0.29 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.241 2.216 . . . . 0.0 110.557 -172.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 168.52 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.506 2.322 . . . . 0.0 108.683 172.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 103.55 -42.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.472 2.709 . . . . 0.0 110.398 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.68 -21.88 7.89 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.131 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.66 59.13 0.74 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.774 1.629 . . . . 0.0 107.776 168.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.8 p -119.57 -137.83 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.327 1.051 . . . . 0.0 109.505 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -72.01 -93.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.234 1.379 . . . . 0.0 111.603 -172.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -57.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.377 0.535 . . . . 0.0 111.662 174.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . 0.47 0.0 OUTLIER 26.23 43.91 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 129.63 3.172 . . . . 0.0 117.481 172.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.45 177.89 8.51 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.47 -1.394 . . . . 0.0 113.069 -174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.04 165.78 25.58 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.151 1.834 . . . . 0.0 110.335 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -102.95 111.1 23.27 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.006 1.722 . . . . 0.0 110.977 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.27 117.38 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.938 0.79 . . . . 0.0 109.341 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.7 -47.68 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.294 1.038 . . . . 0.0 109.013 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -161.12 175.35 12.49 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 122.075 -0.391 . . . . 0.0 110.417 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.22 -160.83 52.72 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.559 1.076 . . . . 0.0 110.762 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 t -151.48 169.86 21.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.6 pt -161.46 160.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 127.234 2.214 . . . . 0.0 107.593 -167.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -114.82 110.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -106.58 37.16 2.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 111.264 170.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -44.21 -40.32 5.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.951 0.796 . . . . 0.0 111.113 171.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -2.83 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.693 1.997 . . . . 0.0 113.427 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -69.19 162.78 26.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.433 1.015 . . . . 0.0 111.11 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -153.0 53.3 0.76 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 160.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.69 -65.97 0.18 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 117.72 -1.133 . . . . 0.0 111.897 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.11 141.31 54.46 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.993 1.27 . . . . 0.0 111.349 -166.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.23 166.38 15.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 124.065 0.853 . . . . 0.0 109.893 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.95 -43.88 70.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.25 -61.97 1.91 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.234 1.014 . . . . 0.0 109.563 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -54.38 -50.95 66.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.979 0.511 . . . . 0.0 111.466 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mtm -53.98 -58.06 8.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.455 -0.778 . . . . 0.0 111.51 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.85 -44.33 70.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.714 1.206 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.64 67.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.811 1.645 . . . . 0.0 111.945 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.93 32.86 0.96 Allowed Glycine 0 C--O 1.223 -0.569 0 CA-C-O 117.601 -1.666 . . . . 0.0 111.774 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.438 ' CG ' HG21 ' A' ' 95' ' ' ILE . 95.8 m-85 -121.02 163.66 17.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.557 2.179 . . . . 0.0 113.635 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 13.2 p -157.25 143.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 123.759 0.824 . . . . 0.0 108.906 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.58 -46.09 57.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.001 0.92 . . . . 0.0 111.652 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m 74.39 -56.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.339 1.055 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -60.71 -23.99 65.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.164 0.986 . . . . 0.0 112.437 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 82.56 1.96 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 107.381 172.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.95 142.81 20.0 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.877 0.871 . . . . 0.0 110.436 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -106.66 131.46 21.68 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 126.558 1.943 . . . . 0.0 109.357 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -78.27 121.37 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.799 2.333 . . . . 0.0 111.725 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -97.29 -12.88 22.37 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.713 -0.617 . . . . 0.0 112.333 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -157.11 -175.23 5.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.563 1.545 . . . . 0.0 106.835 170.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -55.2 140.11 39.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 164.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 p -156.33 146.23 11.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.754 0.788 . . . . 0.0 110.311 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.84 126.8 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.14 147.93 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.878 0.871 . . . . 0.0 109.103 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -104.22 116.74 32.72 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.283 1.033 . . . . 0.0 110.813 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.1 p -79.11 176.25 9.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.244 0.929 . . . . 0.0 109.742 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 67.62 52.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.602 1.161 . . . . 0.0 111.082 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -123.6 43.98 2.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.683 0.793 . . . . 0.0 110.841 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.3 -71.6 0.2 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.82 50.64 1.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.696 -0.627 . . . . 0.0 111.846 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.73 -28.05 1.64 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.594 2.358 . . . . 0.0 111.618 165.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.438 HG21 ' CG ' ' A' ' 73' ' ' TYR . 26.0 pt -91.85 -42.19 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 119.184 0.902 . . . . 0.0 112.552 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 117.351 -1.309 . . . . 0.0 109.254 -177.396 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m 80.8 123.38 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.771 2.029 . . . . 0.0 111.321 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -128.81 156.1 44.13 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.195 0.598 . . . . 0.0 111.222 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.09 102.11 2.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.842 2.457 . . . . 0.0 108.469 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.64 120.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -90.53 131.94 35.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 123.165 0.291 . . . . 0.0 111.004 166.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.21 103.26 12.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 108.285 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mt -74.2 90.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -88.45 154.38 51.15 Favored Pre-proline 0 N--CA 1.444 -0.741 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -57.3 -31.95 92.36 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.87 3.046 . . . . 0.0 112.12 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.84 -33.76 37.49 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.916 2.086 . . . . 0.0 111.087 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.46 61.53 0.27 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 124.898 1.237 . . . . 0.0 110.145 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 68.57 153.79 0.1 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.152 2.181 . . . . 0.0 114.043 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.04 98.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.825 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.36 145.48 45.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.341 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -157.24 172.79 18.0 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.47 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.09 122.61 44.46 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t -122.94 127.86 49.47 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -69.32 141.88 54.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.738 1.256 . . . . 0.0 109.951 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -58.69 -21.75 55.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 129.886 3.274 . . . . 0.0 111.52 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -107.6 12.85 27.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.809 1.644 . . . . 0.0 110.606 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.44 157.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.261 0.937 . . . . 0.0 110.61 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -76.12 149.07 37.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.219 0.608 . . . . 0.0 110.806 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.54 66.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.84 0.829 . . . . 0.0 111.226 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -163.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.583 1.553 . . . . 0.0 108.723 168.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.92 -57.76 11.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -63.08 -35.06 78.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.645 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.43 -56.73 17.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.637 -0.665 . . . . 0.0 109.713 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.86 -39.75 74.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 109.767 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -52.15 -42.15 63.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.869 0.759 . . . . 0.0 112.765 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.07 -23.26 55.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.048 0.451 . . . . 0.0 109.974 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.26 12.88 7.27 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.91 1.719 . . . . 0.0 111.369 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 64.2 mt -80.42 129.66 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.542 0.671 . . . . 0.0 111.1 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -93.32 127.6 38.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.132 0.973 . . . . 0.0 108.436 164.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.73 153.26 67.66 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.31 91.25 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.204 2.603 . . . . 0.0 110.663 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -86.36 -48.88 8.08 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 123.553 0.741 . . . . 0.0 111.346 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t 56.56 -161.85 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.295 0.638 . . . . 0.0 112.332 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m 34.55 -136.03 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.031 2.932 . . . . 0.0 113.278 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 179.08 137.89 0.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.801 2.44 . . . . 0.0 107.966 156.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 70.9 83.32 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.682 1.193 . . . . 0.0 114.167 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -7.95 81.39 0.0 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 128.649 3.023 . . . . 0.0 116.119 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 t -171.14 42.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.158 1.783 . . . . 0.0 107.36 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 p -161.87 168.52 22.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.275 1.43 . . . . 0.0 107.884 -159.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -140.9 90.88 2.36 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.175 0.59 . . . . 0.0 111.399 -167.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 t -169.71 -157.03 0.15 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.272 2.229 . . . . 0.0 105.688 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . 0.292 0.7 OUTLIER 32.53 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 162.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.63 16.15 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.652 -1.28 . . . . 0.0 110.999 -173.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.54 166.09 26.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.004 1.764 . . . . 0.0 110.99 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -102.73 110.2 22.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.761 2.024 . . . . 0.0 110.873 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.04 114.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 119.14 0.882 . . . . 0.0 109.062 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.98 -44.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.3 t -161.54 177.64 9.85 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.99 -168.77 43.93 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -142.71 151.2 41.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.7 pt -142.35 157.2 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -99.74 107.63 19.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.3 39.88 1.64 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.676 0.79 . . . . 0.0 111.442 170.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.2 m -48.71 -38.87 22.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.492 1.042 . . . . 0.0 111.589 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -76.67 50.91 0.72 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.586 1.154 . . . . 0.0 110.321 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -99.79 -65.64 0.95 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.17 1.388 . . . . 0.0 111.546 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 m 43.89 44.82 6.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.622 0.769 . . . . 0.0 111.515 -168.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -154.88 -72.42 0.12 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.159 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.49 143.85 52.6 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.126 0.876 . . . . 0.0 110.642 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.9 164.83 15.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.729 0.643 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.59 -43.19 68.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.163 0.985 . . . . 0.0 108.543 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -52.3 -61.63 2.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.089 0.956 . . . . 0.0 109.421 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -52.52 -52.28 55.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 111.332 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.7 mtt -52.33 -59.88 3.88 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 111.317 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.76 -44.0 73.26 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.954 1.302 . . . . 0.0 110.677 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.18 -20.84 64.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.744 1.618 . . . . 0.0 111.769 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.69 32.94 1.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-O 117.972 -1.46 . . . . 0.0 111.149 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.401 ' CG ' HG21 ' A' ' 95' ' ' ILE . 93.6 m-85 -118.35 165.88 13.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.963 1.882 . . . . 0.0 113.049 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.69 149.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 tp -57.57 -52.47 65.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.969 0.908 . . . . 0.0 110.26 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m 73.37 -55.14 0.68 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.565 1.146 . . . . 0.0 110.129 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -31.38 -63.49 0.17 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.574 2.349 . . . . 0.0 111.777 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.35 60.43 0.94 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.122 1.769 . . . . 0.0 108.25 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.22 138.49 47.61 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 121.725 -0.609 . . . . 0.0 109.89 172.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.4 125.44 37.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.215 1.406 . . . . 0.0 109.416 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -74.25 114.99 4.17 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.858 2.372 . . . . 0.0 110.811 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.4 p -94.71 -9.8 33.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.144 0.884 . . . . 0.0 112.129 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -156.9 -177.7 6.81 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 107.491 169.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -55.58 139.25 44.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 163.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.5 p -157.56 146.43 10.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.483 -165.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.87 124.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.11 152.21 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.885 0.874 . . . . 0.0 108.86 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 17.0 mt-10 -103.99 117.23 33.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.138 0.975 . . . . 0.0 109.854 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 p -80.32 174.63 11.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.381 -0.824 . . . . 0.0 111.301 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.96 55.63 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.654 1.582 . . . . 0.0 111.281 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 20.6 mmtt -126.33 25.81 6.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.429 0.692 . . . . 0.0 112.668 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.13 -70.56 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.19 0.996 . . . . 0.0 108.725 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -79.77 39.12 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.557 -0.714 . . . . 0.0 112.373 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.92 -43.5 3.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.632 1.173 . . . . 0.0 109.275 161.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.401 HG21 ' CG ' ' A' ' 73' ' ' TYR . 21.3 pt -75.89 -41.48 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.314 -1.327 . . . . 0.0 109.559 -177.741 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.473 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m 76.11 85.04 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.216 0.607 . . . . 0.0 112.384 164.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -102.81 156.96 17.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.129 0.572 . . . . 0.0 112.394 -167.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -83.07 89.59 6.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.145 1.778 . . . . 0.0 109.8 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -87.31 127.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.69 131.32 43.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.139 0.427 . . . . 0.0 111.772 166.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 37.6 mt -108.8 105.14 14.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.34 1.025 . . . . 0.0 108.396 166.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.19 94.0 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -93.16 155.24 41.31 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.083 0.953 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -56.5 -32.42 89.48 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.938 3.092 . . . . 0.0 112.147 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.91 48.95 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 126.541 1.936 . . . . 0.0 111.215 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.49 60.08 0.35 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 124.861 1.219 . . . . 0.0 110.935 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 67.89 141.68 0.04 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.263 2.225 . . . . 0.0 114.127 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.64 98.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.059 1.343 . . . . 0.0 107.864 169.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -82.18 133.31 35.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.696 1.599 . . . . 0.0 109.687 171.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.73 172.46 18.56 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 124.4 46.81 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 122.809 0.443 . . . . 0.0 110.224 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.6 t -125.43 128.21 47.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.98 140.06 50.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 123.832 1.777 . . . . 0.0 110.38 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER -55.41 -24.16 28.71 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 129.203 3.001 . . . . 0.0 111.335 173.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.36 7.24 38.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.574 1.549 . . . . 0.0 112.036 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.0 157.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-N 119.796 1.18 . . . . 0.0 110.302 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.53 147.35 41.89 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 122.013 -0.429 . . . . 0.0 110.804 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -53.96 -57.03 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.659 0.383 . . . . 0.0 110.137 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.54 -51.03 61.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.331 0.652 . . . . 0.0 111.089 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.28 -65.59 0.54 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.611 0.764 . . . . 0.0 110.64 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.57 -42.46 78.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.616 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.58 -59.92 3.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.965 -0.46 . . . . 0.0 111.176 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -58.87 -36.4 74.57 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.897 -0.573 . . . . 0.0 110.212 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -54.42 -38.31 66.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.959 0.799 . . . . 0.0 112.695 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.11 -26.53 53.39 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.807 -0.558 . . . . 0.0 109.991 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 12.64 8.36 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.747 1.641 . . . . 0.0 111.133 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.5 mt -74.34 125.53 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.602 0.701 . . . . 0.0 111.02 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.47 119.7 30.96 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.44 1.096 . . . . 0.0 109.041 167.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.2 pt -137.67 156.07 74.83 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.89 125.54 13.85 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.872 1.715 . . . . 0.0 109.921 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -148.94 64.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.233 1.492 . . . . 0.0 108.934 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -58.96 -23.75 61.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.657 -1.277 . . . . 0.0 112.664 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.94 168.03 11.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.658 1.983 . . . . 0.0 108.688 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.63 67.35 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.99 -63.19 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.839 1.655 . . . . 0.0 108.798 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.1 55.48 0.05 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.728 0.68 . . . . 0.0 111.505 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.8 m -167.61 85.98 0.23 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.877 0.871 . . . . 0.0 109.227 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.3 p -148.04 -168.65 3.13 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.19 0.996 . . . . 0.0 108.637 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.9 p -151.93 62.95 0.85 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -163.33 -177.39 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 128.67 2.788 . . . . 0.0 104.719 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 74.89 176.86 0.22 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.676 1.591 . . . . 0.0 112.122 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 140.21 167.4 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.809 2.843 . . . . 0.0 112.985 168.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.98 161.59 27.54 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.65 1.595 . . . . 0.0 111.096 167.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -96.48 111.17 23.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.506 1.923 . . . . 0.0 110.728 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.419 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 19.8 t -61.06 111.01 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.211 1.405 . . . . 0.0 108.675 175.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -83.81 -47.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.015 0.926 . . . . 0.0 108.979 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -161.36 172.67 16.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.54 -162.38 50.24 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.374 0.988 . . . . 0.0 110.667 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -155.88 155.58 33.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.679 -0.895 . . . . 0.0 109.193 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.7 pt -135.3 165.95 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.99 1.716 . . . . 0.0 107.416 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.83 111.32 23.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.56 31.45 5.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.77 -0.633 . . . . 0.0 111.752 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -76.21 57.99 1.2 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.016 1.28 . . . . 0.0 112.175 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -141.29 -40.25 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.789 1.636 . . . . 0.0 111.318 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.48 -177.51 3.14 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.106 -0.996 . . . . 0.0 112.625 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -146.6 75.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -154.28 -76.57 0.11 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.85 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.6 137.3 53.99 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.303 0.956 . . . . 0.0 111.022 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.66 164.35 17.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 124.092 0.87 . . . . 0.0 109.983 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.17 -44.11 64.48 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.613 1.165 . . . . 0.0 108.482 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.32 -62.43 1.63 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.538 1.135 . . . . 0.0 109.671 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -53.97 -50.18 67.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.283 0.633 . . . . 0.0 111.294 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 29.8 mtt -52.78 -59.98 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.933 -0.479 . . . . 0.0 111.343 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.63 -43.29 72.15 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.855 1.262 . . . . 0.0 110.618 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.63 -21.26 65.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.629 1.572 . . . . 0.0 111.948 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 33.66 1.32 Allowed Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.028 -1.429 . . . . 0.0 110.832 173.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.43 ' CG ' HG21 ' A' ' 95' ' ' ILE . 94.1 m-85 -118.75 166.43 12.79 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.965 1.882 . . . . 0.0 112.806 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -162.57 158.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.418 HD13 ' S1 ' ' A' ' 97' ' ' FES . 2.1 pt? -70.24 -52.95 19.25 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.86 1.209 . . . . 0.0 111.962 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 m 60.6 56.61 3.0 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.563 1.173 . . . . 0.0 110.484 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 67.4 m -134.56 -93.37 0.3 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 172.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.5 49.85 1.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.632 1.573 . . . . 0.0 110.456 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.36 146.62 42.33 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -109.28 122.77 38.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 C-N-CA 124.522 1.129 . . . . 0.0 109.553 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -71.24 119.6 6.4 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.543 2.162 . . . . 0.0 111.102 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.9 p -93.7 -13.97 26.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.006 -0.434 . . . . 0.0 111.864 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.0 m -158.66 -177.69 6.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.803 1.641 . . . . 0.0 107.217 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.77 95.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.581 1.552 . . . . 0.0 109.337 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.2 p -99.24 148.75 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 110.236 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.38 125.97 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.77 144.39 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.756 0.822 . . . . 0.0 109.32 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -100.93 113.39 26.32 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.99 0.814 . . . . 0.0 110.538 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.2 p -79.46 175.69 10.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.979 0.809 . . . . 0.0 110.988 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.29 53.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.318 1.447 . . . . 0.0 111.326 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -124.73 24.67 7.68 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.528 0.731 . . . . 0.0 112.837 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -50.46 -70.17 0.09 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.197 0.999 . . . . 0.0 109.252 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.07 42.37 0.4 Allowed 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.854 -0.529 . . . . 0.0 112.037 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -130.33 -27.46 2.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.343 1.457 . . . . 0.0 111.29 163.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.43 HG21 ' CG ' ' A' ' 73' ' ' TYR . 25.0 pt -82.52 -42.89 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 119.468 1.031 . . . . 0.0 113.197 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.567 -1.206 . . . . 0.0 109.933 -176.057 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' FES . . . . . 0.418 ' S1 ' HD13 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m 52.97 75.16 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.301 1.04 . . . . 0.0 113.686 167.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.02 157.74 15.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.305 0.642 . . . . 0.0 112.455 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -81.63 88.65 6.22 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.702 1.601 . . . . 0.0 109.737 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -86.85 123.55 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -95.03 131.82 40.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 117.714 0.234 . . . . 0.0 111.499 170.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.99 105.0 13.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 108.493 169.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 mt -75.55 87.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -83.52 154.77 65.88 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.423 1.089 . . . . 0.0 108.881 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.1 -27.33 78.91 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.716 2.944 . . . . 0.0 112.31 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.64 -31.55 57.56 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 125.666 1.586 . . . . 0.0 110.899 171.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.51 61.89 0.3 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 125.144 1.354 . . . . 0.0 110.571 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 65.82 163.15 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.692 1.997 . . . . 0.0 112.687 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.1 m -132.21 -67.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 75.9 128.58 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.438 1.895 . . . . 0.0 111.594 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -162.43 172.5 15.45 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.246 -0.284 . . . . 0.0 111.389 -170.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 127.47 45.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.7 t -124.75 124.99 43.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.277 0.631 . . . . 0.0 111.332 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -64.33 147.9 51.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.271 1.034 . . . . 0.0 110.588 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -65.35 -14.71 61.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.295 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -107.37 4.05 25.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.851 1.66 . . . . 0.0 111.652 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.59 156.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 119.27 0.941 . . . . 0.0 108.859 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.85 153.74 36.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.46 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -52.68 -53.87 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.361 172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -43.02 89.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.033 -176.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -51.04 -66.54 0.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.57 1.176 . . . . 0.0 107.943 -176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -70.26 -34.11 72.42 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.941 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -59.3 4.65 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.98 -0.45 . . . . 0.0 111.961 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.7 -38.62 75.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.84 -39.34 68.49 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.75 -26.03 59.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.57 13.32 7.47 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.427 1.489 . . . . 0.0 110.936 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 76.4 mt -76.61 128.81 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 117.757 0.779 . . . . 0.0 110.173 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -90.83 119.48 31.07 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.996 1.318 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.5 pt -138.4 159.82 66.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 124.577 1.151 . . . . 0.0 107.946 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -70.56 107.17 1.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.1 1.867 . . . . 0.0 109.104 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -133.66 95.05 3.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 t -80.85 -163.3 0.57 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 162.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . 0.253 10.2 p 32.22 -142.38 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.706 2.002 . . . . 0.0 113.517 -172.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 177.27 42.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.059 2.543 . . . . 0.0 108.749 157.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.12 93.46 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -168.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -35.98 94.02 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.353 1.93 . . . . 0.0 113.008 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 t -173.28 -40.83 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.995 0.918 . . . . 0.0 110.11 -170.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -131.91 69.48 1.48 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.729 0.812 . . . . 0.0 110.462 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.5 p -153.81 -178.63 7.18 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 71.46 146.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.621 2.368 . . . . 0.0 112.354 -170.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.4 166.54 0.23 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.446 1.098 . . . . 0.0 111.426 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.91 170.98 24.68 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 126.041 1.781 . . . . 0.0 110.539 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -102.13 111.21 23.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 110.347 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.51 111.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 108.888 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -83.69 -47.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -161.94 175.79 11.47 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.076 -0.39 . . . . 0.0 110.707 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.97 -160.19 53.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 m -155.16 156.2 35.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.0 pt -140.21 166.21 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 107.85 175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -104.29 109.16 20.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -113.43 58.7 0.66 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.997 0.919 . . . . 0.0 108.684 164.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -94.5 49.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.605 -0.684 . . . . 0.0 110.283 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.88 -55.27 1.3 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.833 0.853 . . . . 0.0 109.924 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -65.29 163.58 15.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -126.27 28.69 5.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 159.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.45 -73.31 0.31 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.326 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.58 143.25 54.26 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.027 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -93.23 167.46 11.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.614 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.15 -43.22 74.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.633 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.9 -61.28 2.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 123.99 0.916 . . . . 0.0 109.423 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.45 -51.29 67.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.614 0.766 . . . . 0.0 111.011 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 63.1 mtt -50.54 -61.25 2.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.903 -0.498 . . . . 0.0 111.421 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.76 -44.24 73.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.709 1.204 . . . . 0.0 110.649 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.28 -22.84 65.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.872 1.669 . . . . 0.0 112.033 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.31 29.02 1.53 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-O 117.778 -1.568 . . . . 0.0 111.998 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -117.5 165.04 14.01 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 120.156 1.978 . . . . 0.0 112.85 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.4 p -158.82 146.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.09 0.956 . . . . 0.0 109.435 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.88 145.2 29.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.347 0.522 . . . . 0.0 109.777 173.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 p -114.43 35.14 4.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.74 1.216 . . . . 0.0 111.304 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.79 -99.07 0.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -92.05 90.91 7.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.455 1.502 . . . . 0.0 109.139 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.3 137.88 30.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.09 125.72 30.47 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 125.145 1.378 . . . . 0.0 110.041 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -73.13 117.77 5.25 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.627 2.218 . . . . 0.0 111.323 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -89.56 -19.03 25.48 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.744 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 m -154.37 -176.21 5.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.474 1.91 . . . . 0.0 107.403 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.09 113.25 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 163.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 p -120.33 143.36 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.611 1.564 . . . . 0.0 109.134 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.82 155.31 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 124.641 1.176 . . . . 0.0 108.087 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.01 114.64 28.9 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.431 1.093 . . . . 0.0 109.268 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -75.18 176.94 6.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.211 0.914 . . . . 0.0 110.839 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 m80 68.95 53.4 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.96 1.304 . . . . 0.0 110.682 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -126.64 28.24 5.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 111.727 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.87 -64.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.73 14.14 0.53 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 -18.37 14.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.789 1.236 . . . . 0.0 109.782 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 28.7 pt -100.34 -40.49 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.419 0.554 . . . . 0.0 111.308 -174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.072 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 m 76.99 117.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 111.837 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -134.84 160.05 39.44 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.412 0.685 . . . . 0.0 111.169 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -87.88 87.21 7.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.842 1.657 . . . . 0.0 109.645 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -83.93 123.04 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -93.37 134.38 35.66 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 168.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.8 mt -113.61 105.89 13.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.884 1.274 . . . . 0.0 107.757 169.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.19 93.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -90.18 155.41 46.93 Favored Pre-proline 0 N--CA 1.443 -0.787 0 C-N-CA 125.215 1.406 . . . . 0.0 108.347 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.27 -30.22 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.687 2.925 . . . . 0.0 112.476 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.98 -32.02 61.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.439 1.896 . . . . 0.0 111.063 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.98 61.66 0.29 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.969 1.271 . . . . 0.0 110.782 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 66.42 162.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.015 2.126 . . . . 0.0 112.368 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.84 -63.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.184 0.593 . . . . 0.0 111.143 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 76.28 132.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.177 1.791 . . . . 0.0 112.04 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -162.27 173.83 13.67 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.29 126.81 41.76 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.0 t -129.26 130.87 46.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 139.29 41.3 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 123.571 1.653 . . . . 0.0 108.905 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -51.13 -27.65 9.02 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 130.019 3.328 . . . . 0.0 111.793 172.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -102.01 8.72 40.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.495 1.518 . . . . 0.0 111.569 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.74 158.05 43.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.488 1.04 . . . . 0.0 110.509 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -76.11 147.75 38.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.72 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.93 -54.36 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tt -78.9 46.4 0.68 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.569 1.148 . . . . 0.0 111.899 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -137.9 -68.73 0.46 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.352 1.461 . . . . 0.0 107.661 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.99 -10.27 47.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.845 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.64 -54.15 6.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.625 -1.297 . . . . 0.0 112.291 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.62 -39.15 67.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.158 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.333 0.3 OUTLIER -58.17 -30.18 66.2 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.87 -28.27 44.14 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.0 12.8 4.71 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.026 1.298 . . . . 0.0 111.293 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.0 mt -73.77 123.46 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.177 0.988 . . . . 0.0 110.139 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -89.34 115.24 26.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.87 159.83 70.29 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 124.114 0.965 . . . . 0.0 109.216 172.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.38 101.31 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.59 2.193 . . . . 0.0 109.933 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -50.37 20.13 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.799 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.316 1.3 m 41.55 -10.81 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 131.68 3.992 . . . . 0.0 121.002 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.7 p -169.15 -151.33 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.963 2.905 . . . . 0.0 105.031 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -166.7 72.46 0.13 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 146.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 167.99 108.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.669 1.987 . . . . 0.0 108.421 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -27.21 83.78 0.0 OUTLIER Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.697 2.57 . . . . 0.0 115.383 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -164.24 -56.1 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.785 0.792 . . . . 0.0 109.644 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -46.3 -40.95 12.52 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.7 1.2 . . . . 0.0 111.711 -177.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.4 m 71.11 63.86 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.044 1.738 . . . . 0.0 111.22 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 p -143.33 -137.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.529 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.2 p 44.92 -75.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 129.08 2.952 . . . . 0.0 115.04 -172.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 48.39 176.38 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.754 2.822 . . . . 0.0 114.468 -171.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.84 161.14 34.91 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -98.91 110.68 23.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.229 1.412 . . . . 0.0 110.302 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.69 109.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.935 0.894 . . . . 0.0 108.729 173.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.44 -49.26 17.37 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.043 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.9 t -160.35 173.07 16.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.67 -167.95 32.6 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -165.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -140.94 159.22 42.68 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 45.1 pt -146.07 166.82 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.239 1.416 . . . . 0.0 107.653 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -110.43 110.02 20.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.99 24.56 11.16 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.962 0.905 . . . . 0.0 112.135 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -74.94 42.15 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.838 1.199 . . . . 0.0 112.634 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -130.38 6.64 4.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.26 1.824 . . . . 0.0 110.155 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -176.48 2.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.426 1.09 . . . . 0.0 112.597 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -156.16 77.5 0.94 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -152.08 -80.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.005 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mp -54.17 138.52 38.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 111.06 -168.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.87 165.06 19.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.183 0.927 . . . . 0.0 109.65 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -42.79 72.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.061 0.944 . . . . 0.0 108.687 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.76 -61.13 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.11 0.964 . . . . 0.0 109.497 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.76 -51.43 63.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.342 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.1 mtt -51.19 -60.05 3.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.325 0.511 . . . . 0.0 111.402 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -54.92 -43.17 73.05 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.783 1.233 . . . . 0.0 110.652 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -20.25 64.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.672 1.589 . . . . 0.0 112.058 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.5 28.88 2.03 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.129 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -112.44 168.52 9.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.736 1.768 . . . . 0.0 112.931 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.5 p -161.22 159.85 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.307 1.443 . . . . 0.0 109.334 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tp -87.08 113.71 23.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.009 1.324 . . . . 0.0 110.721 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.7 m -85.01 46.24 1.25 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.128 -0.983 . . . . 0.0 111.607 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.99 -99.5 0.44 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -83.68 68.79 10.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.791 1.237 . . . . 0.0 109.63 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.41 134.35 54.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.327 1.051 . . . . 0.0 109.343 175.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -105.53 125.3 33.75 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 109.492 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -76.05 115.63 4.19 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.742 2.294 . . . . 0.0 111.874 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 p -93.52 -9.57 37.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.279 0.945 . . . . 0.0 112.102 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -161.96 -177.06 5.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.204 1.802 . . . . 0.0 107.177 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.04 92.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.532 1.533 . . . . 0.0 109.696 168.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.42 146.76 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.963 1.305 . . . . 0.0 110.26 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.85 125.4 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.52 153.69 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 124.287 1.035 . . . . 0.0 108.222 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -103.74 125.73 50.41 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.073 0.949 . . . . 0.0 109.403 170.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 p -91.65 175.8 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.157 0.889 . . . . 0.0 110.7 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.13 60.39 0.65 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.292 1.037 . . . . 0.0 109.288 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -126.01 16.03 7.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.879 0.872 . . . . 0.0 112.499 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -41.31 -70.69 0.1 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.361 1.465 . . . . 0.0 109.777 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -80.99 32.85 0.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.22 -29.37 1.62 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.93 2.092 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.6 pt -81.7 -41.97 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.694 -0.669 . . . . 0.0 112.584 169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.486 -1.245 . . . . 0.0 110.007 -179.176 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m 54.6 71.22 0.54 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.009 1.324 . . . . 0.0 113.176 161.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -93.56 164.35 13.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.975 0.91 . . . . 0.0 111.443 -172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.56 89.33 7.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.145 1.378 . . . . 0.0 108.905 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.4 t -87.01 122.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -93.81 125.58 38.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.269 0.356 . . . . 0.0 110.668 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.1 mt -106.34 98.58 8.23 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 124.955 1.409 . . . . 0.0 108.022 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.6 mt -73.92 89.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -90.25 155.71 46.54 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 125.564 1.545 . . . . 0.0 108.316 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.96 -21.3 68.67 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.777 2.985 . . . . 0.0 112.681 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.54 -29.01 69.73 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.329 1.452 . . . . 0.0 110.862 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.8 61.95 0.35 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 65.6 173.16 0.22 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.505 1.522 . . . . 0.0 112.571 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 p -147.5 -55.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.651 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 71.1 132.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.718 1.607 . . . . 0.0 111.236 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -159.68 167.02 29.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.874 -0.516 . . . . 0.0 111.567 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 127.55 37.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.097 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.5 t -132.03 117.96 19.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.622 0.369 . . . . 0.0 110.696 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.76 148.88 19.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.629 1.972 . . . . 0.0 108.87 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -75.96 -6.79 52.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.769 -0.582 . . . . 0.0 112.328 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.26 36.25 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.457 1.503 . . . . 0.0 110.082 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.6 163.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 121.043 -1.035 . . . . 0.0 111.116 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -81.82 140.11 34.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.595 0.758 . . . . 0.0 111.894 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.84 -7.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.19 -34.93 10.93 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.604 1.161 . . . . 0.0 110.715 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -68.36 -69.46 0.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.17 0.986 . . . . 0.0 110.165 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.259 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.11 -62.16 1.68 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.775 0.83 . . . . 0.0 112.328 170.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -55.18 -40.69 71.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.064 -0.493 . . . . 0.0 109.727 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.3 -36.23 52.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.22 -30.32 34.26 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.508 0.595 . . . . 0.0 110.707 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.69 8.54 4.73 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.538 1.066 . . . . 0.0 112.076 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -70.02 118.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.732 1.266 . . . . 0.0 110.906 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -91.15 77.85 5.94 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.319 1.048 . . . . 0.0 109.634 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.88 157.7 89.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 120.764 -1.21 . . . . 0.0 108.837 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -75.66 60.47 5.92 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.705 2.937 . . . . 0.0 111.65 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -78.46 167.98 20.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 111.338 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -175.45 9.11 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.701 2.0 . . . . 0.0 114.5 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.8 p -143.86 -55.34 0.37 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.622 1.556 . . . . 0.0 111.201 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 69.74 50.99 0.46 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.354 1.462 . . . . 0.0 111.478 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -159.55 76.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.753 0.706 . . . . 0.0 112.251 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.439 ' H ' ' CD2' ' A' ' 78' ' ' HIS . . . 63.91 -83.3 0.05 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.416 ' HA ' ' S2 ' ' A' ' 97' ' ' FES . 51.0 p -164.02 163.29 23.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.104 1.452 . . . . 0.0 111.715 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.8 p -137.04 23.63 3.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.501 1.52 . . . . 0.0 112.117 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t 77.27 36.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.944 1.298 . . . . 0.0 111.485 -175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.1 p -156.65 -172.21 3.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 78.5 m 62.62 126.16 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 126.898 2.079 . . . . 0.0 112.977 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.11 169.26 9.52 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.86 163.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.39 169.54 24.25 Favored Glycine 0 N--CA 1.431 -1.645 0 C-N-CA 126.016 1.769 . . . . 0.0 109.547 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -98.76 110.65 23.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.476 1.511 . . . . 0.0 108.424 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.42 103.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 t -77.03 -44.49 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.0 t -163.46 172.3 14.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.64 -171.98 54.86 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.775 1.178 . . . . 0.0 111.151 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -137.38 157.61 46.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.6 pt -148.15 168.45 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.274 1.829 . . . . 0.0 107.417 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -111.43 110.43 20.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -104.52 35.29 2.78 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.074 0.55 . . . . 0.0 112.078 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 t -54.02 -25.56 21.84 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.623 1.101 . . . . 0.0 113.551 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.28 -23.07 65.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 112.48 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -53.66 158.88 1.73 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.865 1.266 . . . . 0.0 113.222 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.54 49.46 0.54 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.73 -71.7 0.1 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.531 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -57.08 142.1 43.53 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.488 1.04 . . . . 0.0 110.94 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.19 168.61 11.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.031 0.832 . . . . 0.0 109.736 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.38 -42.48 70.43 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.71 -61.25 2.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.581 0.752 . . . . 0.0 109.521 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -55.66 -52.03 65.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.314 0.646 . . . . 0.0 111.283 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.2 mtm -51.81 -58.09 7.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.676 -0.64 . . . . 0.0 111.573 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.95 -42.93 76.97 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.332 1.053 . . . . 0.0 110.555 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.67 -21.27 64.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.56 1.544 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.58 2.23 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 118.355 -1.247 . . . . 0.0 110.859 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.423 ' CG ' HG23 ' A' ' 95' ' ' ILE . 95.0 m-85 -111.56 169.62 8.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.5 1.65 . . . . 0.0 111.564 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -162.17 150.67 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.657 0.783 . . . . 0.0 109.103 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 67.2 tp -64.2 135.02 55.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.637 0.775 . . . . 0.0 110.325 169.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -89.95 -36.81 14.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 111.545 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -50.91 66.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.271 1.028 . . . . 0.0 111.517 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.439 ' CD2' ' H ' ' A' ' 42' ' ' GLY . 1.7 m-70 -132.52 132.1 42.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 109.372 170.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -171.74 141.13 1.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.69 1.596 . . . . 0.0 107.744 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -108.14 119.67 49.14 Favored Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 125.793 1.637 . . . . 0.0 108.863 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.51 116.72 4.37 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.855 2.37 . . . . 0.0 111.341 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 p -91.77 -12.96 32.38 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.002 -0.436 . . . . 0.0 111.404 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -160.82 -178.28 6.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.301 1.84 . . . . 0.0 107.474 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -57.17 96.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.875 1.67 . . . . 0.0 109.251 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -103.0 147.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.727 1.211 . . . . 0.0 110.163 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -116.92 119.46 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.93 142.36 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.41 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 16.4 mt-10 -98.34 119.51 37.15 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.047 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -80.15 177.34 9.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.209 1.368 . . . . 0.0 110.007 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.2 m80 67.61 47.94 1.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.847 1.259 . . . . 0.0 111.11 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 16.3 mmtt -121.38 41.1 3.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.124 0.57 . . . . 0.0 110.22 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -79.04 -60.06 2.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.31 51.86 0.73 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.427 0.691 . . . . 0.0 112.354 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.32 -12.03 0.05 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.443 1.497 . . . . 0.0 113.431 163.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.423 HG23 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -79.87 -40.56 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.916 1.235 . . . . 0.0 111.198 170.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.675 177.746 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' FES . . . . . 0.416 ' S2 ' ' HA ' ' A' ' 43' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m 84.4 88.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.925 1.693 . . . . 0.0 113.97 160.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -117.16 158.8 23.64 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.321 1.448 . . . . 0.0 111.526 -170.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.35 101.52 1.95 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.46 2.304 . . . . 0.0 108.833 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.9 t -107.25 124.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.3 0.375 . . . . 0.0 110.164 174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.8 mt -108.86 106.48 16.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 108.848 167.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.15 99.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -99.27 155.24 36.76 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 124.929 1.291 . . . . 0.0 108.67 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.34 -34.54 89.1 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.995 3.13 . . . . 0.0 112.243 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.8 -34.75 28.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.438 2.295 . . . . 0.0 111.147 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.83 64.62 0.34 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 69.8 151.92 0.1 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.221 2.208 . . . . 0.0 114.045 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.94 111.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.176 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.03 138.19 31.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.705 1.202 . . . . 0.0 109.489 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.02 170.2 22.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.992 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.1 121.97 38.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 t -120.35 127.36 52.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.9 135.27 52.21 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -48.51 -39.45 23.33 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 123.183 1.468 . . . . 0.0 108.537 166.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -8.85 56.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.315 1.846 . . . . 0.0 111.954 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -128.62 155.68 40.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 124.11 0.964 . . . . 0.0 109.815 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -75.49 148.25 39.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.781 -0.575 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.11 50.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.945 0.898 . . . . 0.0 111.152 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.02 -47.65 0.13 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.97 -66.61 0.36 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.277 1.031 . . . . 0.0 111.019 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -69.03 -16.62 63.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.895 -0.503 . . . . 0.0 111.243 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.76 -51.32 35.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -56.6 -39.28 73.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.002 0.921 . . . . 0.0 109.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -50.87 -36.19 36.62 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.78 -28.73 27.94 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.966 -0.459 . . . . 0.0 110.214 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.83 12.89 4.76 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.518 1.532 . . . . 0.0 111.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 80.4 mt -73.81 112.18 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.334 1.067 . . . . 0.0 110.777 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.65 71.91 10.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.559 0.743 . . . . 0.0 110.414 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.23 152.63 95.92 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.76 -1.213 . . . . 0.0 109.469 175.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.03 74.12 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.647 2.898 . . . . 0.0 110.268 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -61.25 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.709 1.204 . . . . 0.0 109.863 172.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.05 13.62 14.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.855 1.262 . . . . 0.0 111.426 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.505 ' CB ' ' S2 ' ' A' ' 97' ' ' FES . 86.8 m -154.0 -107.58 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.63 0.772 . . . . 0.0 109.948 -159.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 174.64 -71.78 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 129.181 2.992 . . . . 0.0 108.915 -169.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 174.73 104.12 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.602 0.761 . . . . 0.0 111.823 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.08 -57.19 3.99 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.479 1.038 . . . . 0.0 114.762 154.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 p -81.53 65.42 6.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.366 1.466 . . . . 0.0 107.394 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.02 -76.28 0.56 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -162.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 81.51 44.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.096 1.358 . . . . 0.0 111.019 -171.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 m -167.61 177.3 5.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 106.168 173.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 39' ' ' CYS 0.648 0.8 OUTLIER 43.66 157.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 129.361 3.064 . . . . 0.0 118.348 -166.338 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.93 167.65 0.73 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 110.254 -173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.14 165.72 27.71 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.554 2.026 . . . . 0.0 110.458 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -102.0 114.96 29.53 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.853 1.661 . . . . 0.0 110.704 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.3 t -64.5 112.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.1 0.96 . . . . 0.0 108.562 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -85.82 -42.37 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -157.02 -171.88 3.82 Favored 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.13 -155.21 22.51 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.71 1.148 . . . . 0.0 111.851 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.1 m -153.98 156.78 38.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.7 pt -136.29 149.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 172.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.8 112.73 24.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -107.84 42.11 1.41 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.468 0.707 . . . . 0.0 111.593 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.29 11.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.929 -1.107 . . . . 0.0 112.791 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -104.42 14.99 29.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.279 1.032 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -113.31 179.85 3.84 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.166 -0.959 . . . . 0.0 112.905 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 t -145.02 68.8 1.24 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 161.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -137.22 -82.54 0.35 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.511 -1.233 . . . . 0.0 111.73 175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -53.79 138.0 36.81 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.529 1.059 . . . . 0.0 111.137 -165.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -85.92 168.54 14.11 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.086 0.866 . . . . 0.0 109.942 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -55.86 -42.66 76.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.358 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.1 -60.54 3.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.802 0.841 . . . . 0.0 109.614 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -54.62 -51.1 66.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.4 mtt -51.74 -59.68 4.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.26 0.482 . . . . 0.0 111.344 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.08 -42.12 72.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.916 1.286 . . . . 0.0 110.795 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.44 -20.2 64.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.412 1.485 . . . . 0.0 111.812 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.88 3.18 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-O 118.613 -1.104 . . . . 0.0 110.528 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.427 ' CG ' HG21 ' A' ' 95' ' ' ILE . 93.2 m-85 -109.76 169.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.077 1.439 . . . . 0.0 111.642 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.4 p -161.14 156.91 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 tp -64.76 128.53 36.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 166.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -68.23 -40.0 82.18 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.6 m -81.51 -177.66 6.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.445 1.898 . . . . 0.0 109.254 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 33.52 50.88 0.31 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.429 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.89 133.32 30.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.132 1.373 . . . . 0.0 108.428 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -107.32 124.12 36.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.213 1.405 . . . . 0.0 111.126 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.49 100.78 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.943 3.095 . . . . 0.0 112.806 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.4 p -81.78 -18.06 45.46 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.06 -0.4 . . . . 0.0 110.89 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -151.98 179.59 8.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.304 . . . . 0.0 107.702 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.38 136.29 53.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 p -155.43 144.52 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.833 0.825 . . . . 0.0 111.662 -164.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.42 123.81 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 151.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -99.03 127.03 44.88 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 118.056 -0.973 . . . . 0.0 108.943 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.2 p -86.57 178.44 7.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.682 1.128 . . . . 0.0 109.073 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 65.5 53.9 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.436 1.094 . . . . 0.0 111.555 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -122.22 18.64 10.71 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.2 -67.19 0.3 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.001 0.92 . . . . 0.0 109.005 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -81.29 23.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.599 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.39 -21.37 9.87 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.541 1.136 . . . . 0.0 110.854 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.427 HG21 ' CG ' ' A' ' 73' ' ' TYR . 18.3 pt -88.47 -42.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 119.478 1.035 . . . . 0.0 112.562 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.879 -1.534 . . . . 0.0 110.068 -177.01 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' FES . . . . . 0.505 ' S2 ' ' CB ' ' A' ' 39' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.4 m 55.48 75.21 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.485 1.114 . . . . 0.0 113.194 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.39 163.44 12.7 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.054 0.942 . . . . 0.0 112.853 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.44 81.87 8.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.98 2.112 . . . . 0.0 109.484 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.5 t -88.04 99.0 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -170.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.76 127.76 34.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.834 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.9 mt -107.95 109.53 21.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.2 mt -78.58 91.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -88.29 155.07 51.87 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 124.023 0.929 . . . . 0.0 108.57 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.05 -37.03 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.468 3.446 . . . . 0.0 112.696 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.5 -36.63 15.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.852 2.461 . . . . 0.0 111.159 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.06 65.08 0.29 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 69.54 165.31 0.26 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 127.02 2.128 . . . . 0.0 112.765 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.87 -59.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.201 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 70.63 145.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.128 1.371 . . . . 0.0 110.966 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -169.54 158.94 8.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.93 0.892 . . . . 0.0 110.39 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 121.71 27.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.8 t -120.49 120.43 35.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.58 0.352 . . . . 0.0 110.427 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.57 141.97 58.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -31.1 61.47 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 125.531 1.532 . . . . 0.0 110.901 169.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -88.31 -5.32 58.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.257 1.023 . . . . 0.0 112.083 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -119.23 149.01 21.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 CA-C-N 119.725 1.148 . . . . 0.0 110.086 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -72.18 150.38 43.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.185 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 56.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.745 0.783 . . . . 0.0 111.528 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.4 tt -163.9 -52.75 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -56.62 13.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.572 0.701 . . . . 0.0 110.159 -175.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -71.29 -23.58 61.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.16 -54.09 43.04 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.549 -0.719 . . . . 0.0 110.226 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -48.75 -46.87 41.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.901 0.88 . . . . 0.0 108.894 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -53.87 -38.74 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.3 -25.59 42.4 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.882 -0.511 . . . . 0.0 109.863 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.03 12.75 5.22 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.827 1.68 . . . . 0.0 111.529 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 98.7 mt -76.23 108.84 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.167 0.984 . . . . 0.0 111.318 -175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -78.87 68.61 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.742 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.13 156.42 80.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.944 -1.097 . . . . 0.0 108.247 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.19 72.01 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.198 3.265 . . . . 0.0 110.374 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.23 161.73 27.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.698 1.999 . . . . 0.0 111.865 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -156.99 -61.15 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.214 1.806 . . . . 0.0 108.379 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.15 162.08 17.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 128.758 2.823 . . . . 0.0 110.417 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -150.28 71.52 1.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.46 1.104 . . . . 0.0 108.828 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.0 44.26 0.15 Allowed 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.391 -0.818 . . . . 0.0 110.766 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.1 -67.93 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.919 1.247 . . . . 0.0 112.923 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.1 t -67.77 76.02 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.128 1.371 . . . . 0.0 111.256 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.3 159.16 8.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.108 0.963 . . . . 0.0 112.774 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.28 -34.68 4.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.002 2.521 . . . . 0.0 110.443 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.4 m -159.52 86.87 0.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 117.485 -1.245 . . . . 0.0 112.656 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 p -175.89 165.27 2.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.841 2.057 . . . . 0.0 110.925 169.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 163.95 169.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.692 2.397 . . . . 0.0 109.592 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.68 167.33 25.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.135 1.826 . . . . 0.0 110.684 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -103.83 112.39 25.33 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.964 1.706 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.97 113.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.389 1.076 . . . . 0.0 109.132 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -85.78 -46.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 t -162.71 174.84 11.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.064 -0.398 . . . . 0.0 110.388 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.5 -173.2 54.44 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.599 1.095 . . . . 0.0 110.928 -170.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -141.44 147.7 38.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.7 pt -145.47 169.97 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.784 1.633 . . . . 0.0 107.408 177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.24 111.72 22.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -114.09 48.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 109.56 168.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -88.99 48.54 1.64 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.526 -1.359 . . . . 0.0 109.585 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.87 -50.15 1.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 110.954 -171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -58.5 -35.04 71.62 Favored 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m 54.32 53.23 11.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.802 0.441 . . . . 0.0 109.917 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -143.91 -68.08 0.33 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.347 -1.311 . . . . 0.0 109.478 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp -55.22 137.43 47.23 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.887 1.221 . . . . 0.0 110.279 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.81 167.49 13.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 124.05 0.844 . . . . 0.0 109.763 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.16 -43.37 64.05 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.926 1.29 . . . . 0.0 108.58 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.11 -60.81 2.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.45 1.1 . . . . 0.0 109.674 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -58.12 -48.34 80.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.211 0.604 . . . . 0.0 111.044 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtt -51.98 -60.57 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.912 -0.493 . . . . 0.0 110.839 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.97 -45.1 71.28 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.777 1.231 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.37 -20.96 63.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.019 1.728 . . . . 0.0 112.059 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.55 30.95 1.74 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 117.802 -1.554 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.491 ' CG ' HG21 ' A' ' 95' ' ' ILE . 94.6 m-85 -118.25 158.39 25.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.981 1.89 . . . . 0.0 113.747 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.2 p -154.65 144.68 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 123.536 0.734 . . . . 0.0 110.671 -175.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.71 147.77 43.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 p -120.65 38.5 4.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.002 0.921 . . . . 0.0 112.325 -170.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 64.6 m -146.01 -43.08 0.2 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 109.846 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -118.86 84.87 2.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.629 1.571 . . . . 0.0 108.234 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 135.94 10.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.147 1.379 . . . . 0.0 107.439 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -116.96 118.65 36.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.768 1.627 . . . . 0.0 109.337 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -74.34 117.85 5.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.587 2.192 . . . . 0.0 111.666 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 p -89.88 -16.03 30.91 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.731 -0.606 . . . . 0.0 111.2 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 m -156.6 -177.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.877 1.671 . . . . 0.0 107.112 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.72 133.67 42.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 161.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -140.75 148.84 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 107.622 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.72 121.12 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 173.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.41 153.62 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -103.32 126.16 50.34 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 109.29 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.9 p -83.8 177.24 8.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.781 1.173 . . . . 0.0 109.263 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.2 m80 70.37 56.23 0.28 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.672 1.189 . . . . 0.0 111.54 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -129.04 31.47 4.89 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.614 0.765 . . . . 0.0 112.582 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -59.77 -66.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -80.23 47.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.649 0.738 . . . . 0.0 111.547 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -140.32 -41.29 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 131.453 3.901 . . . . 0.0 108.949 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.491 HG21 ' CG ' ' A' ' 73' ' ' TYR . 21.5 pt -75.49 -47.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.061 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.058 -1.448 . . . . 0.0 109.758 -173.616 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m 80.85 103.81 0.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.443 1.497 . . . . 0.0 112.502 169.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -118.68 154.93 31.92 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.552 0.691 . . . . 0.0 112.736 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.73 100.67 0.56 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 128.557 2.743 . . . . 0.0 108.65 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.04 125.67 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -97.18 135.72 38.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 165.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 28.5 mt -112.14 106.89 15.62 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 124.505 1.128 . . . . 0.0 108.447 169.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.1 mt -78.42 91.61 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.1 p -94.7 155.86 38.92 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.745 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.476 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 68.6 Cg_exo -53.43 -37.11 81.6 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 125.133 3.889 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.64 -38.06 9.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 128.444 2.698 . . . . 0.0 111.106 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.8 61.9 0.26 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 70.7 152.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 127.558 2.343 . . . . 0.0 112.905 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -152.65 90.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.861 1.315 . . . . 0.0 108.361 172.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -83.22 140.21 32.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.538 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.03 170.58 21.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.188 0.595 . . . . 0.0 112.224 -166.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.42 47.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.2 t -122.32 130.47 53.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.25 131.28 41.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.159 0.981 . . . . 0.0 108.988 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -44.48 -28.6 0.59 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.864 2.066 . . . . 0.0 111.833 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.57 -14.3 58.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.263 1.825 . . . . 0.0 112.489 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.9 154.4 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 0.0 110.078 -166.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -74.94 153.01 38.77 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.516 -1.365 . . . . 0.0 110.053 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -49.27 -51.3 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.815 -0.553 . . . . 0.0 110.866 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.75 72.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.82 -67.78 0.39 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -38.54 82.75 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.44 -61.88 1.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.33 -40.09 70.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.95 -40.27 72.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -19.9 56.73 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.481 -0.762 . . . . 0.0 109.039 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.26 15.08 7.3 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.237 1.399 . . . . 0.0 110.686 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.9 mt -81.81 133.12 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 117.302 0.551 . . . . 0.0 110.043 -175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -93.17 115.2 27.84 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.487 1.115 . . . . 0.0 108.832 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.5 pt -137.05 157.92 73.68 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.63 131.69 13.84 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.474 2.116 . . . . 0.0 109.75 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -172.85 136.59 0.7 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.0 t -155.6 22.69 0.4 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.802 1.183 . . . . 0.0 112.211 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.35 -172.04 1.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -159.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.7 ttt85 -169.47 84.44 0.13 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.517 1.053 . . . . 0.0 110.778 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.66 -60.96 0.09 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.265 0.484 . . . . 0.0 111.768 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.96 -54.58 0.41 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -106.09 73.2 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.807 -0.82 . . . . 0.0 109.053 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.46 -109.88 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 116.494 -1.717 . . . . 0.0 108.581 175.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 p -163.24 151.35 13.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.985 2.63 . . . . 0.0 115.09 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.8 m 71.56 52.03 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.402 2.281 . . . . 0.0 112.442 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.6 m -154.2 81.9 1.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.636 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.21 154.67 29.59 Favored 'General case' 0 CA--C 1.521 -0.153 0 O-C-N 119.582 -1.948 . . . . 0.0 110.537 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.11 167.12 27.9 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.546 1.546 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -105.23 112.57 25.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.516 1.926 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.9 110.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t -83.67 -45.48 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.7 t -160.96 174.41 13.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.977 -0.452 . . . . 0.0 110.292 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.39 -162.8 54.25 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -155.17 155.86 34.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.2 pt -144.22 160.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.724 1.61 . . . . 0.0 107.801 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -101.38 108.14 19.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -104.55 38.67 1.83 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.711 0.804 . . . . 0.0 111.463 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 m -46.56 -38.75 9.9 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.328 0.967 . . . . 0.0 112.414 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -75.26 31.68 0.1 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.934 0.894 . . . . 0.0 112.375 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -91.88 -65.25 1.02 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.321 1.448 . . . . 0.0 113.231 -170.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m 43.49 33.85 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.924 0.89 . . . . 0.0 113.35 -167.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -137.97 -76.47 0.39 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.467 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.5 mp -55.99 141.73 38.67 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.956 0.798 . . . . 0.0 110.174 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -85.38 164.86 17.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 123.812 0.695 . . . . 0.0 109.548 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.48 -40.42 74.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 108.683 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.29 -61.64 2.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.947 0.899 . . . . 0.0 109.402 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.41 -53.11 31.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.628 0.771 . . . . 0.0 111.332 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.3 mtm -50.54 -62.15 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 0.0 111.857 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.94 -43.46 69.84 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.667 1.187 . . . . 0.0 110.72 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.53 64.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.766 1.626 . . . . 0.0 112.112 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.86 26.39 2.11 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-O 117.922 -1.488 . . . . 0.0 111.842 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.442 ' CG ' HG21 ' A' ' 95' ' ' ILE . 94.8 m-85 -113.68 166.25 11.73 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 120.018 1.909 . . . . 0.0 112.88 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.72 153.75 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.46 132.74 42.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -72.08 -49.99 31.89 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.719 -0.613 . . . . 0.0 110.448 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.4 p -74.34 176.85 6.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 m170 50.23 46.57 24.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.817 0.818 . . . . 0.0 111.602 166.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -147.91 125.26 11.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.409 1.084 . . . . 0.0 108.952 -170.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -108.4 125.22 32.36 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 125.547 1.539 . . . . 0.0 109.678 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -71.98 119.36 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.194 1.93 . . . . 0.0 111.757 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -91.3 -17.19 26.33 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.257 -0.902 . . . . 0.0 112.039 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 m -156.21 -173.99 4.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.53 140.17 41.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.66 148.09 15.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.354 0.597 . . . . 0.0 109.853 -173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.54 124.2 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 151.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 123.795 0.838 . . . . 0.0 108.966 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -100.26 121.23 41.14 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.067 0.947 . . . . 0.0 108.605 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.431 ' HG1' ' CD2' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -74.34 179.81 4.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 119.163 0.892 . . . . 0.0 110.712 176.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.476 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 3.5 m-70 65.46 50.47 1.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.761 1.224 . . . . 0.0 112.86 169.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -122.01 15.5 10.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -172.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -45.39 -63.43 0.95 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.795 0.807 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -82.86 21.89 0.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.732 0.813 . . . . 0.0 113.142 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -110.2 -26.14 9.79 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.352 1.061 . . . . 0.0 110.495 162.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.442 HG21 ' CG ' ' A' ' 73' ' ' TYR . 34.6 pt -82.4 -48.85 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 119.478 1.035 . . . . 0.0 112.09 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.253 1.283 0 CA-C-O 117.498 -1.239 . . . . 0.0 109.693 -176.145 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 55.43 68.08 0.92 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.051 1.34 . . . . 0.0 113.844 151.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -98.4 158.25 15.7 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 111.424 -168.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.82 90.21 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.837 1.655 . . . . 0.0 109.135 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.0 120.56 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -88.97 131.08 35.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.878 0.308 . . . . 0.0 111.346 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.8 mt -109.29 103.87 12.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.418 1.487 . . . . 0.0 107.508 166.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.4 mt -74.17 86.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -79.34 154.17 76.77 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.691 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.83 -32.43 94.93 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.949 3.1 . . . . 0.0 112.194 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -32.18 33.82 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 126.429 1.892 . . . . 0.0 110.907 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.01 62.62 0.32 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 125.255 1.407 . . . . 0.0 109.931 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 67.69 161.72 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.728 2.011 . . . . 0.0 112.883 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.4 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.072 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 73.67 129.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.121 1.768 . . . . 0.0 111.987 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -163.73 171.37 15.69 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.29 127.88 40.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.404 0.682 . . . . 0.0 111.524 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.6 t -131.51 130.27 42.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 175.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.3 150.99 39.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 110.108 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -7.38 46.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -115.26 21.01 14.51 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.767 1.627 . . . . 0.0 110.703 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.42 158.12 27.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 O-C-N 121.024 -1.048 . . . . 0.0 110.589 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -77.94 143.45 37.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.566 0.346 . . . . 0.0 110.99 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.6 t -49.07 -62.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 111.523 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tp -49.86 -52.5 32.21 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.537 0.735 . . . . 0.0 111.475 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -54.45 43.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -170.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -58.64 -44.91 90.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.581 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.87 -56.06 14.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.361 -0.837 . . . . 0.0 110.793 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.26 -38.95 81.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.674 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.7 -38.24 54.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.227 0.921 . . . . 0.0 112.301 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.96 -25.86 43.5 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.934 -0.479 . . . . 0.0 110.616 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.92 11.32 10.21 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.82 1.676 . . . . 0.0 111.31 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.24 123.41 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.7 0.75 . . . . 0.0 111.075 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.59 119.37 30.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.703 1.601 . . . . 0.0 109.986 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.9 pt -136.16 148.33 64.13 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 129.46 27.37 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.023 2.482 . . . . 0.0 111.088 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -166.27 143.38 5.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -171.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.0 p -155.62 15.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -175.68 1.77 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.88 2.872 . . . . 0.0 105.833 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -160.67 79.88 0.64 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.658 1.572 . . . . 0.0 109.736 162.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.21 -71.0 0.42 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 122.703 0.401 . . . . 0.0 110.624 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.69 79.04 0.07 OUTLIER Glycine 0 C--N 1.334 0.458 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 p -175.41 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.326 0.651 . . . . 0.0 110.933 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.01 155.36 31.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 110.254 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.8 p -109.07 72.91 0.83 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.7 m -152.43 -154.16 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.436 1.094 . . . . 0.0 108.32 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.1 p 46.82 88.31 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 160.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.88 163.74 38.58 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.595 -1.941 . . . . 0.0 113.056 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.59 160.68 28.45 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.175 1.845 . . . . 0.0 111.085 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -98.26 112.94 24.75 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.026 1.73 . . . . 0.0 111.166 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.16 116.2 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.073 0.851 . . . . 0.0 109.474 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.98 -48.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.998 0.519 . . . . 0.0 109.876 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -160.33 174.06 14.73 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.08 -169.37 43.14 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 m -142.54 149.48 39.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.071 0.948 . . . . 0.0 108.817 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 pt -132.89 165.52 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.027 1.731 . . . . 0.0 107.035 169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -107.13 110.73 22.89 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.45 46.17 1.02 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.112 0.565 . . . . 0.0 110.168 168.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 t -52.83 -44.83 67.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.539 -0.726 . . . . 0.0 109.751 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -78.64 41.99 0.43 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.549 1.54 . . . . 0.0 111.823 -173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -105.86 -72.05 0.73 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.212 1.805 . . . . 0.0 111.672 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.0 t 53.53 61.11 3.28 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.742 -0.599 . . . . 0.0 111.367 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -160.51 -67.43 0.07 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.606 173.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.84 147.41 33.76 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.516 1.053 . . . . 0.0 110.877 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -85.85 160.62 19.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.966 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.36 -41.22 72.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.57 -61.01 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.981 0.912 . . . . 0.0 109.559 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -51.44 -51.07 57.99 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.0 111.202 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.1 mtt -52.18 -60.45 3.19 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.626 -0.671 . . . . 0.0 111.558 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.94 -42.68 76.54 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.379 1.072 . . . . 0.0 110.854 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.99 -19.93 63.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.8 1.64 . . . . 0.0 111.749 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.63 1.31 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 117.559 -1.689 . . . . 0.0 110.949 171.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -116.48 162.27 17.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.48 2.14 . . . . 0.0 113.802 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.08 161.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.729 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -55.42 4.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.217 1.407 . . . . 0.0 110.383 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 80.19 -56.92 0.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.003 1.321 . . . . 0.0 110.487 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.04 -39.21 1.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.102 1.761 . . . . 0.0 112.72 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -143.89 52.84 1.3 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.575 0.75 . . . . 0.0 111.821 173.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.75 151.42 23.05 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 169.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -105.84 126.16 31.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 124.58 1.152 . . . . 0.0 109.215 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.87 119.1 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.659 2.24 . . . . 0.0 110.899 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 p -91.31 -15.04 29.72 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.099 -0.376 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -156.94 -174.71 5.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.49 134.81 40.58 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 p -151.87 148.04 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 109.769 -171.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.71 123.73 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 153.05 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -100.63 119.32 38.39 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.024 0.93 . . . . 0.0 109.477 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.7 p -79.91 175.89 10.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.411 1.005 . . . . 0.0 111.202 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 69.42 56.94 0.36 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.747 1.619 . . . . 0.0 111.814 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -126.96 12.68 7.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.84 -63.73 0.98 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.283 1.033 . . . . 0.0 109.075 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -79.87 26.63 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -110.12 -45.33 3.61 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 pt -71.62 -41.61 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -170.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.996 -1.478 . . . . 0.0 110.325 -178.583 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.401 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m 77.09 100.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.065 1.746 . . . . 0.0 111.498 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -109.17 158.98 17.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.591 0.756 . . . . 0.0 112.055 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.96 104.54 5.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.018 2.127 . . . . 0.0 109.123 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -110.19 111.77 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 122.898 0.479 . . . . 0.0 110.557 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -84.6 128.33 34.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 117.937 0.335 . . . . 0.0 111.456 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.1 mt -106.55 112.13 25.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mt -84.22 86.32 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p -83.32 153.69 65.9 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.097 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -36.92 69.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.654 3.569 . . . . 0.0 113.063 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -46.95 -38.68 11.0 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 127.526 2.33 . . . . 0.0 111.099 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.23 64.22 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.9 166.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 127.215 2.206 . . . . 0.0 112.158 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.72 -59.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.732 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 70.55 142.36 0.05 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.988 1.715 . . . . 0.0 113.086 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -164.34 178.93 7.13 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.811 0.844 . . . . 0.0 111.264 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.86 124.38 48.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.818 1.247 . . . . 0.0 109.086 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.5 t -121.05 128.3 52.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.51 0.324 . . . . 0.0 110.325 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.52 141.06 53.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.782 1.277 . . . . 0.0 108.23 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -65.07 -18.83 65.63 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 128.895 2.878 . . . . 0.0 110.786 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.59 17.52 22.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.811 1.244 . . . . 0.0 111.292 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.35 151.78 32.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.59 1.086 . . . . 0.0 111.501 177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -65.05 138.74 58.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.905 0.882 . . . . 0.0 110.327 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.68 4.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.46 -52.07 2.81 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -45.8 -62.3 1.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.394 1.478 . . . . 0.0 111.246 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -65.07 -28.17 69.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.913 -0.492 . . . . 0.0 111.198 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.45 -52.22 66.14 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 109.542 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -56.67 -41.4 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.037 0.935 . . . . 0.0 109.892 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -51.72 -37.72 52.17 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.73 -25.31 41.13 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.848 -0.532 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.15 11.34 9.04 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.805 1.669 . . . . 0.0 111.284 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 41.2 mt -82.16 126.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 118.208 1.004 . . . . 0.0 110.124 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -90.24 110.98 22.01 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.419 1.088 . . . . 0.0 109.447 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 5.8 pt -136.75 155.28 76.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 170.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.32 110.52 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -148.68 -20.39 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.173 1.389 . . . . 0.0 113.255 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 p -71.81 74.94 0.87 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.151 0.98 . . . . 0.0 111.506 -165.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 -77.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.942 2.097 . . . . 0.0 107.119 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 59.84 96.5 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.134 2.574 . . . . 0.0 113.961 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 150.98 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.821 2.448 . . . . 0.0 113.092 155.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 31.56 -65.28 0.0 OUTLIER Glycine 0 CA--C 1.549 2.187 0 C-N-CA 129.763 3.554 . . . . 0.0 117.55 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.2 t -82.64 62.16 6.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.109 -1.818 . . . . 0.0 109.99 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -114.78 -67.29 1.01 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.538 1.135 . . . . 0.0 112.47 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.2 m -147.28 -106.85 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.024 -1.048 . . . . 0.0 110.705 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 t -153.76 129.99 10.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 p -162.11 150.76 15.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.357 1.463 . . . . 0.0 108.031 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.32 174.64 3.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.585 1.154 . . . . 0.0 110.231 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.4 156.05 26.36 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.092 1.806 . . . . 0.0 111.263 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.98 126.61 34.84 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.5 1.52 . . . . 0.0 110.028 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.534 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 17.3 t -73.73 128.34 36.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 120.11 1.323 . . . . 0.0 108.969 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -108.25 -44.21 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.297 0.639 . . . . 0.0 109.953 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 t -158.93 172.54 18.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.599 0.636 . . . . 0.0 109.715 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.97 -161.76 46.85 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.471 1.034 . . . . 0.0 111.407 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 m -156.24 158.55 37.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.65 -0.912 . . . . 0.0 108.757 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 pt -130.58 179.67 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.498 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.44 118.99 36.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -108.39 34.64 3.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.818 0.847 . . . . 0.0 111.721 169.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.1 t -80.39 36.21 0.36 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.631 -1.293 . . . . 0.0 113.173 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -161.28 43.08 0.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.242 1.017 . . . . 0.0 109.619 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -105.38 -33.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.644 1.978 . . . . 0.0 110.363 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 t 52.55 46.86 25.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.607 0.763 . . . . 0.0 109.792 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -155.12 -72.12 0.12 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.748 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.92 136.32 57.03 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 120.063 1.301 . . . . 0.0 110.973 -170.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.75 164.45 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 123.641 0.588 . . . . 0.0 110.253 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -52.6 -44.01 65.72 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.94 -61.2 2.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.286 1.034 . . . . 0.0 109.766 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -54.34 -49.53 69.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.227 0.611 . . . . 0.0 111.139 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 12.2 mtt -54.59 -58.55 7.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.635 -0.666 . . . . 0.0 111.66 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.33 -43.16 70.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.403 1.081 . . . . 0.0 110.697 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.82 65.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.842 1.657 . . . . 0.0 111.727 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.58 51.33 0.98 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -125.31 146.47 49.55 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.393 1.097 . . . . 0.0 111.915 169.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -170.0 -175.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.6 tp 76.0 167.06 0.27 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.742 1.217 . . . . 0.0 107.769 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.2 p 64.09 170.69 0.18 Allowed 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 124.681 1.238 . . . . 0.0 111.088 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 52.52 21.69 1.88 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.8 t60 103.14 117.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.492 3.117 . . . . 0.0 110.897 -170.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.41 114.1 1.61 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.886 -0.509 . . . . 0.0 111.991 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.08 123.01 40.43 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 125.277 1.431 . . . . 0.0 110.938 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -74.38 120.16 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.716 2.277 . . . . 0.0 111.29 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 p -99.34 -13.0 19.81 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.685 -0.635 . . . . 0.0 112.176 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.1 m -156.28 -173.52 4.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.35 143.85 32.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 p -153.89 151.9 10.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.281 0.562 . . . . 0.0 111.687 -172.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.5 t -135.56 127.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -156.07 141.73 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -167.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.98 118.16 31.34 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.418 -0.801 . . . . 0.0 110.81 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 p -77.3 176.03 9.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.932 0.493 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.23 55.35 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.116 1.366 . . . . 0.0 111.472 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -123.28 33.29 5.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 122.939 0.496 . . . . 0.0 111.967 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.96 -71.93 0.08 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.35 45.0 0.72 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.498 0.666 . . . . 0.0 110.902 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.32 -46.13 2.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.134 1.374 . . . . 0.0 108.296 164.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.9 pt -72.5 -38.81 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.564 1.516 1 CA-C-O 81.463 -18.399 . . . . 0.0 111.435 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.492 ' H2 ' ' CG ' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 m 54.6 72.99 0.43 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 144.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -99.8 155.4 17.67 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.03 101.74 0.42 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.309 2.244 . . . . 0.0 109.314 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.2 109.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -81.76 134.25 35.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.101 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.4 mt -112.13 106.86 15.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 167.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.1 mt -76.66 96.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 156.23 41.69 Favored Pre-proline 0 N--CA 1.444 -0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 108.882 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.55 -36.85 81.94 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.49 3.46 . . . . 0.0 112.505 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.89 -34.84 21.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 127.423 2.289 . . . . 0.0 111.084 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.37 64.21 0.3 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 125.225 1.393 . . . . 0.0 109.693 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 67.9 161.59 0.18 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.996 2.118 . . . . 0.0 112.293 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.75 -58.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.786 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 72.21 143.46 0.06 Allowed 'General case' 0 C--O 1.229 0.017 0 C-N-CA 126.032 1.733 . . . . 0.0 112.79 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -163.43 169.95 18.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.998 0.519 . . . . 0.0 112.012 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 126.35 36.34 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.4 t -119.86 125.11 47.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.653 0.596 . . . . 0.0 110.531 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -69.11 146.27 52.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 123.003 1.383 . . . . 0.0 110.015 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' CG ' ' H2 ' ' A' ' 1' ' ' ALA . 6.8 p-10 -77.0 -1.65 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.257 1.023 . . . . 0.0 111.88 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.06 23.05 10.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.207 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -130.88 149.04 33.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-N 119.465 1.03 . . . . 0.0 110.367 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -64.25 142.83 58.27 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.9 t -49.12 -58.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.07 0.231 . . . . 0.0 110.554 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.6 -36.26 73.74 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -61.49 -62.15 2.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 122.398 1.094 . . . . 0.0 108.337 -169.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.12 -38.15 87.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.589 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.77 -58.21 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.203 -0.935 . . . . 0.0 112.084 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.88 -38.49 78.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 109.573 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.1 -40.81 61.8 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.886 0.766 . . . . 0.0 112.384 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.02 -24.07 55.24 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.886 -0.509 . . . . 0.0 109.948 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.31 15.34 7.73 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.386 1.47 . . . . 0.0 110.669 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.4 mt -77.88 125.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.557 0.678 . . . . 0.0 109.496 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.43 119.53 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.74 0.816 . . . . 0.0 109.166 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.4 pt -140.76 162.16 50.31 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.3 138.23 70.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.637 2.225 . . . . 0.0 109.8 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -164.92 -101.1 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p 50.64 49.66 20.45 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 111.742 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.8 t -150.27 175.0 12.2 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 127.729 2.411 . . . . 0.0 106.023 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -165.07 148.66 8.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 151.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 81.89 101.95 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.772 2.029 . . . . 0.0 111.212 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.67 134.24 7.02 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.309 1.433 . . . . 0.0 112.729 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t 117.47 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 129.202 3.001 . . . . 0.0 107.803 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 p -143.99 -155.84 0.64 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.905 1.282 . . . . 0.0 109.665 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.7 t -153.99 167.01 31.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m 62.89 57.38 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.618 1.167 . . . . 0.0 112.549 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.52 121.13 2.91 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.844 0.858 . . . . 0.0 109.649 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.66 162.2 3.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.288 0.635 . . . . 0.0 111.03 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.09 166.39 25.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.959 1.742 . . . . 0.0 109.977 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.24 114.27 27.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.63 1.572 . . . . 0.0 110.802 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.17 109.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.425 1.09 . . . . 0.0 108.519 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.47 -40.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 -169.74 3.19 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.24 -159.46 14.92 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.333 0.968 . . . . 0.0 112.012 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -155.25 151.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 pt -136.57 154.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.17 107.17 19.64 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.0 27.16 8.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.247 0.619 . . . . 0.0 111.772 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.3 m -78.75 58.21 2.25 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.074 1.307 . . . . 0.0 111.764 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -142.05 -36.98 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.028 2.131 . . . . 0.0 110.987 -173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.29 -169.76 1.5 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.856 2.062 . . . . 0.0 114.12 -174.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.9 m -158.13 77.68 0.8 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.242 1.417 . . . . 0.0 108.727 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -149.57 -65.3 0.22 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.253 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -59.74 145.12 46.28 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.077 1.308 . . . . 0.0 110.639 -176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.54 164.81 14.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.044 0.84 . . . . 0.0 110.243 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.23 -44.4 64.81 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.968 1.307 . . . . 0.0 108.59 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -53.6 -60.97 2.62 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 109.41 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -53.96 -50.09 67.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.279 0.632 . . . . 0.0 111.431 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 64.4 mtt -50.38 -60.51 2.92 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.381 -0.825 . . . . 0.0 111.362 175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.04 -43.33 73.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.416 1.086 . . . . 0.0 110.759 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.69 64.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.725 1.61 . . . . 0.0 111.875 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.21 35.07 1.25 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.498 -1.168 . . . . 0.0 110.332 173.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -116.58 164.46 14.56 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.212 1.506 . . . . 0.0 111.476 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -156.92 148.74 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.796 0.839 . . . . 0.0 108.77 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.7 tp -66.28 141.41 58.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 t -81.94 -38.51 25.12 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.594 0.634 . . . . 0.0 110.316 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.8 m -79.39 179.23 7.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.557 1.143 . . . . 0.0 108.787 171.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 72.1 m80 42.7 51.14 5.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.505 1.122 . . . . 0.0 111.222 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -153.05 123.74 7.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.399 1.08 . . . . 0.0 108.563 -166.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.85 126.52 28.14 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 124.811 1.244 . . . . 0.0 110.215 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -73.36 121.03 6.85 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.361 2.041 . . . . 0.0 111.648 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -95.68 -16.19 22.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.7 m -156.64 -173.97 4.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.5 142.58 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 165.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 p -152.74 149.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.857 0.837 . . . . 0.0 109.9 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.7 123.7 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.63 153.11 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -102.1 128.84 48.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.742 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.4 p -85.44 178.6 7.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.071 0.85 . . . . 0.0 110.04 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.8 m80 63.43 58.22 1.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.838 1.255 . . . . 0.0 110.877 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -126.51 6.15 6.89 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.914 0.885 . . . . 0.0 111.413 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -45.72 -55.53 6.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 127.867 2.467 . . . . 0.0 110.808 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -93.06 33.01 1.21 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 111.956 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.37 -39.59 2.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.615 1.166 . . . . 0.0 108.204 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.2 pt -67.92 -38.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.25 -177.567 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m 75.25 73.51 0.09 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.19 0.995 . . . . 0.0 111.639 137.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -107.09 158.84 16.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.553 1.141 . . . . 0.0 111.629 -159.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 102.8 2.08 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.058 2.143 . . . . 0.0 108.025 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.57 122.24 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -93.02 132.01 37.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.508 0.14 . . . . 0.0 110.691 168.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -108.17 104.64 14.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mt -73.71 95.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -94.85 152.94 40.03 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 124.934 1.293 . . . . 0.0 108.705 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -52.81 -37.33 76.52 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.461 3.441 . . . . 0.0 112.236 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.81 -39.57 8.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 128.819 2.848 . . . . 0.0 111.088 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.16 62.75 0.23 Allowed Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 125.348 1.451 . . . . 0.0 109.555 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.2 157.1 0.17 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 127.597 2.359 . . . . 0.0 114.669 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -159.22 108.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.826 163.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.67 143.53 42.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.073 0.549 . . . . 0.0 110.856 164.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.92 162.71 38.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.401 1.08 . . . . 0.0 110.443 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -84.14 131.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 22.0 t -127.4 129.35 47.38 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.385 -0.126 . . . . 0.0 111.019 170.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.76 136.71 47.25 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.669 0.747 . . . . 0.0 110.298 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.29 -32.75 11.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.655 1.582 . . . . 0.0 112.316 165.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.68 -10.99 59.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.84 1.256 . . . . 0.0 112.285 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.22 148.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 119.141 0.882 . . . . 0.0 109.172 -167.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -74.92 150.44 39.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.686 -1.258 . . . . 0.0 109.576 -174.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -49.96 -40.55 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.284 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.269 0.0 OUTLIER -66.12 -32.22 73.55 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -65.65 -66.71 0.51 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-O 121.458 0.647 . . . . 0.0 109.537 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -56.83 -36.16 69.64 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.956 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.96 -58.93 4.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 122.02 -0.425 . . . . 0.0 111.028 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.08 -36.68 75.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.642 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.82 -39.58 62.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.7 0.682 . . . . 0.0 111.961 171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.46 -29.17 33.84 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.2 14.35 7.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.977 1.751 . . . . 0.0 111.601 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.36 112.28 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 117.754 0.777 . . . . 0.0 109.588 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -84.7 98.09 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.032 1.333 . . . . 0.0 109.159 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.29 156.9 53.98 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.592 -0.692 . . . . 0.0 109.848 174.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -75.67 92.92 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.86 2.373 . . . . 0.0 110.894 -173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -82.89 149.94 26.79 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.554 0.742 . . . . 0.0 111.463 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.25 -37.85 2.19 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.39 1.076 . . . . 0.0 111.104 168.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.98 -34.93 0.17 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.817 1.647 . . . . 0.0 112.118 -161.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.429 0.0 OUTLIER 22.61 98.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.835 3.254 . . . . 0.0 116.565 -165.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.69 -44.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.875 1.27 . . . . 0.0 112.052 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.7 58.99 0.75 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.736 1.16 . . . . 0.0 110.5 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.2 m 174.96 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.343 2.257 . . . . 0.0 108.22 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 21.6 p -152.4 -164.59 1.99 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.384 1.074 . . . . 0.0 109.45 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 t -139.69 47.65 1.84 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.88 177.24 10.02 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -165.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 63.35 132.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.182 2.193 . . . . 0.0 114.836 171.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.73 169.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.826 166.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -134.14 164.59 24.49 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 125.969 1.747 . . . . 0.0 109.208 162.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -98.24 109.25 22.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.796 1.638 . . . . 0.0 109.636 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.7 t -62.32 111.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.6 -42.08 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 122.852 0.461 . . . . 0.0 109.857 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.6 t -155.73 -166.75 2.3 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.48 -158.24 18.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.795 0.712 . . . . 0.0 111.929 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -145.58 154.91 42.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 168.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.3 pt -135.99 165.5 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -106.6 116.36 31.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -111.36 54.12 0.69 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.3 p -50.28 -45.86 54.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.509 -0.744 . . . . 0.0 109.494 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.6 42.83 0.54 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.251 1.42 . . . . 0.0 110.679 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -76.98 160.8 28.86 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.619 -1.3 . . . . 0.0 114.176 -175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 m -67.69 -71.48 0.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.473 1.109 . . . . 0.0 110.896 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -160.06 8.55 0.1 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.562 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.24 140.22 57.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.52 1.055 . . . . 0.0 109.921 -165.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.05 165.34 15.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.992 0.808 . . . . 0.0 109.641 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.17 -39.49 69.6 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.924 0.89 . . . . 0.0 108.757 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.87 -62.38 1.69 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.654 0.782 . . . . 0.0 109.519 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -51.93 -51.41 57.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.215 0.606 . . . . 0.0 111.573 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.0 mtm -51.56 -60.39 3.2 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.711 -0.618 . . . . 0.0 111.487 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.1 -43.39 78.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.704 1.202 . . . . 0.0 110.708 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.13 66.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.733 1.613 . . . . 0.0 111.37 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.71 27.61 1.03 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 116.921 -2.044 . . . . 0.0 112.569 169.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.464 ' CG ' HG21 ' A' ' 95' ' ' ILE . 90.9 m-85 -120.44 167.02 12.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 121.245 2.523 . . . . 0.0 114.953 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -164.69 146.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -171.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.98 148.55 51.82 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.805 1.639 . . . . 0.0 109.299 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -106.32 35.97 2.76 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.038 -1.039 . . . . 0.0 112.107 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 68.5 m -134.89 -105.08 0.22 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.638 1.975 . . . . 0.0 106.44 -174.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -76.4 68.76 2.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.99 0.916 . . . . 0.0 112.053 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.14 138.23 54.71 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.979 0.912 . . . . 0.0 109.434 173.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -108.95 124.4 34.29 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 126.123 1.769 . . . . 0.0 109.603 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -74.3 111.39 3.3 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.726 2.284 . . . . 0.0 111.673 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 p -82.07 -18.93 41.38 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.354 -0.841 . . . . 0.0 110.93 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -155.8 -177.12 6.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.225 1.41 . . . . 0.0 107.736 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.48 140.55 45.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 163.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.61 140.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 121.648 0.737 . . . . 0.0 111.938 -166.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.12 127.28 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.87 153.09 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 124.233 1.013 . . . . 0.0 108.921 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -103.17 125.94 50.1 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.42 1.088 . . . . 0.0 109.232 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.1 p -83.56 177.14 8.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.536 1.516 . . . . 0.0 109.237 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 69.38 57.0 0.36 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 112.106 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -128.05 32.74 4.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -60.47 -68.66 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -81.75 52.64 1.96 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.669 0.747 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.52 -40.43 0.34 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 130.293 3.437 . . . . 0.0 109.363 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.464 HG21 ' CG ' ' A' ' 73' ' ' TYR . 35.1 pt -75.58 -43.28 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 119.007 -0.521 . . . . 0.0 112.278 175.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.076 -1.44 . . . . 0.0 109.569 176.164 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.415 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 C--O 1.226 -0.143 0 CA-C-O 121.69 0.757 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m 61.92 69.68 0.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.884 160.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.8 158.48 15.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.518 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -81.21 84.65 6.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.982 1.713 . . . . 0.0 109.116 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -84.19 127.59 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -97.9 131.83 44.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 169.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.7 mt -109.41 110.93 22.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.732 1.27 . . . . 0.0 108.023 169.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -80.53 86.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.6 p -86.55 154.92 56.69 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.418 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.483 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 51.3 Cg_exo -55.07 -35.73 91.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.738 3.625 . . . . 0.0 112.411 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.39 -38.22 18.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.018 2.527 . . . . 0.0 111.212 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.34 61.86 0.21 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 125.593 1.568 . . . . 0.0 110.423 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 68.2 160.41 0.17 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.12 2.168 . . . . 0.0 111.997 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -129.18 -64.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.386 0.674 . . . . 0.0 111.53 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 75.54 127.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.068 1.747 . . . . 0.0 112.353 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -163.53 168.99 19.39 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.56 35.35 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.869 0.868 . . . . 0.0 112.12 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.0 t -125.98 129.42 49.19 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.743 0.817 . . . . 0.0 111.585 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.24 149.06 31.97 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.756 0.822 . . . . 0.0 110.284 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.5 p-10 -65.34 -19.27 65.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.94 -0.475 . . . . 0.0 111.997 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.05 -3.28 58.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.615 1.166 . . . . 0.0 111.8 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 p -134.24 153.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.52 1.055 . . . . 0.0 110.667 -170.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -76.89 156.23 32.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.126 0.489 . . . . 0.0 112.001 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.78 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.954 0.902 . . . . 0.0 111.596 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.46 -51.14 0.1 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.59 -60.48 2.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.956 0.903 . . . . 0.0 110.929 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -72.22 -5.12 33.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.35 -49.07 6.93 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.396 -0.815 . . . . 0.0 109.618 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -53.63 -38.84 64.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.672 0.789 . . . . 0.0 110.541 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.258 0.4 OUTLIER -58.25 -35.52 71.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 176.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.89 -25.77 40.49 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.61 11.7 6.45 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 125.811 1.672 . . . . 0.0 111.24 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.9 mt -75.44 121.35 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 118.279 1.039 . . . . 0.0 110.566 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -96.39 113.53 25.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 166.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.8 mt -107.33 137.62 19.67 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 163.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.92 114.92 4.17 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.733 2.289 . . . . 0.0 106.916 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 38' ' ' SER . 12.4 m-85 -63.63 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 167.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 37' ' ' TYR . 36.7 t 115.24 -66.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.347 2.659 . . . . 0.0 106.643 -164.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 p -113.5 -175.31 2.64 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 110.868 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.29 150.86 16.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.872 2.069 . . . . 0.0 107.383 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 83.81 91.86 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.725 2.41 . . . . 0.0 111.371 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -35.8 142.8 0.13 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.428 1.966 . . . . 0.0 113.99 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t 89.96 46.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.878 2.471 . . . . 0.0 108.178 -160.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -143.25 137.0 28.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.798 1.639 . . . . 0.0 108.01 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -107.81 77.29 1.11 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.2 1.0 . . . . 0.0 111.193 -168.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.86 -170.37 2.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 48' ' ' ALA . 1.8 m 62.29 175.69 0.13 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.648 1.179 . . . . 0.0 110.992 175.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 47' ' ' CYS . . . 153.91 170.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.514 1.926 . . . . 0.0 111.83 165.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.25 27.66 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 124.834 1.207 . . . . 0.0 111.054 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -101.62 111.04 23.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.175 1.79 . . . . 0.0 110.308 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.2 t -58.8 116.91 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.016 0.927 . . . . 0.0 109.306 173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -93.05 -47.02 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.3 t -158.31 170.71 21.62 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.26 -161.37 54.17 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -168.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -155.88 168.68 26.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.1 pt -147.08 162.26 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 127.581 2.352 . . . . 0.0 107.999 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -105.22 113.48 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.61 28.21 8.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.27 1.028 . . . . 0.0 111.772 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.1 p -57.43 -34.04 68.54 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.323 -0.86 . . . . 0.0 113.17 -172.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.74 -34.08 57.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.841 1.257 . . . . 0.0 113.054 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -55.59 -32.09 62.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -160.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 p 39.53 58.35 2.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.069 1.348 . . . . 0.0 113.12 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -149.51 -71.43 0.19 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.753 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.69 139.33 45.23 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 111.766 -168.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.43 164.91 22.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.05 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.95 -44.44 67.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.6 -61.71 2.11 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.886 0.875 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -53.05 -52.09 59.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.346 0.658 . . . . 0.0 111.433 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.8 mtt -53.87 -58.17 8.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.566 -0.709 . . . . 0.0 111.665 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.79 -43.63 69.43 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.62 1.168 . . . . 0.0 110.557 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.97 65.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.17 28.75 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.913 -1.493 . . . . 0.0 111.072 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CG ' HG21 ' A' ' 95' ' ' ILE . 86.2 m-85 -110.79 163.57 13.64 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 120.067 1.934 . . . . 0.0 113.939 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -158.38 167.58 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.683 1.593 . . . . 0.0 108.885 -168.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tt -118.73 105.47 11.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.821 1.648 . . . . 0.0 110.16 -173.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 p -79.94 48.67 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.358 1.463 . . . . 0.0 112.412 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.72 -59.05 0.2 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.229 0.612 . . . . 0.0 109.798 -164.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -120.64 64.26 0.85 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.278 1.831 . . . . 0.0 106.718 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.94 133.9 30.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.15 123.68 36.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.822 1.649 . . . . 0.0 109.409 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -72.84 114.83 4.14 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.193 2.596 . . . . 0.0 111.063 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 p -88.34 -17.02 31.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.944 0.498 . . . . 0.0 110.834 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 m -157.08 -178.74 7.59 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.543 1.537 . . . . 0.0 108.116 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -53.58 121.4 7.68 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 161.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.25 144.51 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.995 -177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.59 125.28 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.17 154.02 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 123.999 0.92 . . . . 0.0 108.669 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.57 121.87 41.82 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.199 1.0 . . . . 0.0 108.643 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.442 ' HG1' ' CD2' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -74.52 -178.23 3.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.917 1.235 . . . . 0.0 110.999 176.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.483 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 5.1 m-70 65.88 48.45 1.83 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.968 1.307 . . . . 0.0 112.931 169.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -119.31 15.39 13.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -40.65 -68.44 0.18 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.116 0.967 . . . . 0.0 109.68 170.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.81 17.51 0.71 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.991 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.14 -17.48 12.37 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 117.888 -1.054 . . . . 0.0 110.904 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.419 HG21 ' CG ' ' A' ' 73' ' ' TYR . 28.8 pt -89.82 -45.48 15.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 119.98 1.264 . . . . 0.0 111.673 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.157 -176.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 121.051 0.453 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.0 m 57.8 75.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.876 1.271 . . . . 0.0 112.695 169.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -98.39 158.75 15.39 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.56 0.744 . . . . 0.0 112.704 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -81.93 83.77 7.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.992 1.717 . . . . 0.0 109.181 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.66 121.68 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -89.55 132.34 35.13 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.675 167.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 71.8 mt -111.26 106.95 16.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.429 1.492 . . . . 0.0 107.238 170.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.1 mt -76.39 94.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 169.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -89.88 156.29 47.11 Favored Pre-proline 0 N--CA 1.444 -0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 108.689 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -52.12 -38.69 71.17 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.524 3.483 . . . . 0.0 112.422 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.69 -39.49 11.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 128.222 2.609 . . . . 0.0 111.237 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.05 66.19 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 125.585 1.564 . . . . 0.0 109.803 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.7 164.16 0.23 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.221 2.208 . . . . 0.0 112.565 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.71 -60.64 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.311 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 74.27 131.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.41 1.484 . . . . 0.0 111.598 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -162.44 167.86 22.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.54 124.44 39.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.4 t -131.78 123.99 28.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.187 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.79 138.7 56.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.41 1.484 . . . . 0.0 109.637 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -56.17 -27.29 53.85 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.691 1.597 . . . . 0.0 111.916 169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -87.0 1.18 53.67 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 111.865 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.41 156.53 41.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.639 1.109 . . . . 0.0 110.677 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -78.42 149.07 33.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 121.83 -0.543 . . . . 0.0 111.241 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.23 63.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 122.073 0.94 . . . . 0.0 110.423 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -166.32 -51.87 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.44 -63.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.397 0.617 . . . . 0.0 110.98 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -58.02 -32.58 68.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.357 0.599 . . . . 0.0 110.243 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.06 -58.26 9.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.49 -41.51 63.44 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.87 -24.53 48.46 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.77 -0.581 . . . . 0.0 110.073 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.61 12.1 6.86 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.924 1.726 . . . . 0.0 111.736 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 86.7 mt -76.24 111.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 117.826 0.813 . . . . 0.0 111.017 -177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -89.17 73.1 8.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 159.43 29.44 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 121.112 -0.992 . . . . 0.0 108.739 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.6 60.51 7.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.313 2.675 . . . . 0.0 110.989 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -83.43 161.07 21.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.29 0.566 . . . . 0.0 111.219 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.96 8.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 162.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 -72.96 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.945 0.793 . . . . 0.0 111.597 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.35 70.08 0.17 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.948 2.099 . . . . 0.0 112.454 -163.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.8 72.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.902 2.481 . . . . 0.0 111.36 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.8 -98.78 0.02 OUTLIER Glycine 0 CA--C 1.537 1.451 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.4 t -72.25 73.35 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -152.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 47' ' ' CYS . 16.7 p -137.48 -151.56 0.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.368 1.467 . . . . 0.0 111.444 -172.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 t -157.33 66.0 0.5 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.116 1.366 . . . . 0.0 109.049 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.3 m -158.03 62.64 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 3.7 m -141.26 -148.07 0.23 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.264 0.554 . . . . 0.0 109.564 -168.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 81.91 127.01 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.628 1.971 . . . . 0.0 113.206 157.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.51 27.34 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.737 1.637 . . . . 0.0 109.848 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -92.77 111.04 22.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.834 1.254 . . . . 0.0 109.965 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.93 110.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.46 -42.43 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 t -157.24 -167.88 2.45 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.65 -153.64 14.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.01 0.814 . . . . 0.0 111.644 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.6 m -157.28 154.99 29.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 26.9 pt -141.75 166.31 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.43 1.892 . . . . 0.0 106.381 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -109.44 119.71 40.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -108.36 46.31 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.678 0.791 . . . . 0.0 111.295 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 t -63.23 -10.69 16.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -60.13 -61.64 2.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.302 0.955 . . . . 0.0 108.999 167.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 73.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.655 2.382 . . . . 0.0 112.636 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.8 p -83.75 -81.84 0.17 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 122.709 0.403 . . . . 0.0 111.231 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -145.26 8.47 1.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.186 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.0 142.89 55.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.167 0.894 . . . . 0.0 109.194 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.85 167.23 11.76 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.865 0.728 . . . . 0.0 109.67 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.88 -41.91 75.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.966 0.907 . . . . 0.0 109.029 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -60.16 3.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.853 0.861 . . . . 0.0 109.545 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -55.1 -50.32 69.49 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.647 0.779 . . . . 0.0 110.999 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 20.2 mtm -51.29 -59.83 3.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.829 -0.544 . . . . 0.0 112.182 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.04 -43.19 73.53 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.239 1.016 . . . . 0.0 110.511 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.03 -22.89 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.585 1.554 . . . . 0.0 111.797 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.42 35.55 0.8 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-O 118.33 -1.261 . . . . 0.0 111.019 170.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -116.46 161.77 18.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.789 1.794 . . . . 0.0 112.777 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.3 146.0 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.423 1.089 . . . . 0.0 108.74 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.9 pp -70.27 165.7 21.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.611 1.096 . . . . 0.0 110.897 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 p -134.99 41.94 2.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.231 0.613 . . . . 0.0 110.854 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.0 m -137.44 -54.08 0.68 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.425 1.09 . . . . 0.0 110.271 -166.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.72 57.71 1.6 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.978 1.711 . . . . 0.0 109.484 174.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.95 137.95 51.64 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -106.15 120.72 47.9 Favored Pre-proline 0 C--O 1.234 0.267 0 C-N-CA 126.105 1.762 . . . . 0.0 109.275 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -75.4 116.08 4.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.675 2.25 . . . . 0.0 112.031 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -90.41 -15.42 30.99 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.027 -0.421 . . . . 0.0 111.385 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.8 m -158.48 -177.31 6.45 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.088 1.355 . . . . 0.0 108.524 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -64.36 84.46 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.116 1.766 . . . . 0.0 109.941 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 p -85.82 155.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.822 1.249 . . . . 0.0 110.977 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.71 125.09 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.62 153.21 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.509 1.124 . . . . 0.0 108.642 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -101.39 129.09 47.34 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.787 170.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 p -88.51 176.89 6.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.083 1.311 . . . . 0.0 109.463 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 66.11 55.21 0.92 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 0.0 111.487 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -122.0 13.86 10.61 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -46.06 -62.76 1.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.794 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.99 28.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.306 0.642 . . . . 0.0 112.302 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -125.77 -12.35 6.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.819 1.248 . . . . 0.0 111.836 168.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.7 pt -91.21 -40.37 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 119.876 1.216 . . . . 0.0 111.924 172.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.964 -1.494 . . . . 0.0 110.173 178.096 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m 80.97 112.15 0.07 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.228 1.411 . . . . 0.0 111.901 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.4 155.21 37.83 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.75 0.82 . . . . 0.0 111.298 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -76.97 99.65 5.34 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.044 2.537 . . . . 0.0 108.038 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.89 118.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -85.94 129.95 34.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.126 0.266 . . . . 0.0 110.372 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.4 mt -108.92 102.88 11.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.0 mt -71.37 94.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 171.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -93.52 155.21 40.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.66 -32.61 76.25 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.745 2.963 . . . . 0.0 112.244 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.4 -33.91 45.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.679 2.392 . . . . 0.0 111.392 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.52 0.34 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 125.212 1.387 . . . . 0.0 110.489 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 71.47 145.27 0.07 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.868 2.467 . . . . 0.0 114.262 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.23 97.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -69.14 135.91 51.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.847 161.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -151.19 170.33 19.71 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.595 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 119.51 39.17 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.2 t -122.01 126.22 48.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.959 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.59 145.73 45.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.725 1.726 . . . . 0.0 110.936 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 3.1 p-10 -56.74 -24.64 51.14 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 127.198 2.199 . . . . 0.0 112.119 173.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -103.78 10.06 36.75 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.456 1.502 . . . . 0.0 111.332 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 p -134.53 158.36 41.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.52 1.054 . . . . 0.0 110.943 -175.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -77.91 138.08 38.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 t -49.0 -48.93 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.612 0.244 . . . . 0.0 110.916 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -37.81 74.02 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.03 -64.07 0.93 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.718 0.77 . . . . 0.0 108.939 -167.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 20.4 mm100 -57.17 -40.92 78.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.301 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.1 -59.54 3.81 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.753 -0.592 . . . . 0.0 111.454 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.69 -39.71 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.112 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -53.03 -40.95 64.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -75.22 -24.85 57.8 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 121.849 -0.532 . . . . 0.0 109.749 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.88 12.88 6.86 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.615 1.578 . . . . 0.0 111.057 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 89.1 mt -75.77 116.38 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.672 0.736 . . . . 0.0 110.785 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -80.38 63.93 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.9 156.26 87.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.67 76.39 1.94 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.33 2.686 . . . . 0.0 109.512 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -56.32 -63.93 1.03 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.705 1.202 . . . . 0.0 110.561 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t 66.0 -134.14 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.327 1.051 . . . . 0.0 110.882 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 173.24 0.3 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.523 1.056 . . . . 0.0 110.157 165.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.63 101.42 1.99 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 161.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.35 -36.47 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.824 0.849 . . . . 0.0 112.904 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 77.09 1.14 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 -26.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 0.0 111.71 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.04 -179.59 0.96 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.779 0.718 . . . . 0.0 111.091 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t -128.93 69.1 1.39 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.2 p -163.08 168.33 21.06 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.344 1.458 . . . . 0.0 107.178 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 75' ' ' LEU . 0.1 OUTLIER 66.83 147.81 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.008 1.723 . . . . 0.0 111.506 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 168.29 169.27 0.04 OUTLIER 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.49 1.516 . . . . 0.0 111.122 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.22 166.0 26.16 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 125.478 1.513 . . . . 0.0 110.574 168.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -101.35 107.68 19.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.284 1.834 . . . . 0.0 110.087 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -59.56 109.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.19 -46.67 25.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -162.76 177.71 9.1 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.39 -161.96 23.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 m -156.71 144.83 19.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 168.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.1 pt -143.93 164.08 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.817 1.647 . . . . 0.0 106.741 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -108.96 109.9 21.07 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -104.75 25.08 10.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 0.0 111.928 170.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.8 m -77.24 31.4 0.14 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.371 -1.456 . . . . 0.0 113.301 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -125.6 12.94 8.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.828 1.651 . . . . 0.0 109.653 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -115.91 -36.31 4.19 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -161.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m 41.86 64.39 1.09 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -142.9 -74.38 0.28 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.873 168.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -52.22 141.13 19.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.069 0.85 . . . . 0.0 112.244 -168.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -83.94 169.06 15.43 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 124.424 1.078 . . . . 0.0 109.881 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.17 -44.86 71.85 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.64 -62.37 1.69 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.133 0.973 . . . . 0.0 109.482 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.39 -49.3 67.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.017 0.527 . . . . 0.0 111.359 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.18 -60.63 3.07 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.544 -0.722 . . . . 0.0 111.483 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.88 -42.19 68.39 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.248 1.019 . . . . 0.0 110.701 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.25 65.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.872 1.669 . . . . 0.0 112.32 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.83 30.64 1.93 Allowed Glycine 0 C--O 1.221 -0.715 0 CA-C-O 117.554 -1.692 . . . . 0.0 111.527 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.421 ' CG ' HG21 ' A' ' 95' ' ' ILE . 96.4 m-85 -118.12 161.44 19.85 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.52 2.16 . . . . 0.0 113.514 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.69 140.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.518 ' CD1' ' SG ' ' A' ' 47' ' ' CYS . 0.9 OUTLIER -78.46 136.39 37.6 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.18 -57.01 14.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.882 0.873 . . . . 0.0 110.886 -178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 62.8 m -61.56 125.05 22.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.433 0.693 . . . . 0.0 109.648 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 74.04 69.8 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.279 1.032 . . . . 0.0 112.791 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.19 128.4 20.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.214 1.406 . . . . 0.0 109.562 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -112.19 123.01 35.25 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.222 1.809 . . . . 0.0 109.096 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -75.38 129.69 12.23 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.788 2.325 . . . . 0.0 111.595 -177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.3 p -104.05 -12.49 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.5 m -157.16 -174.93 5.14 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.13 127.77 33.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.1 t -135.91 153.76 32.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.674 0.79 . . . . 0.0 109.569 -173.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.63 121.15 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.27 152.83 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.418 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 21.6 mt-10 -101.13 131.2 47.18 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 124.347 1.059 . . . . 0.0 109.284 168.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -88.74 177.46 6.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.153 1.342 . . . . 0.0 109.434 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.1 54.46 0.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.915 1.286 . . . . 0.0 111.437 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.418 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 29.4 mmtt -125.32 22.37 7.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.74 0.816 . . . . 0.0 112.895 -174.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -45.75 -72.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 108.91 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.09 37.57 0.44 Allowed 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.935 -0.478 . . . . 0.0 111.812 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -122.06 -29.54 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.452 1.501 . . . . 0.0 110.647 163.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.421 HG21 ' CG ' ' A' ' 73' ' ' TYR . 26.1 pt -83.68 -45.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 119.347 0.976 . . . . 0.0 112.608 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.981 -1.485 . . . . 0.0 109.803 -175.662 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.489 ' N ' ' OD1' ' A' ' 21' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m 97.41 105.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.767 2.427 . . . . 0.0 112.305 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -131.63 155.61 47.26 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.97 0.908 . . . . 0.0 112.54 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.29 96.93 0.06 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.277 2.631 . . . . 0.0 109.651 169.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.38 118.59 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -85.82 130.24 34.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.471 0.176 . . . . 0.0 111.238 167.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.2 mt -110.06 105.25 14.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 124.483 1.114 . . . . 0.0 108.603 169.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.5 mt -78.3 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -87.11 153.53 54.27 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.99 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.09 -35.05 89.56 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.951 3.101 . . . . 0.0 112.397 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.27 -38.8 13.13 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 127.485 2.314 . . . . 0.0 111.14 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.69 62.12 0.19 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 125.283 1.421 . . . . 0.0 110.197 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 67.43 162.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.111 2.164 . . . . 0.0 111.921 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.49 -59.85 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 123.438 0.695 . . . . 0.0 110.15 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.26 137.45 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 126.354 1.862 . . . . 0.0 112.464 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.64 174.65 11.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.725 0.41 . . . . 0.0 111.722 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 122.77 42.45 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.6 126.58 50.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.21 133.64 49.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.35 -30.87 30.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.315 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -70.1 -14.1 62.51 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.949 1.3 . . . . 0.0 112.136 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.52 160.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.34 147.05 42.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.032 -0.417 . . . . 0.0 111.86 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.2 62.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 122.174 0.987 . . . . 0.0 110.335 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.21 -60.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -49.59 -58.25 5.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.757 1.265 . . . . 0.0 109.823 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -74.93 -20.13 59.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.925 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.72 -52.05 54.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.25 -40.86 68.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.213 0.605 . . . . 0.0 109.976 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.56 -39.61 64.9 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.42 -24.74 46.03 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.704 -0.622 . . . . 0.0 109.763 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.11 10.1 6.97 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.87 1.7 . . . . 0.0 111.37 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.4 mt -78.02 129.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.119 0.96 . . . . 0.0 111.012 -176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -87.2 125.41 34.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 mt -123.04 148.41 54.25 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 164.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.407 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 36.6 Cg_endo -78.17 64.53 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 124.126 3.217 . . . . 0.0 110.859 -171.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -68.73 -31.08 69.89 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.097 0.959 . . . . 0.0 113.488 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 t 57.86 -84.65 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.72 -159.9 0.77 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.268 3.027 . . . . 0.0 108.56 -174.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.414 ' HA ' ' S1 ' ' A' ' 97' ' ' FES . 2.1 ttp180 -166.99 59.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.024 1.284 . . . . 0.0 112.592 169.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.38 10.02 1.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.13 -69.05 0.34 Allowed Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.474 1.034 . . . . 0.0 111.988 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 p -75.45 65.64 1.74 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.6 p -158.16 147.08 19.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.267 1.827 . . . . 0.0 106.1 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.2 m -102.14 85.01 2.58 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.674 -166.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.8 p -159.99 -145.87 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.795 0.725 . . . . 0.0 111.668 167.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.2 m 56.55 -114.92 0.87 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.932 1.693 . . . . 0.0 111.313 165.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 64.05 149.48 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.595 2.358 . . . . 0.0 113.574 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.01 158.31 27.6 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.001 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -95.43 109.81 21.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.074 1.35 . . . . 0.0 109.584 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 40.7 t -61.14 107.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.436 1.094 . . . . 0.0 108.225 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.29 -37.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -157.7 -163.21 1.3 Allowed 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.53 -171.28 51.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.033 0.349 . . . . 0.0 113.168 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.92 129.94 12.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 pt -139.1 152.28 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -100.72 112.97 25.47 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -105.68 41.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.249 0.62 . . . . 0.0 110.765 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -49.79 -37.44 30.04 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.413 1.006 . . . . 0.0 111.495 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.2 6.27 3.69 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.607 0.763 . . . . 0.0 112.455 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -59.33 -62.17 2.08 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.343 1.457 . . . . 0.0 111.858 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.6 m 37.86 39.37 0.22 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.616 1.166 . . . . 0.0 113.355 -165.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -143.85 -70.43 0.31 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.34 1.056 . . . . 0.0 110.484 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -56.9 144.32 34.03 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.987 0.812 . . . . 0.0 110.156 -172.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.19 165.58 14.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.618 0.723 . . . . 0.0 110.233 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.16 -41.35 71.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.818 1.247 . . . . 0.0 108.683 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.54 -60.63 2.93 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.129 0.972 . . . . 0.0 109.465 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -54.41 -48.26 71.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.462 0.705 . . . . 0.0 111.39 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.0 mtt -53.98 -60.18 3.67 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.521 -0.737 . . . . 0.0 111.106 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.67 -44.72 69.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.747 1.219 . . . . 0.0 110.558 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.18 64.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.741 1.617 . . . . 0.0 112.254 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.88 32.59 1.4 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.415 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.42 ' CG ' HG21 ' A' ' 95' ' ' ILE . 95.0 m-85 -120.24 159.38 25.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.343 2.072 . . . . 0.0 113.184 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.4 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 5.1 p -154.26 150.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.552 1.141 . . . . 0.0 108.73 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.24 119.9 22.97 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.7 p -70.76 -45.81 64.09 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.465 -0.772 . . . . 0.0 110.817 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 26.3 p -59.12 -33.58 71.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.503 1.521 . . . . 0.0 112.326 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -128.58 72.24 1.43 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.137 0.975 . . . . 0.0 110.181 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.33 141.47 39.73 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.263 1.025 . . . . 0.0 109.282 168.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.66 118.44 45.08 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.006 1.723 . . . . 0.0 109.281 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -75.85 108.79 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.339 2.693 . . . . 0.0 112.707 -174.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -88.43 -12.98 41.59 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.865 -0.522 . . . . 0.0 111.366 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.8 m -152.62 -177.27 6.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.167 1.387 . . . . 0.0 108.103 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.16 124.21 20.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 166.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.5 t -133.62 156.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.558 0.694 . . . . 0.0 111.282 -173.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.7 t -123.3 118.77 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.39 152.24 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.165 0.986 . . . . 0.0 108.939 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.53 127.55 46.86 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.077 0.951 . . . . 0.0 108.833 170.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -83.33 179.49 7.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.042 1.292 . . . . 0.0 110.139 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.407 ' CE1' ' HD3' ' A' ' 36' ' ' PRO . 1.3 m80 69.73 55.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.153 1.381 . . . . 0.0 111.122 173.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.54 13.59 9.43 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -34.88 -76.29 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.855 2.062 . . . . 0.0 110.767 166.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.77 40.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.002 0.819 . . . . 0.0 112.426 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.37 -28.78 4.94 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.311 1.044 . . . . 0.0 111.047 158.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.42 HG21 ' CG ' ' A' ' 73' ' ' TYR . 34.8 pt -81.42 -48.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.296 0.953 . . . . 0.0 112.896 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.044 -173.306 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' FES . . . . . 0.414 ' S1 ' ' HA ' ' A' ' 40' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 121.612 0.72 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -97.36 159.59 14.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -171.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.95 90.15 6.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.305 1.842 . . . . 0.0 109.614 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 85' ' ' VAL . 65.0 t -89.47 124.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -89.76 132.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.147 0.43 . . . . 0.0 110.836 165.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.543 HD23 HG23 ' A' ' 87' ' ' ILE . 70.4 mt -111.68 103.57 11.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 165.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.5 mt -71.62 95.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -92.79 156.75 40.53 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 124.145 0.978 . . . . 0.0 108.925 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.56 -35.3 76.38 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.2 3.267 . . . . 0.0 112.227 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.3 -30.97 52.8 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 127.376 2.27 . . . . 0.0 111.494 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.53 61.01 0.41 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 125.005 1.288 . . . . 0.0 110.73 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 71.95 142.72 0.06 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 127.768 2.427 . . . . 0.0 114.187 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.93 87.29 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.495 1.118 . . . . 0.0 108.148 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -66.71 132.18 47.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 109.746 167.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -153.38 166.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.133 0.573 . . . . 0.0 111.839 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.23 122.99 39.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.432 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -127.08 123.03 35.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.505 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 143.03 54.9 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.799 1.24 . . . . 0.0 110.099 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -24.99 47.73 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 127.333 2.253 . . . . 0.0 111.182 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -107.88 21.29 17.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.589 1.555 . . . . 0.0 111.462 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -134.55 158.31 41.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.757 1.162 . . . . 0.0 110.633 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -78.68 144.89 34.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.343 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.02 61.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.871 0.868 . . . . 0.0 111.098 173.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 tp -169.11 -61.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.06 -55.95 12.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.057 0.943 . . . . 0.0 109.253 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -77.05 -13.76 59.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.876 0.87 . . . . 0.0 112.831 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -75.57 -50.46 15.51 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 120.945 -1.097 . . . . 0.0 108.603 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -53.38 -38.98 63.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.199 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.61 -38.8 56.26 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.59 -23.89 34.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.764 -0.585 . . . . 0.0 109.608 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.24 15.23 4.25 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.072 1.796 . . . . 0.0 111.473 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.657 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 82.2 mt -80.59 108.41 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.038 0.919 . . . . 0.0 112.445 -170.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.98 72.91 6.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.175 0.99 . . . . 0.0 110.398 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 O-C-N 120.921 -1.112 . . . . 0.0 109.651 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.319 0.58 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.56 164.46 27.01 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 125.942 1.734 . . . . 0.0 110.165 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -98.66 110.25 22.88 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.671 1.588 . . . . 0.0 110.502 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.49 115.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.63 -48.03 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.221 0.609 . . . . 0.0 109.505 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -160.87 173.99 14.51 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.067 -0.396 . . . . 0.0 110.223 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.49 -176.59 47.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.443 1.021 . . . . 0.0 110.742 -168.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -135.15 149.44 49.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.699 HD11 HG21 ' A' ' 74' ' ' VAL . 36.4 pt -147.47 165.29 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.124 1.77 . . . . 0.0 107.54 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.12 113.54 21.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 108.748 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.414 ' CD ' HG23 ' A' ' 74' ' ' VAL . 10.7 pt20 -110.86 31.77 5.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.023 170.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 p . . . . . 0 N--CA 1.467 0.423 0 CA-C-N 121.101 1.773 . . . . 0.0 111.191 -178.71 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.14 166.43 18.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 124.043 0.839 . . . . 0.0 109.85 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -53.56 -43.99 68.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.0 -61.52 2.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.126 0.97 . . . . 0.0 109.608 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -54.95 -50.08 69.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.269 0.627 . . . . 0.0 111.376 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mtt -51.95 -59.36 4.43 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.489 -0.757 . . . . 0.0 111.314 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.03 -42.28 76.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.45 1.1 . . . . 0.0 110.832 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.42 -20.72 65.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.683 1.593 . . . . 0.0 111.753 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.57 33.8 1.06 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 117.786 -1.564 . . . . 0.0 111.413 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.97 162.67 18.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.348 2.074 . . . . 0.0 113.297 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 56' ' ' ILE . 13.0 p . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 125.061 1.344 . . . . 0.0 108.469 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.88 122.96 38.42 Favored Pre-proline 0 C--O 1.235 0.318 0 C-N-CA 125.537 1.535 . . . . 0.0 108.945 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.3 Cg_endo -76.33 113.95 3.79 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.221 2.614 . . . . 0.0 111.284 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 p -89.52 -12.55 39.67 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.375 -0.828 . . . . 0.0 111.749 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.1 m -157.79 -177.88 6.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.634 1.574 . . . . 0.0 107.687 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.5 113.17 1.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 162.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 5' ' ' VAL . 2.5 p -120.57 145.77 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.447 1.499 . . . . 0.0 108.595 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.71 125.63 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.543 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -138.03 155.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -102.87 128.42 49.66 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.28 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.444 ' CG2' HD22 ' A' ' 7' ' ' LEU . 43.0 p -86.4 178.73 7.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.045 1.293 . . . . 0.0 109.093 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.28 51.37 0.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.596 1.158 . . . . 0.0 111.178 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -127.62 37.62 4.18 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.584 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -70.08 0.25 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 165.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -72.92 33.16 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.737 -1.227 . . . . 0.0 113.803 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -121.97 -3.9 9.1 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.707 -1.245 . . . . 0.0 111.751 159.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.7 pt -111.75 -39.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.344 1.429 . . . . 0.0 111.694 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.253 1.275 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.436 175.712 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.101 0.477 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -104.81 156.02 18.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.278 0.561 . . . . 0.0 112.307 -167.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.34 104.39 2.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 127.835 2.454 . . . . 0.0 108.462 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.91 117.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -88.8 131.61 35.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.716 0.235 . . . . 0.0 111.283 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.553 HD12 HD13 ' A' ' 33' ' ' ILE . 79.5 mt -109.19 103.69 12.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.419 1.075 . . . . 0.0 109.105 167.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 53.9 mt -76.44 99.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -89.77 166.69 19.69 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 124.313 1.045 . . . . 0.0 109.48 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.18 -25.85 30.87 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.086 2.524 . . . . 0.0 111.182 166.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -46.11 78.7 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.169 0.988 . . . . 0.0 109.662 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.83 64.94 0.08 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 67.55 147.35 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.522 1.929 . . . . 0.0 113.643 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 p -154.43 105.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.398 165.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.99 142.35 41.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -152.41 169.24 23.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.182 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 123.5 44.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.4 124.72 50.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.734 0.646 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.03 151.55 45.7 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.524 1.63 . . . . 0.0 109.008 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -14.56 59.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 129.333 3.053 . . . . 0.0 110.566 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -114.4 20.04 15.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.533 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.58 148.91 29.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.087 0.858 . . . . 0.0 109.227 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -67.76 146.07 54.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.069 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.2 t -51.09 -51.53 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -57.32 12.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.305 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.94 -63.08 1.06 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.21 0.914 . . . . 0.0 110.611 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -69.69 -34.67 74.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 33' ' ' ILE . . . -51.18 -57.4 8.87 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.676 -0.64 . . . . 0.0 110.911 170.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -55.39 -41.7 73.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.01 -38.59 65.28 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.22 -25.89 58.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.275 0.56 . . . . 0.0 109.794 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.63 13.65 6.09 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.385 1.469 . . . . 0.0 110.946 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.553 HD13 HD12 ' A' ' 7' ' ' LEU . 93.7 mt -75.63 121.6 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 117.624 0.712 . . . . 0.0 110.496 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.04 80.74 8.74 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.912 0.863 . . . . 0.0 113.069 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.692 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -139.04 165.78 25.58 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.151 1.834 . . . . 0.0 110.335 172.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -102.95 111.1 23.27 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.006 1.722 . . . . 0.0 110.977 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.27 117.38 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.938 0.79 . . . . 0.0 109.341 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.7 -47.68 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.294 1.038 . . . . 0.0 109.013 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.451 ' O ' HG23 ' A' ' 85' ' ' VAL . 8.2 t -161.12 175.35 12.49 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 122.075 -0.391 . . . . 0.0 110.417 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.22 -160.83 52.72 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.559 1.076 . . . . 0.0 110.762 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 t -151.48 169.86 21.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.681 ' CD1' HG21 ' A' ' 74' ' ' VAL . 8.6 pt -161.46 160.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 127.234 2.214 . . . . 0.0 107.593 -167.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -114.82 110.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.417 ' CD ' HG23 ' A' ' 74' ' ' VAL . 9.8 pt20 -106.58 37.16 2.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 111.264 170.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 CA--C 1.534 0.336 0 CA-C-N 118.951 0.796 . . . . 0.0 111.113 171.662 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.452 0.168 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.23 166.38 15.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 124.065 0.853 . . . . 0.0 109.893 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.95 -43.88 70.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.25 -61.97 1.91 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.234 1.014 . . . . 0.0 109.563 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -54.38 -50.95 66.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.979 0.511 . . . . 0.0 111.466 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mtm -53.98 -58.06 8.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.455 -0.778 . . . . 0.0 111.51 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.85 -44.33 70.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.714 1.206 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.64 67.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.811 1.645 . . . . 0.0 111.945 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.93 32.86 0.96 Allowed Glycine 0 C--O 1.223 -0.569 0 CA-C-O 117.601 -1.666 . . . . 0.0 111.774 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.544 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.8 m-85 -121.02 163.66 17.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.557 2.179 . . . . 0.0 113.635 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.681 HG21 ' CD1' ' A' ' 56' ' ' ILE . 13.2 p . . . . . 0 N--CA 1.452 -0.369 0 C-N-CA 123.759 0.824 . . . . 0.0 108.906 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -106.66 131.46 21.68 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 126.558 1.943 . . . . 0.0 109.357 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.3 Cg_endo -78.27 121.37 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.799 2.333 . . . . 0.0 111.725 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -97.29 -12.88 22.37 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.713 -0.617 . . . . 0.0 112.333 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -157.11 -175.23 5.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.563 1.545 . . . . 0.0 106.835 170.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -55.2 140.11 39.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 164.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 56' ' ' ILE . 3.3 p -156.33 146.23 11.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.754 0.788 . . . . 0.0 110.311 -168.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.84 126.8 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.692 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -143.14 147.93 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.878 0.871 . . . . 0.0 109.103 -177.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.503 ' N ' HD13 ' A' ' 87' ' ' ILE . 30.5 mt-10 -104.22 116.74 32.72 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.283 1.033 . . . . 0.0 110.813 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.1 p -79.11 176.25 9.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.244 0.929 . . . . 0.0 109.742 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 67.62 52.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.602 1.161 . . . . 0.0 111.082 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -123.6 43.98 2.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.683 0.793 . . . . 0.0 110.841 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.3 -71.6 0.2 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.82 50.64 1.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.696 -0.627 . . . . 0.0 111.846 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.73 -28.05 1.64 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.594 2.358 . . . . 0.0 111.618 165.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.544 HG22 ' CG ' ' A' ' 73' ' ' TYR . 26.0 pt -91.85 -42.19 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 119.184 0.902 . . . . 0.0 112.552 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 117.351 -1.309 . . . . 0.0 109.254 -177.396 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.422 0.154 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -128.81 156.1 44.13 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.195 0.598 . . . . 0.0 111.222 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.09 102.11 2.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.842 2.457 . . . . 0.0 108.469 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.64 120.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -90.53 131.94 35.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 123.165 0.291 . . . . 0.0 111.004 166.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.21 103.26 12.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 108.285 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mt -74.2 90.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -88.45 154.38 51.15 Favored Pre-proline 0 N--CA 1.444 -0.741 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -57.3 -31.95 92.36 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.87 3.046 . . . . 0.0 112.12 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.84 -33.76 37.49 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.916 2.086 . . . . 0.0 111.087 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.46 61.53 0.27 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 124.898 1.237 . . . . 0.0 110.145 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 68.57 153.79 0.1 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.152 2.181 . . . . 0.0 114.043 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.04 98.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.825 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.36 145.48 45.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.341 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -157.24 172.79 18.0 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.47 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.09 122.61 44.46 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t -122.94 127.86 49.47 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -69.32 141.88 54.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.738 1.256 . . . . 0.0 109.951 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -21.75 55.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 129.886 3.274 . . . . 0.0 111.52 173.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -107.6 12.85 27.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.809 1.644 . . . . 0.0 110.606 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.44 157.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.261 0.937 . . . . 0.0 110.61 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -76.12 149.07 37.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.219 0.608 . . . . 0.0 110.806 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.3 t -72.54 66.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.84 0.829 . . . . 0.0 111.226 173.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 26' ' ' ASP . 1.4 pt? -163.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.583 1.553 . . . . 0.0 108.723 168.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' H ' HD23 ' A' ' 25' ' ' LEU . 4.9 t70 -57.92 -57.76 11.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 -170.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -63.08 -35.06 78.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.645 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -56.43 -56.73 17.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.637 -0.665 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.86 -39.75 74.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 109.767 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -52.15 -42.15 63.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.869 0.759 . . . . 0.0 112.765 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.07 -23.26 55.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.048 0.451 . . . . 0.0 109.974 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.26 12.88 7.27 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.91 1.719 . . . . 0.0 111.369 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.53 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 64.2 mt -80.42 129.66 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.542 0.671 . . . . 0.0 111.1 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -93.32 127.6 38.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.132 0.973 . . . . 0.0 108.436 164.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.7 pt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 165.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -142.54 166.09 26.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.004 1.764 . . . . 0.0 110.99 175.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -102.73 110.2 22.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.761 2.024 . . . . 0.0 110.873 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.04 114.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 119.14 0.882 . . . . 0.0 109.062 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.98 -44.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.3 t -161.54 177.64 9.85 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.99 -168.77 43.93 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -142.71 151.2 41.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.707 HG23 HG21 ' A' ' 85' ' ' VAL . 28.7 pt -142.35 157.2 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 173.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -99.74 107.63 19.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.3 39.88 1.64 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.676 0.79 . . . . 0.0 111.442 170.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 119.492 1.042 . . . . 0.0 111.589 174.398 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.9 164.83 15.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.729 0.643 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.59 -43.19 68.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.163 0.985 . . . . 0.0 108.543 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -52.3 -61.63 2.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.089 0.956 . . . . 0.0 109.421 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -52.52 -52.28 55.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 111.332 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.7 mtt -52.33 -59.88 3.88 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 111.317 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.76 -44.0 73.26 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.954 1.302 . . . . 0.0 110.677 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.18 -20.84 64.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.744 1.618 . . . . 0.0 111.769 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.69 32.94 1.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-O 117.972 -1.46 . . . . 0.0 111.149 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.478 ' CG ' HG22 ' A' ' 95' ' ' ILE . 93.6 m-85 -118.35 165.88 13.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.963 1.882 . . . . 0.0 113.049 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.634 HG21 HD11 ' A' ' 56' ' ' ILE . 7.6 p . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . . . . . . . . 0 N--CA 1.46 0.074 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.4 125.44 37.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.215 1.406 . . . . 0.0 109.416 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.8 Cg_endo -74.25 114.99 4.17 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.858 2.372 . . . . 0.0 110.811 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.4 p -94.71 -9.8 33.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.144 0.884 . . . . 0.0 112.129 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -156.9 -177.7 6.81 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 107.491 169.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -55.58 139.25 44.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 163.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.707 HG21 HG23 ' A' ' 56' ' ' ILE . 3.5 p -157.56 146.43 10.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.483 -165.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.87 124.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.423 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -139.11 152.21 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.885 0.874 . . . . 0.0 108.86 178.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 17.0 mt-10 -103.99 117.23 33.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.138 0.975 . . . . 0.0 109.854 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 p -80.32 174.63 11.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.381 -0.824 . . . . 0.0 111.301 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.96 55.63 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.654 1.582 . . . . 0.0 111.281 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 20.6 mmtt -126.33 25.81 6.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.429 0.692 . . . . 0.0 112.668 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.13 -70.56 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.19 0.996 . . . . 0.0 108.725 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -79.77 39.12 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.557 -0.714 . . . . 0.0 112.373 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.92 -43.5 3.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.632 1.173 . . . . 0.0 109.275 161.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.478 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.3 pt -75.89 -41.48 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.314 -1.327 . . . . 0.0 109.559 -177.741 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 121.315 0.579 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -102.81 156.96 17.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.129 0.572 . . . . 0.0 112.394 -167.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -83.07 89.59 6.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.145 1.778 . . . . 0.0 109.8 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG13 HG13 ' A' ' 85' ' ' VAL . 85.2 t -87.31 127.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.69 131.32 43.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.139 0.427 . . . . 0.0 111.772 166.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.466 HD12 HG21 ' A' ' 33' ' ' ILE . 37.6 mt -108.8 105.14 14.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.34 1.025 . . . . 0.0 108.396 166.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.19 94.0 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -93.16 155.24 41.31 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.083 0.953 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -56.5 -32.42 89.48 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.938 3.092 . . . . 0.0 112.147 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.91 48.95 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 126.541 1.936 . . . . 0.0 111.215 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.49 60.08 0.35 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 124.861 1.219 . . . . 0.0 110.935 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 67.89 141.68 0.04 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.263 2.225 . . . . 0.0 114.127 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 33' ' ' ILE . 34.2 m -139.64 98.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.059 1.343 . . . . 0.0 107.864 169.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -82.18 133.31 35.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.696 1.599 . . . . 0.0 109.687 171.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.73 172.46 18.56 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 124.4 46.81 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 122.809 0.443 . . . . 0.0 110.224 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 48.6 t -125.43 128.21 47.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.98 140.06 50.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 123.832 1.777 . . . . 0.0 110.38 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -24.16 28.71 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 129.203 3.001 . . . . 0.0 111.335 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.36 7.24 38.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.574 1.549 . . . . 0.0 112.036 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.0 157.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-N 119.796 1.18 . . . . 0.0 110.302 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.53 147.35 41.89 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 122.013 -0.429 . . . . 0.0 110.804 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -53.96 -57.03 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.659 0.383 . . . . 0.0 110.137 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.54 -51.03 61.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.331 0.652 . . . . 0.0 111.089 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.28 -65.59 0.54 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.611 0.764 . . . . 0.0 110.64 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.57 -42.46 78.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.616 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -53.58 -59.92 3.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.965 -0.46 . . . . 0.0 111.176 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -58.87 -36.4 74.57 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.897 -0.573 . . . . 0.0 110.212 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -54.42 -38.31 66.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.959 0.799 . . . . 0.0 112.695 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.11 -26.53 53.39 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.807 -0.558 . . . . 0.0 109.991 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 12.64 8.36 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.747 1.641 . . . . 0.0 111.133 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 14' ' ' VAL . 91.5 mt -74.34 125.53 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.602 0.701 . . . . 0.0 111.02 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.47 119.7 30.96 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.44 1.096 . . . . 0.0 109.041 167.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 HD13 HD13 ' A' ' 7' ' ' LEU . 14.2 pt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.402 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.689 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -142.98 161.59 27.54 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.65 1.595 . . . . 0.0 111.096 167.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -96.48 111.17 23.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.506 1.923 . . . . 0.0 110.728 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 19.8 t -61.06 111.01 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.211 1.405 . . . . 0.0 108.675 175.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -83.81 -47.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.015 0.926 . . . . 0.0 108.979 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -161.36 172.67 16.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.54 -162.38 50.24 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.374 0.988 . . . . 0.0 110.667 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -155.88 155.58 33.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.679 -0.895 . . . . 0.0 109.193 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.659 HG22 ' HA ' ' A' ' 81' ' ' PRO . 29.7 pt -135.3 165.95 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.99 1.716 . . . . 0.0 107.416 174.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.83 111.32 23.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.56 31.45 5.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.77 -0.633 . . . . 0.0 111.752 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 120.016 1.28 . . . . 0.0 112.175 -178.592 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 119.887 -0.101 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.66 164.35 17.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 124.092 0.87 . . . . 0.0 109.983 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.17 -44.11 64.48 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.613 1.165 . . . . 0.0 108.482 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.32 -62.43 1.63 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.538 1.135 . . . . 0.0 109.671 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -53.97 -50.18 67.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.283 0.633 . . . . 0.0 111.294 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 29.8 mtt -52.78 -59.98 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.933 -0.479 . . . . 0.0 111.343 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.63 -43.29 72.15 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.855 1.262 . . . . 0.0 110.618 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.63 -21.26 65.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.629 1.572 . . . . 0.0 111.948 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 33.66 1.32 Allowed Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.028 -1.429 . . . . 0.0 110.832 173.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.517 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.1 m-85 -118.75 166.43 12.79 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.965 1.882 . . . . 0.0 112.806 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 56' ' ' ILE . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.625 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -109.28 122.77 38.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 C-N-CA 124.522 1.129 . . . . 0.0 109.553 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.659 ' HA ' HG22 ' A' ' 56' ' ' ILE . 10.8 Cg_endo -71.24 119.6 6.4 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.543 2.162 . . . . 0.0 111.102 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.9 p -93.7 -13.97 26.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.006 -0.434 . . . . 0.0 111.864 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.0 m -158.66 -177.69 6.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.803 1.641 . . . . 0.0 107.217 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.77 95.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.581 1.552 . . . . 0.0 109.337 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.546 HG11 ' CG2' ' A' ' 56' ' ' ILE . 4.2 p -99.24 148.75 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 110.236 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.38 125.97 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.689 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -144.77 144.39 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.756 0.822 . . . . 0.0 109.32 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -100.93 113.39 26.32 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.99 0.814 . . . . 0.0 110.538 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.2 p -79.46 175.69 10.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.979 0.809 . . . . 0.0 110.988 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.29 53.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.318 1.447 . . . . 0.0 111.326 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -124.73 24.67 7.68 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.528 0.731 . . . . 0.0 112.837 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -50.46 -70.17 0.09 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.197 0.999 . . . . 0.0 109.252 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.07 42.37 0.4 Allowed 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.854 -0.529 . . . . 0.0 112.037 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -130.33 -27.46 2.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.343 1.457 . . . . 0.0 111.29 163.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.517 HG22 ' CG ' ' A' ' 73' ' ' TYR . 25.0 pt -82.52 -42.89 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 119.468 1.031 . . . . 0.0 113.197 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.567 -1.206 . . . . 0.0 109.933 -176.057 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.02 157.74 15.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.305 0.642 . . . . 0.0 112.455 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -81.63 88.65 6.22 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.702 1.601 . . . . 0.0 109.737 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 85' ' ' VAL . 59.3 t -86.85 123.55 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -95.03 131.82 40.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 117.714 0.234 . . . . 0.0 111.499 170.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.99 105.0 13.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 108.493 169.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 mt -75.55 87.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -83.52 154.77 65.88 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.423 1.089 . . . . 0.0 108.881 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.1 -27.33 78.91 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.716 2.944 . . . . 0.0 112.31 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.64 -31.55 57.56 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 125.666 1.586 . . . . 0.0 110.899 171.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.51 61.89 0.3 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 125.144 1.354 . . . . 0.0 110.571 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 65.82 163.15 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.692 1.997 . . . . 0.0 112.687 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.604 HG23 ' H ' ' A' ' 15' ' ' GLU . 14.1 m -132.21 -67.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 170.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.2 tt0 75.9 128.58 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.438 1.895 . . . . 0.0 111.594 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.6 p90 -162.43 172.5 15.45 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.246 -0.284 . . . . 0.0 111.389 -170.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 127.47 45.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 26.7 t -124.75 124.99 43.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.277 0.631 . . . . 0.0 111.332 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -64.33 147.9 51.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.271 1.034 . . . . 0.0 110.588 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -65.35 -14.71 61.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.295 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -107.37 4.05 25.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.851 1.66 . . . . 0.0 111.652 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.59 156.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 119.27 0.941 . . . . 0.0 108.859 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.85 153.74 36.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.46 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -52.68 -53.87 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.361 172.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -58.67 -43.02 89.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.033 -176.04 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.577 ' N ' HD13 ' A' ' 25' ' ' LEU . 78.4 m-20 -51.04 -66.54 0.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.57 1.176 . . . . 0.0 107.943 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -70.26 -34.11 72.42 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.941 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -59.3 4.65 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.98 -0.45 . . . . 0.0 111.961 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.7 -38.62 75.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.84 -39.34 68.49 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.75 -26.03 59.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.57 13.32 7.47 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.427 1.489 . . . . 0.0 110.936 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.632 HG22 HG23 ' A' ' 35' ' ' ILE . 76.4 mt -76.61 128.81 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 117.757 0.779 . . . . 0.0 110.173 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -90.83 119.48 31.07 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.996 1.318 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.632 HG23 HG22 ' A' ' 33' ' ' ILE . 8.5 pt . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 124.577 1.151 . . . . 0.0 107.946 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.789 0.804 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.91 170.98 24.68 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 126.041 1.781 . . . . 0.0 110.539 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -102.13 111.21 23.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 110.347 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.51 111.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 108.888 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -83.69 -47.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -161.94 175.79 11.47 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.076 -0.39 . . . . 0.0 110.707 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.97 -160.19 53.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 m -155.16 156.2 35.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.944 HD11 HG21 ' A' ' 74' ' ' VAL . 38.0 pt -140.21 166.21 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 107.85 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -104.29 109.16 20.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -113.43 58.7 0.66 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.997 0.919 . . . . 0.0 108.684 164.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.53 0.192 0 O-C-N 121.605 -0.684 . . . . 0.0 110.283 173.011 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -93.23 167.46 11.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.614 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.15 -43.22 74.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.633 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.9 -61.28 2.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 123.99 0.916 . . . . 0.0 109.423 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.45 -51.29 67.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.614 0.766 . . . . 0.0 111.011 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 63.1 mtt -50.54 -61.25 2.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.903 -0.498 . . . . 0.0 111.421 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.76 -44.24 73.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.709 1.204 . . . . 0.0 110.649 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.28 -22.84 65.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.872 1.669 . . . . 0.0 112.033 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.31 29.02 1.53 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-O 117.778 -1.568 . . . . 0.0 111.998 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.6 m-85 -117.5 165.04 14.01 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 120.156 1.978 . . . . 0.0 112.85 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 56' ' ' ILE . 8.4 p . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.09 0.956 . . . . 0.0 109.435 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.09 125.72 30.47 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 125.145 1.378 . . . . 0.0 110.041 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.639 ' HA ' HG22 ' A' ' 56' ' ' ILE . 12.7 Cg_endo -73.13 117.77 5.25 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.627 2.218 . . . . 0.0 111.323 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -89.56 -19.03 25.48 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.744 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 m -154.37 -176.21 5.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.474 1.91 . . . . 0.0 107.403 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.09 113.25 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 163.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 5' ' ' VAL . 1.7 p -120.33 143.36 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.611 1.564 . . . . 0.0 109.134 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.82 155.31 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 124.641 1.176 . . . . 0.0 108.087 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.01 114.64 28.9 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.431 1.093 . . . . 0.0 109.268 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -75.18 176.94 6.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.211 0.914 . . . . 0.0 110.839 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 m80 68.95 53.4 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.96 1.304 . . . . 0.0 110.682 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -126.64 28.24 5.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 111.727 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.87 -64.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.73 14.14 0.53 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 -18.37 14.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.789 1.236 . . . . 0.0 109.782 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.469 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -100.34 -40.49 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.419 0.554 . . . . 0.0 111.308 -174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.072 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -134.84 160.05 39.44 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.412 0.685 . . . . 0.0 111.169 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -87.88 87.21 7.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.842 1.657 . . . . 0.0 109.645 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 85' ' ' VAL . 57.7 t -83.93 123.04 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 25.4 ttmt -93.37 134.38 35.66 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 87' ' ' ILE . 39.8 mt -113.61 105.89 13.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.884 1.274 . . . . 0.0 107.757 169.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.19 93.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -90.18 155.41 46.93 Favored Pre-proline 0 N--CA 1.443 -0.787 0 C-N-CA 125.215 1.406 . . . . 0.0 108.347 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.27 -30.22 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.687 2.925 . . . . 0.0 112.476 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.98 -32.02 61.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.439 1.896 . . . . 0.0 111.063 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.98 61.66 0.29 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.969 1.271 . . . . 0.0 110.782 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 24.1 mt-10 66.42 162.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.015 2.126 . . . . 0.0 112.368 176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 15' ' ' GLU . 16.7 m -135.84 -63.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.184 0.593 . . . . 0.0 111.143 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.536 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.7 tt0 76.28 132.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.177 1.791 . . . . 0.0 112.04 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 33' ' ' ILE . 2.6 p90 -162.27 173.83 13.67 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.29 126.81 41.76 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 16.0 t -129.26 130.87 46.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 139.29 41.3 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 123.571 1.653 . . . . 0.0 108.905 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.13 -27.65 9.02 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 130.019 3.328 . . . . 0.0 111.793 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -102.01 8.72 40.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.495 1.518 . . . . 0.0 111.569 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.74 158.05 43.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.488 1.04 . . . . 0.0 110.509 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -76.11 147.75 38.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.72 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.7 t -55.93 -54.36 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tt -78.9 46.4 0.68 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.569 1.148 . . . . 0.0 111.899 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -137.9 -68.73 0.46 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.352 1.461 . . . . 0.0 107.661 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.99 -10.27 47.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.845 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -77.64 -54.15 6.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.625 -1.297 . . . . 0.0 112.291 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.62 -39.15 67.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.158 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.333 0.3 OUTLIER -58.17 -30.18 66.2 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.87 -28.27 44.14 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.0 12.8 4.71 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.026 1.298 . . . . 0.0 111.293 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 16' ' ' PHE . 72.0 mt -73.77 123.46 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.177 0.988 . . . . 0.0 110.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -89.34 115.24 26.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 33' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 124.114 0.965 . . . . 0.0 109.216 172.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 123.133 1.444 . . . . 0.0 114.468 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.84 161.14 34.91 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -98.91 110.68 23.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.229 1.412 . . . . 0.0 110.302 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.69 109.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.935 0.894 . . . . 0.0 108.729 173.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.44 -49.26 17.37 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.043 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.9 t -160.35 173.07 16.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.67 -167.95 32.6 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -165.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -140.94 159.22 42.68 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.044 HD11 HG21 ' A' ' 74' ' ' VAL . 45.1 pt -146.07 166.82 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.239 1.416 . . . . 0.0 107.653 173.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -110.43 110.02 20.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.99 24.56 11.16 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.962 0.905 . . . . 0.0 112.135 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.54 0.565 0 CA-C-N 119.838 1.199 . . . . 0.0 112.634 -176.368 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.303 0.097 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.87 165.06 19.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.183 0.927 . . . . 0.0 109.65 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -42.79 72.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.061 0.944 . . . . 0.0 108.687 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.76 -61.13 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.11 0.964 . . . . 0.0 109.497 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.76 -51.43 63.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.342 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.1 mtt -51.19 -60.05 3.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.325 0.511 . . . . 0.0 111.402 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -54.92 -43.17 73.05 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.783 1.233 . . . . 0.0 110.652 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -20.25 64.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.672 1.589 . . . . 0.0 112.058 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.5 28.88 2.03 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.129 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.49 ' CG ' HG22 ' A' ' 95' ' ' ILE . 92.8 m-85 -112.44 168.52 9.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.736 1.768 . . . . 0.0 112.931 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.044 HG21 HD11 ' A' ' 56' ' ' ILE . 10.5 p . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 125.307 1.443 . . . . 0.0 109.334 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.659 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -105.53 125.3 33.75 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 109.492 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.634 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.6 Cg_endo -76.05 115.63 4.19 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.742 2.294 . . . . 0.0 111.874 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 p -93.52 -9.57 37.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.279 0.945 . . . . 0.0 112.102 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -161.96 -177.06 5.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.204 1.802 . . . . 0.0 107.177 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.04 92.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.532 1.533 . . . . 0.0 109.696 168.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 56' ' ' ILE . 5.7 p -96.42 146.76 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.963 1.305 . . . . 0.0 110.26 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.85 125.4 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.464 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -134.52 153.69 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 124.287 1.035 . . . . 0.0 108.222 176.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -103.74 125.73 50.41 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.073 0.949 . . . . 0.0 109.403 170.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 p -91.65 175.8 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.157 0.889 . . . . 0.0 110.7 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.13 60.39 0.65 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.292 1.037 . . . . 0.0 109.288 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -126.01 16.03 7.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.879 0.872 . . . . 0.0 112.499 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -41.31 -70.69 0.1 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.361 1.465 . . . . 0.0 109.777 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -80.99 32.85 0.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.22 -29.37 1.62 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.93 2.092 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.49 HG22 ' CG ' ' A' ' 73' ' ' TYR . 39.6 pt -81.7 -41.97 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.694 -0.669 . . . . 0.0 112.584 169.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.486 -1.245 . . . . 0.0 110.007 -179.176 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -93.56 164.35 13.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.975 0.91 . . . . 0.0 111.443 -172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.56 89.33 7.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.145 1.378 . . . . 0.0 108.905 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.642 HG13 HG13 ' A' ' 85' ' ' VAL . 50.4 t -87.01 122.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -93.81 125.58 38.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.269 0.356 . . . . 0.0 110.668 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 33' ' ' ILE . 17.1 mt -106.34 98.58 8.23 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 124.955 1.409 . . . . 0.0 108.022 174.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 35.6 mt -73.92 89.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -90.25 155.71 46.54 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 125.564 1.545 . . . . 0.0 108.316 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.96 -21.3 68.67 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.777 2.985 . . . . 0.0 112.681 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.54 -29.01 69.73 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.329 1.452 . . . . 0.0 110.862 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.8 61.95 0.35 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 65.6 173.16 0.22 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.505 1.522 . . . . 0.0 112.571 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.498 HG21 HG12 ' A' ' 33' ' ' ILE . 5.4 p -147.5 -55.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.651 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 71.1 132.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.718 1.607 . . . . 0.0 111.236 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -159.68 167.02 29.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.874 -0.516 . . . . 0.0 111.567 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 127.55 37.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.097 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 5.5 t -132.03 117.96 19.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.622 0.369 . . . . 0.0 110.696 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.76 148.88 19.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.629 1.972 . . . . 0.0 108.87 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -75.96 -6.79 52.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.769 -0.582 . . . . 0.0 112.328 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.26 36.25 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.457 1.503 . . . . 0.0 110.082 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.6 163.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 121.043 -1.035 . . . . 0.0 111.116 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -81.82 140.11 34.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.595 0.758 . . . . 0.0 111.894 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.0 t -63.84 -7.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.19 -34.93 10.93 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.604 1.161 . . . . 0.0 110.715 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -68.36 -69.46 0.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.17 0.986 . . . . 0.0 110.165 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.259 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -49.11 -62.16 1.68 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.775 0.83 . . . . 0.0 112.328 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -55.18 -40.69 71.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.064 -0.493 . . . . 0.0 109.727 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.3 -36.23 52.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.22 -30.32 34.26 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.508 0.595 . . . . 0.0 110.707 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.69 8.54 4.73 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.538 1.066 . . . . 0.0 112.076 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.648 HD13 HD12 ' A' ' 7' ' ' LEU . 21.1 mt -70.02 118.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.732 1.266 . . . . 0.0 110.906 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -91.15 77.85 5.94 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.319 1.048 . . . . 0.0 109.634 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.566 0 O-C-N 120.764 -1.21 . . . . 0.0 108.837 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.527 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -138.39 169.54 24.25 Favored Glycine 0 N--CA 1.431 -1.645 0 C-N-CA 126.016 1.769 . . . . 0.0 109.547 169.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -98.76 110.65 23.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.476 1.511 . . . . 0.0 108.424 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.42 103.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 t -77.03 -44.49 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 85' ' ' VAL . 9.0 t -163.46 172.3 14.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.64 -171.98 54.86 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.775 1.178 . . . . 0.0 111.151 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -137.38 157.61 46.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 74' ' ' VAL . 31.6 pt -148.15 168.45 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.274 1.829 . . . . 0.0 107.417 174.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -111.43 110.43 20.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -104.52 35.29 2.78 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.074 0.55 . . . . 0.0 112.078 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.536 0.41 0 CA-C-N 119.623 1.101 . . . . 0.0 113.551 -179.751 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.391 0.138 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.19 168.61 11.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.031 0.832 . . . . 0.0 109.736 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.38 -42.48 70.43 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.71 -61.25 2.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.581 0.752 . . . . 0.0 109.521 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -55.66 -52.03 65.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.314 0.646 . . . . 0.0 111.283 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.2 mtm -51.81 -58.09 7.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.676 -0.64 . . . . 0.0 111.573 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.95 -42.93 76.97 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.332 1.053 . . . . 0.0 110.555 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.67 -21.27 64.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.56 1.544 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.58 2.23 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 118.355 -1.247 . . . . 0.0 110.859 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.0 m-85 -111.56 169.62 8.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.5 1.65 . . . . 0.0 111.564 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.027 HG21 HD11 ' A' ' 56' ' ' ILE . 8.5 p . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 123.657 0.783 . . . . 0.0 109.103 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.646 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -108.14 119.67 49.14 Favored Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 125.793 1.637 . . . . 0.0 108.863 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.786 ' HA ' HG22 ' A' ' 56' ' ' ILE . 18.4 Cg_endo -76.51 116.72 4.37 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.855 2.37 . . . . 0.0 111.341 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 p -91.77 -12.96 32.38 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.002 -0.436 . . . . 0.0 111.404 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -160.82 -178.28 6.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.301 1.84 . . . . 0.0 107.474 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -57.17 96.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.875 1.67 . . . . 0.0 109.251 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.642 HG13 HG13 ' A' ' 5' ' ' VAL . 9.1 p -103.0 147.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.727 1.211 . . . . 0.0 110.163 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -116.92 119.46 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.527 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -136.93 142.36 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 16.4 mt-10 -98.34 119.51 37.15 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.047 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -80.15 177.34 9.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.209 1.368 . . . . 0.0 110.007 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.2 m80 67.61 47.94 1.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.847 1.259 . . . . 0.0 111.11 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -121.38 41.1 3.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.124 0.57 . . . . 0.0 110.22 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -79.04 -60.06 2.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.31 51.86 0.73 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.427 0.691 . . . . 0.0 112.354 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.32 -12.03 0.05 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.443 1.497 . . . . 0.0 113.431 163.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.468 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -79.87 -40.56 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.916 1.235 . . . . 0.0 111.198 170.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.675 177.746 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -117.16 158.8 23.64 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.321 1.448 . . . . 0.0 111.526 -170.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.35 101.52 1.95 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.46 2.304 . . . . 0.0 108.833 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 18' ' ' CYS . 18.9 t -107.25 124.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.3 0.375 . . . . 0.0 110.164 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 33' ' ' ILE . 40.8 mt -108.86 106.48 16.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 108.848 167.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.15 99.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -99.27 155.24 36.76 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 124.929 1.291 . . . . 0.0 108.67 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.34 -34.54 89.1 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.995 3.13 . . . . 0.0 112.243 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.8 -34.75 28.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.438 2.295 . . . . 0.0 111.147 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.83 64.62 0.34 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 69.8 151.92 0.1 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.221 2.208 . . . . 0.0 114.045 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.94 111.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.176 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.03 138.19 31.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.705 1.202 . . . . 0.0 109.489 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.02 170.2 22.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.992 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.1 121.97 38.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.495 ' HB3' HG21 ' A' ' 5' ' ' VAL . 9.6 t -120.35 127.36 52.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.9 135.27 52.21 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -48.51 -39.45 23.33 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 123.183 1.468 . . . . 0.0 108.537 166.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -8.85 56.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.315 1.846 . . . . 0.0 111.954 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 27' ' ' GLN . 1.5 p -128.62 155.68 40.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 124.11 0.964 . . . . 0.0 109.815 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -75.49 148.25 39.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.781 -0.575 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.11 50.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.945 0.898 . . . . 0.0 111.152 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.3 pt? -150.02 -47.65 0.13 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.97 -66.61 0.36 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.277 1.031 . . . . 0.0 111.019 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.463 ' HB2' HG11 ' A' ' 22' ' ' VAL . 27.2 tt0 -69.03 -16.62 63.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.895 -0.503 . . . . 0.0 111.243 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.684 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -69.76 -51.32 35.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -56.6 -39.28 73.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.002 0.921 . . . . 0.0 109.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -50.87 -36.19 36.62 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.78 -28.73 27.94 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.966 -0.459 . . . . 0.0 110.214 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.83 12.89 4.76 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.518 1.532 . . . . 0.0 111.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.684 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 80.4 mt -73.81 112.18 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.334 1.067 . . . . 0.0 110.777 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.65 71.91 10.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.559 0.743 . . . . 0.0 110.414 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 O-C-N 120.76 -1.213 . . . . 0.0 109.469 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.14 165.72 27.71 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.554 2.026 . . . . 0.0 110.458 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -102.0 114.96 29.53 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.853 1.661 . . . . 0.0 110.704 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 57.3 t -64.5 112.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.1 0.96 . . . . 0.0 108.562 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -85.82 -42.37 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -157.02 -171.88 3.82 Favored 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.13 -155.21 22.51 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.71 1.148 . . . . 0.0 111.851 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.1 m -153.98 156.78 38.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.775 HG23 HG21 ' A' ' 85' ' ' VAL . 17.7 pt -136.29 149.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 172.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.8 112.73 24.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -107.84 42.11 1.41 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.468 0.707 . . . . 0.0 111.593 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 O-C-N 120.929 -1.107 . . . . 0.0 112.791 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 119.882 -0.104 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -85.92 168.54 14.11 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.086 0.866 . . . . 0.0 109.942 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -55.86 -42.66 76.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.358 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.1 -60.54 3.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.802 0.841 . . . . 0.0 109.614 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -54.62 -51.1 66.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.4 mtt -51.74 -59.68 4.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.26 0.482 . . . . 0.0 111.344 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.08 -42.12 72.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.916 1.286 . . . . 0.0 110.795 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.44 -20.2 64.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.412 1.485 . . . . 0.0 111.812 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.88 3.18 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-O 118.613 -1.104 . . . . 0.0 110.528 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.528 ' CG ' HG22 ' A' ' 95' ' ' ILE . 93.2 m-85 -109.76 169.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.077 1.439 . . . . 0.0 111.642 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 56' ' ' ILE . 12.4 p . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.634 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -107.32 124.12 36.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.213 1.405 . . . . 0.0 111.126 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.758 ' HA ' HG22 ' A' ' 56' ' ' ILE . 19.2 Cg_endo -76.49 100.78 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.943 3.095 . . . . 0.0 112.806 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.4 p -81.78 -18.06 45.46 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.06 -0.4 . . . . 0.0 110.89 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -151.98 179.59 8.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.304 . . . . 0.0 107.702 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.38 136.29 53.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.775 HG21 HG23 ' A' ' 56' ' ' ILE . 2.8 p -155.43 144.52 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.833 0.825 . . . . 0.0 111.662 -164.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.42 123.81 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 151.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -99.03 127.03 44.88 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 118.056 -0.973 . . . . 0.0 108.943 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.2 p -86.57 178.44 7.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.682 1.128 . . . . 0.0 109.073 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 65.5 53.9 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.436 1.094 . . . . 0.0 111.555 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -122.22 18.64 10.71 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.2 -67.19 0.3 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.001 0.92 . . . . 0.0 109.005 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -81.29 23.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.599 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.39 -21.37 9.87 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.541 1.136 . . . . 0.0 110.854 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.528 HG22 ' CG ' ' A' ' 73' ' ' TYR . 18.3 pt -88.47 -42.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 119.478 1.035 . . . . 0.0 112.562 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.879 -1.534 . . . . 0.0 110.068 -177.01 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 121.869 0.842 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.39 163.44 12.7 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.054 0.942 . . . . 0.0 112.853 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.44 81.87 8.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.98 2.112 . . . . 0.0 109.484 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 85' ' ' VAL . 95.5 t -88.04 99.0 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -170.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.76 127.76 34.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.834 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.544 HD12 HD13 ' A' ' 33' ' ' ILE . 66.9 mt -107.95 109.53 21.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.2 mt -78.58 91.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -88.29 155.07 51.87 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 124.023 0.929 . . . . 0.0 108.57 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.05 -37.03 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.468 3.446 . . . . 0.0 112.696 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.5 -36.63 15.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.852 2.461 . . . . 0.0 111.159 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.06 65.08 0.29 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 69.54 165.31 0.26 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 127.02 2.128 . . . . 0.0 112.765 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.87 -59.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.201 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 70.63 145.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.128 1.371 . . . . 0.0 110.966 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 33' ' ' ILE . 3.1 p90 -169.54 158.94 8.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.93 0.892 . . . . 0.0 110.39 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 121.71 27.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.8 t -120.49 120.43 35.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.58 0.352 . . . . 0.0 110.427 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.57 141.97 58.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -55.35 -31.1 61.47 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 125.531 1.532 . . . . 0.0 110.901 169.24 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -88.31 -5.32 58.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.257 1.023 . . . . 0.0 112.083 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -119.23 149.01 21.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 CA-C-N 119.725 1.148 . . . . 0.0 110.086 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -72.18 150.38 43.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.185 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 56.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.745 0.783 . . . . 0.0 111.528 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 25' ' ' LEU . 5.4 tt -163.9 -52.75 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -56.62 13.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.572 0.701 . . . . 0.0 110.159 -175.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -71.29 -23.58 61.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -63.16 -54.09 43.04 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.549 -0.719 . . . . 0.0 110.226 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -48.75 -46.87 41.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.901 0.88 . . . . 0.0 108.894 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -53.87 -38.74 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.3 -25.59 42.4 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.882 -0.511 . . . . 0.0 109.863 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.03 12.75 5.22 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.827 1.68 . . . . 0.0 111.529 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.688 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 98.7 mt -76.23 108.84 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.167 0.984 . . . . 0.0 111.318 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -78.87 68.61 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.742 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 O-C-N 120.944 -1.097 . . . . 0.0 108.247 173.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.554 0.692 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.68 167.33 25.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.135 1.826 . . . . 0.0 110.684 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -103.83 112.39 25.33 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.964 1.706 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.97 113.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.389 1.076 . . . . 0.0 109.132 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -85.78 -46.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 t -162.71 174.84 11.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.064 -0.398 . . . . 0.0 110.388 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.5 -173.2 54.44 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.599 1.095 . . . . 0.0 110.928 -170.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -141.44 147.7 38.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 74' ' ' VAL . 28.7 pt -145.47 169.97 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.784 1.633 . . . . 0.0 107.408 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.24 111.72 22.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -114.09 48.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 109.56 168.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.536 0.422 0 O-C-N 120.526 -1.359 . . . . 0.0 109.585 174.447 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 CA--C 1.521 -0.16 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.81 167.49 13.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 124.05 0.844 . . . . 0.0 109.763 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.16 -43.37 64.05 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.926 1.29 . . . . 0.0 108.58 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.11 -60.81 2.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.45 1.1 . . . . 0.0 109.674 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -58.12 -48.34 80.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.211 0.604 . . . . 0.0 111.044 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtt -51.98 -60.57 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.912 -0.493 . . . . 0.0 110.839 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.97 -45.1 71.28 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.777 1.231 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.37 -20.96 63.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.019 1.728 . . . . 0.0 112.059 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.55 30.95 1.74 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 117.802 -1.554 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.6 m-85 -118.25 158.39 25.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.981 1.89 . . . . 0.0 113.747 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 1.04 HG21 HD11 ' A' ' 56' ' ' ILE . 12.2 p . . . . . 0 N--CA 1.446 -0.627 0 C-N-CA 123.536 0.734 . . . . 0.0 110.671 -175.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -116.96 118.65 36.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.768 1.627 . . . . 0.0 109.337 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.2 Cg_endo -74.34 117.85 5.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.587 2.192 . . . . 0.0 111.666 -175.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 p -89.88 -16.03 30.91 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.731 -0.606 . . . . 0.0 111.2 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 m -156.6 -177.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.877 1.671 . . . . 0.0 107.112 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.72 133.67 42.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 161.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 5' ' ' VAL . 2.5 p -140.75 148.84 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 107.622 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.72 121.12 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 173.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.41 153.62 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -103.32 126.16 50.34 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 109.29 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.9 p -83.8 177.24 8.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.781 1.173 . . . . 0.0 109.263 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.2 m80 70.37 56.23 0.28 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.672 1.189 . . . . 0.0 111.54 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -129.04 31.47 4.89 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.614 0.765 . . . . 0.0 112.582 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -59.77 -66.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -80.23 47.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.649 0.738 . . . . 0.0 111.547 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -140.32 -41.29 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 131.453 3.901 . . . . 0.0 108.949 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.57 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.5 pt -75.49 -47.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.061 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.058 -1.448 . . . . 0.0 109.758 -173.616 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -118.68 154.93 31.92 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.552 0.691 . . . . 0.0 112.736 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.73 100.67 0.56 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 128.557 2.743 . . . . 0.0 108.65 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 85' ' ' VAL . 58.6 t -107.04 125.67 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 27.8 ttmt -97.18 135.72 38.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 165.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.439 HD22 HG23 ' A' ' 89' ' ' THR . 28.5 mt -112.14 106.89 15.62 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 124.505 1.128 . . . . 0.0 108.447 169.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.1 mt -78.42 91.61 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' HG1' ' A' ' 89' ' ' THR . 62.1 p -94.7 155.86 38.92 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.745 176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 68.6 Cg_exo -53.43 -37.11 81.6 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 125.133 3.889 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.64 -38.06 9.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 128.444 2.698 . . . . 0.0 111.106 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.8 61.9 0.26 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 24.4 mt-10 70.7 152.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 127.558 2.343 . . . . 0.0 112.905 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.426 HG11 HG23 ' A' ' 33' ' ' ILE . 13.7 p -152.65 90.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.861 1.315 . . . . 0.0 108.361 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -83.22 140.21 32.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.538 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.03 170.58 21.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.188 0.595 . . . . 0.0 112.224 -166.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.42 47.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.2 t -122.32 130.47 53.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.25 131.28 41.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.159 0.981 . . . . 0.0 108.988 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -44.48 -28.6 0.59 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.864 2.066 . . . . 0.0 111.833 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.57 -14.3 58.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.263 1.825 . . . . 0.0 112.489 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.9 154.4 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 0.0 110.078 -166.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -74.94 153.01 38.77 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.516 -1.365 . . . . 0.0 110.053 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -49.27 -51.3 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.815 -0.553 . . . . 0.0 110.866 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.75 72.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.82 -67.78 0.39 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -38.54 82.75 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.44 -61.88 1.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.33 -40.09 70.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.95 -40.27 72.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -19.9 56.73 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.481 -0.762 . . . . 0.0 109.039 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.26 15.08 7.3 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.237 1.399 . . . . 0.0 110.686 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.426 HG23 HG11 ' A' ' 14' ' ' VAL . 48.9 mt -81.81 133.12 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 117.302 0.551 . . . . 0.0 110.043 -175.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -93.17 115.2 27.84 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.487 1.115 . . . . 0.0 108.832 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 35' ' ' ILE . 5.5 pt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.11 167.12 27.9 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.546 1.546 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -105.23 112.57 25.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.516 1.926 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.9 110.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t -83.67 -45.48 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.7 t -160.96 174.41 13.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.977 -0.452 . . . . 0.0 110.292 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.39 -162.8 54.25 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -155.17 155.86 34.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 74' ' ' VAL . 30.2 pt -144.22 160.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.724 1.61 . . . . 0.0 107.801 -177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -101.38 108.14 19.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -104.55 38.67 1.83 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.711 0.804 . . . . 0.0 111.463 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 119.328 0.967 . . . . 0.0 112.414 175.295 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -85.38 164.86 17.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 123.812 0.695 . . . . 0.0 109.548 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.48 -40.42 74.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 108.683 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.29 -61.64 2.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.947 0.899 . . . . 0.0 109.402 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.41 -53.11 31.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.628 0.771 . . . . 0.0 111.332 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.3 mtm -50.54 -62.15 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 0.0 111.857 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.94 -43.46 69.84 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.667 1.187 . . . . 0.0 110.72 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.53 64.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.766 1.626 . . . . 0.0 112.112 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.86 26.39 2.11 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-O 117.922 -1.488 . . . . 0.0 111.842 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.535 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.8 m-85 -113.68 166.25 11.73 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 120.018 1.909 . . . . 0.0 112.88 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.742 HG21 HD11 ' A' ' 56' ' ' ILE . 8.6 p . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -108.4 125.22 32.36 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 125.547 1.539 . . . . 0.0 109.678 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.9 Cg_endo -71.98 119.36 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.194 1.93 . . . . 0.0 111.757 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -91.3 -17.19 26.33 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.257 -0.902 . . . . 0.0 112.039 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 m -156.21 -173.99 4.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.53 140.17 41.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 53' ' ' SER . 2.5 p -150.66 148.09 15.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.354 0.597 . . . . 0.0 109.853 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.54 124.2 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 151.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 123.795 0.838 . . . . 0.0 108.966 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -100.26 121.23 41.14 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.067 0.947 . . . . 0.0 108.605 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.439 HG23 HD22 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -74.34 179.81 4.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 119.163 0.892 . . . . 0.0 110.712 176.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.565 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 3.5 m-70 65.46 50.47 1.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.761 1.224 . . . . 0.0 112.86 169.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -122.01 15.5 10.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -172.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -45.39 -63.43 0.95 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.795 0.807 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -82.86 21.89 0.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.732 0.813 . . . . 0.0 113.142 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -110.2 -26.14 9.79 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.352 1.061 . . . . 0.0 110.495 162.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.535 HG22 ' CG ' ' A' ' 73' ' ' TYR . 34.6 pt -82.4 -48.85 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 119.478 1.035 . . . . 0.0 112.09 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.253 1.283 0 CA-C-O 117.498 -1.239 . . . . 0.0 109.693 -176.145 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.237 0.4 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -98.4 158.25 15.7 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 111.424 -168.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.82 90.21 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.837 1.655 . . . . 0.0 109.135 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG13 HG13 ' A' ' 85' ' ' VAL . 39.4 t -87.0 120.56 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -88.97 131.08 35.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.878 0.308 . . . . 0.0 111.346 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.8 mt -109.29 103.87 12.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.418 1.487 . . . . 0.0 107.508 166.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.4 mt -74.17 86.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -79.34 154.17 76.77 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.691 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.83 -32.43 94.93 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.949 3.1 . . . . 0.0 112.194 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -32.18 33.82 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 126.429 1.892 . . . . 0.0 110.907 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.01 62.62 0.32 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 125.255 1.407 . . . . 0.0 109.931 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 67.69 161.72 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.728 2.011 . . . . 0.0 112.883 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' H ' ' A' ' 15' ' ' GLU . 19.7 m -132.4 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.072 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 14' ' ' VAL . 4.6 tt0 73.67 129.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.121 1.768 . . . . 0.0 111.987 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -163.73 171.37 15.69 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.29 127.88 40.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.404 0.682 . . . . 0.0 111.524 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . 34.6 t -131.51 130.27 42.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 175.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.3 150.99 39.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 110.108 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -7.38 46.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -115.26 21.01 14.51 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.767 1.627 . . . . 0.0 110.703 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.42 158.12 27.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 O-C-N 121.024 -1.048 . . . . 0.0 110.589 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -77.94 143.45 37.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.566 0.346 . . . . 0.0 110.99 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 79' ' ' ALA . 5.6 t -49.07 -62.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 111.523 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tp -49.86 -52.5 32.21 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.537 0.735 . . . . 0.0 111.475 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -54.45 43.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -170.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -58.64 -44.91 90.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.581 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -50.87 -56.06 14.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.361 -0.837 . . . . 0.0 110.793 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.26 -38.95 81.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.674 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.7 -38.24 54.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.227 0.921 . . . . 0.0 112.301 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.96 -25.86 43.5 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.934 -0.479 . . . . 0.0 110.616 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.92 11.32 10.21 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.82 1.676 . . . . 0.0 111.31 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.589 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 97.1 mt -78.24 123.41 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.7 0.75 . . . . 0.0 111.075 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.59 119.37 30.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.703 1.601 . . . . 0.0 109.986 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.968 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.59 160.68 28.45 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.175 1.845 . . . . 0.0 111.085 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -98.26 112.94 24.75 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.026 1.73 . . . . 0.0 111.166 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.16 116.2 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.073 0.851 . . . . 0.0 109.474 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.98 -48.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.998 0.519 . . . . 0.0 109.876 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -160.33 174.06 14.73 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.08 -169.37 43.14 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 m -142.54 149.48 39.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.071 0.948 . . . . 0.0 108.817 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.768 HG23 HG21 ' A' ' 85' ' ' VAL . 24.9 pt -132.89 165.52 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.027 1.731 . . . . 0.0 107.035 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -107.13 110.73 22.89 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.45 46.17 1.02 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.112 0.565 . . . . 0.0 110.168 168.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.533 0.301 0 O-C-N 121.539 -0.726 . . . . 0.0 109.751 169.737 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -85.85 160.62 19.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.966 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.36 -41.22 72.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.57 -61.01 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.981 0.912 . . . . 0.0 109.559 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -51.44 -51.07 57.99 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.0 111.202 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.1 mtt -52.18 -60.45 3.19 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.626 -0.671 . . . . 0.0 111.558 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.94 -42.68 76.54 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.379 1.072 . . . . 0.0 110.854 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.99 -19.93 63.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.8 1.64 . . . . 0.0 111.749 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.63 1.31 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 117.559 -1.689 . . . . 0.0 110.949 171.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -116.48 162.27 17.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.48 2.14 . . . . 0.0 113.802 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.729 -169.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' CB ' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -105.84 126.16 31.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 124.58 1.152 . . . . 0.0 109.215 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 56' ' ' ILE . 16.4 Cg_endo -75.87 119.1 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.659 2.24 . . . . 0.0 110.899 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 p -91.31 -15.04 29.72 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.099 -0.376 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -156.94 -174.71 5.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.49 134.81 40.58 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.768 HG21 HG23 ' A' ' 56' ' ' ILE . 3.6 p -151.87 148.04 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 109.769 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.71 123.73 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 153.05 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -100.63 119.32 38.39 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.024 0.93 . . . . 0.0 109.477 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.7 p -79.91 175.89 10.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.411 1.005 . . . . 0.0 111.202 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 69.42 56.94 0.36 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.747 1.619 . . . . 0.0 111.814 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -126.96 12.68 7.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.84 -63.73 0.98 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.283 1.033 . . . . 0.0 109.075 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -79.87 26.63 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -110.12 -45.33 3.61 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 pt -71.62 -41.61 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -170.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.996 -1.478 . . . . 0.0 110.325 -178.583 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.819 0.342 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -109.17 158.98 17.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.591 0.756 . . . . 0.0 112.055 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.96 104.54 5.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.018 2.127 . . . . 0.0 109.123 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.592 HG13 HG13 ' A' ' 85' ' ' VAL . 30.2 t -110.19 111.77 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 122.898 0.479 . . . . 0.0 110.557 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -84.6 128.33 34.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 117.937 0.335 . . . . 0.0 111.456 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.1 mt -106.55 112.13 25.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mt -84.22 86.32 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p -83.32 153.69 65.9 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.097 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -36.92 69.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.654 3.569 . . . . 0.0 113.063 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -46.95 -38.68 11.0 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 127.526 2.33 . . . . 0.0 111.099 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.23 64.22 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.9 166.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 127.215 2.206 . . . . 0.0 112.158 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.72 -59.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.732 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 70.55 142.36 0.05 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.988 1.715 . . . . 0.0 113.086 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -164.34 178.93 7.13 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.811 0.844 . . . . 0.0 111.264 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.86 124.38 48.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.818 1.247 . . . . 0.0 109.086 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.5 t -121.05 128.3 52.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.51 0.324 . . . . 0.0 110.325 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.52 141.06 53.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.782 1.277 . . . . 0.0 108.23 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -18.83 65.63 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 128.895 2.878 . . . . 0.0 110.786 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.59 17.52 22.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.811 1.244 . . . . 0.0 111.292 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -134.35 151.78 32.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.59 1.086 . . . . 0.0 111.501 177.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -65.05 138.74 58.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.905 0.882 . . . . 0.0 110.327 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 5' ' ' VAL . 1.9 t -68.68 4.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -109.46 -52.07 2.81 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -45.8 -62.3 1.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.394 1.478 . . . . 0.0 111.246 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.444 ' HB2' HG11 ' A' ' 22' ' ' VAL . 19.3 tt0 -65.07 -28.17 69.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.913 -0.492 . . . . 0.0 111.198 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -60.45 -52.22 66.14 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 109.542 173.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -56.67 -41.4 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.037 0.935 . . . . 0.0 109.892 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -51.72 -37.72 52.17 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.73 -25.31 41.13 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.848 -0.532 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.15 11.34 9.04 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.805 1.669 . . . . 0.0 111.284 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.621 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 41.2 mt -82.16 126.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 118.208 1.004 . . . . 0.0 110.124 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -90.24 110.98 22.01 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.419 1.088 . . . . 0.0 109.447 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 33' ' ' ILE . 5.8 pt . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 170.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 C--O 1.236 0.39 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.699 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -143.4 156.05 26.36 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.092 1.806 . . . . 0.0 111.263 171.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.98 126.61 34.84 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.5 1.52 . . . . 0.0 110.028 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 17.3 t -73.73 128.34 36.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 120.11 1.323 . . . . 0.0 108.969 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -108.25 -44.21 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.297 0.639 . . . . 0.0 109.953 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 t -158.93 172.54 18.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.599 0.636 . . . . 0.0 109.715 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.97 -161.76 46.85 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.471 1.034 . . . . 0.0 111.407 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 m -156.24 158.55 37.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.65 -0.912 . . . . 0.0 108.757 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.712 HG22 ' HA ' ' A' ' 81' ' ' PRO . 8.9 pt -130.58 179.67 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.498 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.44 118.99 36.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.39 34.64 3.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.818 0.847 . . . . 0.0 111.721 169.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 CA--C 1.538 0.504 0 O-C-N 120.631 -1.293 . . . . 0.0 113.173 -166.912 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.309 0.1 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.75 164.45 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 123.641 0.588 . . . . 0.0 110.253 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -52.6 -44.01 65.72 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.94 -61.2 2.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.286 1.034 . . . . 0.0 109.766 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -54.34 -49.53 69.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.227 0.611 . . . . 0.0 111.139 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 12.2 mtt -54.59 -58.55 7.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.635 -0.666 . . . . 0.0 111.66 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.33 -43.16 70.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.403 1.081 . . . . 0.0 110.697 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.82 65.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.842 1.657 . . . . 0.0 111.727 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.58 51.33 0.98 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.453 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.1 m-85 -125.31 146.47 49.55 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.393 1.097 . . . . 0.0 111.915 169.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.08 123.01 40.43 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 125.277 1.431 . . . . 0.0 110.938 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.712 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.6 Cg_endo -74.38 120.16 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.716 2.277 . . . . 0.0 111.29 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 p -99.34 -13.0 19.81 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.685 -0.635 . . . . 0.0 112.176 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.1 m -156.28 -173.52 4.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.35 143.85 32.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG13 HG13 ' A' ' 5' ' ' VAL . 2.6 p -153.89 151.9 10.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.281 0.562 . . . . 0.0 111.687 -172.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.5 t -135.56 127.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.699 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -156.07 141.73 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -167.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.532 ' N ' HD13 ' A' ' 87' ' ' ILE . 23.9 mt-10 -94.98 118.16 31.34 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.418 -0.801 . . . . 0.0 110.81 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 p -77.3 176.03 9.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.932 0.493 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.23 55.35 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.116 1.366 . . . . 0.0 111.472 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -123.28 33.29 5.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 122.939 0.496 . . . . 0.0 111.967 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.96 -71.93 0.08 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.35 45.0 0.72 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.498 0.666 . . . . 0.0 110.902 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.32 -46.13 2.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.134 1.374 . . . . 0.0 108.296 164.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.453 HG22 ' CG ' ' A' ' 73' ' ' TYR . 6.9 pt -72.5 -38.81 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.564 1.516 1 CA-C-O 81.463 -18.399 . . . . 0.0 111.435 -174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -99.8 155.4 17.67 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.03 101.74 0.42 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.309 2.244 . . . . 0.0 109.314 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.2 109.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -81.76 134.25 35.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.101 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.42 HD22 ' CG2' ' A' ' 89' ' ' THR . 75.4 mt -112.13 106.86 15.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 167.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.1 mt -76.66 96.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 156.23 41.69 Favored Pre-proline 0 N--CA 1.444 -0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 108.882 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.55 -36.85 81.94 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.49 3.46 . . . . 0.0 112.505 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.89 -34.84 21.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 127.423 2.289 . . . . 0.0 111.084 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.37 64.21 0.3 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 125.225 1.393 . . . . 0.0 109.693 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 67.9 161.59 0.18 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.996 2.118 . . . . 0.0 112.293 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.75 -58.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.786 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 72.21 143.46 0.06 Allowed 'General case' 0 C--O 1.229 0.017 0 C-N-CA 126.032 1.733 . . . . 0.0 112.79 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.502 ' HB3' HD11 ' A' ' 33' ' ' ILE . 1.7 p90 -163.43 169.95 18.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.998 0.519 . . . . 0.0 112.012 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 126.35 36.34 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.4 t -119.86 125.11 47.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.653 0.596 . . . . 0.0 110.531 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -69.11 146.27 52.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 123.003 1.383 . . . . 0.0 110.015 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.0 -1.65 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.257 1.023 . . . . 0.0 111.88 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.06 23.05 10.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.207 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -130.88 149.04 33.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-N 119.465 1.03 . . . . 0.0 110.367 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -64.25 142.83 58.27 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.9 t -49.12 -58.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.07 0.231 . . . . 0.0 110.554 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 26' ' ' ASP . 2.7 pp -58.6 -36.26 73.74 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.635 ' N ' HD12 ' A' ' 25' ' ' LEU . 20.1 t0 -61.49 -62.15 2.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 122.398 1.094 . . . . 0.0 108.337 -169.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.12 -38.15 87.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.589 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.77 -58.21 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.203 -0.935 . . . . 0.0 112.084 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.88 -38.49 78.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 109.573 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.1 -40.81 61.8 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.886 0.766 . . . . 0.0 112.384 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.02 -24.07 55.24 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.886 -0.509 . . . . 0.0 109.948 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.31 15.34 7.73 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.386 1.47 . . . . 0.0 110.669 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 16' ' ' PHE . 61.4 mt -77.88 125.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.557 0.678 . . . . 0.0 109.496 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.43 119.53 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.74 0.816 . . . . 0.0 109.166 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.467 HG23 HG22 ' A' ' 33' ' ' ILE . 8.4 pt . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.09 166.39 25.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.959 1.742 . . . . 0.0 109.977 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.24 114.27 27.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.63 1.572 . . . . 0.0 110.802 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.422 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 47.0 t -64.17 109.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.425 1.09 . . . . 0.0 108.519 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.47 -40.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 -169.74 3.19 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.24 -159.46 14.92 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.333 0.968 . . . . 0.0 112.012 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -155.25 151.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 81' ' ' PRO . 31.2 pt -136.57 154.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.17 107.17 19.64 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.0 27.16 8.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.247 0.619 . . . . 0.0 111.772 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 120.074 1.307 . . . . 0.0 111.764 -177.805 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.54 164.81 14.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.044 0.84 . . . . 0.0 110.243 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.23 -44.4 64.81 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.968 1.307 . . . . 0.0 108.59 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -53.6 -60.97 2.62 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 109.41 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -53.96 -50.09 67.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.279 0.632 . . . . 0.0 111.431 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 64.4 mtt -50.38 -60.51 2.92 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.381 -0.825 . . . . 0.0 111.362 175.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.04 -43.33 73.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.416 1.086 . . . . 0.0 110.759 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.69 64.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.725 1.61 . . . . 0.0 111.875 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.21 35.07 1.25 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.498 -1.168 . . . . 0.0 110.332 173.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -116.58 164.46 14.56 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.212 1.506 . . . . 0.0 111.476 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 56' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 123.796 0.839 . . . . 0.0 108.77 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.85 126.52 28.14 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 124.811 1.244 . . . . 0.0 110.215 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.2 Cg_endo -73.36 121.03 6.85 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.361 2.041 . . . . 0.0 111.648 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -95.68 -16.19 22.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.7 m -156.64 -173.97 4.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.5 142.58 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 165.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 p -152.74 149.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.857 0.837 . . . . 0.0 109.9 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.7 123.7 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.404 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -135.63 153.11 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -102.1 128.84 48.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.742 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.42 ' CG2' HD22 ' A' ' 7' ' ' LEU . 43.4 p -85.44 178.6 7.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.071 0.85 . . . . 0.0 110.04 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.8 m80 63.43 58.22 1.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.838 1.255 . . . . 0.0 110.877 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -126.51 6.15 6.89 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.914 0.885 . . . . 0.0 111.413 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -45.72 -55.53 6.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 127.867 2.467 . . . . 0.0 110.808 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -93.06 33.01 1.21 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 111.956 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.37 -39.59 2.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.615 1.166 . . . . 0.0 108.204 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.2 pt -67.92 -38.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.25 -177.567 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 122.19 0.995 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -107.09 158.84 16.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.553 1.141 . . . . 0.0 111.629 -159.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 102.8 2.08 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.058 2.143 . . . . 0.0 108.025 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 18' ' ' CYS . 21.7 t -108.57 122.24 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -93.02 132.01 37.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.508 0.14 . . . . 0.0 110.691 168.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -108.17 104.64 14.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mt -73.71 95.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -94.85 152.94 40.03 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 124.934 1.293 . . . . 0.0 108.705 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -52.81 -37.33 76.52 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.461 3.441 . . . . 0.0 112.236 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.81 -39.57 8.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 128.819 2.848 . . . . 0.0 111.088 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.16 62.75 0.23 Allowed Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 125.348 1.451 . . . . 0.0 109.555 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.2 157.1 0.17 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 127.597 2.359 . . . . 0.0 114.669 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -159.22 108.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.826 163.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.67 143.53 42.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.073 0.549 . . . . 0.0 110.856 164.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.92 162.71 38.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.401 1.08 . . . . 0.0 110.443 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -84.14 131.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' HG21 ' A' ' 5' ' ' VAL . 22.0 t -127.4 129.35 47.38 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.385 -0.126 . . . . 0.0 111.019 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.76 136.71 47.25 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.669 0.747 . . . . 0.0 110.298 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.29 -32.75 11.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.655 1.582 . . . . 0.0 112.316 165.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.68 -10.99 59.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.84 1.256 . . . . 0.0 112.285 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -130.22 148.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 119.141 0.882 . . . . 0.0 109.172 -167.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -74.92 150.44 39.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.686 -1.258 . . . . 0.0 109.576 -174.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -49.96 -40.55 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.284 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.426 ' C ' HD22 ' A' ' 25' ' ' LEU 0.269 0.0 OUTLIER -66.12 -32.22 73.55 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 179.252 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -65.65 -66.71 0.51 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-O 121.458 0.647 . . . . 0.0 109.537 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 22' ' ' VAL . 36.0 mm-40 -56.83 -36.16 69.64 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.956 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -49.96 -58.93 4.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 122.02 -0.425 . . . . 0.0 111.028 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.08 -36.68 75.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.642 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.82 -39.58 62.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.7 0.682 . . . . 0.0 111.961 171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.46 -29.17 33.84 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.2 14.35 7.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.977 1.751 . . . . 0.0 111.601 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.726 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 72.7 mt -76.36 112.28 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 117.754 0.777 . . . . 0.0 109.588 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -84.7 98.09 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.032 1.333 . . . . 0.0 109.159 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 O-C-N 121.592 -0.692 . . . . 0.0 109.848 174.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.542 0.687 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -134.14 164.59 24.49 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 125.969 1.747 . . . . 0.0 109.208 162.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -98.24 109.25 22.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.796 1.638 . . . . 0.0 109.636 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.619 HG23 ' HB ' ' A' ' 74' ' ' VAL . 61.7 t -62.32 111.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.6 -42.08 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 122.852 0.461 . . . . 0.0 109.857 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.6 t -155.73 -166.75 2.3 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.48 -158.24 18.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.795 0.712 . . . . 0.0 111.929 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -145.58 154.91 42.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 168.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.654 HG23 HG21 ' A' ' 85' ' ' VAL . 28.3 pt -135.99 165.5 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -106.6 116.36 31.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -111.36 54.12 0.69 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 CA--C 1.534 0.333 0 O-C-N 121.509 -0.744 . . . . 0.0 109.494 169.75 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.05 165.34 15.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.992 0.808 . . . . 0.0 109.641 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.17 -39.49 69.6 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.924 0.89 . . . . 0.0 108.757 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.87 -62.38 1.69 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.654 0.782 . . . . 0.0 109.519 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -51.93 -51.41 57.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.215 0.606 . . . . 0.0 111.573 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.0 mtm -51.56 -60.39 3.2 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.711 -0.618 . . . . 0.0 111.487 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.1 -43.39 78.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.704 1.202 . . . . 0.0 110.708 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.13 66.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.733 1.613 . . . . 0.0 111.37 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.71 27.61 1.03 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 116.921 -2.044 . . . . 0.0 112.569 169.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CG ' HG22 ' A' ' 95' ' ' ILE . 90.9 m-85 -120.44 167.02 12.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 121.245 2.523 . . . . 0.0 114.953 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.619 ' HB ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -171.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -108.95 124.4 34.29 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 126.123 1.769 . . . . 0.0 109.603 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.471 ' HA ' HG22 ' A' ' 56' ' ' ILE . 10.8 Cg_endo -74.3 111.39 3.3 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.726 2.284 . . . . 0.0 111.673 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 p -82.07 -18.93 41.38 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.354 -0.841 . . . . 0.0 110.93 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -155.8 -177.12 6.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.225 1.41 . . . . 0.0 107.736 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.48 140.55 45.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 163.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.654 HG21 HG23 ' A' ' 56' ' ' ILE . 2.7 p -160.61 140.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 121.648 0.737 . . . . 0.0 111.938 -166.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.12 127.28 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.87 153.09 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 124.233 1.013 . . . . 0.0 108.921 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -103.17 125.94 50.1 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.42 1.088 . . . . 0.0 109.232 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.1 p -83.56 177.14 8.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.536 1.516 . . . . 0.0 109.237 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 69.38 57.0 0.36 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 112.106 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -128.05 32.74 4.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -60.47 -68.66 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -81.75 52.64 1.96 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.669 0.747 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.52 -40.43 0.34 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 130.293 3.437 . . . . 0.0 109.363 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.566 HG22 ' CG ' ' A' ' 73' ' ' TYR . 35.1 pt -75.58 -43.28 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 119.007 -0.521 . . . . 0.0 112.278 175.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.076 -1.44 . . . . 0.0 109.569 176.164 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.773 0.796 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.8 158.48 15.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.518 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -81.21 84.65 6.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.982 1.713 . . . . 0.0 109.116 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 85' ' ' VAL . 60.8 t -84.19 127.59 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 8.8 ttmt -97.9 131.83 44.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 169.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.416 HD12 HG21 ' A' ' 33' ' ' ILE . 47.7 mt -109.41 110.93 22.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.732 1.27 . . . . 0.0 108.023 169.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -80.53 86.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.6 p -86.55 154.92 56.69 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.418 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 51.3 Cg_exo -55.07 -35.73 91.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.738 3.625 . . . . 0.0 112.411 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.39 -38.22 18.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.018 2.527 . . . . 0.0 111.212 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.34 61.86 0.21 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 125.593 1.568 . . . . 0.0 110.423 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.425 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 26.8 mt-10 68.2 160.41 0.17 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.12 2.168 . . . . 0.0 111.997 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -129.18 -64.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.386 0.674 . . . . 0.0 111.53 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 75.54 127.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.068 1.747 . . . . 0.0 112.353 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -163.53 168.99 19.39 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.56 35.35 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.869 0.868 . . . . 0.0 112.12 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.0 t -125.98 129.42 49.19 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.743 0.817 . . . . 0.0 111.585 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.24 149.06 31.97 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.756 0.822 . . . . 0.0 110.284 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -65.34 -19.27 65.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.94 -0.475 . . . . 0.0 111.997 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.05 -3.28 58.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.615 1.166 . . . . 0.0 111.8 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 p -134.24 153.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.52 1.055 . . . . 0.0 110.667 -170.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -76.89 156.23 32.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.126 0.489 . . . . 0.0 112.001 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.78 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.954 0.902 . . . . 0.0 111.596 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.46 -51.14 0.1 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.59 -60.48 2.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.956 0.903 . . . . 0.0 110.929 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -72.22 -5.12 33.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -89.35 -49.07 6.93 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.396 -0.815 . . . . 0.0 109.618 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -53.63 -38.84 64.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.672 0.789 . . . . 0.0 110.541 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.258 0.4 OUTLIER -58.25 -35.52 71.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 176.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.89 -25.77 40.49 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.61 11.7 6.45 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 125.811 1.672 . . . . 0.0 111.24 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.668 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 54.9 mt -75.44 121.35 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 118.279 1.039 . . . . 0.0 110.566 -178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -96.39 113.53 25.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 166.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.8 mt . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 163.724 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.25 27.66 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 124.834 1.207 . . . . 0.0 111.054 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -101.62 111.04 23.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.175 1.79 . . . . 0.0 110.308 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG23 ' HB ' ' A' ' 74' ' ' VAL . 78.2 t -58.8 116.91 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.016 0.927 . . . . 0.0 109.306 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -93.05 -47.02 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 85' ' ' VAL . 23.3 t -158.31 170.71 21.62 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.26 -161.37 54.17 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -168.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -155.88 168.68 26.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 81' ' ' PRO . 29.1 pt -147.08 162.26 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 127.581 2.352 . . . . 0.0 107.999 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -105.22 113.48 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.61 28.21 8.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.27 1.028 . . . . 0.0 111.772 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.1 p . . . . . 0 CA--C 1.539 0.521 0 O-C-N 121.323 -0.86 . . . . 0.0 113.17 -172.859 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.43 164.91 22.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.05 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.95 -44.44 67.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.6 -61.71 2.11 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.886 0.875 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -53.05 -52.09 59.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.346 0.658 . . . . 0.0 111.433 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.8 mtt -53.87 -58.17 8.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.566 -0.709 . . . . 0.0 111.665 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.79 -43.63 69.43 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.62 1.168 . . . . 0.0 110.557 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.97 65.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.17 28.75 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.913 -1.493 . . . . 0.0 111.072 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.503 ' CG ' HG22 ' A' ' 95' ' ' ILE . 86.2 m-85 -110.79 163.57 13.64 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 120.067 1.934 . . . . 0.0 113.939 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 56' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.581 0 C-N-CA 125.683 1.593 . . . . 0.0 108.885 -168.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.609 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.15 123.68 36.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.822 1.649 . . . . 0.0 109.409 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.792 ' HA ' HG22 ' A' ' 56' ' ' ILE . 15.7 Cg_endo -72.84 114.83 4.14 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.193 2.596 . . . . 0.0 111.063 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 p -88.34 -17.02 31.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.944 0.498 . . . . 0.0 110.834 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 m -157.08 -178.74 7.59 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.543 1.537 . . . . 0.0 108.116 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -53.58 121.4 7.68 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 161.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 5' ' ' VAL . 7.2 p -135.25 144.51 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.995 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.59 125.28 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.17 154.02 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 123.999 0.92 . . . . 0.0 108.669 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.57 121.87 41.82 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.199 1.0 . . . . 0.0 108.643 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -178.23 3.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.917 1.235 . . . . 0.0 110.999 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.582 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 5.1 m-70 65.88 48.45 1.83 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.968 1.307 . . . . 0.0 112.931 169.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -119.31 15.39 13.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -40.65 -68.44 0.18 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.116 0.967 . . . . 0.0 109.68 170.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.81 17.51 0.71 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.991 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.14 -17.48 12.37 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 117.888 -1.054 . . . . 0.0 110.904 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.503 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.8 pt -89.82 -45.48 15.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 119.98 1.264 . . . . 0.0 111.673 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.157 -176.905 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -98.39 158.75 15.39 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.56 0.744 . . . . 0.0 112.704 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -81.93 83.77 7.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.992 1.717 . . . . 0.0 109.181 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 85' ' ' VAL . 94.7 t -81.66 121.68 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -89.55 132.34 35.13 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.675 167.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.436 HD12 HD13 ' A' ' 33' ' ' ILE . 71.8 mt -111.26 106.95 16.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.429 1.492 . . . . 0.0 107.238 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 23.1 mt -76.39 94.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 169.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -89.88 156.29 47.11 Favored Pre-proline 0 N--CA 1.444 -0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 108.689 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -52.12 -38.69 71.17 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.524 3.483 . . . . 0.0 112.422 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.69 -39.49 11.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 128.222 2.609 . . . . 0.0 111.237 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.05 66.19 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 125.585 1.564 . . . . 0.0 109.803 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.7 164.16 0.23 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.221 2.208 . . . . 0.0 112.565 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.71 -60.64 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.311 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 74.27 131.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.41 1.484 . . . . 0.0 111.598 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -162.44 167.86 22.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.54 124.44 39.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.4 t -131.78 123.99 28.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.187 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.79 138.7 56.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.41 1.484 . . . . 0.0 109.637 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 1.8 p-10 -56.17 -27.29 53.85 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.691 1.597 . . . . 0.0 111.916 169.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -87.0 1.18 53.67 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 111.865 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.41 156.53 41.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.639 1.109 . . . . 0.0 110.677 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -78.42 149.07 33.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 121.83 -0.543 . . . . 0.0 111.241 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.23 63.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 122.073 0.94 . . . . 0.0 110.423 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.512 ' C ' HD13 ' A' ' 25' ' ' LEU . 1.9 tm? -166.32 -51.87 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.44 -63.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.397 0.617 . . . . 0.0 110.98 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -58.02 -32.58 68.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.357 0.599 . . . . 0.0 110.243 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.734 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -58.06 -58.26 9.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.49 -41.51 63.44 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.87 -24.53 48.46 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.77 -0.581 . . . . 0.0 110.073 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.61 12.1 6.86 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.924 1.726 . . . . 0.0 111.736 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.734 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 86.7 mt -76.24 111.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 117.826 0.813 . . . . 0.0 111.017 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -89.17 73.1 8.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.579 0 O-C-N 121.112 -0.992 . . . . 0.0 108.739 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 122.454 1.121 . . . . 0.0 113.206 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.51 27.34 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.737 1.637 . . . . 0.0 109.848 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -92.77 111.04 22.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.834 1.254 . . . . 0.0 109.965 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.93 110.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.46 -42.43 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 t -157.24 -167.88 2.45 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.65 -153.64 14.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.01 0.814 . . . . 0.0 111.644 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.6 m -157.28 154.99 29.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.617 HG22 ' HA ' ' A' ' 81' ' ' PRO . 26.9 pt -141.75 166.31 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.43 1.892 . . . . 0.0 106.381 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -109.44 119.71 40.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -108.36 46.31 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.678 0.791 . . . . 0.0 111.295 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.303 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.85 167.23 11.76 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.865 0.728 . . . . 0.0 109.67 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.88 -41.91 75.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.966 0.907 . . . . 0.0 109.029 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -60.16 3.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.853 0.861 . . . . 0.0 109.545 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -55.1 -50.32 69.49 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.647 0.779 . . . . 0.0 110.999 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 20.2 mtm -51.29 -59.83 3.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.829 -0.544 . . . . 0.0 112.182 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.04 -43.19 73.53 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.239 1.016 . . . . 0.0 110.511 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.03 -22.89 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.585 1.554 . . . . 0.0 111.797 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.42 35.55 0.8 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-O 118.33 -1.261 . . . . 0.0 111.019 170.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.443 ' CG ' HG22 ' A' ' 95' ' ' ILE . 91.0 m-85 -116.46 161.77 18.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.789 1.794 . . . . 0.0 112.777 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.423 1.089 . . . . 0.0 108.74 -177.146 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.253 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -106.15 120.72 47.9 Favored Pre-proline 0 C--O 1.234 0.267 0 C-N-CA 126.105 1.762 . . . . 0.0 109.275 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.617 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.0 Cg_endo -75.4 116.08 4.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.675 2.25 . . . . 0.0 112.031 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -90.41 -15.42 30.99 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.027 -0.421 . . . . 0.0 111.385 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.8 m -158.48 -177.31 6.45 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.088 1.355 . . . . 0.0 108.524 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -64.36 84.46 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.116 1.766 . . . . 0.0 109.941 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 5' ' ' VAL . 2.1 p -85.82 155.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.822 1.249 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.71 125.09 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -139.62 153.21 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.509 1.124 . . . . 0.0 108.642 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 29.3 mt-10 -101.39 129.09 47.34 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.787 170.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 p -88.51 176.89 6.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.083 1.311 . . . . 0.0 109.463 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 66.11 55.21 0.92 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 0.0 111.487 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -122.0 13.86 10.61 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -46.06 -62.76 1.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.794 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.99 28.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.306 0.642 . . . . 0.0 112.302 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -125.77 -12.35 6.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.819 1.248 . . . . 0.0 111.836 168.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.443 HG22 ' CG ' ' A' ' 73' ' ' TYR . 46.7 pt -91.21 -40.37 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 119.876 1.216 . . . . 0.0 111.924 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.964 -1.494 . . . . 0.0 110.173 178.096 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.4 155.21 37.83 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.75 0.82 . . . . 0.0 111.298 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -76.97 99.65 5.34 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.044 2.537 . . . . 0.0 108.038 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.89 118.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -85.94 129.95 34.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.126 0.266 . . . . 0.0 110.372 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 33' ' ' ILE . 77.4 mt -108.92 102.88 11.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 39.0 mt -71.37 94.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 171.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -93.52 155.21 40.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.66 -32.61 76.25 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.745 2.963 . . . . 0.0 112.244 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.4 -33.91 45.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.679 2.392 . . . . 0.0 111.392 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.52 0.34 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 125.212 1.387 . . . . 0.0 110.489 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 71.47 145.27 0.07 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.868 2.467 . . . . 0.0 114.262 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.456 HG21 HG23 ' A' ' 33' ' ' ILE . 35.3 m -143.23 97.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -69.14 135.91 51.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.847 161.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' A' ' 33' ' ' ILE . 4.8 p90 -151.19 170.33 19.71 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.595 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 119.51 39.17 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 9.2 t -122.01 126.22 48.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.959 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.59 145.73 45.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.725 1.726 . . . . 0.0 110.936 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -56.74 -24.64 51.14 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 127.198 2.199 . . . . 0.0 112.119 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -103.78 10.06 36.75 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.456 1.502 . . . . 0.0 111.332 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.432 HG11 ' CG ' ' A' ' 27' ' ' GLN . 1.7 p -134.53 158.36 41.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.52 1.054 . . . . 0.0 110.943 -175.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -77.91 138.08 38.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 t -49.0 -48.93 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.612 0.244 . . . . 0.0 110.916 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -37.81 74.02 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.03 -64.07 0.93 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.718 0.77 . . . . 0.0 108.939 -167.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.432 ' CG ' HG11 ' A' ' 22' ' ' VAL . 20.4 mm100 -57.17 -40.92 78.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.301 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 33' ' ' ILE . . . -50.1 -59.54 3.81 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.753 -0.592 . . . . 0.0 111.454 175.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.69 -39.71 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.112 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -53.03 -40.95 64.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -75.22 -24.85 57.8 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 121.849 -0.532 . . . . 0.0 109.749 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.88 12.88 6.86 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.615 1.578 . . . . 0.0 111.057 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 28' ' ' ALA . 89.1 mt -75.77 116.38 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.672 0.736 . . . . 0.0 110.785 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -80.38 63.93 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.382 0.61 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.22 166.0 26.16 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 125.478 1.513 . . . . 0.0 110.574 168.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -101.35 107.68 19.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.284 1.834 . . . . 0.0 110.087 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -59.56 109.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.19 -46.67 25.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -162.76 177.71 9.1 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . 95.39 -161.96 23.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.518 ' H ' HG22 ' A' ' 85' ' ' VAL . 6.6 m -156.71 144.83 19.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 168.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.946 HD11 HG21 ' A' ' 74' ' ' VAL . 49.1 pt -143.93 164.08 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.817 1.647 . . . . 0.0 106.741 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -108.96 109.9 21.07 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -104.75 25.08 10.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 0.0 111.928 170.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 CA--C 1.539 0.522 0 O-C-N 120.371 -1.456 . . . . 0.0 113.301 -177.868 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -83.94 169.06 15.43 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 124.424 1.078 . . . . 0.0 109.881 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.17 -44.86 71.85 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.64 -62.37 1.69 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.133 0.973 . . . . 0.0 109.482 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.39 -49.3 67.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.017 0.527 . . . . 0.0 111.359 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.18 -60.63 3.07 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.544 -0.722 . . . . 0.0 111.483 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.88 -42.19 68.39 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.248 1.019 . . . . 0.0 110.701 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.25 65.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.872 1.669 . . . . 0.0 112.32 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.83 30.64 1.93 Allowed Glycine 0 C--O 1.221 -0.715 0 CA-C-O 117.554 -1.692 . . . . 0.0 111.527 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CG ' HG22 ' A' ' 95' ' ' ILE . 96.4 m-85 -118.12 161.44 19.85 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.52 2.16 . . . . 0.0 113.514 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.946 HG21 HD11 ' A' ' 56' ' ' ILE . 7.1 p . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 118.779 -0.629 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -112.19 123.01 35.25 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.222 1.809 . . . . 0.0 109.096 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.618 ' HA ' HG22 ' A' ' 56' ' ' ILE . 16.8 Cg_endo -75.38 129.69 12.23 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.788 2.325 . . . . 0.0 111.595 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.3 p -104.05 -12.49 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.5 m -157.16 -174.93 5.14 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.13 127.77 33.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.607 HG21 HG23 ' A' ' 56' ' ' ILE . 25.1 t -135.91 153.76 32.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.674 0.79 . . . . 0.0 109.569 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.63 121.15 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.452 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.27 152.83 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.198 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 21.6 mt-10 -101.13 131.2 47.18 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 124.347 1.059 . . . . 0.0 109.284 168.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -88.74 177.46 6.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.153 1.342 . . . . 0.0 109.434 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.1 54.46 0.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.915 1.286 . . . . 0.0 111.437 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -125.32 22.37 7.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.74 0.816 . . . . 0.0 112.895 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -45.75 -72.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 108.91 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.09 37.57 0.44 Allowed 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.935 -0.478 . . . . 0.0 111.812 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -122.06 -29.54 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.452 1.501 . . . . 0.0 110.647 163.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.526 HG22 ' CG ' ' A' ' 73' ' ' TYR . 26.1 pt -83.68 -45.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 119.347 0.976 . . . . 0.0 112.608 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.981 -1.485 . . . . 0.0 109.803 -175.662 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -131.63 155.61 47.26 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.97 0.908 . . . . 0.0 112.54 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.29 96.93 0.06 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.277 2.631 . . . . 0.0 109.651 169.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.38 118.59 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -85.82 130.24 34.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.471 0.176 . . . . 0.0 111.238 167.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.41 ' CD1' HD11 ' A' ' 35' ' ' ILE . 64.2 mt -110.06 105.25 14.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 124.483 1.114 . . . . 0.0 108.603 169.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.5 mt -78.3 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -87.11 153.53 54.27 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.99 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.09 -35.05 89.56 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.951 3.101 . . . . 0.0 112.397 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.27 -38.8 13.13 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 127.485 2.314 . . . . 0.0 111.14 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.69 62.12 0.19 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 125.283 1.421 . . . . 0.0 110.197 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 67.43 162.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.111 2.164 . . . . 0.0 111.921 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.49 -59.85 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 123.438 0.695 . . . . 0.0 110.15 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.26 137.45 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 126.354 1.862 . . . . 0.0 112.464 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.64 174.65 11.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.725 0.41 . . . . 0.0 111.722 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 122.77 42.45 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.6 126.58 50.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.21 133.64 49.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.35 -30.87 30.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.315 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.1 -14.1 62.51 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.949 1.3 . . . . 0.0 112.136 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.52 160.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.34 147.05 42.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.032 -0.417 . . . . 0.0 111.86 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.2 62.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 122.174 0.987 . . . . 0.0 110.335 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.21 -60.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -49.59 -58.25 5.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.757 1.265 . . . . 0.0 109.823 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -74.93 -20.13 59.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.925 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -65.72 -52.05 54.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.25 -40.86 68.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.213 0.605 . . . . 0.0 109.976 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.56 -39.61 64.9 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.42 -24.74 46.03 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.704 -0.622 . . . . 0.0 109.763 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.11 10.1 6.97 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.87 1.7 . . . . 0.0 111.37 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.609 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 71.4 mt -78.02 129.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.119 0.96 . . . . 0.0 111.012 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -87.2 125.41 34.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' A' ' 7' ' ' LEU . 17.8 mt . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 164.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 122.803 1.287 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.01 158.31 27.6 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.001 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -95.43 109.81 21.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.074 1.35 . . . . 0.0 109.584 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 40.7 t -61.14 107.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.436 1.094 . . . . 0.0 108.225 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.29 -37.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -157.7 -163.21 1.3 Allowed 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . 73.53 -171.28 51.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.033 0.349 . . . . 0.0 113.168 172.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.425 ' H ' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -150.92 129.94 12.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.66 HG23 HG21 ' A' ' 85' ' ' VAL . 16.7 pt -139.1 152.28 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -100.72 112.97 25.47 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -105.68 41.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.249 0.62 . . . . 0.0 110.765 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 119.413 1.006 . . . . 0.0 111.495 176.225 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.231 0.111 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.19 165.58 14.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.618 0.723 . . . . 0.0 110.233 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.16 -41.35 71.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.818 1.247 . . . . 0.0 108.683 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.54 -60.63 2.93 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.129 0.972 . . . . 0.0 109.465 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -54.41 -48.26 71.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.462 0.705 . . . . 0.0 111.39 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.0 mtt -53.98 -60.18 3.67 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.521 -0.737 . . . . 0.0 111.106 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.67 -44.72 69.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.747 1.219 . . . . 0.0 110.558 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.18 64.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.741 1.617 . . . . 0.0 112.254 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.88 32.59 1.4 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.415 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.54 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.0 m-85 -120.24 159.38 25.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.343 2.072 . . . . 0.0 113.184 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.423 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.552 1.141 . . . . 0.0 108.73 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.66 118.44 45.08 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.006 1.723 . . . . 0.0 109.281 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.536 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.8 Cg_endo -75.85 108.79 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.339 2.693 . . . . 0.0 112.707 -174.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -88.43 -12.98 41.59 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.865 -0.522 . . . . 0.0 111.366 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.8 m -152.62 -177.27 6.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.167 1.387 . . . . 0.0 108.103 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.16 124.21 20.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 166.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.66 HG21 HG23 ' A' ' 56' ' ' ILE . 53.5 t -133.62 156.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.558 0.694 . . . . 0.0 111.282 -173.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.7 t -123.3 118.77 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.39 152.24 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.165 0.986 . . . . 0.0 108.939 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.53 127.55 46.86 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.077 0.951 . . . . 0.0 108.833 170.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -83.33 179.49 7.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.042 1.292 . . . . 0.0 110.139 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 69.73 55.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.153 1.381 . . . . 0.0 111.122 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.54 13.59 9.43 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -34.88 -76.29 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.855 2.062 . . . . 0.0 110.767 166.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.77 40.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.002 0.819 . . . . 0.0 112.426 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.37 -28.78 4.94 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.311 1.044 . . . . 0.0 111.047 158.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.54 HG22 ' CG ' ' A' ' 73' ' ' TYR . 34.8 pt -81.42 -48.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.296 0.953 . . . . 0.0 112.896 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.044 -173.306 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.409 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.7 m 58.78 78.25 0.26 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.536 0.735 . . . . 0.0 112.203 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -97.36 159.59 14.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -171.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.95 90.15 6.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.305 1.842 . . . . 0.0 109.614 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 85' ' ' VAL . 65.0 t -89.47 124.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -89.76 132.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.147 0.43 . . . . 0.0 110.836 165.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.543 HD23 HG23 ' A' ' 87' ' ' ILE . 70.4 mt -111.68 103.57 11.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 165.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.5 mt -71.62 95.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -92.79 156.75 40.53 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 124.145 0.978 . . . . 0.0 108.925 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.56 -35.3 76.38 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.2 3.267 . . . . 0.0 112.227 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.3 -30.97 52.8 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 127.376 2.27 . . . . 0.0 111.494 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.53 61.01 0.41 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 125.005 1.288 . . . . 0.0 110.73 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 71.95 142.72 0.06 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 127.768 2.427 . . . . 0.0 114.187 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.93 87.29 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.495 1.118 . . . . 0.0 108.148 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -66.71 132.18 47.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 109.746 167.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -153.38 166.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.133 0.573 . . . . 0.0 111.839 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.23 122.99 39.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.432 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -127.08 123.03 35.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.505 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 143.03 54.9 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.799 1.24 . . . . 0.0 110.099 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -56.35 -24.99 47.73 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 127.333 2.253 . . . . 0.0 111.182 173.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -107.88 21.29 17.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.589 1.555 . . . . 0.0 111.462 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -134.55 158.31 41.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.757 1.162 . . . . 0.0 110.633 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -78.68 144.89 34.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.343 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.02 61.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.871 0.868 . . . . 0.0 111.098 173.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 tp -169.11 -61.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.06 -55.95 12.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.057 0.943 . . . . 0.0 109.253 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -77.05 -13.76 59.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.876 0.87 . . . . 0.0 112.831 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -75.57 -50.46 15.51 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 120.945 -1.097 . . . . 0.0 108.603 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -53.38 -38.98 63.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.199 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.61 -38.8 56.26 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.59 -23.89 34.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.764 -0.585 . . . . 0.0 109.608 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.24 15.23 4.25 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.072 1.796 . . . . 0.0 111.473 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.657 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 82.2 mt -80.59 108.41 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.038 0.919 . . . . 0.0 112.445 -170.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.98 72.91 6.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.175 0.99 . . . . 0.0 110.398 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.53 156.25 91.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 120.921 -1.112 . . . . 0.0 109.651 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.43 71.06 6.03 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 124.034 3.156 . . . . 0.0 109.436 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.84 150.9 19.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.736 2.014 . . . . 0.0 108.926 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.7 m -128.37 -22.51 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.624 0.77 . . . . 0.0 112.765 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 170.36 10.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 126.237 1.815 . . . . 0.0 107.688 -171.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -135.12 83.86 2.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.623 0.647 . . . . 0.0 109.404 164.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.51 -47.5 0.89 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.647 1.579 . . . . 0.0 111.561 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.99 46.32 2.08 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.157 0.884 . . . . 0.0 111.934 172.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -154.14 69.21 0.77 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.8 m -131.27 -176.61 4.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.617 1.167 . . . . 0.0 109.986 -162.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.5 m -144.73 50.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -158.27 -152.56 0.34 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.438 1.495 . . . . 0.0 107.258 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.4 p 45.1 71.23 0.28 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.391 1.476 . . . . 0.0 114.504 165.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.09 25.68 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 120.49 -1.381 . . . . 0.0 112.387 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.56 164.46 27.01 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 125.942 1.734 . . . . 0.0 110.165 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -98.66 110.25 22.88 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.671 1.588 . . . . 0.0 110.502 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.49 115.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.63 -48.03 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.221 0.609 . . . . 0.0 109.505 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -160.87 173.99 14.51 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.067 -0.396 . . . . 0.0 110.223 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.49 -176.59 47.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.443 1.021 . . . . 0.0 110.742 -168.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -135.15 149.44 49.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.699 HD11 HG21 ' A' ' 74' ' ' VAL . 36.4 pt -147.47 165.29 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.124 1.77 . . . . 0.0 107.54 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.12 113.54 21.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 108.748 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.414 ' CD ' HG23 ' A' ' 74' ' ' VAL . 10.7 pt20 -110.86 31.77 5.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.023 170.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 p -74.49 64.8 1.2 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.101 1.773 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -154.48 -42.37 0.09 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.714 1.205 . . . . 0.0 110.849 -165.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.55 178.58 1.98 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.193 0.997 . . . . 0.0 112.829 176.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 t -144.99 82.77 1.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 164.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -156.45 -73.16 0.1 Allowed 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.263 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.42 138.45 51.23 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.195 0.907 . . . . 0.0 111.456 -167.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.14 166.43 18.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 124.043 0.839 . . . . 0.0 109.85 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -53.56 -43.99 68.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.0 -61.52 2.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.126 0.97 . . . . 0.0 109.608 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -54.95 -50.08 69.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.269 0.627 . . . . 0.0 111.376 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mtt -51.95 -59.36 4.43 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.489 -0.757 . . . . 0.0 111.314 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.03 -42.28 76.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.45 1.1 . . . . 0.0 110.832 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.42 -20.72 65.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.683 1.593 . . . . 0.0 111.753 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.57 33.8 1.06 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 117.786 -1.564 . . . . 0.0 111.413 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.97 162.67 18.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.348 2.074 . . . . 0.0 113.297 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 56' ' ' ILE . 13.0 p -152.52 147.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.061 1.344 . . . . 0.0 108.469 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.454 HD23 ' H ' ' A' ' 78' ' ' HIS . 0.7 OUTLIER -64.48 154.57 35.47 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -116.03 19.25 15.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.4 m -111.38 -48.36 3.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.122 1.369 . . . . 0.0 109.931 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.454 ' H ' HD23 ' A' ' 75' ' ' LEU . 27.4 m80 -117.69 89.88 3.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.014 1.725 . . . . 0.0 108.515 -176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -152.05 131.87 13.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.88 122.96 38.42 Favored Pre-proline 0 C--O 1.235 0.318 0 C-N-CA 125.537 1.535 . . . . 0.0 108.945 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.3 Cg_endo -76.33 113.95 3.79 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.221 2.614 . . . . 0.0 111.284 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 p -89.52 -12.55 39.67 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.375 -0.828 . . . . 0.0 111.749 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.1 m -157.79 -177.88 6.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.634 1.574 . . . . 0.0 107.687 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.5 113.17 1.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 162.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 5' ' ' VAL . 2.5 p -120.57 145.77 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.447 1.499 . . . . 0.0 108.595 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.71 125.63 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.543 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -138.03 155.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -102.87 128.42 49.66 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.28 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.444 ' CG2' HD22 ' A' ' 7' ' ' LEU . 43.0 p -86.4 178.73 7.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.045 1.293 . . . . 0.0 109.093 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.28 51.37 0.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.596 1.158 . . . . 0.0 111.178 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -127.62 37.62 4.18 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.584 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -70.08 0.25 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 165.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -72.92 33.16 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.737 -1.227 . . . . 0.0 113.803 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -121.97 -3.9 9.1 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.707 -1.245 . . . . 0.0 111.751 159.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.7 pt -111.75 -39.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.344 1.429 . . . . 0.0 111.694 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.253 1.275 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.436 175.712 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.497 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m 78.8 89.57 0.06 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.7 0.8 . . . . 0.0 112.088 157.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -104.81 156.02 18.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.278 0.561 . . . . 0.0 112.307 -167.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.34 104.39 2.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 127.835 2.454 . . . . 0.0 108.462 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.91 117.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -88.8 131.61 35.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.716 0.235 . . . . 0.0 111.283 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.553 HD12 HD13 ' A' ' 33' ' ' ILE . 79.5 mt -109.19 103.69 12.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.419 1.075 . . . . 0.0 109.105 167.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 53.9 mt -76.44 99.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -89.77 166.69 19.69 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 124.313 1.045 . . . . 0.0 109.48 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.18 -25.85 30.87 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.086 2.524 . . . . 0.0 111.182 166.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -46.11 78.7 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.169 0.988 . . . . 0.0 109.662 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.83 64.94 0.08 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 67.55 147.35 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.522 1.929 . . . . 0.0 113.643 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 p -154.43 105.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.398 165.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.99 142.35 41.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -152.41 169.24 23.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.182 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 123.5 44.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.4 124.72 50.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.734 0.646 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.03 151.55 45.7 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.524 1.63 . . . . 0.0 109.008 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -76.99 -14.56 59.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 129.333 3.053 . . . . 0.0 110.566 -177.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -114.4 20.04 15.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.533 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.58 148.91 29.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.087 0.858 . . . . 0.0 109.227 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -67.76 146.07 54.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.069 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.2 t -51.09 -51.53 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -57.32 12.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.305 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.94 -63.08 1.06 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.21 0.914 . . . . 0.0 110.611 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -69.69 -34.67 74.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 33' ' ' ILE . . . -51.18 -57.4 8.87 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.676 -0.64 . . . . 0.0 110.911 170.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -55.39 -41.7 73.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.01 -38.59 65.28 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.22 -25.89 58.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.275 0.56 . . . . 0.0 109.794 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.63 13.65 6.09 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.385 1.469 . . . . 0.0 110.946 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.553 HD13 HD12 ' A' ' 7' ' ' LEU . 93.7 mt -75.63 121.6 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 117.624 0.712 . . . . 0.0 110.496 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.04 80.74 8.74 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 155.33 86.59 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -64.81 133.69 37.36 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -169.19 156.8 7.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -168.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -168.75 -51.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.05 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 p -94.11 -150.17 0.29 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.241 2.216 . . . . 0.0 110.557 -172.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 168.52 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.506 2.322 . . . . 0.0 108.683 172.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 103.55 -42.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.472 2.709 . . . . 0.0 110.398 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.68 -21.88 7.89 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.131 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.66 59.13 0.74 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.774 1.629 . . . . 0.0 107.776 168.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.8 p -119.57 -137.83 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.327 1.051 . . . . 0.0 109.505 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -72.01 -93.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.234 1.379 . . . . 0.0 111.603 -172.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -57.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.377 0.535 . . . . 0.0 111.662 174.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . 0.47 0.0 OUTLIER 26.23 43.91 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 129.63 3.172 . . . . 0.0 117.481 172.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 95' ' ' ILE . . . -82.45 177.89 8.51 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.47 -1.394 . . . . 0.0 113.069 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.692 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -139.04 165.78 25.58 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.151 1.834 . . . . 0.0 110.335 172.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -102.95 111.1 23.27 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.006 1.722 . . . . 0.0 110.977 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.27 117.38 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.938 0.79 . . . . 0.0 109.341 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.7 -47.68 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.294 1.038 . . . . 0.0 109.013 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.451 ' O ' HG23 ' A' ' 85' ' ' VAL . 8.2 t -161.12 175.35 12.49 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 122.075 -0.391 . . . . 0.0 110.417 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.22 -160.83 52.72 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.559 1.076 . . . . 0.0 110.762 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 t -151.48 169.86 21.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.681 ' CD1' HG21 ' A' ' 74' ' ' VAL . 8.6 pt -161.46 160.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 127.234 2.214 . . . . 0.0 107.593 -167.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -114.82 110.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.417 ' CD ' HG23 ' A' ' 74' ' ' VAL . 9.8 pt20 -106.58 37.16 2.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 111.264 170.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -44.21 -40.32 5.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.951 0.796 . . . . 0.0 111.113 171.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -2.83 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.693 1.997 . . . . 0.0 113.427 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -69.19 162.78 26.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.433 1.015 . . . . 0.0 111.11 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -153.0 53.3 0.76 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 160.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.69 -65.97 0.18 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 117.72 -1.133 . . . . 0.0 111.897 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.11 141.31 54.46 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.993 1.27 . . . . 0.0 111.349 -166.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.23 166.38 15.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 124.065 0.853 . . . . 0.0 109.893 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.95 -43.88 70.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.25 -61.97 1.91 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.234 1.014 . . . . 0.0 109.563 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -54.38 -50.95 66.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.979 0.511 . . . . 0.0 111.466 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mtm -53.98 -58.06 8.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.455 -0.778 . . . . 0.0 111.51 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.85 -44.33 70.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.714 1.206 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.64 67.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.811 1.645 . . . . 0.0 111.945 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.93 32.86 0.96 Allowed Glycine 0 C--O 1.223 -0.569 0 CA-C-O 117.601 -1.666 . . . . 0.0 111.774 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.544 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.8 m-85 -121.02 163.66 17.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.557 2.179 . . . . 0.0 113.635 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.681 HG21 ' CD1' ' A' ' 56' ' ' ILE . 13.2 p -157.25 143.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 123.759 0.824 . . . . 0.0 108.906 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.58 -46.09 57.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.001 0.92 . . . . 0.0 111.652 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m 74.39 -56.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.339 1.055 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -60.71 -23.99 65.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.164 0.986 . . . . 0.0 112.437 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 82.56 1.96 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 107.381 172.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.95 142.81 20.0 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.877 0.871 . . . . 0.0 110.436 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -106.66 131.46 21.68 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 126.558 1.943 . . . . 0.0 109.357 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.3 Cg_endo -78.27 121.37 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.799 2.333 . . . . 0.0 111.725 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -97.29 -12.88 22.37 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.713 -0.617 . . . . 0.0 112.333 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -157.11 -175.23 5.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.563 1.545 . . . . 0.0 106.835 170.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -55.2 140.11 39.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 164.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 56' ' ' ILE . 3.3 p -156.33 146.23 11.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.754 0.788 . . . . 0.0 110.311 -168.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.84 126.8 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.692 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -143.14 147.93 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.878 0.871 . . . . 0.0 109.103 -177.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' N ' HD13 ' A' ' 87' ' ' ILE . 30.5 mt-10 -104.22 116.74 32.72 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.283 1.033 . . . . 0.0 110.813 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.1 p -79.11 176.25 9.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.244 0.929 . . . . 0.0 109.742 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 67.62 52.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.602 1.161 . . . . 0.0 111.082 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -123.6 43.98 2.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.683 0.793 . . . . 0.0 110.841 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.3 -71.6 0.2 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.82 50.64 1.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.696 -0.627 . . . . 0.0 111.846 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.73 -28.05 1.64 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.594 2.358 . . . . 0.0 111.618 165.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.544 HG22 ' CG ' ' A' ' 73' ' ' TYR . 26.0 pt -91.85 -42.19 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 119.184 0.902 . . . . 0.0 112.552 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 117.351 -1.309 . . . . 0.0 109.254 -177.396 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m 80.8 123.38 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.771 2.029 . . . . 0.0 111.321 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -128.81 156.1 44.13 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.195 0.598 . . . . 0.0 111.222 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.09 102.11 2.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.842 2.457 . . . . 0.0 108.469 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.64 120.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -90.53 131.94 35.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 123.165 0.291 . . . . 0.0 111.004 166.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.21 103.26 12.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 108.285 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mt -74.2 90.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -88.45 154.38 51.15 Favored Pre-proline 0 N--CA 1.444 -0.741 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -57.3 -31.95 92.36 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.87 3.046 . . . . 0.0 112.12 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.84 -33.76 37.49 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.916 2.086 . . . . 0.0 111.087 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.46 61.53 0.27 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 124.898 1.237 . . . . 0.0 110.145 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 68.57 153.79 0.1 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.152 2.181 . . . . 0.0 114.043 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.04 98.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.825 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.36 145.48 45.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.341 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -157.24 172.79 18.0 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.47 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.09 122.61 44.46 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t -122.94 127.86 49.47 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -69.32 141.88 54.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.738 1.256 . . . . 0.0 109.951 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -58.69 -21.75 55.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 129.886 3.274 . . . . 0.0 111.52 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -107.6 12.85 27.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.809 1.644 . . . . 0.0 110.606 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.44 157.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.261 0.937 . . . . 0.0 110.61 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -76.12 149.07 37.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.219 0.608 . . . . 0.0 110.806 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.3 t -72.54 66.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.84 0.829 . . . . 0.0 111.226 173.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 26' ' ' ASP . 1.4 pt? -163.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.583 1.553 . . . . 0.0 108.723 168.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' H ' HD23 ' A' ' 25' ' ' LEU . 4.9 t70 -57.92 -57.76 11.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 -170.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -63.08 -35.06 78.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.645 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -56.43 -56.73 17.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.637 -0.665 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.86 -39.75 74.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 109.767 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -52.15 -42.15 63.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.869 0.759 . . . . 0.0 112.765 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.07 -23.26 55.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.048 0.451 . . . . 0.0 109.974 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.26 12.88 7.27 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.91 1.719 . . . . 0.0 111.369 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.53 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 64.2 mt -80.42 129.66 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.542 0.671 . . . . 0.0 111.1 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -93.32 127.6 38.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.132 0.973 . . . . 0.0 108.436 164.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.73 153.26 67.66 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.31 91.25 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.204 2.603 . . . . 0.0 110.663 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -86.36 -48.88 8.08 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 123.553 0.741 . . . . 0.0 111.346 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t 56.56 -161.85 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.295 0.638 . . . . 0.0 112.332 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m 34.55 -136.03 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.031 2.932 . . . . 0.0 113.278 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 179.08 137.89 0.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.801 2.44 . . . . 0.0 107.966 156.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 70.9 83.32 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.682 1.193 . . . . 0.0 114.167 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -7.95 81.39 0.0 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 128.649 3.023 . . . . 0.0 116.119 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 t -171.14 42.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.158 1.783 . . . . 0.0 107.36 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 p -161.87 168.52 22.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.275 1.43 . . . . 0.0 107.884 -159.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -140.9 90.88 2.36 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.175 0.59 . . . . 0.0 111.399 -167.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 t -169.71 -157.03 0.15 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.272 2.229 . . . . 0.0 105.688 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . 0.292 0.7 OUTLIER 32.53 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 162.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.63 16.15 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.652 -1.28 . . . . 0.0 110.999 -173.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -142.54 166.09 26.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.004 1.764 . . . . 0.0 110.99 175.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -102.73 110.2 22.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.761 2.024 . . . . 0.0 110.873 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.04 114.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 119.14 0.882 . . . . 0.0 109.062 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.98 -44.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.3 t -161.54 177.64 9.85 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.99 -168.77 43.93 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -142.71 151.2 41.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.707 HG23 HG21 ' A' ' 85' ' ' VAL . 28.7 pt -142.35 157.2 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 173.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -99.74 107.63 19.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.3 39.88 1.64 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.676 0.79 . . . . 0.0 111.442 170.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.2 m -48.71 -38.87 22.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.492 1.042 . . . . 0.0 111.589 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -76.67 50.91 0.72 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.586 1.154 . . . . 0.0 110.321 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.741 ' HA ' HD22 ' A' ' 75' ' ' LEU . 6.5 pt20 -99.79 -65.64 0.95 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.17 1.388 . . . . 0.0 111.546 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 m 43.89 44.82 6.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.622 0.769 . . . . 0.0 111.515 -168.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -154.88 -72.42 0.12 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.159 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.49 143.85 52.6 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.126 0.876 . . . . 0.0 110.642 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.9 164.83 15.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.729 0.643 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.59 -43.19 68.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.163 0.985 . . . . 0.0 108.543 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -52.3 -61.63 2.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.089 0.956 . . . . 0.0 109.421 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -52.52 -52.28 55.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 111.332 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.7 mtt -52.33 -59.88 3.88 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 111.317 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.76 -44.0 73.26 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.954 1.302 . . . . 0.0 110.677 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.18 -20.84 64.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.744 1.618 . . . . 0.0 111.769 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.69 32.94 1.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-O 117.972 -1.46 . . . . 0.0 111.149 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.478 ' CG ' HG22 ' A' ' 95' ' ' ILE . 93.6 m-85 -118.35 165.88 13.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.963 1.882 . . . . 0.0 113.049 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.634 HG21 HD11 ' A' ' 56' ' ' ILE . 7.6 p -161.69 149.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -175.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 61' ' ' GLN . 29.2 tp -57.57 -52.47 65.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.969 0.908 . . . . 0.0 110.26 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m 73.37 -55.14 0.68 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.565 1.146 . . . . 0.0 110.129 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -31.38 -63.49 0.17 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.574 2.349 . . . . 0.0 111.777 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.35 60.43 0.94 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.122 1.769 . . . . 0.0 108.25 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -111.22 138.49 47.61 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 121.725 -0.609 . . . . 0.0 109.89 172.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.4 125.44 37.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.215 1.406 . . . . 0.0 109.416 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.8 Cg_endo -74.25 114.99 4.17 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.858 2.372 . . . . 0.0 110.811 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.4 p -94.71 -9.8 33.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.144 0.884 . . . . 0.0 112.129 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -156.9 -177.7 6.81 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 107.491 169.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -55.58 139.25 44.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 163.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.707 HG21 HG23 ' A' ' 56' ' ' ILE . 3.5 p -157.56 146.43 10.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.483 -165.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.87 124.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.423 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -139.11 152.21 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.885 0.874 . . . . 0.0 108.86 178.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 17.0 mt-10 -103.99 117.23 33.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.138 0.975 . . . . 0.0 109.854 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 p -80.32 174.63 11.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.381 -0.824 . . . . 0.0 111.301 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.96 55.63 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.654 1.582 . . . . 0.0 111.281 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 20.6 mmtt -126.33 25.81 6.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.429 0.692 . . . . 0.0 112.668 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.13 -70.56 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.19 0.996 . . . . 0.0 108.725 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -79.77 39.12 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.557 -0.714 . . . . 0.0 112.373 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.92 -43.5 3.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.632 1.173 . . . . 0.0 109.275 161.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.478 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.3 pt -75.89 -41.48 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.314 -1.327 . . . . 0.0 109.559 -177.741 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m 76.11 85.04 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.216 0.607 . . . . 0.0 112.384 164.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -102.81 156.96 17.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.129 0.572 . . . . 0.0 112.394 -167.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -83.07 89.59 6.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.145 1.778 . . . . 0.0 109.8 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG13 HG13 ' A' ' 85' ' ' VAL . 85.2 t -87.31 127.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.69 131.32 43.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.139 0.427 . . . . 0.0 111.772 166.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.466 HD12 HG21 ' A' ' 33' ' ' ILE . 37.6 mt -108.8 105.14 14.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.34 1.025 . . . . 0.0 108.396 166.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.19 94.0 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -93.16 155.24 41.31 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.083 0.953 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -56.5 -32.42 89.48 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.938 3.092 . . . . 0.0 112.147 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.91 48.95 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 126.541 1.936 . . . . 0.0 111.215 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.49 60.08 0.35 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 124.861 1.219 . . . . 0.0 110.935 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 67.89 141.68 0.04 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.263 2.225 . . . . 0.0 114.127 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 33' ' ' ILE . 34.2 m -139.64 98.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.059 1.343 . . . . 0.0 107.864 169.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -82.18 133.31 35.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.696 1.599 . . . . 0.0 109.687 171.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.73 172.46 18.56 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 124.4 46.81 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 122.809 0.443 . . . . 0.0 110.224 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 48.6 t -125.43 128.21 47.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.98 140.06 50.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 123.832 1.777 . . . . 0.0 110.38 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -24.16 28.71 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 129.203 3.001 . . . . 0.0 111.335 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.36 7.24 38.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.574 1.549 . . . . 0.0 112.036 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.0 157.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-N 119.796 1.18 . . . . 0.0 110.302 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.53 147.35 41.89 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 122.013 -0.429 . . . . 0.0 110.804 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -53.96 -57.03 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.659 0.383 . . . . 0.0 110.137 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.54 -51.03 61.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.331 0.652 . . . . 0.0 111.089 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.28 -65.59 0.54 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.611 0.764 . . . . 0.0 110.64 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.57 -42.46 78.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.616 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -53.58 -59.92 3.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.965 -0.46 . . . . 0.0 111.176 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -58.87 -36.4 74.57 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.897 -0.573 . . . . 0.0 110.212 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -54.42 -38.31 66.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.959 0.799 . . . . 0.0 112.695 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.11 -26.53 53.39 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.807 -0.558 . . . . 0.0 109.991 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 12.64 8.36 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.747 1.641 . . . . 0.0 111.133 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 14' ' ' VAL . 91.5 mt -74.34 125.53 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.602 0.701 . . . . 0.0 111.02 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.47 119.7 30.96 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.44 1.096 . . . . 0.0 109.041 167.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 HD13 HD13 ' A' ' 7' ' ' LEU . 14.2 pt -137.67 156.07 74.83 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.89 125.54 13.85 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.872 1.715 . . . . 0.0 109.921 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -148.94 64.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.233 1.492 . . . . 0.0 108.934 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -58.96 -23.75 61.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.657 -1.277 . . . . 0.0 112.664 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.94 168.03 11.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.658 1.983 . . . . 0.0 108.688 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.63 67.35 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.99 -63.19 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.839 1.655 . . . . 0.0 108.798 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.1 55.48 0.05 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.728 0.68 . . . . 0.0 111.505 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.8 m -167.61 85.98 0.23 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.877 0.871 . . . . 0.0 109.227 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.3 p -148.04 -168.65 3.13 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.19 0.996 . . . . 0.0 108.637 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.9 p -151.93 62.95 0.85 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -163.33 -177.39 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 128.67 2.788 . . . . 0.0 104.719 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 74.89 176.86 0.22 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.676 1.591 . . . . 0.0 112.122 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 140.21 167.4 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.809 2.843 . . . . 0.0 112.985 168.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.689 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -142.98 161.59 27.54 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.65 1.595 . . . . 0.0 111.096 167.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -96.48 111.17 23.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.506 1.923 . . . . 0.0 110.728 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 19.8 t -61.06 111.01 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.211 1.405 . . . . 0.0 108.675 175.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -83.81 -47.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.015 0.926 . . . . 0.0 108.979 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -161.36 172.67 16.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.54 -162.38 50.24 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.374 0.988 . . . . 0.0 110.667 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -155.88 155.58 33.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.679 -0.895 . . . . 0.0 109.193 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.659 HG22 ' HA ' ' A' ' 81' ' ' PRO . 29.7 pt -135.3 165.95 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.99 1.716 . . . . 0.0 107.416 174.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.83 111.32 23.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.56 31.45 5.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.77 -0.633 . . . . 0.0 111.752 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -76.21 57.99 1.2 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.016 1.28 . . . . 0.0 112.175 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -141.29 -40.25 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.789 1.636 . . . . 0.0 111.318 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' CB ' HD13 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -74.48 -177.51 3.14 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.106 -0.996 . . . . 0.0 112.625 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -146.6 75.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -154.28 -76.57 0.11 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.85 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.6 137.3 53.99 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.303 0.956 . . . . 0.0 111.022 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.66 164.35 17.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 124.092 0.87 . . . . 0.0 109.983 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.17 -44.11 64.48 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.613 1.165 . . . . 0.0 108.482 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.32 -62.43 1.63 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.538 1.135 . . . . 0.0 109.671 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -53.97 -50.18 67.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.283 0.633 . . . . 0.0 111.294 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 29.8 mtt -52.78 -59.98 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.933 -0.479 . . . . 0.0 111.343 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.63 -43.29 72.15 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.855 1.262 . . . . 0.0 110.618 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.63 -21.26 65.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.629 1.572 . . . . 0.0 111.948 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 33.66 1.32 Allowed Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.028 -1.429 . . . . 0.0 110.832 173.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.517 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.1 m-85 -118.75 166.43 12.79 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.965 1.882 . . . . 0.0 112.806 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -162.57 158.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.591 HD12 ' S1 ' ' A' ' 97' ' ' FES . 2.1 pt? -70.24 -52.95 19.25 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.86 1.209 . . . . 0.0 111.962 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.461 ' O ' HG22 ' A' ' 76' ' ' THR . 21.4 m 60.6 56.61 3.0 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.563 1.173 . . . . 0.0 110.484 -170.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.406 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 67.4 m -134.56 -93.37 0.3 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 172.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.5 49.85 1.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.632 1.573 . . . . 0.0 110.456 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.625 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -116.36 146.62 42.33 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -109.28 122.77 38.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 C-N-CA 124.522 1.129 . . . . 0.0 109.553 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.659 ' HA ' HG22 ' A' ' 56' ' ' ILE . 10.8 Cg_endo -71.24 119.6 6.4 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.543 2.162 . . . . 0.0 111.102 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.9 p -93.7 -13.97 26.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.006 -0.434 . . . . 0.0 111.864 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.0 m -158.66 -177.69 6.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.803 1.641 . . . . 0.0 107.217 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.77 95.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.581 1.552 . . . . 0.0 109.337 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.546 HG11 ' CG2' ' A' ' 56' ' ' ILE . 4.2 p -99.24 148.75 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 110.236 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.38 125.97 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.689 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -144.77 144.39 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.756 0.822 . . . . 0.0 109.32 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -100.93 113.39 26.32 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.99 0.814 . . . . 0.0 110.538 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.2 p -79.46 175.69 10.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.979 0.809 . . . . 0.0 110.988 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.29 53.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.318 1.447 . . . . 0.0 111.326 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -124.73 24.67 7.68 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.528 0.731 . . . . 0.0 112.837 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -50.46 -70.17 0.09 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.197 0.999 . . . . 0.0 109.252 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.07 42.37 0.4 Allowed 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.854 -0.529 . . . . 0.0 112.037 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -130.33 -27.46 2.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.343 1.457 . . . . 0.0 111.29 163.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.517 HG22 ' CG ' ' A' ' 73' ' ' TYR . 25.0 pt -82.52 -42.89 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 119.468 1.031 . . . . 0.0 113.197 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.567 -1.206 . . . . 0.0 109.933 -176.057 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.591 ' S1 ' HD12 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m 52.97 75.16 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.301 1.04 . . . . 0.0 113.686 167.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.02 157.74 15.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.305 0.642 . . . . 0.0 112.455 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -81.63 88.65 6.22 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.702 1.601 . . . . 0.0 109.737 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 85' ' ' VAL . 59.3 t -86.85 123.55 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -95.03 131.82 40.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 117.714 0.234 . . . . 0.0 111.499 170.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.99 105.0 13.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 108.493 169.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 mt -75.55 87.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -83.52 154.77 65.88 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.423 1.089 . . . . 0.0 108.881 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.1 -27.33 78.91 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.716 2.944 . . . . 0.0 112.31 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.64 -31.55 57.56 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 125.666 1.586 . . . . 0.0 110.899 171.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.51 61.89 0.3 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 125.144 1.354 . . . . 0.0 110.571 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 65.82 163.15 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.692 1.997 . . . . 0.0 112.687 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.604 HG23 ' H ' ' A' ' 15' ' ' GLU . 14.1 m -132.21 -67.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 170.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.2 tt0 75.9 128.58 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.438 1.895 . . . . 0.0 111.594 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.6 p90 -162.43 172.5 15.45 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.246 -0.284 . . . . 0.0 111.389 -170.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 127.47 45.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 26.7 t -124.75 124.99 43.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.277 0.631 . . . . 0.0 111.332 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -64.33 147.9 51.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.271 1.034 . . . . 0.0 110.588 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -65.35 -14.71 61.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.295 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -107.37 4.05 25.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.851 1.66 . . . . 0.0 111.652 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.59 156.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 119.27 0.941 . . . . 0.0 108.859 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.85 153.74 36.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.46 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -52.68 -53.87 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.361 172.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -58.67 -43.02 89.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.033 -176.04 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' N ' HD13 ' A' ' 25' ' ' LEU . 78.4 m-20 -51.04 -66.54 0.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.57 1.176 . . . . 0.0 107.943 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -70.26 -34.11 72.42 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.941 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -59.3 4.65 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.98 -0.45 . . . . 0.0 111.961 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.7 -38.62 75.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.84 -39.34 68.49 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.75 -26.03 59.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.57 13.32 7.47 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.427 1.489 . . . . 0.0 110.936 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.632 HG22 HG23 ' A' ' 35' ' ' ILE . 76.4 mt -76.61 128.81 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 117.757 0.779 . . . . 0.0 110.173 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -90.83 119.48 31.07 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.996 1.318 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.632 HG23 HG22 ' A' ' 33' ' ' ILE . 8.5 pt -138.4 159.82 66.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 124.577 1.151 . . . . 0.0 107.946 173.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -70.56 107.17 1.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.1 1.867 . . . . 0.0 109.104 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -133.66 95.05 3.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 t -80.85 -163.3 0.57 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 162.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . 0.253 10.2 p 32.22 -142.38 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.706 2.002 . . . . 0.0 113.517 -172.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 177.27 42.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.059 2.543 . . . . 0.0 108.749 157.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.12 93.46 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -168.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -35.98 94.02 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.353 1.93 . . . . 0.0 113.008 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 t -173.28 -40.83 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.995 0.918 . . . . 0.0 110.11 -170.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -131.91 69.48 1.48 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.729 0.812 . . . . 0.0 110.462 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.5 p -153.81 -178.63 7.18 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 0.7 OUTLIER 71.46 146.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.621 2.368 . . . . 0.0 112.354 -170.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' CYS . . . 174.4 166.54 0.23 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.446 1.098 . . . . 0.0 111.426 170.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.91 170.98 24.68 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 126.041 1.781 . . . . 0.0 110.539 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -102.13 111.21 23.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 110.347 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.51 111.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 108.888 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -83.69 -47.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -161.94 175.79 11.47 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.076 -0.39 . . . . 0.0 110.707 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.97 -160.19 53.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 m -155.16 156.2 35.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.944 HD11 HG21 ' A' ' 74' ' ' VAL . 38.0 pt -140.21 166.21 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 107.85 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -104.29 109.16 20.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -113.43 58.7 0.66 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.997 0.919 . . . . 0.0 108.684 164.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -94.5 49.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.605 -0.684 . . . . 0.0 110.283 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.88 -55.27 1.3 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.833 0.853 . . . . 0.0 109.924 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -65.29 163.58 15.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -126.27 28.69 5.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 159.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.45 -73.31 0.31 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.326 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.58 143.25 54.26 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.027 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -93.23 167.46 11.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.614 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.15 -43.22 74.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.633 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.9 -61.28 2.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 123.99 0.916 . . . . 0.0 109.423 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.45 -51.29 67.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.614 0.766 . . . . 0.0 111.011 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 63.1 mtt -50.54 -61.25 2.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.903 -0.498 . . . . 0.0 111.421 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.76 -44.24 73.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.709 1.204 . . . . 0.0 110.649 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.28 -22.84 65.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.872 1.669 . . . . 0.0 112.033 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.31 29.02 1.53 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-O 117.778 -1.568 . . . . 0.0 111.998 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.6 m-85 -117.5 165.04 14.01 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 120.156 1.978 . . . . 0.0 112.85 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 56' ' ' ILE . 8.4 p -158.82 146.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.09 0.956 . . . . 0.0 109.435 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -82.88 145.2 29.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.347 0.522 . . . . 0.0 109.777 173.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 p -114.43 35.14 4.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.74 1.216 . . . . 0.0 111.304 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.485 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 1.3 m -97.79 -99.07 0.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -92.05 90.91 7.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.455 1.502 . . . . 0.0 109.139 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -142.3 137.88 30.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.09 125.72 30.47 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 125.145 1.378 . . . . 0.0 110.041 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.639 ' HA ' HG22 ' A' ' 56' ' ' ILE . 12.7 Cg_endo -73.13 117.77 5.25 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.627 2.218 . . . . 0.0 111.323 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -89.56 -19.03 25.48 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.744 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 m -154.37 -176.21 5.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.474 1.91 . . . . 0.0 107.403 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.09 113.25 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 163.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 5' ' ' VAL . 1.7 p -120.33 143.36 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.611 1.564 . . . . 0.0 109.134 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.82 155.31 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 124.641 1.176 . . . . 0.0 108.087 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.01 114.64 28.9 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.431 1.093 . . . . 0.0 109.268 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -75.18 176.94 6.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.211 0.914 . . . . 0.0 110.839 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 m80 68.95 53.4 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.96 1.304 . . . . 0.0 110.682 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -126.64 28.24 5.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 111.727 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.87 -64.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.73 14.14 0.53 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 -18.37 14.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.789 1.236 . . . . 0.0 109.782 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.469 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -100.34 -40.49 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.419 0.554 . . . . 0.0 111.308 -174.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.072 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 m 76.99 117.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 111.837 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -134.84 160.05 39.44 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.412 0.685 . . . . 0.0 111.169 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -87.88 87.21 7.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.842 1.657 . . . . 0.0 109.645 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 85' ' ' VAL . 57.7 t -83.93 123.04 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 25.4 ttmt -93.37 134.38 35.66 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 87' ' ' ILE . 39.8 mt -113.61 105.89 13.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.884 1.274 . . . . 0.0 107.757 169.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.19 93.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -90.18 155.41 46.93 Favored Pre-proline 0 N--CA 1.443 -0.787 0 C-N-CA 125.215 1.406 . . . . 0.0 108.347 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.27 -30.22 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.687 2.925 . . . . 0.0 112.476 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.98 -32.02 61.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.439 1.896 . . . . 0.0 111.063 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.98 61.66 0.29 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.969 1.271 . . . . 0.0 110.782 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 24.1 mt-10 66.42 162.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.015 2.126 . . . . 0.0 112.368 176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 15' ' ' GLU . 16.7 m -135.84 -63.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.184 0.593 . . . . 0.0 111.143 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.536 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.7 tt0 76.28 132.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.177 1.791 . . . . 0.0 112.04 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 33' ' ' ILE . 2.6 p90 -162.27 173.83 13.67 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.29 126.81 41.76 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 16.0 t -129.26 130.87 46.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 139.29 41.3 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 123.571 1.653 . . . . 0.0 108.905 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -51.13 -27.65 9.02 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 130.019 3.328 . . . . 0.0 111.793 172.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -102.01 8.72 40.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.495 1.518 . . . . 0.0 111.569 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.74 158.05 43.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.488 1.04 . . . . 0.0 110.509 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -76.11 147.75 38.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.72 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.7 t -55.93 -54.36 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tt -78.9 46.4 0.68 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.569 1.148 . . . . 0.0 111.899 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -137.9 -68.73 0.46 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.352 1.461 . . . . 0.0 107.661 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.99 -10.27 47.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.845 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -77.64 -54.15 6.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.625 -1.297 . . . . 0.0 112.291 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.62 -39.15 67.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.158 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.333 0.3 OUTLIER -58.17 -30.18 66.2 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.87 -28.27 44.14 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.0 12.8 4.71 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.026 1.298 . . . . 0.0 111.293 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 16' ' ' PHE . 72.0 mt -73.77 123.46 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.177 0.988 . . . . 0.0 110.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -89.34 115.24 26.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -131.87 159.83 70.29 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 124.114 0.965 . . . . 0.0 109.216 172.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.38 101.31 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.59 2.193 . . . . 0.0 109.933 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -50.37 20.13 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.799 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.316 1.3 m 41.55 -10.81 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 131.68 3.992 . . . . 0.0 121.002 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.7 p -169.15 -151.33 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.963 2.905 . . . . 0.0 105.031 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -166.7 72.46 0.13 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 146.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 167.99 108.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.669 1.987 . . . . 0.0 108.421 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -27.21 83.78 0.0 OUTLIER Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.697 2.57 . . . . 0.0 115.383 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -164.24 -56.1 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.785 0.792 . . . . 0.0 109.644 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -46.3 -40.95 12.52 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.7 1.2 . . . . 0.0 111.711 -177.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 20.4 m 71.11 63.86 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.044 1.738 . . . . 0.0 111.22 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 p -143.33 -137.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.529 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.2 p 44.92 -75.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 129.08 2.952 . . . . 0.0 115.04 -172.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 48.39 176.38 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.754 2.822 . . . . 0.0 114.468 -171.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.84 161.14 34.91 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -98.91 110.68 23.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.229 1.412 . . . . 0.0 110.302 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.69 109.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.935 0.894 . . . . 0.0 108.729 173.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.44 -49.26 17.37 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.043 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.9 t -160.35 173.07 16.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.67 -167.95 32.6 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -165.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -140.94 159.22 42.68 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.044 HD11 HG21 ' A' ' 74' ' ' VAL . 45.1 pt -146.07 166.82 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.239 1.416 . . . . 0.0 107.653 173.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -110.43 110.02 20.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.99 24.56 11.16 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.962 0.905 . . . . 0.0 112.135 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -74.94 42.15 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.838 1.199 . . . . 0.0 112.634 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -130.38 6.64 4.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.26 1.824 . . . . 0.0 110.155 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -176.48 2.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.426 1.09 . . . . 0.0 112.597 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -156.16 77.5 0.94 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 95' ' ' ILE . 2.0 t80 -152.08 -80.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.005 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mp -54.17 138.52 38.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 111.06 -168.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.87 165.06 19.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.183 0.927 . . . . 0.0 109.65 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -42.79 72.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.061 0.944 . . . . 0.0 108.687 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.76 -61.13 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.11 0.964 . . . . 0.0 109.497 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.76 -51.43 63.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.342 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.1 mtt -51.19 -60.05 3.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.325 0.511 . . . . 0.0 111.402 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -54.92 -43.17 73.05 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.783 1.233 . . . . 0.0 110.652 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -20.25 64.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.672 1.589 . . . . 0.0 112.058 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.5 28.88 2.03 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.129 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.49 ' CG ' HG22 ' A' ' 95' ' ' ILE . 92.8 m-85 -112.44 168.52 9.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.736 1.768 . . . . 0.0 112.931 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.044 HG21 HD11 ' A' ' 56' ' ' ILE . 10.5 p -161.22 159.85 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.307 1.443 . . . . 0.0 109.334 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tp -87.08 113.71 23.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.009 1.324 . . . . 0.0 110.721 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.7 m -85.01 46.24 1.25 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.128 -0.983 . . . . 0.0 111.607 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.99 -99.5 0.44 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -83.68 68.79 10.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.791 1.237 . . . . 0.0 109.63 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.659 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -116.41 134.35 54.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.327 1.051 . . . . 0.0 109.343 175.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -105.53 125.3 33.75 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 109.492 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.634 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.6 Cg_endo -76.05 115.63 4.19 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.742 2.294 . . . . 0.0 111.874 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 p -93.52 -9.57 37.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.279 0.945 . . . . 0.0 112.102 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -161.96 -177.06 5.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.204 1.802 . . . . 0.0 107.177 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.04 92.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.532 1.533 . . . . 0.0 109.696 168.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 56' ' ' ILE . 5.7 p -96.42 146.76 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.963 1.305 . . . . 0.0 110.26 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.85 125.4 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.464 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -134.52 153.69 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 124.287 1.035 . . . . 0.0 108.222 176.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -103.74 125.73 50.41 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.073 0.949 . . . . 0.0 109.403 170.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 p -91.65 175.8 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.157 0.889 . . . . 0.0 110.7 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.13 60.39 0.65 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.292 1.037 . . . . 0.0 109.288 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -126.01 16.03 7.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.879 0.872 . . . . 0.0 112.499 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -41.31 -70.69 0.1 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.361 1.465 . . . . 0.0 109.777 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -80.99 32.85 0.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.22 -29.37 1.62 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.93 2.092 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.51 HD11 ' CE2' ' A' ' 63' ' ' PHE . 39.6 pt -81.7 -41.97 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.694 -0.669 . . . . 0.0 112.584 169.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.486 -1.245 . . . . 0.0 110.007 -179.176 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m 54.6 71.22 0.54 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.009 1.324 . . . . 0.0 113.176 161.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -93.56 164.35 13.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.975 0.91 . . . . 0.0 111.443 -172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.56 89.33 7.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.145 1.378 . . . . 0.0 108.905 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.642 HG13 HG13 ' A' ' 85' ' ' VAL . 50.4 t -87.01 122.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -93.81 125.58 38.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.269 0.356 . . . . 0.0 110.668 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 33' ' ' ILE . 17.1 mt -106.34 98.58 8.23 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 124.955 1.409 . . . . 0.0 108.022 174.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 35.6 mt -73.92 89.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -90.25 155.71 46.54 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 125.564 1.545 . . . . 0.0 108.316 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.96 -21.3 68.67 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.777 2.985 . . . . 0.0 112.681 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.54 -29.01 69.73 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.329 1.452 . . . . 0.0 110.862 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.8 61.95 0.35 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 65.6 173.16 0.22 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.505 1.522 . . . . 0.0 112.571 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.498 HG21 HG12 ' A' ' 33' ' ' ILE . 5.4 p -147.5 -55.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.651 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 71.1 132.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.718 1.607 . . . . 0.0 111.236 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -159.68 167.02 29.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.874 -0.516 . . . . 0.0 111.567 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 127.55 37.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.097 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 5.5 t -132.03 117.96 19.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.622 0.369 . . . . 0.0 110.696 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.76 148.88 19.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.629 1.972 . . . . 0.0 108.87 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -75.96 -6.79 52.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.769 -0.582 . . . . 0.0 112.328 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.26 36.25 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.457 1.503 . . . . 0.0 110.082 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.6 163.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 121.043 -1.035 . . . . 0.0 111.116 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -81.82 140.11 34.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.595 0.758 . . . . 0.0 111.894 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.0 t -63.84 -7.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.19 -34.93 10.93 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.604 1.161 . . . . 0.0 110.715 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -68.36 -69.46 0.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.17 0.986 . . . . 0.0 110.165 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.259 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -49.11 -62.16 1.68 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.775 0.83 . . . . 0.0 112.328 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -55.18 -40.69 71.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.064 -0.493 . . . . 0.0 109.727 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.3 -36.23 52.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.22 -30.32 34.26 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.508 0.595 . . . . 0.0 110.707 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.69 8.54 4.73 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.538 1.066 . . . . 0.0 112.076 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.648 HD13 HD12 ' A' ' 7' ' ' LEU . 21.1 mt -70.02 118.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.732 1.266 . . . . 0.0 110.906 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -91.15 77.85 5.94 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.319 1.048 . . . . 0.0 109.634 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.88 157.7 89.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 120.764 -1.21 . . . . 0.0 108.837 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -75.66 60.47 5.92 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.705 2.937 . . . . 0.0 111.65 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -78.46 167.98 20.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 111.338 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -175.45 9.11 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.701 2.0 . . . . 0.0 114.5 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.8 p -143.86 -55.34 0.37 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.622 1.556 . . . . 0.0 111.201 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 69.74 50.99 0.46 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.354 1.462 . . . . 0.0 111.478 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -159.55 76.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.753 0.706 . . . . 0.0 112.251 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.59 ' O ' HD21 ' A' ' 75' ' ' LEU . . . 63.91 -83.3 0.05 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.447 ' HA ' ' S2 ' ' A' ' 97' ' ' FES . 51.0 p -164.02 163.29 23.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.104 1.452 . . . . 0.0 111.715 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.8 p -137.04 23.63 3.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.501 1.52 . . . . 0.0 112.117 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t 77.27 36.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.944 1.298 . . . . 0.0 111.485 -175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.1 p -156.65 -172.21 3.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 78.5 m 62.62 126.16 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 126.898 2.079 . . . . 0.0 112.977 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 95' ' ' ILE . . . -169.11 169.26 9.52 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.86 163.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.527 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -138.39 169.54 24.25 Favored Glycine 0 N--CA 1.431 -1.645 0 C-N-CA 126.016 1.769 . . . . 0.0 109.547 169.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -98.76 110.65 23.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.476 1.511 . . . . 0.0 108.424 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.42 103.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 t -77.03 -44.49 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 85' ' ' VAL . 9.0 t -163.46 172.3 14.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.64 -171.98 54.86 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.775 1.178 . . . . 0.0 111.151 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -137.38 157.61 46.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 74' ' ' VAL . 31.6 pt -148.15 168.45 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.274 1.829 . . . . 0.0 107.417 174.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -111.43 110.43 20.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -104.52 35.29 2.78 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.074 0.55 . . . . 0.0 112.078 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 t -54.02 -25.56 21.84 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.623 1.101 . . . . 0.0 113.551 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.28 -23.07 65.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 112.48 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -53.66 158.88 1.73 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.865 1.266 . . . . 0.0 113.222 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.54 49.46 0.54 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.73 -71.7 0.1 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.531 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -57.08 142.1 43.53 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.488 1.04 . . . . 0.0 110.94 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.19 168.61 11.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.031 0.832 . . . . 0.0 109.736 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.38 -42.48 70.43 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.71 -61.25 2.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.581 0.752 . . . . 0.0 109.521 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -55.66 -52.03 65.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.314 0.646 . . . . 0.0 111.283 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.2 mtm -51.81 -58.09 7.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.676 -0.64 . . . . 0.0 111.573 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.95 -42.93 76.97 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.332 1.053 . . . . 0.0 110.555 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.67 -21.27 64.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.56 1.544 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.58 2.23 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 118.355 -1.247 . . . . 0.0 110.859 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.0 m-85 -111.56 169.62 8.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.5 1.65 . . . . 0.0 111.564 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.027 HG21 HD11 ' A' ' 56' ' ' ILE . 8.5 p -162.17 150.67 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.657 0.783 . . . . 0.0 109.103 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.59 HD21 ' O ' ' A' ' 42' ' ' GLY . 67.2 tp -64.2 135.02 55.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.637 0.775 . . . . 0.0 110.325 169.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -89.95 -36.81 14.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 111.545 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -50.91 66.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.271 1.028 . . . . 0.0 111.517 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.518 ' CD2' ' H ' ' A' ' 42' ' ' GLY . 1.7 m-70 -132.52 132.1 42.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 109.372 170.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.646 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -171.74 141.13 1.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.69 1.596 . . . . 0.0 107.744 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -108.14 119.67 49.14 Favored Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 125.793 1.637 . . . . 0.0 108.863 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.786 ' HA ' HG22 ' A' ' 56' ' ' ILE . 18.4 Cg_endo -76.51 116.72 4.37 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.855 2.37 . . . . 0.0 111.341 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 p -91.77 -12.96 32.38 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.002 -0.436 . . . . 0.0 111.404 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -160.82 -178.28 6.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.301 1.84 . . . . 0.0 107.474 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -57.17 96.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.875 1.67 . . . . 0.0 109.251 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG13 HG13 ' A' ' 5' ' ' VAL . 9.1 p -103.0 147.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.727 1.211 . . . . 0.0 110.163 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -116.92 119.46 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.527 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -136.93 142.36 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 16.4 mt-10 -98.34 119.51 37.15 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.047 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -80.15 177.34 9.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.209 1.368 . . . . 0.0 110.007 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.2 m80 67.61 47.94 1.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.847 1.259 . . . . 0.0 111.11 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -121.38 41.1 3.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.124 0.57 . . . . 0.0 110.22 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -79.04 -60.06 2.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.31 51.86 0.73 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.427 0.691 . . . . 0.0 112.354 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.32 -12.03 0.05 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.443 1.497 . . . . 0.0 113.431 163.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.468 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -79.87 -40.56 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.916 1.235 . . . . 0.0 111.198 170.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.675 177.746 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.447 ' S2 ' ' HA ' ' A' ' 43' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m 84.4 88.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.925 1.693 . . . . 0.0 113.97 160.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -117.16 158.8 23.64 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.321 1.448 . . . . 0.0 111.526 -170.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.35 101.52 1.95 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.46 2.304 . . . . 0.0 108.833 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 18' ' ' CYS . 18.9 t -107.25 124.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.3 0.375 . . . . 0.0 110.164 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 33' ' ' ILE . 40.8 mt -108.86 106.48 16.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 108.848 167.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.15 99.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -99.27 155.24 36.76 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 124.929 1.291 . . . . 0.0 108.67 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.34 -34.54 89.1 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.995 3.13 . . . . 0.0 112.243 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.8 -34.75 28.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.438 2.295 . . . . 0.0 111.147 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.83 64.62 0.34 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 69.8 151.92 0.1 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.221 2.208 . . . . 0.0 114.045 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.94 111.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.176 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.03 138.19 31.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.705 1.202 . . . . 0.0 109.489 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.02 170.2 22.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.992 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.1 121.97 38.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.495 ' HB3' HG21 ' A' ' 5' ' ' VAL . 9.6 t -120.35 127.36 52.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.9 135.27 52.21 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -48.51 -39.45 23.33 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 123.183 1.468 . . . . 0.0 108.537 166.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -8.85 56.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.315 1.846 . . . . 0.0 111.954 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 27' ' ' GLN . 1.5 p -128.62 155.68 40.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 124.11 0.964 . . . . 0.0 109.815 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -75.49 148.25 39.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.781 -0.575 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.11 50.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.945 0.898 . . . . 0.0 111.152 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.3 pt? -150.02 -47.65 0.13 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.97 -66.61 0.36 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.277 1.031 . . . . 0.0 111.019 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.463 ' HB2' HG11 ' A' ' 22' ' ' VAL . 27.2 tt0 -69.03 -16.62 63.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.895 -0.503 . . . . 0.0 111.243 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.684 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -69.76 -51.32 35.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -56.6 -39.28 73.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.002 0.921 . . . . 0.0 109.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -50.87 -36.19 36.62 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.78 -28.73 27.94 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.966 -0.459 . . . . 0.0 110.214 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.83 12.89 4.76 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.518 1.532 . . . . 0.0 111.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.684 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 80.4 mt -73.81 112.18 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.334 1.067 . . . . 0.0 110.777 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.65 71.91 10.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.559 0.743 . . . . 0.0 110.414 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.23 152.63 95.92 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.76 -1.213 . . . . 0.0 109.469 175.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.03 74.12 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.647 2.898 . . . . 0.0 110.268 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -61.25 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.709 1.204 . . . . 0.0 109.863 172.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.05 13.62 14.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.855 1.262 . . . . 0.0 111.426 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.527 ' HB2' ' S2 ' ' A' ' 97' ' ' FES . 86.8 m -154.0 -107.58 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.63 0.772 . . . . 0.0 109.948 -159.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 174.64 -71.78 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 129.181 2.992 . . . . 0.0 108.915 -169.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 174.73 104.12 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.602 0.761 . . . . 0.0 111.823 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.08 -57.19 3.99 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.479 1.038 . . . . 0.0 114.762 154.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 p -81.53 65.42 6.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.366 1.466 . . . . 0.0 107.394 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.02 -76.28 0.56 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -162.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 81.51 44.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.096 1.358 . . . . 0.0 111.019 -171.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 m -167.61 177.3 5.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 106.168 173.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 39' ' ' CYS 0.648 0.8 OUTLIER 43.66 157.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 129.361 3.064 . . . . 0.0 118.348 -166.338 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.93 167.65 0.73 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 110.254 -173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.14 165.72 27.71 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.554 2.026 . . . . 0.0 110.458 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -102.0 114.96 29.53 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.853 1.661 . . . . 0.0 110.704 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 57.3 t -64.5 112.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.1 0.96 . . . . 0.0 108.562 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -85.82 -42.37 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -157.02 -171.88 3.82 Favored 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.13 -155.21 22.51 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.71 1.148 . . . . 0.0 111.851 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.1 m -153.98 156.78 38.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.775 HG23 HG21 ' A' ' 85' ' ' VAL . 17.7 pt -136.29 149.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 172.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.8 112.73 24.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -107.84 42.11 1.41 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.468 0.707 . . . . 0.0 111.593 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.29 11.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.929 -1.107 . . . . 0.0 112.791 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -104.42 14.99 29.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.279 1.032 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -113.31 179.85 3.84 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.166 -0.959 . . . . 0.0 112.905 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 t -145.02 68.8 1.24 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 161.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.404 ' CE2' HD11 ' A' ' 95' ' ' ILE . 2.4 t80 -137.22 -82.54 0.35 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.511 -1.233 . . . . 0.0 111.73 175.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -53.79 138.0 36.81 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.529 1.059 . . . . 0.0 111.137 -165.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -85.92 168.54 14.11 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.086 0.866 . . . . 0.0 109.942 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -55.86 -42.66 76.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.358 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.1 -60.54 3.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.802 0.841 . . . . 0.0 109.614 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -54.62 -51.1 66.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.4 mtt -51.74 -59.68 4.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.26 0.482 . . . . 0.0 111.344 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.08 -42.12 72.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.916 1.286 . . . . 0.0 110.795 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.44 -20.2 64.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.412 1.485 . . . . 0.0 111.812 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.88 3.18 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-O 118.613 -1.104 . . . . 0.0 110.528 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.528 ' CG ' HG22 ' A' ' 95' ' ' ILE . 93.2 m-85 -109.76 169.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.077 1.439 . . . . 0.0 111.642 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 56' ' ' ILE . 12.4 p -161.14 156.91 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.402 HD11 ' S1 ' ' A' ' 97' ' ' FES . 6.4 tp -64.76 128.53 36.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 166.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -68.23 -40.0 82.18 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.6 m -81.51 -177.66 6.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.445 1.898 . . . . 0.0 109.254 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 33.52 50.88 0.31 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.429 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.634 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -139.89 133.32 30.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.132 1.373 . . . . 0.0 108.428 -174.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -107.32 124.12 36.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.213 1.405 . . . . 0.0 111.126 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.758 ' HA ' HG22 ' A' ' 56' ' ' ILE . 19.2 Cg_endo -76.49 100.78 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.943 3.095 . . . . 0.0 112.806 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.4 p -81.78 -18.06 45.46 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.06 -0.4 . . . . 0.0 110.89 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -151.98 179.59 8.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.304 . . . . 0.0 107.702 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.38 136.29 53.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.775 HG21 HG23 ' A' ' 56' ' ' ILE . 2.8 p -155.43 144.52 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.833 0.825 . . . . 0.0 111.662 -164.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.42 123.81 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 151.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -99.03 127.03 44.88 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 118.056 -0.973 . . . . 0.0 108.943 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.2 p -86.57 178.44 7.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.682 1.128 . . . . 0.0 109.073 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 65.5 53.9 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.436 1.094 . . . . 0.0 111.555 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -122.22 18.64 10.71 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.2 -67.19 0.3 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.001 0.92 . . . . 0.0 109.005 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -81.29 23.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.599 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.39 -21.37 9.87 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.541 1.136 . . . . 0.0 110.854 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.528 HG22 ' CG ' ' A' ' 73' ' ' TYR . 18.3 pt -88.47 -42.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 119.478 1.035 . . . . 0.0 112.562 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.879 -1.534 . . . . 0.0 110.068 -177.01 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.527 ' S2 ' ' HB2' ' A' ' 39' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.4 m 55.48 75.21 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.485 1.114 . . . . 0.0 113.194 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.39 163.44 12.7 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.054 0.942 . . . . 0.0 112.853 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.44 81.87 8.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.98 2.112 . . . . 0.0 109.484 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 85' ' ' VAL . 95.5 t -88.04 99.0 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -170.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.76 127.76 34.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.834 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.544 HD12 HD13 ' A' ' 33' ' ' ILE . 66.9 mt -107.95 109.53 21.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.2 mt -78.58 91.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -88.29 155.07 51.87 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 124.023 0.929 . . . . 0.0 108.57 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.05 -37.03 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.468 3.446 . . . . 0.0 112.696 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.5 -36.63 15.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.852 2.461 . . . . 0.0 111.159 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.06 65.08 0.29 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 69.54 165.31 0.26 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 127.02 2.128 . . . . 0.0 112.765 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.87 -59.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.201 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 70.63 145.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.128 1.371 . . . . 0.0 110.966 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 33' ' ' ILE . 3.1 p90 -169.54 158.94 8.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.93 0.892 . . . . 0.0 110.39 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 121.71 27.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.8 t -120.49 120.43 35.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.58 0.352 . . . . 0.0 110.427 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.57 141.97 58.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -55.35 -31.1 61.47 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 125.531 1.532 . . . . 0.0 110.901 169.24 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -88.31 -5.32 58.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.257 1.023 . . . . 0.0 112.083 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -119.23 149.01 21.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 CA-C-N 119.725 1.148 . . . . 0.0 110.086 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -72.18 150.38 43.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.185 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 56.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.745 0.783 . . . . 0.0 111.528 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 25' ' ' LEU . 5.4 tt -163.9 -52.75 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -56.62 13.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.572 0.701 . . . . 0.0 110.159 -175.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -71.29 -23.58 61.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -63.16 -54.09 43.04 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.549 -0.719 . . . . 0.0 110.226 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -48.75 -46.87 41.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.901 0.88 . . . . 0.0 108.894 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -53.87 -38.74 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.3 -25.59 42.4 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.882 -0.511 . . . . 0.0 109.863 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.03 12.75 5.22 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.827 1.68 . . . . 0.0 111.529 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.688 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 98.7 mt -76.23 108.84 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.167 0.984 . . . . 0.0 111.318 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -78.87 68.61 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.742 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.13 156.42 80.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.944 -1.097 . . . . 0.0 108.247 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.19 72.01 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.198 3.265 . . . . 0.0 110.374 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.23 161.73 27.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.698 1.999 . . . . 0.0 111.865 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -156.99 -61.15 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.214 1.806 . . . . 0.0 108.379 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.15 162.08 17.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 128.758 2.823 . . . . 0.0 110.417 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -150.28 71.52 1.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.46 1.104 . . . . 0.0 108.828 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.0 44.26 0.15 Allowed 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.391 -0.818 . . . . 0.0 110.766 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' H ' ' CD2' ' A' ' 78' ' ' HIS . . . 67.1 -67.93 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.919 1.247 . . . . 0.0 112.923 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.1 t -67.77 76.02 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.128 1.371 . . . . 0.0 111.256 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.3 159.16 8.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.108 0.963 . . . . 0.0 112.774 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.28 -34.68 4.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.002 2.521 . . . . 0.0 110.443 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.4 m -159.52 86.87 0.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 117.485 -1.245 . . . . 0.0 112.656 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.429 ' HB3' ' S2 ' ' A' ' 97' ' ' FES . 1.4 p -175.89 165.27 2.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.841 2.057 . . . . 0.0 110.925 169.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 163.95 169.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.692 2.397 . . . . 0.0 109.592 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.68 167.33 25.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.135 1.826 . . . . 0.0 110.684 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -103.83 112.39 25.33 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.964 1.706 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.97 113.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.389 1.076 . . . . 0.0 109.132 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -85.78 -46.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 t -162.71 174.84 11.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.064 -0.398 . . . . 0.0 110.388 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.5 -173.2 54.44 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.599 1.095 . . . . 0.0 110.928 -170.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -141.44 147.7 38.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 74' ' ' VAL . 28.7 pt -145.47 169.97 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.784 1.633 . . . . 0.0 107.408 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.24 111.72 22.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -114.09 48.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 109.56 168.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -88.99 48.54 1.64 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.526 -1.359 . . . . 0.0 109.585 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.87 -50.15 1.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 110.954 -171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -58.5 -35.04 71.62 Favored 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m 54.32 53.23 11.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.802 0.441 . . . . 0.0 109.917 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -143.91 -68.08 0.33 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.347 -1.311 . . . . 0.0 109.478 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp -55.22 137.43 47.23 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.887 1.221 . . . . 0.0 110.279 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.81 167.49 13.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 124.05 0.844 . . . . 0.0 109.763 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.16 -43.37 64.05 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.926 1.29 . . . . 0.0 108.58 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.11 -60.81 2.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.45 1.1 . . . . 0.0 109.674 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -58.12 -48.34 80.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.211 0.604 . . . . 0.0 111.044 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtt -51.98 -60.57 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.912 -0.493 . . . . 0.0 110.839 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.97 -45.1 71.28 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.777 1.231 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.37 -20.96 63.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.019 1.728 . . . . 0.0 112.059 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.55 30.95 1.74 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 117.802 -1.554 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.6 m-85 -118.25 158.39 25.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.981 1.89 . . . . 0.0 113.747 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.04 HG21 HD11 ' A' ' 56' ' ' ILE . 12.2 p -154.65 144.68 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 123.536 0.734 . . . . 0.0 110.671 -175.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.71 147.77 43.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 p -120.65 38.5 4.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.002 0.921 . . . . 0.0 112.325 -170.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 64.6 m -146.01 -43.08 0.2 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 109.846 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.407 ' CD2' ' H ' ' A' ' 42' ' ' GLY . 16.0 m-70 -118.86 84.87 2.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.629 1.571 . . . . 0.0 108.234 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 135.94 10.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.147 1.379 . . . . 0.0 107.439 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -116.96 118.65 36.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.768 1.627 . . . . 0.0 109.337 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.2 Cg_endo -74.34 117.85 5.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.587 2.192 . . . . 0.0 111.666 -175.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 p -89.88 -16.03 30.91 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.731 -0.606 . . . . 0.0 111.2 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 m -156.6 -177.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.877 1.671 . . . . 0.0 107.112 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.72 133.67 42.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 161.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 5' ' ' VAL . 2.5 p -140.75 148.84 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 107.622 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.72 121.12 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 173.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.41 153.62 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -103.32 126.16 50.34 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 109.29 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.9 p -83.8 177.24 8.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.781 1.173 . . . . 0.0 109.263 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.2 m80 70.37 56.23 0.28 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.672 1.189 . . . . 0.0 111.54 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -129.04 31.47 4.89 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.614 0.765 . . . . 0.0 112.582 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -59.77 -66.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -80.23 47.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.649 0.738 . . . . 0.0 111.547 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -140.32 -41.29 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 131.453 3.901 . . . . 0.0 108.949 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.57 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.5 pt -75.49 -47.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.061 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.058 -1.448 . . . . 0.0 109.758 -173.616 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.429 ' S2 ' ' HB3' ' A' ' 47' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m 80.85 103.81 0.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.443 1.497 . . . . 0.0 112.502 169.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -118.68 154.93 31.92 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.552 0.691 . . . . 0.0 112.736 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.73 100.67 0.56 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 128.557 2.743 . . . . 0.0 108.65 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 85' ' ' VAL . 58.6 t -107.04 125.67 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 27.8 ttmt -97.18 135.72 38.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 165.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.439 HD22 HG23 ' A' ' 89' ' ' THR . 28.5 mt -112.14 106.89 15.62 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 124.505 1.128 . . . . 0.0 108.447 169.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.1 mt -78.42 91.61 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' HG1' ' A' ' 89' ' ' THR . 62.1 p -94.7 155.86 38.92 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.745 176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 68.6 Cg_exo -53.43 -37.11 81.6 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 125.133 3.889 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.64 -38.06 9.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 128.444 2.698 . . . . 0.0 111.106 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.8 61.9 0.26 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 24.4 mt-10 70.7 152.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 127.558 2.343 . . . . 0.0 112.905 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG11 HG23 ' A' ' 33' ' ' ILE . 13.7 p -152.65 90.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.861 1.315 . . . . 0.0 108.361 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -83.22 140.21 32.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.538 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.03 170.58 21.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.188 0.595 . . . . 0.0 112.224 -166.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.42 47.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.2 t -122.32 130.47 53.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.25 131.28 41.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.159 0.981 . . . . 0.0 108.988 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -44.48 -28.6 0.59 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.864 2.066 . . . . 0.0 111.833 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.57 -14.3 58.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.263 1.825 . . . . 0.0 112.489 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.9 154.4 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 0.0 110.078 -166.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -74.94 153.01 38.77 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.516 -1.365 . . . . 0.0 110.053 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -49.27 -51.3 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.815 -0.553 . . . . 0.0 110.866 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.75 72.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.82 -67.78 0.39 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -38.54 82.75 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.44 -61.88 1.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.33 -40.09 70.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.95 -40.27 72.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -19.9 56.73 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.481 -0.762 . . . . 0.0 109.039 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.26 15.08 7.3 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.237 1.399 . . . . 0.0 110.686 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.426 HG23 HG11 ' A' ' 14' ' ' VAL . 48.9 mt -81.81 133.12 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 117.302 0.551 . . . . 0.0 110.043 -175.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -93.17 115.2 27.84 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.487 1.115 . . . . 0.0 108.832 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 35' ' ' ILE . 5.5 pt -137.05 157.92 73.68 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.63 131.69 13.84 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.474 2.116 . . . . 0.0 109.75 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -172.85 136.59 0.7 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.0 t -155.6 22.69 0.4 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.802 1.183 . . . . 0.0 112.211 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.35 -172.04 1.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -159.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HA ' ' S1 ' ' A' ' 97' ' ' FES . 2.7 ttt85 -169.47 84.44 0.13 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.517 1.053 . . . . 0.0 110.778 176.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.66 -60.96 0.09 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.265 0.484 . . . . 0.0 111.768 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.96 -54.58 0.41 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -106.09 73.2 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.807 -0.82 . . . . 0.0 109.053 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.46 -109.88 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 116.494 -1.717 . . . . 0.0 108.581 175.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 p -163.24 151.35 13.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.985 2.63 . . . . 0.0 115.09 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.433 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 19.8 m 71.56 52.03 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.402 2.281 . . . . 0.0 112.442 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.6 m -154.2 81.9 1.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.636 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.21 154.67 29.59 Favored 'General case' 0 CA--C 1.521 -0.153 0 O-C-N 119.582 -1.948 . . . . 0.0 110.537 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.11 167.12 27.9 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.546 1.546 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -105.23 112.57 25.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.516 1.926 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.9 110.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t -83.67 -45.48 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.7 t -160.96 174.41 13.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.977 -0.452 . . . . 0.0 110.292 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.39 -162.8 54.25 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -155.17 155.86 34.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 74' ' ' VAL . 30.2 pt -144.22 160.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.724 1.61 . . . . 0.0 107.801 -177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -101.38 108.14 19.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -104.55 38.67 1.83 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.711 0.804 . . . . 0.0 111.463 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 m -46.56 -38.75 9.9 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.328 0.967 . . . . 0.0 112.414 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -75.26 31.68 0.1 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.934 0.894 . . . . 0.0 112.375 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -91.88 -65.25 1.02 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.321 1.448 . . . . 0.0 113.231 -170.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m 43.49 33.85 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.924 0.89 . . . . 0.0 113.35 -167.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -137.97 -76.47 0.39 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.467 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.5 mp -55.99 141.73 38.67 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.956 0.798 . . . . 0.0 110.174 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -85.38 164.86 17.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 123.812 0.695 . . . . 0.0 109.548 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.48 -40.42 74.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 108.683 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.29 -61.64 2.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.947 0.899 . . . . 0.0 109.402 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.41 -53.11 31.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.628 0.771 . . . . 0.0 111.332 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.3 mtm -50.54 -62.15 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 0.0 111.857 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.94 -43.46 69.84 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.667 1.187 . . . . 0.0 110.72 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.53 64.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.766 1.626 . . . . 0.0 112.112 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.86 26.39 2.11 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-O 117.922 -1.488 . . . . 0.0 111.842 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.8 m-85 -113.68 166.25 11.73 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 120.018 1.909 . . . . 0.0 112.88 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.742 HG21 HD11 ' A' ' 56' ' ' ILE . 8.6 p -160.72 153.75 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 77' ' ' CYS . 0.3 OUTLIER -74.46 132.74 42.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -72.08 -49.99 31.89 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.719 -0.613 . . . . 0.0 110.448 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.419 ' SG ' HD22 ' A' ' 75' ' ' LEU . 3.4 p -74.34 176.85 6.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 m170 50.23 46.57 24.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.817 0.818 . . . . 0.0 111.602 166.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -147.91 125.26 11.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.409 1.084 . . . . 0.0 108.952 -170.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -108.4 125.22 32.36 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 125.547 1.539 . . . . 0.0 109.678 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.9 Cg_endo -71.98 119.36 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.194 1.93 . . . . 0.0 111.757 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -91.3 -17.19 26.33 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.257 -0.902 . . . . 0.0 112.039 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 m -156.21 -173.99 4.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.53 140.17 41.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 53' ' ' SER . 2.5 p -150.66 148.09 15.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.354 0.597 . . . . 0.0 109.853 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.54 124.2 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 151.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 123.795 0.838 . . . . 0.0 108.966 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -100.26 121.23 41.14 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.067 0.947 . . . . 0.0 108.605 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.439 HG23 HD22 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -74.34 179.81 4.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 119.163 0.892 . . . . 0.0 110.712 176.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.565 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 3.5 m-70 65.46 50.47 1.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.761 1.224 . . . . 0.0 112.86 169.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -122.01 15.5 10.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -172.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 46' ' ' SER . 27.1 tp10 -45.39 -63.43 0.95 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.795 0.807 . . . . 0.0 109.125 174.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -82.86 21.89 0.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.732 0.813 . . . . 0.0 113.142 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -110.2 -26.14 9.79 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.352 1.061 . . . . 0.0 110.495 162.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.535 HG22 ' CG ' ' A' ' 73' ' ' TYR . 34.6 pt -82.4 -48.85 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 119.478 1.035 . . . . 0.0 112.09 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.253 1.283 0 CA-C-O 117.498 -1.239 . . . . 0.0 109.693 -176.145 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.418 ' S1 ' ' HA ' ' A' ' 40' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 55.43 68.08 0.92 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.051 1.34 . . . . 0.0 113.844 151.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -98.4 158.25 15.7 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 111.424 -168.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.82 90.21 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.837 1.655 . . . . 0.0 109.135 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG13 HG13 ' A' ' 85' ' ' VAL . 39.4 t -87.0 120.56 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -88.97 131.08 35.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.878 0.308 . . . . 0.0 111.346 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.8 mt -109.29 103.87 12.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.418 1.487 . . . . 0.0 107.508 166.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.4 mt -74.17 86.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -79.34 154.17 76.77 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.691 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.83 -32.43 94.93 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.949 3.1 . . . . 0.0 112.194 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -32.18 33.82 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 126.429 1.892 . . . . 0.0 110.907 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.01 62.62 0.32 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 125.255 1.407 . . . . 0.0 109.931 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 67.69 161.72 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.728 2.011 . . . . 0.0 112.883 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' H ' ' A' ' 15' ' ' GLU . 19.7 m -132.4 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.072 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 14' ' ' VAL . 4.6 tt0 73.67 129.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.121 1.768 . . . . 0.0 111.987 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -163.73 171.37 15.69 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.29 127.88 40.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.404 0.682 . . . . 0.0 111.524 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . 34.6 t -131.51 130.27 42.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 175.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.3 150.99 39.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 110.108 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -7.38 46.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -115.26 21.01 14.51 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.767 1.627 . . . . 0.0 110.703 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.42 158.12 27.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 O-C-N 121.024 -1.048 . . . . 0.0 110.589 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 78' ' ' HIS . 41.2 m-85 -77.94 143.45 37.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.566 0.346 . . . . 0.0 110.99 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 79' ' ' ALA . 5.6 t -49.07 -62.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 111.523 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tp -49.86 -52.5 32.21 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.537 0.735 . . . . 0.0 111.475 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -54.45 43.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -170.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -58.64 -44.91 90.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.581 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -50.87 -56.06 14.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.361 -0.837 . . . . 0.0 110.793 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.26 -38.95 81.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.674 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.7 -38.24 54.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.227 0.921 . . . . 0.0 112.301 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.96 -25.86 43.5 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.934 -0.479 . . . . 0.0 110.616 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.92 11.32 10.21 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.82 1.676 . . . . 0.0 111.31 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.589 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 97.1 mt -78.24 123.41 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.7 0.75 . . . . 0.0 111.075 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.59 119.37 30.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.703 1.601 . . . . 0.0 109.986 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.9 pt -136.16 148.33 64.13 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 129.46 27.37 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.023 2.482 . . . . 0.0 111.088 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -166.27 143.38 5.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -171.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.0 p -155.62 15.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -175.68 1.77 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.88 2.872 . . . . 0.0 105.833 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -160.67 79.88 0.64 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.658 1.572 . . . . 0.0 109.736 162.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.21 -71.0 0.42 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 122.703 0.401 . . . . 0.0 110.624 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.69 79.04 0.07 OUTLIER Glycine 0 C--N 1.334 0.458 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 p -175.41 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.326 0.651 . . . . 0.0 110.933 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.01 155.36 31.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 110.254 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.8 p -109.07 72.91 0.83 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.7 m -152.43 -154.16 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.436 1.094 . . . . 0.0 108.32 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.1 p 46.82 88.31 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 160.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.88 163.74 38.58 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.595 -1.941 . . . . 0.0 113.056 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.59 160.68 28.45 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.175 1.845 . . . . 0.0 111.085 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -98.26 112.94 24.75 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.026 1.73 . . . . 0.0 111.166 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.16 116.2 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.073 0.851 . . . . 0.0 109.474 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.98 -48.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.998 0.519 . . . . 0.0 109.876 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -160.33 174.06 14.73 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.08 -169.37 43.14 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 m -142.54 149.48 39.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.071 0.948 . . . . 0.0 108.817 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.768 HG23 HG21 ' A' ' 85' ' ' VAL . 24.9 pt -132.89 165.52 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.027 1.731 . . . . 0.0 107.035 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -107.13 110.73 22.89 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.45 46.17 1.02 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.112 0.565 . . . . 0.0 110.168 168.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 t -52.83 -44.83 67.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.539 -0.726 . . . . 0.0 109.751 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -78.64 41.99 0.43 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.549 1.54 . . . . 0.0 111.823 -173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -105.86 -72.05 0.73 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.212 1.805 . . . . 0.0 111.672 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.0 t 53.53 61.11 3.28 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.742 -0.599 . . . . 0.0 111.367 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -160.51 -67.43 0.07 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.606 173.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.84 147.41 33.76 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.516 1.053 . . . . 0.0 110.877 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -85.85 160.62 19.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.966 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.36 -41.22 72.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.57 -61.01 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.981 0.912 . . . . 0.0 109.559 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -51.44 -51.07 57.99 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.0 111.202 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.1 mtt -52.18 -60.45 3.19 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.626 -0.671 . . . . 0.0 111.558 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.94 -42.68 76.54 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.379 1.072 . . . . 0.0 110.854 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.99 -19.93 63.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.8 1.64 . . . . 0.0 111.749 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.63 1.31 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 117.559 -1.689 . . . . 0.0 110.949 171.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -116.48 162.27 17.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.48 2.14 . . . . 0.0 113.802 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.08 161.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.729 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -55.42 4.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.217 1.407 . . . . 0.0 110.383 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 80.19 -56.92 0.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.003 1.321 . . . . 0.0 110.487 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.04 -39.21 1.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.102 1.761 . . . . 0.0 112.72 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -143.89 52.84 1.3 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.575 0.75 . . . . 0.0 111.821 173.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' CB ' HD12 ' A' ' 56' ' ' ILE . . . -103.75 151.42 23.05 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 169.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -105.84 126.16 31.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 124.58 1.152 . . . . 0.0 109.215 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 56' ' ' ILE . 16.4 Cg_endo -75.87 119.1 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.659 2.24 . . . . 0.0 110.899 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 p -91.31 -15.04 29.72 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.099 -0.376 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -156.94 -174.71 5.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.49 134.81 40.58 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.768 HG21 HG23 ' A' ' 56' ' ' ILE . 3.6 p -151.87 148.04 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 109.769 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.71 123.73 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 153.05 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -100.63 119.32 38.39 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.024 0.93 . . . . 0.0 109.477 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.7 p -79.91 175.89 10.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.411 1.005 . . . . 0.0 111.202 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 69.42 56.94 0.36 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.747 1.619 . . . . 0.0 111.814 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -126.96 12.68 7.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.84 -63.73 0.98 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.283 1.033 . . . . 0.0 109.075 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -79.87 26.63 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -110.12 -45.33 3.61 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 pt -71.62 -41.61 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -170.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.996 -1.478 . . . . 0.0 110.325 -178.583 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m 77.09 100.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.065 1.746 . . . . 0.0 111.498 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -109.17 158.98 17.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.591 0.756 . . . . 0.0 112.055 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.96 104.54 5.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.018 2.127 . . . . 0.0 109.123 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.592 HG13 HG13 ' A' ' 85' ' ' VAL . 30.2 t -110.19 111.77 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 122.898 0.479 . . . . 0.0 110.557 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -84.6 128.33 34.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 117.937 0.335 . . . . 0.0 111.456 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.1 mt -106.55 112.13 25.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mt -84.22 86.32 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p -83.32 153.69 65.9 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.097 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -36.92 69.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.654 3.569 . . . . 0.0 113.063 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -46.95 -38.68 11.0 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 127.526 2.33 . . . . 0.0 111.099 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.23 64.22 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.9 166.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 127.215 2.206 . . . . 0.0 112.158 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.72 -59.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.732 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 70.55 142.36 0.05 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.988 1.715 . . . . 0.0 113.086 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -164.34 178.93 7.13 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.811 0.844 . . . . 0.0 111.264 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.86 124.38 48.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.818 1.247 . . . . 0.0 109.086 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.5 t -121.05 128.3 52.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.51 0.324 . . . . 0.0 110.325 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.52 141.06 53.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.782 1.277 . . . . 0.0 108.23 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -65.07 -18.83 65.63 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 128.895 2.878 . . . . 0.0 110.786 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.59 17.52 22.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.811 1.244 . . . . 0.0 111.292 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -134.35 151.78 32.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.59 1.086 . . . . 0.0 111.501 177.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -65.05 138.74 58.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.905 0.882 . . . . 0.0 110.327 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 5' ' ' VAL . 1.9 t -68.68 4.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -109.46 -52.07 2.81 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -45.8 -62.3 1.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.394 1.478 . . . . 0.0 111.246 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.444 ' HB2' HG11 ' A' ' 22' ' ' VAL . 19.3 tt0 -65.07 -28.17 69.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.913 -0.492 . . . . 0.0 111.198 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -60.45 -52.22 66.14 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 109.542 173.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -56.67 -41.4 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.037 0.935 . . . . 0.0 109.892 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -51.72 -37.72 52.17 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.73 -25.31 41.13 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.848 -0.532 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.15 11.34 9.04 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.805 1.669 . . . . 0.0 111.284 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.621 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 41.2 mt -82.16 126.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 118.208 1.004 . . . . 0.0 110.124 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -90.24 110.98 22.01 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.419 1.088 . . . . 0.0 109.447 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 33' ' ' ILE . 5.8 pt -136.75 155.28 76.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 170.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.32 110.52 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -148.68 -20.39 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.173 1.389 . . . . 0.0 113.255 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 p -71.81 74.94 0.87 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.151 0.98 . . . . 0.0 111.506 -165.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 -77.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.942 2.097 . . . . 0.0 107.119 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 59.84 96.5 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.134 2.574 . . . . 0.0 113.961 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 150.98 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.821 2.448 . . . . 0.0 113.092 155.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 31.56 -65.28 0.0 OUTLIER Glycine 0 CA--C 1.549 2.187 0 C-N-CA 129.763 3.554 . . . . 0.0 117.55 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.2 t -82.64 62.16 6.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.109 -1.818 . . . . 0.0 109.99 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -114.78 -67.29 1.01 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.538 1.135 . . . . 0.0 112.47 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.2 m -147.28 -106.85 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.024 -1.048 . . . . 0.0 110.705 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 t -153.76 129.99 10.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 p -162.11 150.76 15.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.357 1.463 . . . . 0.0 108.031 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . -173.32 174.64 3.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.585 1.154 . . . . 0.0 110.231 -176.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.699 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -143.4 156.05 26.36 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.092 1.806 . . . . 0.0 111.263 171.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.98 126.61 34.84 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.5 1.52 . . . . 0.0 110.028 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 17.3 t -73.73 128.34 36.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 120.11 1.323 . . . . 0.0 108.969 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -108.25 -44.21 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.297 0.639 . . . . 0.0 109.953 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 t -158.93 172.54 18.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.599 0.636 . . . . 0.0 109.715 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.97 -161.76 46.85 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.471 1.034 . . . . 0.0 111.407 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 m -156.24 158.55 37.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.65 -0.912 . . . . 0.0 108.757 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.712 HG22 ' HA ' ' A' ' 81' ' ' PRO . 8.9 pt -130.58 179.67 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.498 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.44 118.99 36.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.39 34.64 3.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.818 0.847 . . . . 0.0 111.721 169.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.1 t -80.39 36.21 0.36 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.631 -1.293 . . . . 0.0 113.173 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -161.28 43.08 0.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.242 1.017 . . . . 0.0 109.619 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -105.38 -33.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.644 1.978 . . . . 0.0 110.363 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 t 52.55 46.86 25.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.607 0.763 . . . . 0.0 109.792 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -155.12 -72.12 0.12 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.748 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.92 136.32 57.03 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 120.063 1.301 . . . . 0.0 110.973 -170.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.75 164.45 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 123.641 0.588 . . . . 0.0 110.253 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -52.6 -44.01 65.72 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.94 -61.2 2.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.286 1.034 . . . . 0.0 109.766 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -54.34 -49.53 69.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.227 0.611 . . . . 0.0 111.139 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 12.2 mtt -54.59 -58.55 7.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.635 -0.666 . . . . 0.0 111.66 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.33 -43.16 70.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.403 1.081 . . . . 0.0 110.697 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.82 65.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.842 1.657 . . . . 0.0 111.727 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.58 51.33 0.98 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.453 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.1 m-85 -125.31 146.47 49.55 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.393 1.097 . . . . 0.0 111.915 169.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -170.0 -175.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.494 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 87' ' ' ILE . 3.6 tp 76.0 167.06 0.27 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.742 1.217 . . . . 0.0 107.769 171.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.576 ' HA ' HD21 ' A' ' 25' ' ' LEU . 2.2 p 64.09 170.69 0.18 Allowed 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 124.681 1.238 . . . . 0.0 111.088 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 52.52 21.69 1.88 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.8 t60 103.14 117.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.492 3.117 . . . . 0.0 110.897 -170.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.41 114.1 1.61 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.886 -0.509 . . . . 0.0 111.991 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.08 123.01 40.43 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 125.277 1.431 . . . . 0.0 110.938 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.712 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.6 Cg_endo -74.38 120.16 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.716 2.277 . . . . 0.0 111.29 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 p -99.34 -13.0 19.81 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.685 -0.635 . . . . 0.0 112.176 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.1 m -156.28 -173.52 4.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.35 143.85 32.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG13 HG13 ' A' ' 5' ' ' VAL . 2.6 p -153.89 151.9 10.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.281 0.562 . . . . 0.0 111.687 -172.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.5 t -135.56 127.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.699 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -156.07 141.73 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -167.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.532 ' N ' HD13 ' A' ' 87' ' ' ILE . 23.9 mt-10 -94.98 118.16 31.34 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.418 -0.801 . . . . 0.0 110.81 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 p -77.3 176.03 9.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.932 0.493 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.23 55.35 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.116 1.366 . . . . 0.0 111.472 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -123.28 33.29 5.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 122.939 0.496 . . . . 0.0 111.967 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.96 -71.93 0.08 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.35 45.0 0.72 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.498 0.666 . . . . 0.0 110.902 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.32 -46.13 2.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.134 1.374 . . . . 0.0 108.296 164.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.453 HG22 ' CG ' ' A' ' 73' ' ' TYR . 6.9 pt -72.5 -38.81 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.564 1.516 1 CA-C-O 81.463 -18.399 . . . . 0.0 111.435 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' H1 ' ' CG ' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 m 54.6 72.99 0.43 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 144.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -99.8 155.4 17.67 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.03 101.74 0.42 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.309 2.244 . . . . 0.0 109.314 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.2 109.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -81.76 134.25 35.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.101 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.42 HD22 ' CG2' ' A' ' 89' ' ' THR . 75.4 mt -112.13 106.86 15.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 167.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.1 mt -76.66 96.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 156.23 41.69 Favored Pre-proline 0 N--CA 1.444 -0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 108.882 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.55 -36.85 81.94 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.49 3.46 . . . . 0.0 112.505 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.89 -34.84 21.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 127.423 2.289 . . . . 0.0 111.084 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.37 64.21 0.3 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 125.225 1.393 . . . . 0.0 109.693 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 67.9 161.59 0.18 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.996 2.118 . . . . 0.0 112.293 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.75 -58.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.786 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 72.21 143.46 0.06 Allowed 'General case' 0 C--O 1.229 0.017 0 C-N-CA 126.032 1.733 . . . . 0.0 112.79 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.502 ' HB3' HD11 ' A' ' 33' ' ' ILE . 1.7 p90 -163.43 169.95 18.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.998 0.519 . . . . 0.0 112.012 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 126.35 36.34 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.4 t -119.86 125.11 47.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.653 0.596 . . . . 0.0 110.531 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -69.11 146.27 52.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 123.003 1.383 . . . . 0.0 110.015 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 6.8 p-10 -77.0 -1.65 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.257 1.023 . . . . 0.0 111.88 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.06 23.05 10.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.207 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -130.88 149.04 33.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-N 119.465 1.03 . . . . 0.0 110.367 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -64.25 142.83 58.27 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.9 t -49.12 -58.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.07 0.231 . . . . 0.0 110.554 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 26' ' ' ASP . 2.7 pp -58.6 -36.26 73.74 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.635 ' N ' HD12 ' A' ' 25' ' ' LEU . 20.1 t0 -61.49 -62.15 2.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 122.398 1.094 . . . . 0.0 108.337 -169.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.12 -38.15 87.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.589 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.77 -58.21 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.203 -0.935 . . . . 0.0 112.084 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.88 -38.49 78.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 109.573 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.1 -40.81 61.8 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.886 0.766 . . . . 0.0 112.384 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.02 -24.07 55.24 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.886 -0.509 . . . . 0.0 109.948 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.31 15.34 7.73 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.386 1.47 . . . . 0.0 110.669 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 16' ' ' PHE . 61.4 mt -77.88 125.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.557 0.678 . . . . 0.0 109.496 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.43 119.53 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.74 0.816 . . . . 0.0 109.166 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.467 HG23 HG22 ' A' ' 33' ' ' ILE . 8.4 pt -140.76 162.16 50.31 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 175.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.3 138.23 70.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.637 2.225 . . . . 0.0 109.8 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -164.92 -101.1 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p 50.64 49.66 20.45 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 111.742 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.8 t -150.27 175.0 12.2 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 127.729 2.411 . . . . 0.0 106.023 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -165.07 148.66 8.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 151.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 81.89 101.95 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.772 2.029 . . . . 0.0 111.212 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.67 134.24 7.02 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.309 1.433 . . . . 0.0 112.729 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t 117.47 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 129.202 3.001 . . . . 0.0 107.803 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 p -143.99 -155.84 0.64 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.905 1.282 . . . . 0.0 109.665 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.7 t -153.99 167.01 31.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m 62.89 57.38 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.618 1.167 . . . . 0.0 112.549 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.52 121.13 2.91 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.844 0.858 . . . . 0.0 109.649 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.66 162.2 3.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.288 0.635 . . . . 0.0 111.03 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.09 166.39 25.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.959 1.742 . . . . 0.0 109.977 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.24 114.27 27.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.63 1.572 . . . . 0.0 110.802 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 47.0 t -64.17 109.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.425 1.09 . . . . 0.0 108.519 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.47 -40.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 -169.74 3.19 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.24 -159.46 14.92 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.333 0.968 . . . . 0.0 112.012 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -155.25 151.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 81' ' ' PRO . 31.2 pt -136.57 154.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.17 107.17 19.64 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.0 27.16 8.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.247 0.619 . . . . 0.0 111.772 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.3 m -78.75 58.21 2.25 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.074 1.307 . . . . 0.0 111.764 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -142.05 -36.98 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.028 2.131 . . . . 0.0 110.987 -173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.575 ' CB ' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.29 -169.76 1.5 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.856 2.062 . . . . 0.0 114.12 -174.341 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.9 m -158.13 77.68 0.8 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.242 1.417 . . . . 0.0 108.727 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -149.57 -65.3 0.22 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.253 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -59.74 145.12 46.28 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.077 1.308 . . . . 0.0 110.639 -176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.54 164.81 14.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.044 0.84 . . . . 0.0 110.243 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.23 -44.4 64.81 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.968 1.307 . . . . 0.0 108.59 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -53.6 -60.97 2.62 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 109.41 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -53.96 -50.09 67.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.279 0.632 . . . . 0.0 111.431 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 64.4 mtt -50.38 -60.51 2.92 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.381 -0.825 . . . . 0.0 111.362 175.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.04 -43.33 73.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.416 1.086 . . . . 0.0 110.759 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.69 64.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.725 1.61 . . . . 0.0 111.875 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.21 35.07 1.25 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.498 -1.168 . . . . 0.0 110.332 173.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -116.58 164.46 14.56 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.212 1.506 . . . . 0.0 111.476 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 56' ' ' ILE . 11.1 p -156.92 148.74 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.796 0.839 . . . . 0.0 108.77 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 ' CB ' ' A' ' 61' ' ' GLN . 4.7 tp -66.28 141.41 58.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 t -81.94 -38.51 25.12 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.594 0.634 . . . . 0.0 110.316 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.431 ' SG ' HD23 ' A' ' 25' ' ' LEU . 3.8 m -79.39 179.23 7.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.557 1.143 . . . . 0.0 108.787 171.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 72.1 m80 42.7 51.14 5.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.505 1.122 . . . . 0.0 111.222 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -153.05 123.74 7.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.399 1.08 . . . . 0.0 108.563 -166.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.85 126.52 28.14 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 124.811 1.244 . . . . 0.0 110.215 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.2 Cg_endo -73.36 121.03 6.85 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.361 2.041 . . . . 0.0 111.648 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -95.68 -16.19 22.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.7 m -156.64 -173.97 4.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.5 142.58 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 165.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 p -152.74 149.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.857 0.837 . . . . 0.0 109.9 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.7 123.7 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.404 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -135.63 153.11 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -102.1 128.84 48.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.742 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.42 ' CG2' HD22 ' A' ' 7' ' ' LEU . 43.4 p -85.44 178.6 7.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.071 0.85 . . . . 0.0 110.04 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.8 m80 63.43 58.22 1.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.838 1.255 . . . . 0.0 110.877 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -126.51 6.15 6.89 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.914 0.885 . . . . 0.0 111.413 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -45.72 -55.53 6.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 127.867 2.467 . . . . 0.0 110.808 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -93.06 33.01 1.21 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 111.956 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.37 -39.59 2.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.615 1.166 . . . . 0.0 108.204 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.2 pt -67.92 -38.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.25 -177.567 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.429 ' S2 ' HD21 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m 75.25 73.51 0.09 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.19 0.995 . . . . 0.0 111.639 137.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -107.09 158.84 16.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.553 1.141 . . . . 0.0 111.629 -159.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 102.8 2.08 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.058 2.143 . . . . 0.0 108.025 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 18' ' ' CYS . 21.7 t -108.57 122.24 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -93.02 132.01 37.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.508 0.14 . . . . 0.0 110.691 168.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -108.17 104.64 14.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mt -73.71 95.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -94.85 152.94 40.03 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 124.934 1.293 . . . . 0.0 108.705 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -52.81 -37.33 76.52 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.461 3.441 . . . . 0.0 112.236 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.81 -39.57 8.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 128.819 2.848 . . . . 0.0 111.088 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.16 62.75 0.23 Allowed Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 125.348 1.451 . . . . 0.0 109.555 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.2 157.1 0.17 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 127.597 2.359 . . . . 0.0 114.669 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -159.22 108.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.826 163.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.67 143.53 42.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.073 0.549 . . . . 0.0 110.856 164.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.92 162.71 38.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.401 1.08 . . . . 0.0 110.443 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -84.14 131.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' HG21 ' A' ' 5' ' ' VAL . 22.0 t -127.4 129.35 47.38 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.385 -0.126 . . . . 0.0 111.019 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.76 136.71 47.25 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.669 0.747 . . . . 0.0 110.298 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.29 -32.75 11.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.655 1.582 . . . . 0.0 112.316 165.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.68 -10.99 59.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.84 1.256 . . . . 0.0 112.285 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -130.22 148.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 119.141 0.882 . . . . 0.0 109.172 -167.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -74.92 150.44 39.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.686 -1.258 . . . . 0.0 109.576 -174.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -49.96 -40.55 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.284 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.426 ' C ' HD22 ' A' ' 25' ' ' LEU 0.269 0.0 OUTLIER -66.12 -32.22 73.55 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 179.252 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -65.65 -66.71 0.51 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-O 121.458 0.647 . . . . 0.0 109.537 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 22' ' ' VAL . 36.0 mm-40 -56.83 -36.16 69.64 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.956 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -49.96 -58.93 4.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 122.02 -0.425 . . . . 0.0 111.028 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.08 -36.68 75.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.642 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.82 -39.58 62.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.7 0.682 . . . . 0.0 111.961 171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.46 -29.17 33.84 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.2 14.35 7.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.977 1.751 . . . . 0.0 111.601 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.726 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 72.7 mt -76.36 112.28 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 117.754 0.777 . . . . 0.0 109.588 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -84.7 98.09 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.032 1.333 . . . . 0.0 109.159 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG22 ' CE1' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -87.29 156.9 53.98 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.592 -0.692 . . . . 0.0 109.848 174.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 35' ' ' ILE . 39.5 Cg_endo -75.67 92.92 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.86 2.373 . . . . 0.0 110.894 -173.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.557 ' CE1' HG22 ' A' ' 35' ' ' ILE . 16.7 m-85 -82.89 149.94 26.79 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.554 0.742 . . . . 0.0 111.463 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.25 -37.85 2.19 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.39 1.076 . . . . 0.0 111.104 168.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.98 -34.93 0.17 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.817 1.647 . . . . 0.0 112.118 -161.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.429 0.0 OUTLIER 22.61 98.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.835 3.254 . . . . 0.0 116.565 -165.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.69 -44.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.875 1.27 . . . . 0.0 112.052 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.7 58.99 0.75 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.736 1.16 . . . . 0.0 110.5 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.2 m 174.96 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.343 2.257 . . . . 0.0 108.22 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 21.6 p -152.4 -164.59 1.99 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.384 1.074 . . . . 0.0 109.45 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 t -139.69 47.65 1.84 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.88 177.24 10.02 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -165.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 63.35 132.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.182 2.193 . . . . 0.0 114.836 171.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . -174.73 169.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.826 166.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -134.14 164.59 24.49 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 125.969 1.747 . . . . 0.0 109.208 162.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -98.24 109.25 22.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.796 1.638 . . . . 0.0 109.636 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.619 HG23 ' HB ' ' A' ' 74' ' ' VAL . 61.7 t -62.32 111.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.6 -42.08 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 122.852 0.461 . . . . 0.0 109.857 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.6 t -155.73 -166.75 2.3 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.48 -158.24 18.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.795 0.712 . . . . 0.0 111.929 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -145.58 154.91 42.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 168.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.654 HG23 HG21 ' A' ' 85' ' ' VAL . 28.3 pt -135.99 165.5 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -106.6 116.36 31.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -111.36 54.12 0.69 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.3 p -50.28 -45.86 54.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.509 -0.744 . . . . 0.0 109.494 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.6 42.83 0.54 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.251 1.42 . . . . 0.0 110.679 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.4 ' HA ' HD13 ' A' ' 75' ' ' LEU . 20.8 pt20 -76.98 160.8 28.86 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.619 -1.3 . . . . 0.0 114.176 -175.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 m -67.69 -71.48 0.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.473 1.109 . . . . 0.0 110.896 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -160.06 8.55 0.1 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.562 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.24 140.22 57.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.52 1.055 . . . . 0.0 109.921 -165.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.05 165.34 15.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.992 0.808 . . . . 0.0 109.641 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.17 -39.49 69.6 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.924 0.89 . . . . 0.0 108.757 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.87 -62.38 1.69 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.654 0.782 . . . . 0.0 109.519 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -51.93 -51.41 57.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.215 0.606 . . . . 0.0 111.573 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.0 mtm -51.56 -60.39 3.2 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.711 -0.618 . . . . 0.0 111.487 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.1 -43.39 78.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.704 1.202 . . . . 0.0 110.708 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.13 66.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.733 1.613 . . . . 0.0 111.37 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.71 27.61 1.03 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 116.921 -2.044 . . . . 0.0 112.569 169.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CG ' HG22 ' A' ' 95' ' ' ILE . 90.9 m-85 -120.44 167.02 12.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 121.245 2.523 . . . . 0.0 114.953 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.619 ' HB ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -164.69 146.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -171.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -66.98 148.55 51.82 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.805 1.639 . . . . 0.0 109.299 174.232 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -106.32 35.97 2.76 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.038 -1.039 . . . . 0.0 112.107 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.408 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 68.5 m -134.89 -105.08 0.22 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.638 1.975 . . . . 0.0 106.44 -174.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -76.4 68.76 2.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.99 0.916 . . . . 0.0 112.053 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -123.14 138.23 54.71 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.979 0.912 . . . . 0.0 109.434 173.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -108.95 124.4 34.29 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 126.123 1.769 . . . . 0.0 109.603 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.471 ' HA ' HG22 ' A' ' 56' ' ' ILE . 10.8 Cg_endo -74.3 111.39 3.3 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.726 2.284 . . . . 0.0 111.673 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 p -82.07 -18.93 41.38 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.354 -0.841 . . . . 0.0 110.93 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -155.8 -177.12 6.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.225 1.41 . . . . 0.0 107.736 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.48 140.55 45.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 163.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.654 HG21 HG23 ' A' ' 56' ' ' ILE . 2.7 p -160.61 140.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 121.648 0.737 . . . . 0.0 111.938 -166.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.12 127.28 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.87 153.09 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 124.233 1.013 . . . . 0.0 108.921 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -103.17 125.94 50.1 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.42 1.088 . . . . 0.0 109.232 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.1 p -83.56 177.14 8.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.536 1.516 . . . . 0.0 109.237 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' CG ' ' HG3' ' A' ' 36' ' ' PRO . 2.9 m80 69.38 57.0 0.36 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 112.106 174.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -128.05 32.74 4.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -60.47 -68.66 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -81.75 52.64 1.96 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.669 0.747 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.52 -40.43 0.34 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 130.293 3.437 . . . . 0.0 109.363 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.566 HG22 ' CG ' ' A' ' 73' ' ' TYR . 35.1 pt -75.58 -43.28 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 119.007 -0.521 . . . . 0.0 112.278 175.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.076 -1.44 . . . . 0.0 109.569 176.164 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.415 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 C--O 1.226 -0.143 0 CA-C-O 121.69 0.757 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m 61.92 69.68 0.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.884 160.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.8 158.48 15.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.518 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -81.21 84.65 6.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.982 1.713 . . . . 0.0 109.116 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 85' ' ' VAL . 60.8 t -84.19 127.59 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 8.8 ttmt -97.9 131.83 44.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 169.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD12 HG21 ' A' ' 33' ' ' ILE . 47.7 mt -109.41 110.93 22.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.732 1.27 . . . . 0.0 108.023 169.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -80.53 86.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.6 p -86.55 154.92 56.69 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.418 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 51.3 Cg_exo -55.07 -35.73 91.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.738 3.625 . . . . 0.0 112.411 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.39 -38.22 18.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.018 2.527 . . . . 0.0 111.212 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.34 61.86 0.21 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 125.593 1.568 . . . . 0.0 110.423 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.425 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 26.8 mt-10 68.2 160.41 0.17 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.12 2.168 . . . . 0.0 111.997 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -129.18 -64.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.386 0.674 . . . . 0.0 111.53 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 75.54 127.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.068 1.747 . . . . 0.0 112.353 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -163.53 168.99 19.39 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.56 35.35 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.869 0.868 . . . . 0.0 112.12 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.0 t -125.98 129.42 49.19 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.743 0.817 . . . . 0.0 111.585 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.24 149.06 31.97 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.756 0.822 . . . . 0.0 110.284 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.5 p-10 -65.34 -19.27 65.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.94 -0.475 . . . . 0.0 111.997 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.05 -3.28 58.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.615 1.166 . . . . 0.0 111.8 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 p -134.24 153.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.52 1.055 . . . . 0.0 110.667 -170.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -76.89 156.23 32.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.126 0.489 . . . . 0.0 112.001 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.78 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.954 0.902 . . . . 0.0 111.596 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.46 -51.14 0.1 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.59 -60.48 2.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.956 0.903 . . . . 0.0 110.929 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -72.22 -5.12 33.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -89.35 -49.07 6.93 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.396 -0.815 . . . . 0.0 109.618 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -53.63 -38.84 64.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.672 0.789 . . . . 0.0 110.541 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.258 0.4 OUTLIER -58.25 -35.52 71.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 176.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.89 -25.77 40.49 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.61 11.7 6.45 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 125.811 1.672 . . . . 0.0 111.24 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.668 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 54.9 mt -75.44 121.35 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 118.279 1.039 . . . . 0.0 110.566 -178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -96.39 113.53 25.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 166.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.8 mt -107.33 137.62 19.67 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 163.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.92 114.92 4.17 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.733 2.289 . . . . 0.0 106.916 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 38' ' ' SER . 12.4 m-85 -63.63 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 167.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 37' ' ' TYR . 36.7 t 115.24 -66.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.347 2.659 . . . . 0.0 106.643 -164.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 p -113.5 -175.31 2.64 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 110.868 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.29 150.86 16.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.872 2.069 . . . . 0.0 107.383 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 83.81 91.86 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.725 2.41 . . . . 0.0 111.371 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -35.8 142.8 0.13 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.428 1.966 . . . . 0.0 113.99 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t 89.96 46.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.878 2.471 . . . . 0.0 108.178 -160.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -143.25 137.0 28.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.798 1.639 . . . . 0.0 108.01 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -107.81 77.29 1.11 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.2 1.0 . . . . 0.0 111.193 -168.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.86 -170.37 2.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 1.8 m 62.29 175.69 0.13 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.648 1.179 . . . . 0.0 110.992 175.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 47' ' ' CYS . . . 153.91 170.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.514 1.926 . . . . 0.0 111.83 165.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.25 27.66 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 124.834 1.207 . . . . 0.0 111.054 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -101.62 111.04 23.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.175 1.79 . . . . 0.0 110.308 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG23 ' HB ' ' A' ' 74' ' ' VAL . 78.2 t -58.8 116.91 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.016 0.927 . . . . 0.0 109.306 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -93.05 -47.02 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 85' ' ' VAL . 23.3 t -158.31 170.71 21.62 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.26 -161.37 54.17 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -168.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -155.88 168.68 26.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 81' ' ' PRO . 29.1 pt -147.08 162.26 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 127.581 2.352 . . . . 0.0 107.999 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -105.22 113.48 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.61 28.21 8.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.27 1.028 . . . . 0.0 111.772 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.1 p -57.43 -34.04 68.54 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.323 -0.86 . . . . 0.0 113.17 -172.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.74 -34.08 57.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.841 1.257 . . . . 0.0 113.054 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.548 ' HB2' HD13 ' A' ' 75' ' ' LEU . 14.0 pt20 -55.59 -32.09 62.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -160.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 p 39.53 58.35 2.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.069 1.348 . . . . 0.0 113.12 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -149.51 -71.43 0.19 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.753 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' CD1' HD12 ' A' ' 75' ' ' LEU . 7.6 mp -55.69 139.33 45.23 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 111.766 -168.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.43 164.91 22.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.05 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.95 -44.44 67.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.6 -61.71 2.11 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.886 0.875 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -53.05 -52.09 59.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.346 0.658 . . . . 0.0 111.433 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.8 mtt -53.87 -58.17 8.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.566 -0.709 . . . . 0.0 111.665 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.79 -43.63 69.43 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.62 1.168 . . . . 0.0 110.557 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.97 65.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.17 28.75 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.913 -1.493 . . . . 0.0 111.072 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.503 ' CG ' HG22 ' A' ' 95' ' ' ILE . 86.2 m-85 -110.79 163.57 13.64 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 120.067 1.934 . . . . 0.0 113.939 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -158.38 167.58 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.683 1.593 . . . . 0.0 108.885 -168.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 61' ' ' GLN . 1.3 tt -118.73 105.47 11.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.821 1.648 . . . . 0.0 110.16 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 p -79.94 48.67 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.358 1.463 . . . . 0.0 112.412 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.72 -59.05 0.2 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.229 0.612 . . . . 0.0 109.798 -164.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.425 ' H ' HD23 ' A' ' 75' ' ' LEU . 3.3 m80 -120.64 64.26 0.85 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.278 1.831 . . . . 0.0 106.718 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.609 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -139.94 133.9 30.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.15 123.68 36.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.822 1.649 . . . . 0.0 109.409 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.792 ' HA ' HG22 ' A' ' 56' ' ' ILE . 15.7 Cg_endo -72.84 114.83 4.14 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.193 2.596 . . . . 0.0 111.063 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 p -88.34 -17.02 31.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.944 0.498 . . . . 0.0 110.834 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 m -157.08 -178.74 7.59 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.543 1.537 . . . . 0.0 108.116 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -53.58 121.4 7.68 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 161.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 5' ' ' VAL . 7.2 p -135.25 144.51 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.995 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.59 125.28 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.17 154.02 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 123.999 0.92 . . . . 0.0 108.669 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.57 121.87 41.82 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.199 1.0 . . . . 0.0 108.643 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -178.23 3.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.917 1.235 . . . . 0.0 110.999 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.582 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 5.1 m-70 65.88 48.45 1.83 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.968 1.307 . . . . 0.0 112.931 169.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -119.31 15.39 13.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -40.65 -68.44 0.18 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.116 0.967 . . . . 0.0 109.68 170.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.81 17.51 0.71 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.991 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.14 -17.48 12.37 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 117.888 -1.054 . . . . 0.0 110.904 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.503 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.8 pt -89.82 -45.48 15.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 119.98 1.264 . . . . 0.0 111.673 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.157 -176.905 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.51 ' S1 ' HD11 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 121.051 0.453 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.0 m 57.8 75.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.876 1.271 . . . . 0.0 112.695 169.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -98.39 158.75 15.39 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.56 0.744 . . . . 0.0 112.704 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -81.93 83.77 7.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.992 1.717 . . . . 0.0 109.181 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 85' ' ' VAL . 94.7 t -81.66 121.68 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -89.55 132.34 35.13 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.675 167.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.436 HD12 HD13 ' A' ' 33' ' ' ILE . 71.8 mt -111.26 106.95 16.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.429 1.492 . . . . 0.0 107.238 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 23.1 mt -76.39 94.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 169.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -89.88 156.29 47.11 Favored Pre-proline 0 N--CA 1.444 -0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 108.689 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -52.12 -38.69 71.17 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.524 3.483 . . . . 0.0 112.422 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.69 -39.49 11.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 128.222 2.609 . . . . 0.0 111.237 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.05 66.19 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 125.585 1.564 . . . . 0.0 109.803 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.7 164.16 0.23 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.221 2.208 . . . . 0.0 112.565 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.71 -60.64 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.311 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 74.27 131.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.41 1.484 . . . . 0.0 111.598 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -162.44 167.86 22.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.54 124.44 39.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.4 t -131.78 123.99 28.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.187 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.79 138.7 56.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.41 1.484 . . . . 0.0 109.637 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 1.8 p-10 -56.17 -27.29 53.85 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.691 1.597 . . . . 0.0 111.916 169.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -87.0 1.18 53.67 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 111.865 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.41 156.53 41.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.639 1.109 . . . . 0.0 110.677 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -78.42 149.07 33.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 121.83 -0.543 . . . . 0.0 111.241 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.23 63.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 122.073 0.94 . . . . 0.0 110.423 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' C ' HD13 ' A' ' 25' ' ' LEU . 1.9 tm? -166.32 -51.87 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.44 -63.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.397 0.617 . . . . 0.0 110.98 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -58.02 -32.58 68.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.357 0.599 . . . . 0.0 110.243 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.734 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -58.06 -58.26 9.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.49 -41.51 63.44 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.87 -24.53 48.46 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.77 -0.581 . . . . 0.0 110.073 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.61 12.1 6.86 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.924 1.726 . . . . 0.0 111.736 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.734 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 86.7 mt -76.24 111.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 117.826 0.813 . . . . 0.0 111.017 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -89.17 73.1 8.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 159.43 29.44 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 121.112 -0.992 . . . . 0.0 108.739 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 59.7 Cg_endo -78.6 60.51 7.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.313 2.675 . . . . 0.0 110.989 -174.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CB ' ' HD2' ' A' ' 40' ' ' ARG . 39.3 p90 -83.43 161.07 21.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.29 0.566 . . . . 0.0 111.219 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.96 8.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 162.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 -72.96 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.945 0.793 . . . . 0.0 111.597 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HD2' ' CB ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER 71.35 70.08 0.17 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.948 2.099 . . . . 0.0 112.454 -163.418 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.8 72.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.902 2.481 . . . . 0.0 111.36 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.8 -98.78 0.02 OUTLIER Glycine 0 CA--C 1.537 1.451 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.4 t -72.25 73.35 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -152.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 47' ' ' CYS . 16.7 p -137.48 -151.56 0.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.368 1.467 . . . . 0.0 111.444 -172.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 t -157.33 66.0 0.5 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.116 1.366 . . . . 0.0 109.049 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.3 m -158.03 62.64 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 3.7 m -141.26 -148.07 0.23 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.264 0.554 . . . . 0.0 109.564 -168.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 81.91 127.01 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.628 1.971 . . . . 0.0 113.206 157.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.51 27.34 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.737 1.637 . . . . 0.0 109.848 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -92.77 111.04 22.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.834 1.254 . . . . 0.0 109.965 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.93 110.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.46 -42.43 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 t -157.24 -167.88 2.45 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.65 -153.64 14.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.01 0.814 . . . . 0.0 111.644 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.6 m -157.28 154.99 29.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.617 HG22 ' HA ' ' A' ' 81' ' ' PRO . 26.9 pt -141.75 166.31 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.43 1.892 . . . . 0.0 106.381 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -109.44 119.71 40.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -108.36 46.31 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.678 0.791 . . . . 0.0 111.295 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 t -63.23 -10.69 16.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -60.13 -61.64 2.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.302 0.955 . . . . 0.0 108.999 167.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 73.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.655 2.382 . . . . 0.0 112.636 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.8 p -83.75 -81.84 0.17 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 122.709 0.403 . . . . 0.0 111.231 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 95' ' ' ILE . 36.3 p90 -145.26 8.47 1.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.186 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.0 142.89 55.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.167 0.894 . . . . 0.0 109.194 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.85 167.23 11.76 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.865 0.728 . . . . 0.0 109.67 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.88 -41.91 75.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.966 0.907 . . . . 0.0 109.029 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -60.16 3.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.853 0.861 . . . . 0.0 109.545 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -55.1 -50.32 69.49 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.647 0.779 . . . . 0.0 110.999 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 20.2 mtm -51.29 -59.83 3.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.829 -0.544 . . . . 0.0 112.182 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.04 -43.19 73.53 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.239 1.016 . . . . 0.0 110.511 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.03 -22.89 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.585 1.554 . . . . 0.0 111.797 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.42 35.55 0.8 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-O 118.33 -1.261 . . . . 0.0 111.019 170.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.443 ' CG ' HG22 ' A' ' 95' ' ' ILE . 91.0 m-85 -116.46 161.77 18.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.789 1.794 . . . . 0.0 112.777 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.3 146.0 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.423 1.089 . . . . 0.0 108.74 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' CD1' ' H ' ' A' ' 78' ' ' HIS . 3.9 pp -70.27 165.7 21.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.611 1.096 . . . . 0.0 110.897 171.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 p -134.99 41.94 2.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.231 0.613 . . . . 0.0 110.854 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.0 m -137.44 -54.08 0.68 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.425 1.09 . . . . 0.0 110.271 -166.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.426 ' H ' ' CD1' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -128.72 57.71 1.6 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.978 1.711 . . . . 0.0 109.484 174.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.95 137.95 51.64 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -106.15 120.72 47.9 Favored Pre-proline 0 C--O 1.234 0.267 0 C-N-CA 126.105 1.762 . . . . 0.0 109.275 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.617 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.0 Cg_endo -75.4 116.08 4.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.675 2.25 . . . . 0.0 112.031 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -90.41 -15.42 30.99 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.027 -0.421 . . . . 0.0 111.385 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.8 m -158.48 -177.31 6.45 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.088 1.355 . . . . 0.0 108.524 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -64.36 84.46 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.116 1.766 . . . . 0.0 109.941 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 5' ' ' VAL . 2.1 p -85.82 155.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.822 1.249 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.71 125.09 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -139.62 153.21 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.509 1.124 . . . . 0.0 108.642 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 29.3 mt-10 -101.39 129.09 47.34 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.787 170.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 p -88.51 176.89 6.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.083 1.311 . . . . 0.0 109.463 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.405 ' CE1' ' HD3' ' A' ' 36' ' ' PRO . 2.9 m80 66.11 55.21 0.92 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 0.0 111.487 176.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -122.0 13.86 10.61 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -46.06 -62.76 1.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.794 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.99 28.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.306 0.642 . . . . 0.0 112.302 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -125.77 -12.35 6.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.819 1.248 . . . . 0.0 111.836 168.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.443 HG22 ' CG ' ' A' ' 73' ' ' TYR . 46.7 pt -91.21 -40.37 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 119.876 1.216 . . . . 0.0 111.924 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.964 -1.494 . . . . 0.0 110.173 178.096 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m 80.97 112.15 0.07 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.228 1.411 . . . . 0.0 111.901 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.4 155.21 37.83 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.75 0.82 . . . . 0.0 111.298 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -76.97 99.65 5.34 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.044 2.537 . . . . 0.0 108.038 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.89 118.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -85.94 129.95 34.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.126 0.266 . . . . 0.0 110.372 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 33' ' ' ILE . 77.4 mt -108.92 102.88 11.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 39.0 mt -71.37 94.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 171.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -93.52 155.21 40.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.66 -32.61 76.25 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.745 2.963 . . . . 0.0 112.244 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.4 -33.91 45.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.679 2.392 . . . . 0.0 111.392 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.52 0.34 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 125.212 1.387 . . . . 0.0 110.489 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 71.47 145.27 0.07 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.868 2.467 . . . . 0.0 114.262 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.456 HG21 HG23 ' A' ' 33' ' ' ILE . 35.3 m -143.23 97.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -69.14 135.91 51.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.847 161.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' A' ' 33' ' ' ILE . 4.8 p90 -151.19 170.33 19.71 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.595 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 119.51 39.17 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 9.2 t -122.01 126.22 48.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.959 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.59 145.73 45.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.725 1.726 . . . . 0.0 110.936 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -56.74 -24.64 51.14 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 127.198 2.199 . . . . 0.0 112.119 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -103.78 10.06 36.75 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.456 1.502 . . . . 0.0 111.332 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.432 HG11 ' CG ' ' A' ' 27' ' ' GLN . 1.7 p -134.53 158.36 41.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.52 1.054 . . . . 0.0 110.943 -175.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -77.91 138.08 38.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 t -49.0 -48.93 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.612 0.244 . . . . 0.0 110.916 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -37.81 74.02 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.03 -64.07 0.93 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.718 0.77 . . . . 0.0 108.939 -167.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.432 ' CG ' HG11 ' A' ' 22' ' ' VAL . 20.4 mm100 -57.17 -40.92 78.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.301 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 33' ' ' ILE . . . -50.1 -59.54 3.81 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.753 -0.592 . . . . 0.0 111.454 175.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.69 -39.71 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.112 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -53.03 -40.95 64.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -75.22 -24.85 57.8 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 121.849 -0.532 . . . . 0.0 109.749 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.88 12.88 6.86 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.615 1.578 . . . . 0.0 111.057 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 28' ' ' ALA . 89.1 mt -75.77 116.38 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.672 0.736 . . . . 0.0 110.785 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -80.38 63.93 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.9 156.26 87.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.67 76.39 1.94 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.33 2.686 . . . . 0.0 109.512 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -56.32 -63.93 1.03 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.705 1.202 . . . . 0.0 110.561 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t 66.0 -134.14 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.327 1.051 . . . . 0.0 110.882 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 173.24 0.3 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.523 1.056 . . . . 0.0 110.157 165.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.63 101.42 1.99 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 161.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.35 -36.47 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.824 0.849 . . . . 0.0 112.904 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 77.09 1.14 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 -26.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 0.0 111.71 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.04 -179.59 0.96 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.779 0.718 . . . . 0.0 111.091 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t -128.93 69.1 1.39 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.2 p -163.08 168.33 21.06 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.344 1.458 . . . . 0.0 107.178 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 75' ' ' LEU . 0.1 OUTLIER 66.83 147.81 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.008 1.723 . . . . 0.0 111.506 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' CYS . . . 168.29 169.27 0.04 OUTLIER 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.49 1.516 . . . . 0.0 111.122 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.22 166.0 26.16 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 125.478 1.513 . . . . 0.0 110.574 168.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -101.35 107.68 19.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.284 1.834 . . . . 0.0 110.087 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -59.56 109.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.19 -46.67 25.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -162.76 177.71 9.1 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . 95.39 -161.96 23.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.518 ' H ' HG22 ' A' ' 85' ' ' VAL . 6.6 m -156.71 144.83 19.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 168.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.946 HD11 HG21 ' A' ' 74' ' ' VAL . 49.1 pt -143.93 164.08 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.817 1.647 . . . . 0.0 106.741 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -108.96 109.9 21.07 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -104.75 25.08 10.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 0.0 111.928 170.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.8 m -77.24 31.4 0.14 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.371 -1.456 . . . . 0.0 113.301 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -125.6 12.94 8.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.828 1.651 . . . . 0.0 109.653 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.618 ' HB2' HD23 ' A' ' 75' ' ' LEU . 10.2 pt20 -115.91 -36.31 4.19 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -161.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m 41.86 64.39 1.09 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -142.9 -74.38 0.28 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.873 168.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' A' ' 75' ' ' LEU . 7.1 mp -52.22 141.13 19.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.069 0.85 . . . . 0.0 112.244 -168.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -83.94 169.06 15.43 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 124.424 1.078 . . . . 0.0 109.881 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.17 -44.86 71.85 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.64 -62.37 1.69 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.133 0.973 . . . . 0.0 109.482 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.39 -49.3 67.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.017 0.527 . . . . 0.0 111.359 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.18 -60.63 3.07 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.544 -0.722 . . . . 0.0 111.483 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.88 -42.19 68.39 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.248 1.019 . . . . 0.0 110.701 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.25 65.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.872 1.669 . . . . 0.0 112.32 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.83 30.64 1.93 Allowed Glycine 0 C--O 1.221 -0.715 0 CA-C-O 117.554 -1.692 . . . . 0.0 111.527 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CG ' HG22 ' A' ' 95' ' ' ILE . 96.4 m-85 -118.12 161.44 19.85 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.52 2.16 . . . . 0.0 113.514 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.946 HG21 HD11 ' A' ' 56' ' ' ILE . 7.1 p -146.69 140.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -78.46 136.39 37.6 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.535 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.42 ' N ' HD12 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -60.18 -57.01 14.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.882 0.873 . . . . 0.0 110.886 -178.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 62.8 m -61.56 125.05 22.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.433 0.693 . . . . 0.0 109.648 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 74.04 69.8 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.279 1.032 . . . . 0.0 112.791 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.19 128.4 20.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.214 1.406 . . . . 0.0 109.562 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -112.19 123.01 35.25 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.222 1.809 . . . . 0.0 109.096 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.618 ' HA ' HG22 ' A' ' 56' ' ' ILE . 16.8 Cg_endo -75.38 129.69 12.23 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.788 2.325 . . . . 0.0 111.595 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.3 p -104.05 -12.49 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.5 m -157.16 -174.93 5.14 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.13 127.77 33.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.607 HG21 HG23 ' A' ' 56' ' ' ILE . 25.1 t -135.91 153.76 32.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.674 0.79 . . . . 0.0 109.569 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.63 121.15 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.452 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.27 152.83 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 21.6 mt-10 -101.13 131.2 47.18 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 124.347 1.059 . . . . 0.0 109.284 168.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -88.74 177.46 6.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.153 1.342 . . . . 0.0 109.434 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.1 54.46 0.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.915 1.286 . . . . 0.0 111.437 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -125.32 22.37 7.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.74 0.816 . . . . 0.0 112.895 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -45.75 -72.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 108.91 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.09 37.57 0.44 Allowed 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.935 -0.478 . . . . 0.0 111.812 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -122.06 -29.54 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.452 1.501 . . . . 0.0 110.647 163.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.526 HG22 ' CG ' ' A' ' 73' ' ' TYR . 26.1 pt -83.68 -45.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 119.347 0.976 . . . . 0.0 112.608 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.981 -1.485 . . . . 0.0 109.803 -175.662 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.577 ' S2 ' HD11 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.489 ' N ' ' OD1' ' A' ' 21' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m 97.41 105.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.767 2.427 . . . . 0.0 112.305 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -131.63 155.61 47.26 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.97 0.908 . . . . 0.0 112.54 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.29 96.93 0.06 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.277 2.631 . . . . 0.0 109.651 169.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.38 118.59 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -85.82 130.24 34.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.471 0.176 . . . . 0.0 111.238 167.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.41 ' CD1' HD11 ' A' ' 35' ' ' ILE . 64.2 mt -110.06 105.25 14.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 124.483 1.114 . . . . 0.0 108.603 169.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.5 mt -78.3 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -87.11 153.53 54.27 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.99 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.09 -35.05 89.56 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.951 3.101 . . . . 0.0 112.397 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.27 -38.8 13.13 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 127.485 2.314 . . . . 0.0 111.14 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.69 62.12 0.19 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 125.283 1.421 . . . . 0.0 110.197 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 67.43 162.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.111 2.164 . . . . 0.0 111.921 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.49 -59.85 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 123.438 0.695 . . . . 0.0 110.15 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.26 137.45 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 126.354 1.862 . . . . 0.0 112.464 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.64 174.65 11.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.725 0.41 . . . . 0.0 111.722 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 122.77 42.45 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.6 126.58 50.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.21 133.64 49.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.35 -30.87 30.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.315 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -70.1 -14.1 62.51 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.949 1.3 . . . . 0.0 112.136 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.52 160.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.34 147.05 42.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.032 -0.417 . . . . 0.0 111.86 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.2 62.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 122.174 0.987 . . . . 0.0 110.335 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.21 -60.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -49.59 -58.25 5.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.757 1.265 . . . . 0.0 109.823 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -74.93 -20.13 59.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.925 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -65.72 -52.05 54.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.25 -40.86 68.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.213 0.605 . . . . 0.0 109.976 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.56 -39.61 64.9 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.42 -24.74 46.03 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.704 -0.622 . . . . 0.0 109.763 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.11 10.1 6.97 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.87 1.7 . . . . 0.0 111.37 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.609 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 71.4 mt -78.02 129.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.119 0.96 . . . . 0.0 111.012 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -87.2 125.41 34.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' A' ' 7' ' ' LEU . 17.8 mt -123.04 148.41 54.25 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 164.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 36.6 Cg_endo -78.17 64.53 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 124.126 3.217 . . . . 0.0 110.859 -171.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -68.73 -31.08 69.89 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.097 0.959 . . . . 0.0 113.488 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 t 57.86 -84.65 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.72 -159.9 0.77 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.268 3.027 . . . . 0.0 108.56 -174.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HA ' ' S1 ' ' A' ' 97' ' ' FES . 2.1 ttp180 -166.99 59.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.024 1.284 . . . . 0.0 112.592 169.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.38 10.02 1.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.13 -69.05 0.34 Allowed Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.474 1.034 . . . . 0.0 111.988 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 p -75.45 65.64 1.74 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.6 p -158.16 147.08 19.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.267 1.827 . . . . 0.0 106.1 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.2 m -102.14 85.01 2.58 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.674 -166.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.8 p -159.99 -145.87 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.795 0.725 . . . . 0.0 111.668 167.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.2 m 56.55 -114.92 0.87 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.932 1.693 . . . . 0.0 111.313 165.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 64.05 149.48 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.595 2.358 . . . . 0.0 113.574 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.01 158.31 27.6 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.001 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -95.43 109.81 21.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.074 1.35 . . . . 0.0 109.584 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 40.7 t -61.14 107.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.436 1.094 . . . . 0.0 108.225 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.29 -37.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -157.7 -163.21 1.3 Allowed 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . 73.53 -171.28 51.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.033 0.349 . . . . 0.0 113.168 172.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.425 ' H ' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -150.92 129.94 12.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.66 HG23 HG21 ' A' ' 85' ' ' VAL . 16.7 pt -139.1 152.28 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -100.72 112.97 25.47 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -105.68 41.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.249 0.62 . . . . 0.0 110.765 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -49.79 -37.44 30.04 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.413 1.006 . . . . 0.0 111.495 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.2 6.27 3.69 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.607 0.763 . . . . 0.0 112.455 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -59.33 -62.17 2.08 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.343 1.457 . . . . 0.0 111.858 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.6 m 37.86 39.37 0.22 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.616 1.166 . . . . 0.0 113.355 -165.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -143.85 -70.43 0.31 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.34 1.056 . . . . 0.0 110.484 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.41 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 6.9 mp -56.9 144.32 34.03 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.987 0.812 . . . . 0.0 110.156 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.19 165.58 14.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.618 0.723 . . . . 0.0 110.233 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.16 -41.35 71.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.818 1.247 . . . . 0.0 108.683 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.54 -60.63 2.93 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.129 0.972 . . . . 0.0 109.465 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -54.41 -48.26 71.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.462 0.705 . . . . 0.0 111.39 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.0 mtt -53.98 -60.18 3.67 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.521 -0.737 . . . . 0.0 111.106 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.67 -44.72 69.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.747 1.219 . . . . 0.0 110.558 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.18 64.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.741 1.617 . . . . 0.0 112.254 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.88 32.59 1.4 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.415 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.54 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.0 m-85 -120.24 159.38 25.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.343 2.072 . . . . 0.0 113.184 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.423 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 5.1 p -154.26 150.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.552 1.141 . . . . 0.0 108.73 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.626 HD22 ' SG ' ' A' ' 77' ' ' CYS . 0.4 OUTLIER -79.24 119.9 22.97 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.7 p -70.76 -45.81 64.09 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.465 -0.772 . . . . 0.0 110.817 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.626 ' SG ' HD22 ' A' ' 75' ' ' LEU . 26.3 p -59.12 -33.58 71.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.503 1.521 . . . . 0.0 112.326 -177.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -128.58 72.24 1.43 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.137 0.975 . . . . 0.0 110.181 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -138.33 141.47 39.73 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.263 1.025 . . . . 0.0 109.282 168.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.66 118.44 45.08 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.006 1.723 . . . . 0.0 109.281 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.536 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.8 Cg_endo -75.85 108.79 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.339 2.693 . . . . 0.0 112.707 -174.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -88.43 -12.98 41.59 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.865 -0.522 . . . . 0.0 111.366 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.8 m -152.62 -177.27 6.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.167 1.387 . . . . 0.0 108.103 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.16 124.21 20.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 166.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.66 HG21 HG23 ' A' ' 56' ' ' ILE . 53.5 t -133.62 156.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.558 0.694 . . . . 0.0 111.282 -173.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.7 t -123.3 118.77 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.39 152.24 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.165 0.986 . . . . 0.0 108.939 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.53 127.55 46.86 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.077 0.951 . . . . 0.0 108.833 170.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -83.33 179.49 7.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.042 1.292 . . . . 0.0 110.139 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.455 ' CE1' ' HD3' ' A' ' 36' ' ' PRO . 1.3 m80 69.73 55.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.153 1.381 . . . . 0.0 111.122 173.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.54 13.59 9.43 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -34.88 -76.29 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.855 2.062 . . . . 0.0 110.767 166.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.77 40.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.002 0.819 . . . . 0.0 112.426 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.37 -28.78 4.94 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.311 1.044 . . . . 0.0 111.047 158.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.54 HG22 ' CG ' ' A' ' 73' ' ' TYR . 34.8 pt -81.42 -48.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.296 0.953 . . . . 0.0 112.896 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.044 -173.306 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 97' ' ' FES . . . . . 0.45 ' S1 ' ' HA ' ' A' ' 40' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 121.612 0.72 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -97.36 159.59 14.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -171.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.95 90.15 6.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.305 1.842 . . . . 0.0 109.614 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 85' ' ' VAL . 65.0 t -89.47 124.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -89.76 132.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.147 0.43 . . . . 0.0 110.836 165.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.543 HD23 HG23 ' A' ' 87' ' ' ILE . 70.4 mt -111.68 103.57 11.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 165.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.5 mt -71.62 95.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -92.79 156.75 40.53 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 124.145 0.978 . . . . 0.0 108.925 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.56 -35.3 76.38 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.2 3.267 . . . . 0.0 112.227 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.3 -30.97 52.8 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 127.376 2.27 . . . . 0.0 111.494 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.53 61.01 0.41 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 125.005 1.288 . . . . 0.0 110.73 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 71.95 142.72 0.06 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 127.768 2.427 . . . . 0.0 114.187 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.93 87.29 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.495 1.118 . . . . 0.0 108.148 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -66.71 132.18 47.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 109.746 167.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -153.38 166.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.133 0.573 . . . . 0.0 111.839 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.23 122.99 39.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.432 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -127.08 123.03 35.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.505 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 143.03 54.9 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.799 1.24 . . . . 0.0 110.099 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -24.99 47.73 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 127.333 2.253 . . . . 0.0 111.182 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -107.88 21.29 17.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.589 1.555 . . . . 0.0 111.462 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -134.55 158.31 41.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.757 1.162 . . . . 0.0 110.633 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -78.68 144.89 34.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.343 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.02 61.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.871 0.868 . . . . 0.0 111.098 173.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 tp -169.11 -61.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.06 -55.95 12.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.057 0.943 . . . . 0.0 109.253 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -77.05 -13.76 59.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.876 0.87 . . . . 0.0 112.831 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -75.57 -50.46 15.51 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 120.945 -1.097 . . . . 0.0 108.603 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -53.38 -38.98 63.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.199 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.61 -38.8 56.26 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.59 -23.89 34.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.764 -0.585 . . . . 0.0 109.608 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.24 15.23 4.25 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.072 1.796 . . . . 0.0 111.473 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.657 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 82.2 mt -80.59 108.41 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.038 0.919 . . . . 0.0 112.445 -170.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.98 72.91 6.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.175 0.99 . . . . 0.0 110.398 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 O-C-N 120.921 -1.112 . . . . 0.0 109.651 175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.319 0.58 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.56 164.46 27.01 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 125.942 1.734 . . . . 0.0 110.165 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -98.66 110.25 22.88 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.671 1.588 . . . . 0.0 110.502 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.49 115.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.63 -48.03 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.221 0.609 . . . . 0.0 109.505 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -160.87 173.99 14.51 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.067 -0.396 . . . . 0.0 110.223 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.49 -176.59 47.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.443 1.021 . . . . 0.0 110.742 -168.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -135.15 149.44 49.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.699 HD11 HG21 ' A' ' 74' ' ' VAL . 36.4 pt -147.47 165.29 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.124 1.77 . . . . 0.0 107.54 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.12 113.54 21.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 108.748 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.414 ' CD ' HG23 ' A' ' 74' ' ' VAL . 10.7 pt20 -110.86 31.77 5.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.023 170.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 p . . . . . 0 N--CA 1.467 0.423 0 CA-C-N 121.101 1.773 . . . . 0.0 111.191 -178.71 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.14 166.43 18.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 124.043 0.839 . . . . 0.0 109.85 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -53.56 -43.99 68.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.0 -61.52 2.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.126 0.97 . . . . 0.0 109.608 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -54.95 -50.08 69.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.269 0.627 . . . . 0.0 111.376 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mtt -51.95 -59.36 4.43 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.489 -0.757 . . . . 0.0 111.314 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.03 -42.28 76.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.45 1.1 . . . . 0.0 110.832 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.42 -20.72 65.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.683 1.593 . . . . 0.0 111.753 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.57 33.8 1.06 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 117.786 -1.564 . . . . 0.0 111.413 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.97 162.67 18.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.348 2.074 . . . . 0.0 113.297 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 56' ' ' ILE . 13.0 p . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 125.061 1.344 . . . . 0.0 108.469 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.88 122.96 38.42 Favored Pre-proline 0 C--O 1.235 0.318 0 C-N-CA 125.537 1.535 . . . . 0.0 108.945 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.3 Cg_endo -76.33 113.95 3.79 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.221 2.614 . . . . 0.0 111.284 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 p -89.52 -12.55 39.67 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.375 -0.828 . . . . 0.0 111.749 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.1 m -157.79 -177.88 6.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.634 1.574 . . . . 0.0 107.687 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.5 113.17 1.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 162.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 5' ' ' VAL . 2.5 p -120.57 145.77 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.447 1.499 . . . . 0.0 108.595 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.71 125.63 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.543 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -138.03 155.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -102.87 128.42 49.66 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.28 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.444 ' CG2' HD22 ' A' ' 7' ' ' LEU . 43.0 p -86.4 178.73 7.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.045 1.293 . . . . 0.0 109.093 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.28 51.37 0.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.596 1.158 . . . . 0.0 111.178 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -127.62 37.62 4.18 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.584 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -70.08 0.25 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 165.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -72.92 33.16 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.737 -1.227 . . . . 0.0 113.803 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -121.97 -3.9 9.1 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.707 -1.245 . . . . 0.0 111.751 159.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.7 pt -111.75 -39.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.344 1.429 . . . . 0.0 111.694 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.253 1.275 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.436 175.712 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.101 0.477 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -104.81 156.02 18.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.278 0.561 . . . . 0.0 112.307 -167.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.34 104.39 2.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 127.835 2.454 . . . . 0.0 108.462 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.91 117.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -88.8 131.61 35.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.716 0.235 . . . . 0.0 111.283 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.553 HD12 HD13 ' A' ' 33' ' ' ILE . 79.5 mt -109.19 103.69 12.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.419 1.075 . . . . 0.0 109.105 167.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 53.9 mt -76.44 99.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -89.77 166.69 19.69 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 124.313 1.045 . . . . 0.0 109.48 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.18 -25.85 30.87 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.086 2.524 . . . . 0.0 111.182 166.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -46.11 78.7 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.169 0.988 . . . . 0.0 109.662 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.83 64.94 0.08 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 67.55 147.35 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.522 1.929 . . . . 0.0 113.643 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 p -154.43 105.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.398 165.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.99 142.35 41.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -152.41 169.24 23.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.182 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 123.5 44.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.4 124.72 50.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.734 0.646 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.03 151.55 45.7 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.524 1.63 . . . . 0.0 109.008 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -14.56 59.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 129.333 3.053 . . . . 0.0 110.566 -177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -114.4 20.04 15.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.533 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.58 148.91 29.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.087 0.858 . . . . 0.0 109.227 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -67.76 146.07 54.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.069 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.2 t -51.09 -51.53 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -57.32 12.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.305 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.94 -63.08 1.06 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.21 0.914 . . . . 0.0 110.611 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -69.69 -34.67 74.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 33' ' ' ILE . . . -51.18 -57.4 8.87 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.676 -0.64 . . . . 0.0 110.911 170.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -55.39 -41.7 73.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.01 -38.59 65.28 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.22 -25.89 58.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.275 0.56 . . . . 0.0 109.794 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.63 13.65 6.09 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.385 1.469 . . . . 0.0 110.946 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.553 HD13 HD12 ' A' ' 7' ' ' LEU . 93.7 mt -75.63 121.6 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 117.624 0.712 . . . . 0.0 110.496 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.04 80.74 8.74 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-O 121.912 0.863 . . . . 0.0 113.069 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.692 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -139.04 165.78 25.58 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.151 1.834 . . . . 0.0 110.335 172.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -102.95 111.1 23.27 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.006 1.722 . . . . 0.0 110.977 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.27 117.38 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.938 0.79 . . . . 0.0 109.341 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.7 -47.68 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.294 1.038 . . . . 0.0 109.013 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.451 ' O ' HG23 ' A' ' 85' ' ' VAL . 8.2 t -161.12 175.35 12.49 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 122.075 -0.391 . . . . 0.0 110.417 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.22 -160.83 52.72 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.559 1.076 . . . . 0.0 110.762 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 t -151.48 169.86 21.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.681 ' CD1' HG21 ' A' ' 74' ' ' VAL . 8.6 pt -161.46 160.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 127.234 2.214 . . . . 0.0 107.593 -167.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -114.82 110.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.417 ' CD ' HG23 ' A' ' 74' ' ' VAL . 9.8 pt20 -106.58 37.16 2.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 111.264 170.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 CA--C 1.534 0.336 0 CA-C-N 118.951 0.796 . . . . 0.0 111.113 171.662 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 120.452 0.168 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.23 166.38 15.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 124.065 0.853 . . . . 0.0 109.893 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.95 -43.88 70.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.25 -61.97 1.91 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.234 1.014 . . . . 0.0 109.563 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -54.38 -50.95 66.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.979 0.511 . . . . 0.0 111.466 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mtm -53.98 -58.06 8.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.455 -0.778 . . . . 0.0 111.51 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.85 -44.33 70.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.714 1.206 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.64 67.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.811 1.645 . . . . 0.0 111.945 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.93 32.86 0.96 Allowed Glycine 0 C--O 1.223 -0.569 0 CA-C-O 117.601 -1.666 . . . . 0.0 111.774 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.544 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.8 m-85 -121.02 163.66 17.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.557 2.179 . . . . 0.0 113.635 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.681 HG21 ' CD1' ' A' ' 56' ' ' ILE . 13.2 p . . . . . 0 N--CA 1.452 -0.369 0 C-N-CA 123.759 0.824 . . . . 0.0 108.906 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.17 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -106.66 131.46 21.68 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 126.558 1.943 . . . . 0.0 109.357 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.3 Cg_endo -78.27 121.37 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.799 2.333 . . . . 0.0 111.725 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -97.29 -12.88 22.37 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.713 -0.617 . . . . 0.0 112.333 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -157.11 -175.23 5.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.563 1.545 . . . . 0.0 106.835 170.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -55.2 140.11 39.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 164.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 56' ' ' ILE . 3.3 p -156.33 146.23 11.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.754 0.788 . . . . 0.0 110.311 -168.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.84 126.8 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.692 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -143.14 147.93 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.878 0.871 . . . . 0.0 109.103 -177.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.503 ' N ' HD13 ' A' ' 87' ' ' ILE . 30.5 mt-10 -104.22 116.74 32.72 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.283 1.033 . . . . 0.0 110.813 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.1 p -79.11 176.25 9.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.244 0.929 . . . . 0.0 109.742 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 67.62 52.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.602 1.161 . . . . 0.0 111.082 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -123.6 43.98 2.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.683 0.793 . . . . 0.0 110.841 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.3 -71.6 0.2 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.82 50.64 1.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.696 -0.627 . . . . 0.0 111.846 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.73 -28.05 1.64 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.594 2.358 . . . . 0.0 111.618 165.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.544 HG22 ' CG ' ' A' ' 73' ' ' TYR . 26.0 pt -91.85 -42.19 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 119.184 0.902 . . . . 0.0 112.552 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 117.351 -1.309 . . . . 0.0 109.254 -177.396 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.422 0.154 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -128.81 156.1 44.13 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.195 0.598 . . . . 0.0 111.222 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.09 102.11 2.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.842 2.457 . . . . 0.0 108.469 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.64 120.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -90.53 131.94 35.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 123.165 0.291 . . . . 0.0 111.004 166.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.21 103.26 12.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 108.285 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mt -74.2 90.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -88.45 154.38 51.15 Favored Pre-proline 0 N--CA 1.444 -0.741 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -57.3 -31.95 92.36 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.87 3.046 . . . . 0.0 112.12 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.84 -33.76 37.49 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.916 2.086 . . . . 0.0 111.087 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.46 61.53 0.27 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 124.898 1.237 . . . . 0.0 110.145 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 68.57 153.79 0.1 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.152 2.181 . . . . 0.0 114.043 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.04 98.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.825 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.36 145.48 45.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.341 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -157.24 172.79 18.0 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.47 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.09 122.61 44.46 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t -122.94 127.86 49.47 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -69.32 141.88 54.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.738 1.256 . . . . 0.0 109.951 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -21.75 55.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 129.886 3.274 . . . . 0.0 111.52 173.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -107.6 12.85 27.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.809 1.644 . . . . 0.0 110.606 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.44 157.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.261 0.937 . . . . 0.0 110.61 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -76.12 149.07 37.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.219 0.608 . . . . 0.0 110.806 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.3 t -72.54 66.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.84 0.829 . . . . 0.0 111.226 173.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 26' ' ' ASP . 1.4 pt? -163.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.583 1.553 . . . . 0.0 108.723 168.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' H ' HD23 ' A' ' 25' ' ' LEU . 4.9 t70 -57.92 -57.76 11.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 -170.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -63.08 -35.06 78.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.645 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -56.43 -56.73 17.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.637 -0.665 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.86 -39.75 74.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 109.767 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -52.15 -42.15 63.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.869 0.759 . . . . 0.0 112.765 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.07 -23.26 55.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.048 0.451 . . . . 0.0 109.974 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.26 12.88 7.27 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.91 1.719 . . . . 0.0 111.369 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.53 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 64.2 mt -80.42 129.66 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.542 0.671 . . . . 0.0 111.1 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -93.32 127.6 38.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.132 0.973 . . . . 0.0 108.436 164.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.7 pt . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 165.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -142.54 166.09 26.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.004 1.764 . . . . 0.0 110.99 175.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -102.73 110.2 22.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.761 2.024 . . . . 0.0 110.873 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.04 114.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 119.14 0.882 . . . . 0.0 109.062 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.98 -44.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.3 t -161.54 177.64 9.85 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.99 -168.77 43.93 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -142.71 151.2 41.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.707 HG23 HG21 ' A' ' 85' ' ' VAL . 28.7 pt -142.35 157.2 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 173.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -99.74 107.63 19.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.3 39.88 1.64 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.676 0.79 . . . . 0.0 111.442 170.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 119.492 1.042 . . . . 0.0 111.589 174.398 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.9 164.83 15.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.729 0.643 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.59 -43.19 68.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.163 0.985 . . . . 0.0 108.543 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -52.3 -61.63 2.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.089 0.956 . . . . 0.0 109.421 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -52.52 -52.28 55.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 111.332 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.7 mtt -52.33 -59.88 3.88 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 111.317 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.76 -44.0 73.26 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.954 1.302 . . . . 0.0 110.677 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.18 -20.84 64.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.744 1.618 . . . . 0.0 111.769 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.69 32.94 1.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-O 117.972 -1.46 . . . . 0.0 111.149 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.478 ' CG ' HG22 ' A' ' 95' ' ' ILE . 93.6 m-85 -118.35 165.88 13.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.963 1.882 . . . . 0.0 113.049 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.634 HG21 HD11 ' A' ' 56' ' ' ILE . 7.6 p . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . . . . . . . . 0 N--CA 1.46 0.074 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.4 125.44 37.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.215 1.406 . . . . 0.0 109.416 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.8 Cg_endo -74.25 114.99 4.17 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.858 2.372 . . . . 0.0 110.811 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.4 p -94.71 -9.8 33.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.144 0.884 . . . . 0.0 112.129 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -156.9 -177.7 6.81 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 107.491 169.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -55.58 139.25 44.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 163.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.707 HG21 HG23 ' A' ' 56' ' ' ILE . 3.5 p -157.56 146.43 10.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.483 -165.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.87 124.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.423 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -139.11 152.21 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.885 0.874 . . . . 0.0 108.86 178.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 17.0 mt-10 -103.99 117.23 33.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.138 0.975 . . . . 0.0 109.854 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 p -80.32 174.63 11.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.381 -0.824 . . . . 0.0 111.301 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.96 55.63 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.654 1.582 . . . . 0.0 111.281 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 20.6 mmtt -126.33 25.81 6.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.429 0.692 . . . . 0.0 112.668 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.13 -70.56 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.19 0.996 . . . . 0.0 108.725 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -79.77 39.12 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.557 -0.714 . . . . 0.0 112.373 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.92 -43.5 3.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.632 1.173 . . . . 0.0 109.275 161.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.478 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.3 pt -75.89 -41.48 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.314 -1.327 . . . . 0.0 109.559 -177.741 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 121.315 0.579 . . . . 0.0 112.384 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -102.81 156.96 17.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.129 0.572 . . . . 0.0 112.394 -167.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -83.07 89.59 6.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.145 1.778 . . . . 0.0 109.8 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG13 HG13 ' A' ' 85' ' ' VAL . 85.2 t -87.31 127.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.69 131.32 43.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.139 0.427 . . . . 0.0 111.772 166.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.466 HD12 HG21 ' A' ' 33' ' ' ILE . 37.6 mt -108.8 105.14 14.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.34 1.025 . . . . 0.0 108.396 166.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.19 94.0 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -93.16 155.24 41.31 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.083 0.953 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -56.5 -32.42 89.48 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.938 3.092 . . . . 0.0 112.147 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.91 48.95 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 126.541 1.936 . . . . 0.0 111.215 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.49 60.08 0.35 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 124.861 1.219 . . . . 0.0 110.935 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 67.89 141.68 0.04 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.263 2.225 . . . . 0.0 114.127 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 33' ' ' ILE . 34.2 m -139.64 98.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.059 1.343 . . . . 0.0 107.864 169.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -82.18 133.31 35.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.696 1.599 . . . . 0.0 109.687 171.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.73 172.46 18.56 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 124.4 46.81 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 122.809 0.443 . . . . 0.0 110.224 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 48.6 t -125.43 128.21 47.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.98 140.06 50.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 123.832 1.777 . . . . 0.0 110.38 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -24.16 28.71 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 129.203 3.001 . . . . 0.0 111.335 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.36 7.24 38.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.574 1.549 . . . . 0.0 112.036 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.0 157.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-N 119.796 1.18 . . . . 0.0 110.302 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.53 147.35 41.89 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 122.013 -0.429 . . . . 0.0 110.804 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -53.96 -57.03 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.659 0.383 . . . . 0.0 110.137 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.54 -51.03 61.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.331 0.652 . . . . 0.0 111.089 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.28 -65.59 0.54 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.611 0.764 . . . . 0.0 110.64 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.57 -42.46 78.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.616 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -53.58 -59.92 3.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.965 -0.46 . . . . 0.0 111.176 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -58.87 -36.4 74.57 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.897 -0.573 . . . . 0.0 110.212 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -54.42 -38.31 66.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.959 0.799 . . . . 0.0 112.695 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.11 -26.53 53.39 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.807 -0.558 . . . . 0.0 109.991 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 12.64 8.36 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.747 1.641 . . . . 0.0 111.133 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 14' ' ' VAL . 91.5 mt -74.34 125.53 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.602 0.701 . . . . 0.0 111.02 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.47 119.7 30.96 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.44 1.096 . . . . 0.0 109.041 167.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 HD13 HD13 ' A' ' 7' ' ' LEU . 14.2 pt . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.402 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.689 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -142.98 161.59 27.54 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.65 1.595 . . . . 0.0 111.096 167.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -96.48 111.17 23.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.506 1.923 . . . . 0.0 110.728 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 19.8 t -61.06 111.01 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.211 1.405 . . . . 0.0 108.675 175.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -83.81 -47.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.015 0.926 . . . . 0.0 108.979 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -161.36 172.67 16.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.54 -162.38 50.24 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.374 0.988 . . . . 0.0 110.667 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -155.88 155.58 33.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.679 -0.895 . . . . 0.0 109.193 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.659 HG22 ' HA ' ' A' ' 81' ' ' PRO . 29.7 pt -135.3 165.95 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.99 1.716 . . . . 0.0 107.416 174.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.83 111.32 23.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.56 31.45 5.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.77 -0.633 . . . . 0.0 111.752 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 120.016 1.28 . . . . 0.0 112.175 -178.592 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 119.887 -0.101 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.66 164.35 17.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 124.092 0.87 . . . . 0.0 109.983 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.17 -44.11 64.48 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.613 1.165 . . . . 0.0 108.482 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.32 -62.43 1.63 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.538 1.135 . . . . 0.0 109.671 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -53.97 -50.18 67.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.283 0.633 . . . . 0.0 111.294 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 29.8 mtt -52.78 -59.98 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.933 -0.479 . . . . 0.0 111.343 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.63 -43.29 72.15 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.855 1.262 . . . . 0.0 110.618 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.63 -21.26 65.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.629 1.572 . . . . 0.0 111.948 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 33.66 1.32 Allowed Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.028 -1.429 . . . . 0.0 110.832 173.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.517 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.1 m-85 -118.75 166.43 12.79 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.965 1.882 . . . . 0.0 112.806 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 56' ' ' ILE . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.173 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.625 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -109.28 122.77 38.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 C-N-CA 124.522 1.129 . . . . 0.0 109.553 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.659 ' HA ' HG22 ' A' ' 56' ' ' ILE . 10.8 Cg_endo -71.24 119.6 6.4 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.543 2.162 . . . . 0.0 111.102 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.9 p -93.7 -13.97 26.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.006 -0.434 . . . . 0.0 111.864 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.0 m -158.66 -177.69 6.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.803 1.641 . . . . 0.0 107.217 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.77 95.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.581 1.552 . . . . 0.0 109.337 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.546 HG11 ' CG2' ' A' ' 56' ' ' ILE . 4.2 p -99.24 148.75 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 110.236 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.38 125.97 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.689 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -144.77 144.39 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.756 0.822 . . . . 0.0 109.32 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -100.93 113.39 26.32 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.99 0.814 . . . . 0.0 110.538 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.2 p -79.46 175.69 10.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.979 0.809 . . . . 0.0 110.988 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.29 53.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.318 1.447 . . . . 0.0 111.326 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -124.73 24.67 7.68 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.528 0.731 . . . . 0.0 112.837 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -50.46 -70.17 0.09 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.197 0.999 . . . . 0.0 109.252 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.07 42.37 0.4 Allowed 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.854 -0.529 . . . . 0.0 112.037 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -130.33 -27.46 2.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.343 1.457 . . . . 0.0 111.29 163.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.517 HG22 ' CG ' ' A' ' 73' ' ' TYR . 25.0 pt -82.52 -42.89 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 119.468 1.031 . . . . 0.0 113.197 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.567 -1.206 . . . . 0.0 109.933 -176.057 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.02 157.74 15.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.305 0.642 . . . . 0.0 112.455 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -81.63 88.65 6.22 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.702 1.601 . . . . 0.0 109.737 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 85' ' ' VAL . 59.3 t -86.85 123.55 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -95.03 131.82 40.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 117.714 0.234 . . . . 0.0 111.499 170.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.99 105.0 13.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 108.493 169.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 mt -75.55 87.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -83.52 154.77 65.88 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.423 1.089 . . . . 0.0 108.881 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.1 -27.33 78.91 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.716 2.944 . . . . 0.0 112.31 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.64 -31.55 57.56 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 125.666 1.586 . . . . 0.0 110.899 171.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.51 61.89 0.3 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 125.144 1.354 . . . . 0.0 110.571 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 65.82 163.15 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.692 1.997 . . . . 0.0 112.687 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.604 HG23 ' H ' ' A' ' 15' ' ' GLU . 14.1 m -132.21 -67.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 170.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.2 tt0 75.9 128.58 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.438 1.895 . . . . 0.0 111.594 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.6 p90 -162.43 172.5 15.45 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.246 -0.284 . . . . 0.0 111.389 -170.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 127.47 45.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 26.7 t -124.75 124.99 43.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.277 0.631 . . . . 0.0 111.332 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -64.33 147.9 51.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.271 1.034 . . . . 0.0 110.588 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -65.35 -14.71 61.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.295 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -107.37 4.05 25.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.851 1.66 . . . . 0.0 111.652 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.59 156.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 119.27 0.941 . . . . 0.0 108.859 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.85 153.74 36.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.46 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -52.68 -53.87 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.361 172.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -58.67 -43.02 89.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.033 -176.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.577 ' N ' HD13 ' A' ' 25' ' ' LEU . 78.4 m-20 -51.04 -66.54 0.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.57 1.176 . . . . 0.0 107.943 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -70.26 -34.11 72.42 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.941 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -59.3 4.65 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.98 -0.45 . . . . 0.0 111.961 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.7 -38.62 75.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.84 -39.34 68.49 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.75 -26.03 59.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.57 13.32 7.47 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.427 1.489 . . . . 0.0 110.936 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.632 HG22 HG23 ' A' ' 35' ' ' ILE . 76.4 mt -76.61 128.81 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 117.757 0.779 . . . . 0.0 110.173 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -90.83 119.48 31.07 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.996 1.318 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.632 HG23 HG22 ' A' ' 33' ' ' ILE . 8.5 pt . . . . . 0 CA--C 1.532 0.283 0 C-N-CA 124.577 1.151 . . . . 0.0 107.946 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.789 0.804 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.91 170.98 24.68 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 126.041 1.781 . . . . 0.0 110.539 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -102.13 111.21 23.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 110.347 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.51 111.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 108.888 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -83.69 -47.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -161.94 175.79 11.47 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.076 -0.39 . . . . 0.0 110.707 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.97 -160.19 53.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 m -155.16 156.2 35.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.944 HD11 HG21 ' A' ' 74' ' ' VAL . 38.0 pt -140.21 166.21 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 107.85 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -104.29 109.16 20.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -113.43 58.7 0.66 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.997 0.919 . . . . 0.0 108.684 164.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.53 0.192 0 O-C-N 121.605 -0.684 . . . . 0.0 110.283 173.011 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -93.23 167.46 11.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.614 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.15 -43.22 74.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.633 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.9 -61.28 2.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 123.99 0.916 . . . . 0.0 109.423 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.45 -51.29 67.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.614 0.766 . . . . 0.0 111.011 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 63.1 mtt -50.54 -61.25 2.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.903 -0.498 . . . . 0.0 111.421 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.76 -44.24 73.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.709 1.204 . . . . 0.0 110.649 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.28 -22.84 65.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.872 1.669 . . . . 0.0 112.033 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.31 29.02 1.53 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-O 117.778 -1.568 . . . . 0.0 111.998 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.6 m-85 -117.5 165.04 14.01 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 120.156 1.978 . . . . 0.0 112.85 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 56' ' ' ILE . 8.4 p . . . . . 0 N--CA 1.452 -0.331 0 C-N-CA 124.09 0.956 . . . . 0.0 109.435 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.09 125.72 30.47 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 125.145 1.378 . . . . 0.0 110.041 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.639 ' HA ' HG22 ' A' ' 56' ' ' ILE . 12.7 Cg_endo -73.13 117.77 5.25 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.627 2.218 . . . . 0.0 111.323 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -89.56 -19.03 25.48 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.744 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 m -154.37 -176.21 5.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.474 1.91 . . . . 0.0 107.403 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.09 113.25 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 163.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 5' ' ' VAL . 1.7 p -120.33 143.36 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.611 1.564 . . . . 0.0 109.134 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.82 155.31 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 124.641 1.176 . . . . 0.0 108.087 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.01 114.64 28.9 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.431 1.093 . . . . 0.0 109.268 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -75.18 176.94 6.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.211 0.914 . . . . 0.0 110.839 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 m80 68.95 53.4 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.96 1.304 . . . . 0.0 110.682 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -126.64 28.24 5.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 111.727 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.87 -64.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.73 14.14 0.53 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 -18.37 14.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.789 1.236 . . . . 0.0 109.782 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.469 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -100.34 -40.49 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.419 0.554 . . . . 0.0 111.308 -174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.072 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -134.84 160.05 39.44 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.412 0.685 . . . . 0.0 111.169 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -87.88 87.21 7.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.842 1.657 . . . . 0.0 109.645 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 85' ' ' VAL . 57.7 t -83.93 123.04 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 25.4 ttmt -93.37 134.38 35.66 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 87' ' ' ILE . 39.8 mt -113.61 105.89 13.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.884 1.274 . . . . 0.0 107.757 169.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.19 93.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -90.18 155.41 46.93 Favored Pre-proline 0 N--CA 1.443 -0.787 0 C-N-CA 125.215 1.406 . . . . 0.0 108.347 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.27 -30.22 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.687 2.925 . . . . 0.0 112.476 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.98 -32.02 61.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.439 1.896 . . . . 0.0 111.063 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.98 61.66 0.29 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.969 1.271 . . . . 0.0 110.782 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 24.1 mt-10 66.42 162.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.015 2.126 . . . . 0.0 112.368 176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 15' ' ' GLU . 16.7 m -135.84 -63.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.184 0.593 . . . . 0.0 111.143 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.536 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.7 tt0 76.28 132.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.177 1.791 . . . . 0.0 112.04 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 33' ' ' ILE . 2.6 p90 -162.27 173.83 13.67 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.29 126.81 41.76 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 16.0 t -129.26 130.87 46.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 139.29 41.3 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 123.571 1.653 . . . . 0.0 108.905 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.13 -27.65 9.02 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 130.019 3.328 . . . . 0.0 111.793 172.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -102.01 8.72 40.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.495 1.518 . . . . 0.0 111.569 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.74 158.05 43.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.488 1.04 . . . . 0.0 110.509 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -76.11 147.75 38.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.72 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.7 t -55.93 -54.36 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tt -78.9 46.4 0.68 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.569 1.148 . . . . 0.0 111.899 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -137.9 -68.73 0.46 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.352 1.461 . . . . 0.0 107.661 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.99 -10.27 47.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.845 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -77.64 -54.15 6.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.625 -1.297 . . . . 0.0 112.291 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.62 -39.15 67.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.158 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.333 0.3 OUTLIER -58.17 -30.18 66.2 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.87 -28.27 44.14 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.0 12.8 4.71 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.026 1.298 . . . . 0.0 111.293 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 16' ' ' PHE . 72.0 mt -73.77 123.46 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.177 0.988 . . . . 0.0 110.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -89.34 115.24 26.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 33' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 124.114 0.965 . . . . 0.0 109.216 172.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 123.133 1.444 . . . . 0.0 114.468 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.84 161.14 34.91 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -98.91 110.68 23.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.229 1.412 . . . . 0.0 110.302 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.69 109.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.935 0.894 . . . . 0.0 108.729 173.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.44 -49.26 17.37 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.043 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.9 t -160.35 173.07 16.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.67 -167.95 32.6 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -165.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -140.94 159.22 42.68 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.044 HD11 HG21 ' A' ' 74' ' ' VAL . 45.1 pt -146.07 166.82 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.239 1.416 . . . . 0.0 107.653 173.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -110.43 110.02 20.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.99 24.56 11.16 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.962 0.905 . . . . 0.0 112.135 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.54 0.565 0 CA-C-N 119.838 1.199 . . . . 0.0 112.634 -176.368 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.303 0.097 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.87 165.06 19.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.183 0.927 . . . . 0.0 109.65 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -42.79 72.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.061 0.944 . . . . 0.0 108.687 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.76 -61.13 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.11 0.964 . . . . 0.0 109.497 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.76 -51.43 63.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.342 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.1 mtt -51.19 -60.05 3.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.325 0.511 . . . . 0.0 111.402 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -54.92 -43.17 73.05 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.783 1.233 . . . . 0.0 110.652 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -20.25 64.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.672 1.589 . . . . 0.0 112.058 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.5 28.88 2.03 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.129 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.49 ' CG ' HG22 ' A' ' 95' ' ' ILE . 92.8 m-85 -112.44 168.52 9.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.736 1.768 . . . . 0.0 112.931 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.044 HG21 HD11 ' A' ' 56' ' ' ILE . 10.5 p . . . . . 0 N--CA 1.45 -0.432 0 C-N-CA 125.307 1.443 . . . . 0.0 109.334 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.659 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -105.53 125.3 33.75 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 109.492 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.634 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.6 Cg_endo -76.05 115.63 4.19 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.742 2.294 . . . . 0.0 111.874 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 p -93.52 -9.57 37.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.279 0.945 . . . . 0.0 112.102 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -161.96 -177.06 5.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.204 1.802 . . . . 0.0 107.177 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.04 92.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.532 1.533 . . . . 0.0 109.696 168.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 56' ' ' ILE . 5.7 p -96.42 146.76 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.963 1.305 . . . . 0.0 110.26 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.85 125.4 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.464 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -134.52 153.69 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 124.287 1.035 . . . . 0.0 108.222 176.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -103.74 125.73 50.41 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.073 0.949 . . . . 0.0 109.403 170.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 p -91.65 175.8 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.157 0.889 . . . . 0.0 110.7 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.13 60.39 0.65 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.292 1.037 . . . . 0.0 109.288 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -126.01 16.03 7.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.879 0.872 . . . . 0.0 112.499 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -41.31 -70.69 0.1 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.361 1.465 . . . . 0.0 109.777 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -80.99 32.85 0.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.22 -29.37 1.62 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.93 2.092 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.49 HG22 ' CG ' ' A' ' 73' ' ' TYR . 39.6 pt -81.7 -41.97 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.694 -0.669 . . . . 0.0 112.584 169.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.486 -1.245 . . . . 0.0 110.007 -179.176 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -93.56 164.35 13.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.975 0.91 . . . . 0.0 111.443 -172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.56 89.33 7.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.145 1.378 . . . . 0.0 108.905 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.642 HG13 HG13 ' A' ' 85' ' ' VAL . 50.4 t -87.01 122.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -93.81 125.58 38.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.269 0.356 . . . . 0.0 110.668 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 33' ' ' ILE . 17.1 mt -106.34 98.58 8.23 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 124.955 1.409 . . . . 0.0 108.022 174.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 35.6 mt -73.92 89.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -90.25 155.71 46.54 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 125.564 1.545 . . . . 0.0 108.316 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.96 -21.3 68.67 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.777 2.985 . . . . 0.0 112.681 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.54 -29.01 69.73 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.329 1.452 . . . . 0.0 110.862 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.8 61.95 0.35 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 65.6 173.16 0.22 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.505 1.522 . . . . 0.0 112.571 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.498 HG21 HG12 ' A' ' 33' ' ' ILE . 5.4 p -147.5 -55.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.651 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 71.1 132.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.718 1.607 . . . . 0.0 111.236 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -159.68 167.02 29.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.874 -0.516 . . . . 0.0 111.567 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 127.55 37.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.097 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 5.5 t -132.03 117.96 19.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.622 0.369 . . . . 0.0 110.696 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.76 148.88 19.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.629 1.972 . . . . 0.0 108.87 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -75.96 -6.79 52.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.769 -0.582 . . . . 0.0 112.328 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.26 36.25 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.457 1.503 . . . . 0.0 110.082 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.6 163.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 121.043 -1.035 . . . . 0.0 111.116 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -81.82 140.11 34.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.595 0.758 . . . . 0.0 111.894 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.0 t -63.84 -7.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.19 -34.93 10.93 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.604 1.161 . . . . 0.0 110.715 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -68.36 -69.46 0.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.17 0.986 . . . . 0.0 110.165 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.259 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -49.11 -62.16 1.68 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.775 0.83 . . . . 0.0 112.328 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -55.18 -40.69 71.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.064 -0.493 . . . . 0.0 109.727 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.3 -36.23 52.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.22 -30.32 34.26 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.508 0.595 . . . . 0.0 110.707 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.69 8.54 4.73 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.538 1.066 . . . . 0.0 112.076 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.648 HD13 HD12 ' A' ' 7' ' ' LEU . 21.1 mt -70.02 118.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.732 1.266 . . . . 0.0 110.906 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -91.15 77.85 5.94 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.319 1.048 . . . . 0.0 109.634 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.566 0 O-C-N 120.764 -1.21 . . . . 0.0 108.837 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.527 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -138.39 169.54 24.25 Favored Glycine 0 N--CA 1.431 -1.645 0 C-N-CA 126.016 1.769 . . . . 0.0 109.547 169.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -98.76 110.65 23.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.476 1.511 . . . . 0.0 108.424 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.42 103.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 t -77.03 -44.49 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 85' ' ' VAL . 9.0 t -163.46 172.3 14.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.64 -171.98 54.86 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.775 1.178 . . . . 0.0 111.151 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -137.38 157.61 46.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 74' ' ' VAL . 31.6 pt -148.15 168.45 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.274 1.829 . . . . 0.0 107.417 174.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -111.43 110.43 20.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -104.52 35.29 2.78 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.074 0.55 . . . . 0.0 112.078 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 CA--C 1.536 0.41 0 CA-C-N 119.623 1.101 . . . . 0.0 113.551 -179.751 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.391 0.138 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.19 168.61 11.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.031 0.832 . . . . 0.0 109.736 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.38 -42.48 70.43 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.71 -61.25 2.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.581 0.752 . . . . 0.0 109.521 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -55.66 -52.03 65.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.314 0.646 . . . . 0.0 111.283 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.2 mtm -51.81 -58.09 7.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.676 -0.64 . . . . 0.0 111.573 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.95 -42.93 76.97 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.332 1.053 . . . . 0.0 110.555 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.67 -21.27 64.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.56 1.544 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.58 2.23 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 118.355 -1.247 . . . . 0.0 110.859 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.0 m-85 -111.56 169.62 8.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.5 1.65 . . . . 0.0 111.564 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.027 HG21 HD11 ' A' ' 56' ' ' ILE . 8.5 p . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 123.657 0.783 . . . . 0.0 109.103 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.646 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -108.14 119.67 49.14 Favored Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 125.793 1.637 . . . . 0.0 108.863 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.786 ' HA ' HG22 ' A' ' 56' ' ' ILE . 18.4 Cg_endo -76.51 116.72 4.37 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.855 2.37 . . . . 0.0 111.341 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 p -91.77 -12.96 32.38 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.002 -0.436 . . . . 0.0 111.404 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -160.82 -178.28 6.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.301 1.84 . . . . 0.0 107.474 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -57.17 96.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.875 1.67 . . . . 0.0 109.251 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.642 HG13 HG13 ' A' ' 5' ' ' VAL . 9.1 p -103.0 147.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.727 1.211 . . . . 0.0 110.163 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -116.92 119.46 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.527 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -136.93 142.36 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 16.4 mt-10 -98.34 119.51 37.15 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.047 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -80.15 177.34 9.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.209 1.368 . . . . 0.0 110.007 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.2 m80 67.61 47.94 1.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.847 1.259 . . . . 0.0 111.11 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -121.38 41.1 3.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.124 0.57 . . . . 0.0 110.22 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -79.04 -60.06 2.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.31 51.86 0.73 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.427 0.691 . . . . 0.0 112.354 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.32 -12.03 0.05 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.443 1.497 . . . . 0.0 113.431 163.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.468 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -79.87 -40.56 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.916 1.235 . . . . 0.0 111.198 170.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.675 177.746 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -117.16 158.8 23.64 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.321 1.448 . . . . 0.0 111.526 -170.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.35 101.52 1.95 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.46 2.304 . . . . 0.0 108.833 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 18' ' ' CYS . 18.9 t -107.25 124.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.3 0.375 . . . . 0.0 110.164 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 33' ' ' ILE . 40.8 mt -108.86 106.48 16.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 108.848 167.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.15 99.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -99.27 155.24 36.76 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 124.929 1.291 . . . . 0.0 108.67 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.34 -34.54 89.1 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.995 3.13 . . . . 0.0 112.243 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.8 -34.75 28.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.438 2.295 . . . . 0.0 111.147 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.83 64.62 0.34 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 69.8 151.92 0.1 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.221 2.208 . . . . 0.0 114.045 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.94 111.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.176 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.03 138.19 31.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.705 1.202 . . . . 0.0 109.489 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.02 170.2 22.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.992 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.1 121.97 38.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.495 ' HB3' HG21 ' A' ' 5' ' ' VAL . 9.6 t -120.35 127.36 52.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.9 135.27 52.21 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -48.51 -39.45 23.33 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 123.183 1.468 . . . . 0.0 108.537 166.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -8.85 56.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.315 1.846 . . . . 0.0 111.954 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 27' ' ' GLN . 1.5 p -128.62 155.68 40.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 124.11 0.964 . . . . 0.0 109.815 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -75.49 148.25 39.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.781 -0.575 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.11 50.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.945 0.898 . . . . 0.0 111.152 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.3 pt? -150.02 -47.65 0.13 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.97 -66.61 0.36 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.277 1.031 . . . . 0.0 111.019 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.463 ' HB2' HG11 ' A' ' 22' ' ' VAL . 27.2 tt0 -69.03 -16.62 63.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.895 -0.503 . . . . 0.0 111.243 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.684 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -69.76 -51.32 35.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -56.6 -39.28 73.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.002 0.921 . . . . 0.0 109.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -50.87 -36.19 36.62 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.78 -28.73 27.94 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.966 -0.459 . . . . 0.0 110.214 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.83 12.89 4.76 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.518 1.532 . . . . 0.0 111.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.684 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 80.4 mt -73.81 112.18 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.334 1.067 . . . . 0.0 110.777 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.65 71.91 10.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.559 0.743 . . . . 0.0 110.414 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 O-C-N 120.76 -1.213 . . . . 0.0 109.469 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.791 0.329 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.14 165.72 27.71 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.554 2.026 . . . . 0.0 110.458 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -102.0 114.96 29.53 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.853 1.661 . . . . 0.0 110.704 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 57.3 t -64.5 112.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.1 0.96 . . . . 0.0 108.562 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -85.82 -42.37 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -157.02 -171.88 3.82 Favored 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.13 -155.21 22.51 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.71 1.148 . . . . 0.0 111.851 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.1 m -153.98 156.78 38.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.775 HG23 HG21 ' A' ' 85' ' ' VAL . 17.7 pt -136.29 149.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 172.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.8 112.73 24.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -107.84 42.11 1.41 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.468 0.707 . . . . 0.0 111.593 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.629 0 O-C-N 120.929 -1.107 . . . . 0.0 112.791 -175.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 119.882 -0.104 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -85.92 168.54 14.11 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.086 0.866 . . . . 0.0 109.942 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -55.86 -42.66 76.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.358 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.1 -60.54 3.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.802 0.841 . . . . 0.0 109.614 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -54.62 -51.1 66.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.4 mtt -51.74 -59.68 4.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.26 0.482 . . . . 0.0 111.344 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.08 -42.12 72.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.916 1.286 . . . . 0.0 110.795 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.44 -20.2 64.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.412 1.485 . . . . 0.0 111.812 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.88 3.18 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-O 118.613 -1.104 . . . . 0.0 110.528 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.528 ' CG ' HG22 ' A' ' 95' ' ' ILE . 93.2 m-85 -109.76 169.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.077 1.439 . . . . 0.0 111.642 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 56' ' ' ILE . 12.4 p . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.634 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -107.32 124.12 36.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.213 1.405 . . . . 0.0 111.126 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.758 ' HA ' HG22 ' A' ' 56' ' ' ILE . 19.2 Cg_endo -76.49 100.78 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.943 3.095 . . . . 0.0 112.806 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.4 p -81.78 -18.06 45.46 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.06 -0.4 . . . . 0.0 110.89 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -151.98 179.59 8.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.304 . . . . 0.0 107.702 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.38 136.29 53.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.775 HG21 HG23 ' A' ' 56' ' ' ILE . 2.8 p -155.43 144.52 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.833 0.825 . . . . 0.0 111.662 -164.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.42 123.81 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 151.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -99.03 127.03 44.88 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 118.056 -0.973 . . . . 0.0 108.943 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.2 p -86.57 178.44 7.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.682 1.128 . . . . 0.0 109.073 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 65.5 53.9 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.436 1.094 . . . . 0.0 111.555 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -122.22 18.64 10.71 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.2 -67.19 0.3 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.001 0.92 . . . . 0.0 109.005 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -81.29 23.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.599 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.39 -21.37 9.87 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.541 1.136 . . . . 0.0 110.854 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.528 HG22 ' CG ' ' A' ' 73' ' ' TYR . 18.3 pt -88.47 -42.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 119.478 1.035 . . . . 0.0 112.562 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.879 -1.534 . . . . 0.0 110.068 -177.01 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 121.869 0.842 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.39 163.44 12.7 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.054 0.942 . . . . 0.0 112.853 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.44 81.87 8.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.98 2.112 . . . . 0.0 109.484 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 85' ' ' VAL . 95.5 t -88.04 99.0 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -170.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.76 127.76 34.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.834 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.544 HD12 HD13 ' A' ' 33' ' ' ILE . 66.9 mt -107.95 109.53 21.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.2 mt -78.58 91.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -88.29 155.07 51.87 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 124.023 0.929 . . . . 0.0 108.57 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.05 -37.03 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.468 3.446 . . . . 0.0 112.696 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.5 -36.63 15.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.852 2.461 . . . . 0.0 111.159 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.06 65.08 0.29 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 69.54 165.31 0.26 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 127.02 2.128 . . . . 0.0 112.765 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.87 -59.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.201 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 70.63 145.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.128 1.371 . . . . 0.0 110.966 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 33' ' ' ILE . 3.1 p90 -169.54 158.94 8.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.93 0.892 . . . . 0.0 110.39 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 121.71 27.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.8 t -120.49 120.43 35.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.58 0.352 . . . . 0.0 110.427 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.57 141.97 58.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -55.35 -31.1 61.47 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 125.531 1.532 . . . . 0.0 110.901 169.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -88.31 -5.32 58.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.257 1.023 . . . . 0.0 112.083 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -119.23 149.01 21.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 CA-C-N 119.725 1.148 . . . . 0.0 110.086 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -72.18 150.38 43.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.185 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 56.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.745 0.783 . . . . 0.0 111.528 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 25' ' ' LEU . 5.4 tt -163.9 -52.75 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -56.62 13.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.572 0.701 . . . . 0.0 110.159 -175.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -71.29 -23.58 61.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -63.16 -54.09 43.04 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.549 -0.719 . . . . 0.0 110.226 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -48.75 -46.87 41.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.901 0.88 . . . . 0.0 108.894 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -53.87 -38.74 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.3 -25.59 42.4 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.882 -0.511 . . . . 0.0 109.863 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.03 12.75 5.22 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.827 1.68 . . . . 0.0 111.529 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.688 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 98.7 mt -76.23 108.84 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.167 0.984 . . . . 0.0 111.318 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -78.87 68.61 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.742 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 O-C-N 120.944 -1.097 . . . . 0.0 108.247 173.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 CA-C-O 121.554 0.692 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.68 167.33 25.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.135 1.826 . . . . 0.0 110.684 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -103.83 112.39 25.33 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.964 1.706 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.97 113.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.389 1.076 . . . . 0.0 109.132 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -85.78 -46.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 t -162.71 174.84 11.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.064 -0.398 . . . . 0.0 110.388 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.5 -173.2 54.44 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.599 1.095 . . . . 0.0 110.928 -170.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -141.44 147.7 38.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 74' ' ' VAL . 28.7 pt -145.47 169.97 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.784 1.633 . . . . 0.0 107.408 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.24 111.72 22.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -114.09 48.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 109.56 168.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.536 0.422 0 O-C-N 120.526 -1.359 . . . . 0.0 109.585 174.447 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 CA--C 1.521 -0.16 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.81 167.49 13.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 124.05 0.844 . . . . 0.0 109.763 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.16 -43.37 64.05 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.926 1.29 . . . . 0.0 108.58 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.11 -60.81 2.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.45 1.1 . . . . 0.0 109.674 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -58.12 -48.34 80.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.211 0.604 . . . . 0.0 111.044 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtt -51.98 -60.57 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.912 -0.493 . . . . 0.0 110.839 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.97 -45.1 71.28 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.777 1.231 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.37 -20.96 63.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.019 1.728 . . . . 0.0 112.059 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.55 30.95 1.74 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 117.802 -1.554 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.6 m-85 -118.25 158.39 25.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.981 1.89 . . . . 0.0 113.747 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 1.04 HG21 HD11 ' A' ' 56' ' ' ILE . 12.2 p . . . . . 0 N--CA 1.446 -0.627 0 C-N-CA 123.536 0.734 . . . . 0.0 110.671 -175.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -116.96 118.65 36.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.768 1.627 . . . . 0.0 109.337 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.2 Cg_endo -74.34 117.85 5.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.587 2.192 . . . . 0.0 111.666 -175.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 p -89.88 -16.03 30.91 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.731 -0.606 . . . . 0.0 111.2 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 m -156.6 -177.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.877 1.671 . . . . 0.0 107.112 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.72 133.67 42.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 161.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 5' ' ' VAL . 2.5 p -140.75 148.84 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 107.622 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.72 121.12 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 173.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.41 153.62 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -103.32 126.16 50.34 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 109.29 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.9 p -83.8 177.24 8.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.781 1.173 . . . . 0.0 109.263 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.2 m80 70.37 56.23 0.28 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.672 1.189 . . . . 0.0 111.54 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -129.04 31.47 4.89 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.614 0.765 . . . . 0.0 112.582 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -59.77 -66.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -80.23 47.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.649 0.738 . . . . 0.0 111.547 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -140.32 -41.29 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 131.453 3.901 . . . . 0.0 108.949 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.57 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.5 pt -75.49 -47.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.061 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.058 -1.448 . . . . 0.0 109.758 -173.616 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -118.68 154.93 31.92 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.552 0.691 . . . . 0.0 112.736 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.73 100.67 0.56 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 128.557 2.743 . . . . 0.0 108.65 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 85' ' ' VAL . 58.6 t -107.04 125.67 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 27.8 ttmt -97.18 135.72 38.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 165.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.439 HD22 HG23 ' A' ' 89' ' ' THR . 28.5 mt -112.14 106.89 15.62 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 124.505 1.128 . . . . 0.0 108.447 169.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.1 mt -78.42 91.61 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' HG1' ' A' ' 89' ' ' THR . 62.1 p -94.7 155.86 38.92 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.745 176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 68.6 Cg_exo -53.43 -37.11 81.6 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 125.133 3.889 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.64 -38.06 9.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 128.444 2.698 . . . . 0.0 111.106 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.8 61.9 0.26 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 24.4 mt-10 70.7 152.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 127.558 2.343 . . . . 0.0 112.905 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.426 HG11 HG23 ' A' ' 33' ' ' ILE . 13.7 p -152.65 90.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.861 1.315 . . . . 0.0 108.361 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -83.22 140.21 32.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.538 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.03 170.58 21.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.188 0.595 . . . . 0.0 112.224 -166.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.42 47.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.2 t -122.32 130.47 53.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.25 131.28 41.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.159 0.981 . . . . 0.0 108.988 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -44.48 -28.6 0.59 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.864 2.066 . . . . 0.0 111.833 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.57 -14.3 58.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.263 1.825 . . . . 0.0 112.489 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.9 154.4 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 0.0 110.078 -166.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -74.94 153.01 38.77 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.516 -1.365 . . . . 0.0 110.053 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -49.27 -51.3 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.815 -0.553 . . . . 0.0 110.866 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.75 72.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.82 -67.78 0.39 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -38.54 82.75 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.44 -61.88 1.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.33 -40.09 70.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.95 -40.27 72.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -19.9 56.73 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.481 -0.762 . . . . 0.0 109.039 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.26 15.08 7.3 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.237 1.399 . . . . 0.0 110.686 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.426 HG23 HG11 ' A' ' 14' ' ' VAL . 48.9 mt -81.81 133.12 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 117.302 0.551 . . . . 0.0 110.043 -175.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -93.17 115.2 27.84 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.487 1.115 . . . . 0.0 108.832 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 35' ' ' ILE . 5.5 pt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.11 167.12 27.9 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.546 1.546 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -105.23 112.57 25.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.516 1.926 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.9 110.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t -83.67 -45.48 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.7 t -160.96 174.41 13.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.977 -0.452 . . . . 0.0 110.292 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.39 -162.8 54.25 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -155.17 155.86 34.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 74' ' ' VAL . 30.2 pt -144.22 160.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.724 1.61 . . . . 0.0 107.801 -177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -101.38 108.14 19.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -104.55 38.67 1.83 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.711 0.804 . . . . 0.0 111.463 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 119.328 0.967 . . . . 0.0 112.414 175.295 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -85.38 164.86 17.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 123.812 0.695 . . . . 0.0 109.548 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.48 -40.42 74.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 108.683 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.29 -61.64 2.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.947 0.899 . . . . 0.0 109.402 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.41 -53.11 31.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.628 0.771 . . . . 0.0 111.332 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.3 mtm -50.54 -62.15 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 0.0 111.857 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.94 -43.46 69.84 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.667 1.187 . . . . 0.0 110.72 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.53 64.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.766 1.626 . . . . 0.0 112.112 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.86 26.39 2.11 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-O 117.922 -1.488 . . . . 0.0 111.842 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.535 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.8 m-85 -113.68 166.25 11.73 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 120.018 1.909 . . . . 0.0 112.88 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.742 HG21 HD11 ' A' ' 56' ' ' ILE . 8.6 p . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -108.4 125.22 32.36 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 125.547 1.539 . . . . 0.0 109.678 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.9 Cg_endo -71.98 119.36 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.194 1.93 . . . . 0.0 111.757 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -91.3 -17.19 26.33 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.257 -0.902 . . . . 0.0 112.039 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 m -156.21 -173.99 4.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.53 140.17 41.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 53' ' ' SER . 2.5 p -150.66 148.09 15.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.354 0.597 . . . . 0.0 109.853 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.54 124.2 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 151.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 123.795 0.838 . . . . 0.0 108.966 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -100.26 121.23 41.14 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.067 0.947 . . . . 0.0 108.605 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.439 HG23 HD22 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -74.34 179.81 4.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 119.163 0.892 . . . . 0.0 110.712 176.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.565 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 3.5 m-70 65.46 50.47 1.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.761 1.224 . . . . 0.0 112.86 169.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -122.01 15.5 10.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -172.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -45.39 -63.43 0.95 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.795 0.807 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -82.86 21.89 0.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.732 0.813 . . . . 0.0 113.142 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -110.2 -26.14 9.79 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.352 1.061 . . . . 0.0 110.495 162.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.535 HG22 ' CG ' ' A' ' 73' ' ' TYR . 34.6 pt -82.4 -48.85 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 119.478 1.035 . . . . 0.0 112.09 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.253 1.283 0 CA-C-O 117.498 -1.239 . . . . 0.0 109.693 -176.145 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.237 0.4 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -98.4 158.25 15.7 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 111.424 -168.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.82 90.21 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.837 1.655 . . . . 0.0 109.135 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 HG13 HG13 ' A' ' 85' ' ' VAL . 39.4 t -87.0 120.56 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -88.97 131.08 35.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.878 0.308 . . . . 0.0 111.346 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.8 mt -109.29 103.87 12.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.418 1.487 . . . . 0.0 107.508 166.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.4 mt -74.17 86.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -79.34 154.17 76.77 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.691 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.83 -32.43 94.93 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.949 3.1 . . . . 0.0 112.194 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -32.18 33.82 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 126.429 1.892 . . . . 0.0 110.907 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.01 62.62 0.32 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 125.255 1.407 . . . . 0.0 109.931 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 67.69 161.72 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.728 2.011 . . . . 0.0 112.883 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' H ' ' A' ' 15' ' ' GLU . 19.7 m -132.4 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.072 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 14' ' ' VAL . 4.6 tt0 73.67 129.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.121 1.768 . . . . 0.0 111.987 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -163.73 171.37 15.69 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.29 127.88 40.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.404 0.682 . . . . 0.0 111.524 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . 34.6 t -131.51 130.27 42.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 175.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.3 150.99 39.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 110.108 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -7.38 46.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -115.26 21.01 14.51 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.767 1.627 . . . . 0.0 110.703 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.42 158.12 27.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 O-C-N 121.024 -1.048 . . . . 0.0 110.589 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -77.94 143.45 37.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.566 0.346 . . . . 0.0 110.99 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 79' ' ' ALA . 5.6 t -49.07 -62.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 111.523 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tp -49.86 -52.5 32.21 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.537 0.735 . . . . 0.0 111.475 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -54.45 43.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -170.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -58.64 -44.91 90.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.581 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -50.87 -56.06 14.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.361 -0.837 . . . . 0.0 110.793 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.26 -38.95 81.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.674 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.7 -38.24 54.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.227 0.921 . . . . 0.0 112.301 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.96 -25.86 43.5 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.934 -0.479 . . . . 0.0 110.616 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.92 11.32 10.21 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.82 1.676 . . . . 0.0 111.31 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.589 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 97.1 mt -78.24 123.41 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.7 0.75 . . . . 0.0 111.075 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.59 119.37 30.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.703 1.601 . . . . 0.0 109.986 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.59 160.68 28.45 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.175 1.845 . . . . 0.0 111.085 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -98.26 112.94 24.75 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.026 1.73 . . . . 0.0 111.166 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.16 116.2 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.073 0.851 . . . . 0.0 109.474 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.98 -48.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.998 0.519 . . . . 0.0 109.876 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -160.33 174.06 14.73 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.08 -169.37 43.14 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 m -142.54 149.48 39.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.071 0.948 . . . . 0.0 108.817 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.768 HG23 HG21 ' A' ' 85' ' ' VAL . 24.9 pt -132.89 165.52 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.027 1.731 . . . . 0.0 107.035 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -107.13 110.73 22.89 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.45 46.17 1.02 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.112 0.565 . . . . 0.0 110.168 168.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 CA--C 1.533 0.301 0 O-C-N 121.539 -0.726 . . . . 0.0 109.751 169.737 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 121.003 0.43 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -85.85 160.62 19.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.966 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.36 -41.22 72.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.57 -61.01 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.981 0.912 . . . . 0.0 109.559 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -51.44 -51.07 57.99 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.0 111.202 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.1 mtt -52.18 -60.45 3.19 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.626 -0.671 . . . . 0.0 111.558 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.94 -42.68 76.54 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.379 1.072 . . . . 0.0 110.854 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.99 -19.93 63.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.8 1.64 . . . . 0.0 111.749 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.63 1.31 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 117.559 -1.689 . . . . 0.0 110.949 171.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -116.48 162.27 17.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.48 2.14 . . . . 0.0 113.802 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.729 -169.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' CB ' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -105.84 126.16 31.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 124.58 1.152 . . . . 0.0 109.215 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 56' ' ' ILE . 16.4 Cg_endo -75.87 119.1 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.659 2.24 . . . . 0.0 110.899 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 p -91.31 -15.04 29.72 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.099 -0.376 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -156.94 -174.71 5.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.49 134.81 40.58 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.768 HG21 HG23 ' A' ' 56' ' ' ILE . 3.6 p -151.87 148.04 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 109.769 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.71 123.73 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 153.05 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -100.63 119.32 38.39 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.024 0.93 . . . . 0.0 109.477 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.7 p -79.91 175.89 10.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.411 1.005 . . . . 0.0 111.202 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 69.42 56.94 0.36 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.747 1.619 . . . . 0.0 111.814 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -126.96 12.68 7.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.84 -63.73 0.98 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.283 1.033 . . . . 0.0 109.075 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -79.87 26.63 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -110.12 -45.33 3.61 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 pt -71.62 -41.61 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -170.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.996 -1.478 . . . . 0.0 110.325 -178.583 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.819 0.342 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -109.17 158.98 17.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.591 0.756 . . . . 0.0 112.055 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.96 104.54 5.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.018 2.127 . . . . 0.0 109.123 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.592 HG13 HG13 ' A' ' 85' ' ' VAL . 30.2 t -110.19 111.77 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 122.898 0.479 . . . . 0.0 110.557 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -84.6 128.33 34.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 117.937 0.335 . . . . 0.0 111.456 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.1 mt -106.55 112.13 25.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mt -84.22 86.32 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p -83.32 153.69 65.9 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.097 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -36.92 69.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.654 3.569 . . . . 0.0 113.063 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -46.95 -38.68 11.0 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 127.526 2.33 . . . . 0.0 111.099 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.23 64.22 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.9 166.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 127.215 2.206 . . . . 0.0 112.158 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.72 -59.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.732 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 70.55 142.36 0.05 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.988 1.715 . . . . 0.0 113.086 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -164.34 178.93 7.13 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.811 0.844 . . . . 0.0 111.264 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.86 124.38 48.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.818 1.247 . . . . 0.0 109.086 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.5 t -121.05 128.3 52.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.51 0.324 . . . . 0.0 110.325 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.52 141.06 53.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.782 1.277 . . . . 0.0 108.23 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -18.83 65.63 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 128.895 2.878 . . . . 0.0 110.786 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.59 17.52 22.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.811 1.244 . . . . 0.0 111.292 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -134.35 151.78 32.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.59 1.086 . . . . 0.0 111.501 177.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -65.05 138.74 58.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.905 0.882 . . . . 0.0 110.327 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 5' ' ' VAL . 1.9 t -68.68 4.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -109.46 -52.07 2.81 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -45.8 -62.3 1.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.394 1.478 . . . . 0.0 111.246 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.444 ' HB2' HG11 ' A' ' 22' ' ' VAL . 19.3 tt0 -65.07 -28.17 69.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.913 -0.492 . . . . 0.0 111.198 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -60.45 -52.22 66.14 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 109.542 173.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -56.67 -41.4 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.037 0.935 . . . . 0.0 109.892 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -51.72 -37.72 52.17 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.73 -25.31 41.13 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.848 -0.532 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.15 11.34 9.04 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.805 1.669 . . . . 0.0 111.284 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.621 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 41.2 mt -82.16 126.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 118.208 1.004 . . . . 0.0 110.124 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -90.24 110.98 22.01 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.419 1.088 . . . . 0.0 109.447 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 33' ' ' ILE . 5.8 pt . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 170.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 C--O 1.236 0.39 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.699 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -143.4 156.05 26.36 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.092 1.806 . . . . 0.0 111.263 171.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.98 126.61 34.84 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.5 1.52 . . . . 0.0 110.028 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 17.3 t -73.73 128.34 36.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 120.11 1.323 . . . . 0.0 108.969 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -108.25 -44.21 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.297 0.639 . . . . 0.0 109.953 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 t -158.93 172.54 18.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.599 0.636 . . . . 0.0 109.715 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.97 -161.76 46.85 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.471 1.034 . . . . 0.0 111.407 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 m -156.24 158.55 37.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.65 -0.912 . . . . 0.0 108.757 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.712 HG22 ' HA ' ' A' ' 81' ' ' PRO . 8.9 pt -130.58 179.67 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.498 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.44 118.99 36.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.417 ' NE2' HG23 ' A' ' 74' ' ' VAL . 8.7 pt20 -108.39 34.64 3.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.818 0.847 . . . . 0.0 111.721 169.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 CA--C 1.538 0.504 0 O-C-N 120.631 -1.293 . . . . 0.0 113.173 -166.912 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.309 0.1 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.75 164.45 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 123.641 0.588 . . . . 0.0 110.253 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -52.6 -44.01 65.72 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.94 -61.2 2.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.286 1.034 . . . . 0.0 109.766 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -54.34 -49.53 69.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.227 0.611 . . . . 0.0 111.139 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 12.2 mtt -54.59 -58.55 7.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.635 -0.666 . . . . 0.0 111.66 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.33 -43.16 70.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.403 1.081 . . . . 0.0 110.697 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.82 65.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.842 1.657 . . . . 0.0 111.727 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.58 51.33 0.98 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.453 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.1 m-85 -125.31 146.47 49.55 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.393 1.097 . . . . 0.0 111.915 169.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 119.056 -0.497 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.08 123.01 40.43 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 125.277 1.431 . . . . 0.0 110.938 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.712 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.6 Cg_endo -74.38 120.16 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.716 2.277 . . . . 0.0 111.29 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 p -99.34 -13.0 19.81 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.685 -0.635 . . . . 0.0 112.176 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.1 m -156.28 -173.52 4.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.35 143.85 32.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG13 HG13 ' A' ' 5' ' ' VAL . 2.6 p -153.89 151.9 10.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.281 0.562 . . . . 0.0 111.687 -172.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.5 t -135.56 127.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.699 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -156.07 141.73 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -167.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.532 ' N ' HD13 ' A' ' 87' ' ' ILE . 23.9 mt-10 -94.98 118.16 31.34 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.418 -0.801 . . . . 0.0 110.81 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 p -77.3 176.03 9.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.932 0.493 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.23 55.35 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.116 1.366 . . . . 0.0 111.472 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -123.28 33.29 5.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 122.939 0.496 . . . . 0.0 111.967 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.96 -71.93 0.08 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.35 45.0 0.72 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.498 0.666 . . . . 0.0 110.902 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.32 -46.13 2.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.134 1.374 . . . . 0.0 108.296 164.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.453 HG22 ' CG ' ' A' ' 73' ' ' TYR . 6.9 pt -72.5 -38.81 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.564 1.516 1 CA-C-O 81.463 -18.399 . . . . 0.0 111.435 -174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -99.8 155.4 17.67 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.03 101.74 0.42 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.309 2.244 . . . . 0.0 109.314 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.2 109.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -81.76 134.25 35.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.101 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.42 HD22 ' CG2' ' A' ' 89' ' ' THR . 75.4 mt -112.13 106.86 15.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 167.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.1 mt -76.66 96.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 156.23 41.69 Favored Pre-proline 0 N--CA 1.444 -0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 108.882 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.55 -36.85 81.94 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.49 3.46 . . . . 0.0 112.505 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.89 -34.84 21.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 127.423 2.289 . . . . 0.0 111.084 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.37 64.21 0.3 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 125.225 1.393 . . . . 0.0 109.693 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 67.9 161.59 0.18 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.996 2.118 . . . . 0.0 112.293 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.75 -58.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.786 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 72.21 143.46 0.06 Allowed 'General case' 0 C--O 1.229 0.017 0 C-N-CA 126.032 1.733 . . . . 0.0 112.79 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.502 ' HB3' HD11 ' A' ' 33' ' ' ILE . 1.7 p90 -163.43 169.95 18.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.998 0.519 . . . . 0.0 112.012 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 126.35 36.34 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.4 t -119.86 125.11 47.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.653 0.596 . . . . 0.0 110.531 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -69.11 146.27 52.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 123.003 1.383 . . . . 0.0 110.015 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.0 -1.65 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.257 1.023 . . . . 0.0 111.88 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.06 23.05 10.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.207 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -130.88 149.04 33.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-N 119.465 1.03 . . . . 0.0 110.367 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -64.25 142.83 58.27 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.9 t -49.12 -58.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.07 0.231 . . . . 0.0 110.554 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 26' ' ' ASP . 2.7 pp -58.6 -36.26 73.74 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.635 ' N ' HD12 ' A' ' 25' ' ' LEU . 20.1 t0 -61.49 -62.15 2.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 122.398 1.094 . . . . 0.0 108.337 -169.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.12 -38.15 87.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.589 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.77 -58.21 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.203 -0.935 . . . . 0.0 112.084 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.88 -38.49 78.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 109.573 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.1 -40.81 61.8 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.886 0.766 . . . . 0.0 112.384 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.02 -24.07 55.24 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.886 -0.509 . . . . 0.0 109.948 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.31 15.34 7.73 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.386 1.47 . . . . 0.0 110.669 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 16' ' ' PHE . 61.4 mt -77.88 125.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.557 0.678 . . . . 0.0 109.496 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.43 119.53 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.74 0.816 . . . . 0.0 109.166 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.467 HG23 HG22 ' A' ' 33' ' ' ILE . 8.4 pt . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-O 121.031 0.443 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.09 166.39 25.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.959 1.742 . . . . 0.0 109.977 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.24 114.27 27.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.63 1.572 . . . . 0.0 110.802 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.422 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 47.0 t -64.17 109.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.425 1.09 . . . . 0.0 108.519 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.47 -40.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 -169.74 3.19 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.24 -159.46 14.92 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.333 0.968 . . . . 0.0 112.012 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -155.25 151.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 81' ' ' PRO . 31.2 pt -136.57 154.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.17 107.17 19.64 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.0 27.16 8.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.247 0.619 . . . . 0.0 111.772 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 120.074 1.307 . . . . 0.0 111.764 -177.805 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.639 -0.134 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.54 164.81 14.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.044 0.84 . . . . 0.0 110.243 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.23 -44.4 64.81 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.968 1.307 . . . . 0.0 108.59 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -53.6 -60.97 2.62 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 109.41 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -53.96 -50.09 67.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.279 0.632 . . . . 0.0 111.431 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 64.4 mtt -50.38 -60.51 2.92 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.381 -0.825 . . . . 0.0 111.362 175.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.04 -43.33 73.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.416 1.086 . . . . 0.0 110.759 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.69 64.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.725 1.61 . . . . 0.0 111.875 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.21 35.07 1.25 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.498 -1.168 . . . . 0.0 110.332 173.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -116.58 164.46 14.56 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.212 1.506 . . . . 0.0 111.476 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 56' ' ' ILE . 11.1 p . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 123.796 0.839 . . . . 0.0 108.77 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.85 126.52 28.14 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 124.811 1.244 . . . . 0.0 110.215 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.2 Cg_endo -73.36 121.03 6.85 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.361 2.041 . . . . 0.0 111.648 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -95.68 -16.19 22.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.7 m -156.64 -173.97 4.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.5 142.58 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 165.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 p -152.74 149.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.857 0.837 . . . . 0.0 109.9 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.7 123.7 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.404 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -135.63 153.11 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -102.1 128.84 48.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.742 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.42 ' CG2' HD22 ' A' ' 7' ' ' LEU . 43.4 p -85.44 178.6 7.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.071 0.85 . . . . 0.0 110.04 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.8 m80 63.43 58.22 1.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.838 1.255 . . . . 0.0 110.877 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -126.51 6.15 6.89 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.914 0.885 . . . . 0.0 111.413 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -45.72 -55.53 6.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 127.867 2.467 . . . . 0.0 110.808 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -93.06 33.01 1.21 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 111.956 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.37 -39.59 2.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.615 1.166 . . . . 0.0 108.204 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.2 pt -67.92 -38.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.25 -177.567 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 122.19 0.995 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -107.09 158.84 16.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.553 1.141 . . . . 0.0 111.629 -159.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 102.8 2.08 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.058 2.143 . . . . 0.0 108.025 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 18' ' ' CYS . 21.7 t -108.57 122.24 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -93.02 132.01 37.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.508 0.14 . . . . 0.0 110.691 168.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -108.17 104.64 14.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mt -73.71 95.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -94.85 152.94 40.03 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 124.934 1.293 . . . . 0.0 108.705 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -52.81 -37.33 76.52 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.461 3.441 . . . . 0.0 112.236 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.81 -39.57 8.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 128.819 2.848 . . . . 0.0 111.088 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.16 62.75 0.23 Allowed Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 125.348 1.451 . . . . 0.0 109.555 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.2 157.1 0.17 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 127.597 2.359 . . . . 0.0 114.669 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -159.22 108.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.826 163.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.67 143.53 42.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.073 0.549 . . . . 0.0 110.856 164.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.92 162.71 38.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.401 1.08 . . . . 0.0 110.443 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -84.14 131.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' HG21 ' A' ' 5' ' ' VAL . 22.0 t -127.4 129.35 47.38 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.385 -0.126 . . . . 0.0 111.019 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.76 136.71 47.25 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.669 0.747 . . . . 0.0 110.298 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.29 -32.75 11.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.655 1.582 . . . . 0.0 112.316 165.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.68 -10.99 59.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.84 1.256 . . . . 0.0 112.285 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -130.22 148.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 119.141 0.882 . . . . 0.0 109.172 -167.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -74.92 150.44 39.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.686 -1.258 . . . . 0.0 109.576 -174.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -49.96 -40.55 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.284 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.426 ' C ' HD22 ' A' ' 25' ' ' LEU 0.269 0.0 OUTLIER -66.12 -32.22 73.55 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 179.252 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -65.65 -66.71 0.51 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-O 121.458 0.647 . . . . 0.0 109.537 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 22' ' ' VAL . 36.0 mm-40 -56.83 -36.16 69.64 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.956 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -49.96 -58.93 4.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 122.02 -0.425 . . . . 0.0 111.028 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.08 -36.68 75.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.642 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.82 -39.58 62.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.7 0.682 . . . . 0.0 111.961 171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.46 -29.17 33.84 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.2 14.35 7.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.977 1.751 . . . . 0.0 111.601 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.726 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 72.7 mt -76.36 112.28 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 117.754 0.777 . . . . 0.0 109.588 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -84.7 98.09 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.032 1.333 . . . . 0.0 109.159 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 O-C-N 121.592 -0.692 . . . . 0.0 109.848 174.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 N--CA 1.447 -0.607 0 CA-C-O 121.542 0.687 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -134.14 164.59 24.49 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 125.969 1.747 . . . . 0.0 109.208 162.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -98.24 109.25 22.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.796 1.638 . . . . 0.0 109.636 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.619 HG23 ' HB ' ' A' ' 74' ' ' VAL . 61.7 t -62.32 111.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.6 -42.08 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 122.852 0.461 . . . . 0.0 109.857 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.6 t -155.73 -166.75 2.3 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.48 -158.24 18.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.795 0.712 . . . . 0.0 111.929 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -145.58 154.91 42.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 168.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.654 HG23 HG21 ' A' ' 85' ' ' VAL . 28.3 pt -135.99 165.5 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -106.6 116.36 31.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -111.36 54.12 0.69 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.3 p . . . . . 0 CA--C 1.534 0.333 0 O-C-N 121.509 -0.744 . . . . 0.0 109.494 169.75 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.05 165.34 15.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.992 0.808 . . . . 0.0 109.641 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.17 -39.49 69.6 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.924 0.89 . . . . 0.0 108.757 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.87 -62.38 1.69 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.654 0.782 . . . . 0.0 109.519 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -51.93 -51.41 57.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.215 0.606 . . . . 0.0 111.573 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.0 mtm -51.56 -60.39 3.2 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.711 -0.618 . . . . 0.0 111.487 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.1 -43.39 78.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.704 1.202 . . . . 0.0 110.708 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.13 66.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.733 1.613 . . . . 0.0 111.37 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.71 27.61 1.03 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 116.921 -2.044 . . . . 0.0 112.569 169.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CG ' HG22 ' A' ' 95' ' ' ILE . 90.9 m-85 -120.44 167.02 12.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 121.245 2.523 . . . . 0.0 114.953 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.619 ' HB ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -171.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 118.799 -0.62 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -108.95 124.4 34.29 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 126.123 1.769 . . . . 0.0 109.603 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.471 ' HA ' HG22 ' A' ' 56' ' ' ILE . 10.8 Cg_endo -74.3 111.39 3.3 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.726 2.284 . . . . 0.0 111.673 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 p -82.07 -18.93 41.38 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.354 -0.841 . . . . 0.0 110.93 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -155.8 -177.12 6.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.225 1.41 . . . . 0.0 107.736 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.48 140.55 45.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 163.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.654 HG21 HG23 ' A' ' 56' ' ' ILE . 2.7 p -160.61 140.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 121.648 0.737 . . . . 0.0 111.938 -166.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.12 127.28 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.87 153.09 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 124.233 1.013 . . . . 0.0 108.921 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -103.17 125.94 50.1 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.42 1.088 . . . . 0.0 109.232 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.1 p -83.56 177.14 8.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.536 1.516 . . . . 0.0 109.237 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 69.38 57.0 0.36 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 112.106 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -128.05 32.74 4.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -60.47 -68.66 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -81.75 52.64 1.96 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.669 0.747 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.52 -40.43 0.34 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 130.293 3.437 . . . . 0.0 109.363 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.566 HG22 ' CG ' ' A' ' 73' ' ' TYR . 35.1 pt -75.58 -43.28 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 119.007 -0.521 . . . . 0.0 112.278 175.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.076 -1.44 . . . . 0.0 109.569 176.164 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.773 0.796 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.8 158.48 15.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.518 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -81.21 84.65 6.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.982 1.713 . . . . 0.0 109.116 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 85' ' ' VAL . 60.8 t -84.19 127.59 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 8.8 ttmt -97.9 131.83 44.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 169.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.416 HD12 HG21 ' A' ' 33' ' ' ILE . 47.7 mt -109.41 110.93 22.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.732 1.27 . . . . 0.0 108.023 169.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -80.53 86.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.6 p -86.55 154.92 56.69 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.418 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 51.3 Cg_exo -55.07 -35.73 91.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.738 3.625 . . . . 0.0 112.411 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.39 -38.22 18.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.018 2.527 . . . . 0.0 111.212 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.34 61.86 0.21 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 125.593 1.568 . . . . 0.0 110.423 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.425 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 26.8 mt-10 68.2 160.41 0.17 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.12 2.168 . . . . 0.0 111.997 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -129.18 -64.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.386 0.674 . . . . 0.0 111.53 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 75.54 127.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.068 1.747 . . . . 0.0 112.353 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -163.53 168.99 19.39 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.56 35.35 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.869 0.868 . . . . 0.0 112.12 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.0 t -125.98 129.42 49.19 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.743 0.817 . . . . 0.0 111.585 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.24 149.06 31.97 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.756 0.822 . . . . 0.0 110.284 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -65.34 -19.27 65.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.94 -0.475 . . . . 0.0 111.997 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.05 -3.28 58.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.615 1.166 . . . . 0.0 111.8 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 p -134.24 153.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.52 1.055 . . . . 0.0 110.667 -170.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -76.89 156.23 32.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.126 0.489 . . . . 0.0 112.001 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.78 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.954 0.902 . . . . 0.0 111.596 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.46 -51.14 0.1 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.59 -60.48 2.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.956 0.903 . . . . 0.0 110.929 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -72.22 -5.12 33.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -89.35 -49.07 6.93 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.396 -0.815 . . . . 0.0 109.618 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -53.63 -38.84 64.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.672 0.789 . . . . 0.0 110.541 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.258 0.4 OUTLIER -58.25 -35.52 71.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 176.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.89 -25.77 40.49 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.61 11.7 6.45 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 125.811 1.672 . . . . 0.0 111.24 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.668 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 54.9 mt -75.44 121.35 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 118.279 1.039 . . . . 0.0 110.566 -178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -96.39 113.53 25.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 166.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.8 mt . . . . . 0 N--CA 1.439 -1.022 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 163.724 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.25 27.66 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 124.834 1.207 . . . . 0.0 111.054 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -101.62 111.04 23.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.175 1.79 . . . . 0.0 110.308 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.462 HG23 ' HB ' ' A' ' 74' ' ' VAL . 78.2 t -58.8 116.91 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.016 0.927 . . . . 0.0 109.306 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -93.05 -47.02 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 85' ' ' VAL . 23.3 t -158.31 170.71 21.62 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.26 -161.37 54.17 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -168.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -155.88 168.68 26.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 81' ' ' PRO . 29.1 pt -147.08 162.26 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 127.581 2.352 . . . . 0.0 107.999 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -105.22 113.48 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.61 28.21 8.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.27 1.028 . . . . 0.0 111.772 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.1 p . . . . . 0 CA--C 1.539 0.521 0 O-C-N 121.323 -0.86 . . . . 0.0 113.17 -172.859 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.43 164.91 22.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.05 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.95 -44.44 67.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.6 -61.71 2.11 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.886 0.875 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -53.05 -52.09 59.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.346 0.658 . . . . 0.0 111.433 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.8 mtt -53.87 -58.17 8.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.566 -0.709 . . . . 0.0 111.665 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.79 -43.63 69.43 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.62 1.168 . . . . 0.0 110.557 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.97 65.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.17 28.75 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.913 -1.493 . . . . 0.0 111.072 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.503 ' CG ' HG22 ' A' ' 95' ' ' ILE . 86.2 m-85 -110.79 163.57 13.64 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 120.067 1.934 . . . . 0.0 113.939 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 56' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.581 0 C-N-CA 125.683 1.593 . . . . 0.0 108.885 -168.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.609 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.15 123.68 36.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.822 1.649 . . . . 0.0 109.409 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.792 ' HA ' HG22 ' A' ' 56' ' ' ILE . 15.7 Cg_endo -72.84 114.83 4.14 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.193 2.596 . . . . 0.0 111.063 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 p -88.34 -17.02 31.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.944 0.498 . . . . 0.0 110.834 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 m -157.08 -178.74 7.59 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.543 1.537 . . . . 0.0 108.116 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -53.58 121.4 7.68 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 161.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 5' ' ' VAL . 7.2 p -135.25 144.51 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.995 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.59 125.28 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.17 154.02 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 123.999 0.92 . . . . 0.0 108.669 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.57 121.87 41.82 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.199 1.0 . . . . 0.0 108.643 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -178.23 3.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.917 1.235 . . . . 0.0 110.999 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.582 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 5.1 m-70 65.88 48.45 1.83 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.968 1.307 . . . . 0.0 112.931 169.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -119.31 15.39 13.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -40.65 -68.44 0.18 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.116 0.967 . . . . 0.0 109.68 170.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.81 17.51 0.71 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.991 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.14 -17.48 12.37 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 117.888 -1.054 . . . . 0.0 110.904 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.503 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.8 pt -89.82 -45.48 15.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 119.98 1.264 . . . . 0.0 111.673 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.157 -176.905 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -98.39 158.75 15.39 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.56 0.744 . . . . 0.0 112.704 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -81.93 83.77 7.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.992 1.717 . . . . 0.0 109.181 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 85' ' ' VAL . 94.7 t -81.66 121.68 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -89.55 132.34 35.13 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.675 167.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.436 HD12 HD13 ' A' ' 33' ' ' ILE . 71.8 mt -111.26 106.95 16.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.429 1.492 . . . . 0.0 107.238 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 23.1 mt -76.39 94.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 169.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -89.88 156.29 47.11 Favored Pre-proline 0 N--CA 1.444 -0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 108.689 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -52.12 -38.69 71.17 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.524 3.483 . . . . 0.0 112.422 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.69 -39.49 11.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 128.222 2.609 . . . . 0.0 111.237 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.05 66.19 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 125.585 1.564 . . . . 0.0 109.803 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.7 164.16 0.23 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.221 2.208 . . . . 0.0 112.565 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.71 -60.64 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.311 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 74.27 131.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.41 1.484 . . . . 0.0 111.598 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -162.44 167.86 22.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.54 124.44 39.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.4 t -131.78 123.99 28.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.187 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.79 138.7 56.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.41 1.484 . . . . 0.0 109.637 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 1.8 p-10 -56.17 -27.29 53.85 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.691 1.597 . . . . 0.0 111.916 169.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -87.0 1.18 53.67 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 111.865 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.41 156.53 41.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.639 1.109 . . . . 0.0 110.677 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -78.42 149.07 33.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 121.83 -0.543 . . . . 0.0 111.241 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.23 63.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 122.073 0.94 . . . . 0.0 110.423 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.512 ' C ' HD13 ' A' ' 25' ' ' LEU . 1.9 tm? -166.32 -51.87 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.44 -63.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.397 0.617 . . . . 0.0 110.98 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -58.02 -32.58 68.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.357 0.599 . . . . 0.0 110.243 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.734 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -58.06 -58.26 9.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.49 -41.51 63.44 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.87 -24.53 48.46 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.77 -0.581 . . . . 0.0 110.073 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.61 12.1 6.86 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.924 1.726 . . . . 0.0 111.736 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.734 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 86.7 mt -76.24 111.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 117.826 0.813 . . . . 0.0 111.017 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -89.17 73.1 8.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.579 0 O-C-N 121.112 -0.992 . . . . 0.0 108.739 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 122.454 1.121 . . . . 0.0 113.206 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.51 27.34 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.737 1.637 . . . . 0.0 109.848 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -92.77 111.04 22.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.834 1.254 . . . . 0.0 109.965 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.93 110.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.46 -42.43 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 t -157.24 -167.88 2.45 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.65 -153.64 14.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.01 0.814 . . . . 0.0 111.644 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.6 m -157.28 154.99 29.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.617 HG22 ' HA ' ' A' ' 81' ' ' PRO . 26.9 pt -141.75 166.31 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.43 1.892 . . . . 0.0 106.381 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -109.44 119.71 40.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -108.36 46.31 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.678 0.791 . . . . 0.0 111.295 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.303 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.85 167.23 11.76 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.865 0.728 . . . . 0.0 109.67 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.88 -41.91 75.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.966 0.907 . . . . 0.0 109.029 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -60.16 3.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.853 0.861 . . . . 0.0 109.545 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -55.1 -50.32 69.49 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.647 0.779 . . . . 0.0 110.999 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 20.2 mtm -51.29 -59.83 3.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.829 -0.544 . . . . 0.0 112.182 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.04 -43.19 73.53 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.239 1.016 . . . . 0.0 110.511 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.03 -22.89 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.585 1.554 . . . . 0.0 111.797 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.42 35.55 0.8 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-O 118.33 -1.261 . . . . 0.0 111.019 170.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.443 ' CG ' HG22 ' A' ' 95' ' ' ILE . 91.0 m-85 -116.46 161.77 18.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.789 1.794 . . . . 0.0 112.777 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 124.423 1.089 . . . . 0.0 108.74 -177.146 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.253 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -106.15 120.72 47.9 Favored Pre-proline 0 C--O 1.234 0.267 0 C-N-CA 126.105 1.762 . . . . 0.0 109.275 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.617 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.0 Cg_endo -75.4 116.08 4.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.675 2.25 . . . . 0.0 112.031 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -90.41 -15.42 30.99 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.027 -0.421 . . . . 0.0 111.385 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.8 m -158.48 -177.31 6.45 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.088 1.355 . . . . 0.0 108.524 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -64.36 84.46 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.116 1.766 . . . . 0.0 109.941 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 5' ' ' VAL . 2.1 p -85.82 155.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.822 1.249 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.71 125.09 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -139.62 153.21 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.509 1.124 . . . . 0.0 108.642 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 29.3 mt-10 -101.39 129.09 47.34 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.787 170.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 p -88.51 176.89 6.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.083 1.311 . . . . 0.0 109.463 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 66.11 55.21 0.92 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 0.0 111.487 176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -122.0 13.86 10.61 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -46.06 -62.76 1.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.794 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.99 28.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.306 0.642 . . . . 0.0 112.302 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -125.77 -12.35 6.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.819 1.248 . . . . 0.0 111.836 168.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.443 HG22 ' CG ' ' A' ' 73' ' ' TYR . 46.7 pt -91.21 -40.37 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 119.876 1.216 . . . . 0.0 111.924 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.964 -1.494 . . . . 0.0 110.173 178.096 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.4 155.21 37.83 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.75 0.82 . . . . 0.0 111.298 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -76.97 99.65 5.34 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.044 2.537 . . . . 0.0 108.038 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.89 118.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -85.94 129.95 34.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.126 0.266 . . . . 0.0 110.372 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 33' ' ' ILE . 77.4 mt -108.92 102.88 11.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 39.0 mt -71.37 94.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 171.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -93.52 155.21 40.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.66 -32.61 76.25 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.745 2.963 . . . . 0.0 112.244 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.4 -33.91 45.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.679 2.392 . . . . 0.0 111.392 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.52 0.34 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 125.212 1.387 . . . . 0.0 110.489 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 71.47 145.27 0.07 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.868 2.467 . . . . 0.0 114.262 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.456 HG21 HG23 ' A' ' 33' ' ' ILE . 35.3 m -143.23 97.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -69.14 135.91 51.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.847 161.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' A' ' 33' ' ' ILE . 4.8 p90 -151.19 170.33 19.71 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.595 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 119.51 39.17 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 9.2 t -122.01 126.22 48.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.959 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.59 145.73 45.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.725 1.726 . . . . 0.0 110.936 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -56.74 -24.64 51.14 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 127.198 2.199 . . . . 0.0 112.119 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -103.78 10.06 36.75 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.456 1.502 . . . . 0.0 111.332 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.432 HG11 ' CG ' ' A' ' 27' ' ' GLN . 1.7 p -134.53 158.36 41.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.52 1.054 . . . . 0.0 110.943 -175.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -77.91 138.08 38.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 t -49.0 -48.93 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.612 0.244 . . . . 0.0 110.916 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -37.81 74.02 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.03 -64.07 0.93 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.718 0.77 . . . . 0.0 108.939 -167.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.432 ' CG ' HG11 ' A' ' 22' ' ' VAL . 20.4 mm100 -57.17 -40.92 78.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.301 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 33' ' ' ILE . . . -50.1 -59.54 3.81 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.753 -0.592 . . . . 0.0 111.454 175.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.69 -39.71 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.112 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -53.03 -40.95 64.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -75.22 -24.85 57.8 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 121.849 -0.532 . . . . 0.0 109.749 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.88 12.88 6.86 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.615 1.578 . . . . 0.0 111.057 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 28' ' ' ALA . 89.1 mt -75.77 116.38 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.672 0.736 . . . . 0.0 110.785 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -80.38 63.93 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.382 0.61 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.22 166.0 26.16 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 125.478 1.513 . . . . 0.0 110.574 168.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -101.35 107.68 19.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.284 1.834 . . . . 0.0 110.087 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -59.56 109.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.19 -46.67 25.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -162.76 177.71 9.1 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . 95.39 -161.96 23.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.518 ' H ' HG22 ' A' ' 85' ' ' VAL . 6.6 m -156.71 144.83 19.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 168.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.946 HD11 HG21 ' A' ' 74' ' ' VAL . 49.1 pt -143.93 164.08 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.817 1.647 . . . . 0.0 106.741 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -108.96 109.9 21.07 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -104.75 25.08 10.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 0.0 111.928 170.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 CA--C 1.539 0.522 0 O-C-N 120.371 -1.456 . . . . 0.0 113.301 -177.868 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -83.94 169.06 15.43 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 124.424 1.078 . . . . 0.0 109.881 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.17 -44.86 71.85 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.64 -62.37 1.69 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.133 0.973 . . . . 0.0 109.482 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.39 -49.3 67.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.017 0.527 . . . . 0.0 111.359 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.18 -60.63 3.07 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.544 -0.722 . . . . 0.0 111.483 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.88 -42.19 68.39 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.248 1.019 . . . . 0.0 110.701 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.25 65.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.872 1.669 . . . . 0.0 112.32 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.83 30.64 1.93 Allowed Glycine 0 C--O 1.221 -0.715 0 CA-C-O 117.554 -1.692 . . . . 0.0 111.527 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CG ' HG22 ' A' ' 95' ' ' ILE . 96.4 m-85 -118.12 161.44 19.85 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.52 2.16 . . . . 0.0 113.514 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.946 HG21 HD11 ' A' ' 56' ' ' ILE . 7.1 p . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 118.779 -0.629 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -112.19 123.01 35.25 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.222 1.809 . . . . 0.0 109.096 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.618 ' HA ' HG22 ' A' ' 56' ' ' ILE . 16.8 Cg_endo -75.38 129.69 12.23 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.788 2.325 . . . . 0.0 111.595 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.3 p -104.05 -12.49 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.5 m -157.16 -174.93 5.14 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.13 127.77 33.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.607 HG21 HG23 ' A' ' 56' ' ' ILE . 25.1 t -135.91 153.76 32.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.674 0.79 . . . . 0.0 109.569 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.63 121.15 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.452 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.27 152.83 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 21.6 mt-10 -101.13 131.2 47.18 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 124.347 1.059 . . . . 0.0 109.284 168.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -88.74 177.46 6.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.153 1.342 . . . . 0.0 109.434 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.1 54.46 0.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.915 1.286 . . . . 0.0 111.437 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -125.32 22.37 7.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.74 0.816 . . . . 0.0 112.895 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -45.75 -72.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 108.91 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.09 37.57 0.44 Allowed 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.935 -0.478 . . . . 0.0 111.812 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -122.06 -29.54 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.452 1.501 . . . . 0.0 110.647 163.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.526 HG22 ' CG ' ' A' ' 73' ' ' TYR . 26.1 pt -83.68 -45.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 119.347 0.976 . . . . 0.0 112.608 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.981 -1.485 . . . . 0.0 109.803 -175.662 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -131.63 155.61 47.26 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.97 0.908 . . . . 0.0 112.54 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.29 96.93 0.06 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.277 2.631 . . . . 0.0 109.651 169.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.38 118.59 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -85.82 130.24 34.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.471 0.176 . . . . 0.0 111.238 167.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.41 ' CD1' HD11 ' A' ' 35' ' ' ILE . 64.2 mt -110.06 105.25 14.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 124.483 1.114 . . . . 0.0 108.603 169.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.5 mt -78.3 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -87.11 153.53 54.27 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.99 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.09 -35.05 89.56 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.951 3.101 . . . . 0.0 112.397 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.27 -38.8 13.13 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 127.485 2.314 . . . . 0.0 111.14 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.69 62.12 0.19 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 125.283 1.421 . . . . 0.0 110.197 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 67.43 162.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.111 2.164 . . . . 0.0 111.921 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.49 -59.85 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 123.438 0.695 . . . . 0.0 110.15 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.26 137.45 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 126.354 1.862 . . . . 0.0 112.464 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.64 174.65 11.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.725 0.41 . . . . 0.0 111.722 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 122.77 42.45 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.6 126.58 50.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.21 133.64 49.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.35 -30.87 30.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.315 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.1 -14.1 62.51 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.949 1.3 . . . . 0.0 112.136 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.52 160.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.34 147.05 42.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.032 -0.417 . . . . 0.0 111.86 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.2 62.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 122.174 0.987 . . . . 0.0 110.335 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.21 -60.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -49.59 -58.25 5.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.757 1.265 . . . . 0.0 109.823 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -74.93 -20.13 59.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.925 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -65.72 -52.05 54.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.25 -40.86 68.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.213 0.605 . . . . 0.0 109.976 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.56 -39.61 64.9 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.42 -24.74 46.03 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.704 -0.622 . . . . 0.0 109.763 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.11 10.1 6.97 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.87 1.7 . . . . 0.0 111.37 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.609 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 71.4 mt -78.02 129.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.119 0.96 . . . . 0.0 111.012 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -87.2 125.41 34.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' A' ' 7' ' ' LEU . 17.8 mt . . . . . 0 N--CA 1.441 -0.878 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 164.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 122.803 1.287 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.01 158.31 27.6 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.001 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -95.43 109.81 21.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.074 1.35 . . . . 0.0 109.584 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 40.7 t -61.14 107.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.436 1.094 . . . . 0.0 108.225 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.29 -37.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -157.7 -163.21 1.3 Allowed 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . 73.53 -171.28 51.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.033 0.349 . . . . 0.0 113.168 172.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.425 ' H ' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -150.92 129.94 12.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.66 HG23 HG21 ' A' ' 85' ' ' VAL . 16.7 pt -139.1 152.28 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -100.72 112.97 25.47 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -105.68 41.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.249 0.62 . . . . 0.0 110.765 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.533 0.292 0 CA-C-N 119.413 1.006 . . . . 0.0 111.495 176.225 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.231 0.111 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.19 165.58 14.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.618 0.723 . . . . 0.0 110.233 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.16 -41.35 71.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.818 1.247 . . . . 0.0 108.683 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.54 -60.63 2.93 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.129 0.972 . . . . 0.0 109.465 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -54.41 -48.26 71.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.462 0.705 . . . . 0.0 111.39 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.0 mtt -53.98 -60.18 3.67 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.521 -0.737 . . . . 0.0 111.106 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.67 -44.72 69.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.747 1.219 . . . . 0.0 110.558 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.18 64.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.741 1.617 . . . . 0.0 112.254 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.88 32.59 1.4 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.415 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.54 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.0 m-85 -120.24 159.38 25.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.343 2.072 . . . . 0.0 113.184 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.423 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 5.1 p . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.552 1.141 . . . . 0.0 108.73 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . . . . . . 0 CA--C 1.523 -0.079 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.66 118.44 45.08 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.006 1.723 . . . . 0.0 109.281 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.536 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.8 Cg_endo -75.85 108.79 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.339 2.693 . . . . 0.0 112.707 -174.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -88.43 -12.98 41.59 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.865 -0.522 . . . . 0.0 111.366 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.8 m -152.62 -177.27 6.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.167 1.387 . . . . 0.0 108.103 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.16 124.21 20.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 166.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.66 HG21 HG23 ' A' ' 56' ' ' ILE . 53.5 t -133.62 156.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.558 0.694 . . . . 0.0 111.282 -173.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.7 t -123.3 118.77 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.39 152.24 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.165 0.986 . . . . 0.0 108.939 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.53 127.55 46.86 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.077 0.951 . . . . 0.0 108.833 170.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -83.33 179.49 7.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.042 1.292 . . . . 0.0 110.139 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.3 m80 69.73 55.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.153 1.381 . . . . 0.0 111.122 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.54 13.59 9.43 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -34.88 -76.29 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.855 2.062 . . . . 0.0 110.767 166.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.77 40.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.002 0.819 . . . . 0.0 112.426 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.37 -28.78 4.94 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.311 1.044 . . . . 0.0 111.047 158.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.54 HG22 ' CG ' ' A' ' 73' ' ' TYR . 34.8 pt -81.42 -48.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.296 0.953 . . . . 0.0 112.896 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.044 -173.306 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.409 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 C--O 1.225 -0.206 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.7 m 58.78 78.25 0.26 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.536 0.735 . . . . 0.0 112.203 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -97.36 159.59 14.83 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -171.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -82.95 90.15 6.96 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.305 1.842 . . . . 0.0 109.614 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 85' ' ' VAL . 65.0 t -89.47 124.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -89.76 132.21 35.32 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.147 0.43 . . . . 0.0 110.836 165.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.543 HD23 HG23 ' A' ' 87' ' ' ILE . 70.4 mt -111.68 103.57 11.88 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 165.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.5 mt -71.62 95.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.8 p -92.79 156.75 40.53 Favored Pre-proline 0 N--CA 1.442 -0.847 0 C-N-CA 124.145 0.978 . . . . 0.0 108.925 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -53.56 -35.3 76.38 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 124.2 3.267 . . . . 0.0 112.227 175.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.3 -30.97 52.8 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 127.376 2.27 . . . . 0.0 111.494 176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.53 61.01 0.41 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 125.005 1.288 . . . . 0.0 110.73 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 71.95 142.72 0.06 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 127.768 2.427 . . . . 0.0 114.187 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.93 87.29 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.495 1.118 . . . . 0.0 108.148 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -66.71 132.18 47.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 109.746 167.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -153.38 166.68 31.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.133 0.573 . . . . 0.0 111.839 -175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.23 122.99 39.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.9 0.381 . . . . 0.0 110.432 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.9 t -127.08 123.03 35.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.505 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 143.03 54.9 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.799 1.24 . . . . 0.0 110.099 177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -56.35 -24.99 47.73 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 127.333 2.253 . . . . 0.0 111.182 173.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -107.88 21.29 17.63 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.589 1.555 . . . . 0.0 111.462 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -134.55 158.31 41.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.757 1.162 . . . . 0.0 110.633 173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -78.68 144.89 34.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.343 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.02 61.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.871 0.868 . . . . 0.0 111.098 173.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.0 tp -169.11 -61.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.06 -55.95 12.74 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.057 0.943 . . . . 0.0 109.253 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -77.05 -13.76 59.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.876 0.87 . . . . 0.0 112.831 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -75.57 -50.46 15.51 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 120.945 -1.097 . . . . 0.0 108.603 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -53.38 -38.98 63.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.199 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.61 -38.8 56.26 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -82.59 -23.89 34.19 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.764 -0.585 . . . . 0.0 109.608 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.24 15.23 4.25 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.072 1.796 . . . . 0.0 111.473 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.657 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 82.2 mt -80.59 108.41 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.038 0.919 . . . . 0.0 112.445 -170.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -79.98 72.91 6.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.175 0.99 . . . . 0.0 110.398 175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.53 156.25 91.03 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 120.921 -1.112 . . . . 0.0 109.651 175.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.43 71.06 6.03 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 124.034 3.156 . . . . 0.0 109.436 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.84 150.9 19.98 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.736 2.014 . . . . 0.0 108.926 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.7 m -128.37 -22.51 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.624 0.77 . . . . 0.0 112.765 171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.33 170.36 10.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 126.237 1.815 . . . . 0.0 107.688 -171.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -135.12 83.86 2.05 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.623 0.647 . . . . 0.0 109.404 164.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.51 -47.5 0.89 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.647 1.579 . . . . 0.0 111.561 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.99 46.32 2.08 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.157 0.884 . . . . 0.0 111.934 172.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.2 t -154.14 69.21 0.77 Allowed 'General case' 0 C--O 1.231 0.116 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 32.8 m -131.27 -176.61 4.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.617 1.167 . . . . 0.0 109.986 -162.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.5 m -144.73 50.24 1.28 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -158.27 -152.56 0.34 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.438 1.495 . . . . 0.0 107.258 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.4 p 45.1 71.23 0.28 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.391 1.476 . . . . 0.0 114.504 165.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.24 166.09 25.68 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 120.49 -1.381 . . . . 0.0 112.387 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.56 164.46 27.01 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 125.942 1.734 . . . . 0.0 110.165 174.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -98.66 110.25 22.88 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.671 1.588 . . . . 0.0 110.502 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.8 t -58.49 115.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.4 t -88.63 -48.03 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.221 0.609 . . . . 0.0 109.505 174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -160.87 173.99 14.51 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.067 -0.396 . . . . 0.0 110.223 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.49 -176.59 47.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.443 1.021 . . . . 0.0 110.742 -168.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 m -135.15 149.44 49.98 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.699 HD11 HG21 ' A' ' 74' ' ' VAL . 36.4 pt -147.47 165.29 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.124 1.77 . . . . 0.0 107.54 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -119.12 113.54 21.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.81 0.844 . . . . 0.0 108.748 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.414 ' CD ' HG23 ' A' ' 74' ' ' VAL . 10.7 pt20 -110.86 31.77 5.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 117.875 -1.059 . . . . 0.0 111.023 170.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 p -74.49 64.8 1.2 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.101 1.773 . . . . 0.0 111.191 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -154.48 -42.37 0.09 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.714 1.205 . . . . 0.0 110.849 -165.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.55 178.58 1.98 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 122.193 0.997 . . . . 0.0 112.829 176.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 t -144.99 82.77 1.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 164.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -156.45 -73.16 0.1 Allowed 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.263 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -56.42 138.45 51.23 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.195 0.907 . . . . 0.0 111.456 -167.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -83.14 166.43 18.67 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 124.043 0.839 . . . . 0.0 109.85 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -53.56 -43.99 68.94 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -52.0 -61.52 2.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.126 0.97 . . . . 0.0 109.608 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -54.95 -50.08 69.76 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.269 0.627 . . . . 0.0 111.376 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.3 mtt -51.95 -59.36 4.43 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.489 -0.757 . . . . 0.0 111.314 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.03 -42.28 76.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.45 1.1 . . . . 0.0 110.832 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.42 -20.72 65.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.683 1.593 . . . . 0.0 111.753 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.57 33.8 1.06 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-O 117.786 -1.564 . . . . 0.0 111.413 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.97 162.67 18.14 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 120.348 2.074 . . . . 0.0 113.297 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.699 HG21 HD11 ' A' ' 56' ' ' ILE . 13.0 p -152.52 147.64 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.061 1.344 . . . . 0.0 108.469 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.454 HD23 ' H ' ' A' ' 78' ' ' HIS . 0.7 OUTLIER -64.48 154.57 35.47 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 167.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.3 t -116.03 19.25 15.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.4 m -111.38 -48.36 3.1 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.122 1.369 . . . . 0.0 109.931 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.454 ' H ' HD23 ' A' ' 75' ' ' LEU . 27.4 m80 -117.69 89.88 3.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.014 1.725 . . . . 0.0 108.515 -176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -152.05 131.87 13.27 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -108.88 122.96 38.42 Favored Pre-proline 0 C--O 1.235 0.318 0 C-N-CA 125.537 1.535 . . . . 0.0 108.945 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.3 Cg_endo -76.33 113.95 3.79 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.221 2.614 . . . . 0.0 111.284 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 p -89.52 -12.55 39.67 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 121.375 -0.828 . . . . 0.0 111.749 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.1 m -157.79 -177.88 6.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.634 1.574 . . . . 0.0 107.687 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.5 113.17 1.07 Allowed 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 162.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 5' ' ' VAL . 2.5 p -120.57 145.77 26.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.447 1.499 . . . . 0.0 108.595 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -114.71 125.63 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 170.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.543 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -138.03 155.46 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -102.87 128.42 49.66 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.28 169.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.444 ' CG2' HD22 ' A' ' 7' ' ' LEU . 43.0 p -86.4 178.73 7.03 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 120.045 1.293 . . . . 0.0 109.093 177.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.28 51.37 0.51 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.596 1.158 . . . . 0.0 111.178 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -127.62 37.62 4.18 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.468 0.707 . . . . 0.0 111.584 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -70.08 0.25 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 165.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -72.92 33.16 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.737 -1.227 . . . . 0.0 113.803 176.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -121.97 -3.9 9.1 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.707 -1.245 . . . . 0.0 111.751 159.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.7 pt -111.75 -39.38 3.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.344 1.429 . . . . 0.0 111.694 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 C--O 1.253 1.275 0 CA-C-O 117.48 -1.248 . . . . 0.0 109.436 175.712 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.497 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.5 m 78.8 89.57 0.06 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.7 0.8 . . . . 0.0 112.088 157.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -104.81 156.02 18.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.278 0.561 . . . . 0.0 112.307 -167.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.34 104.39 2.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 127.835 2.454 . . . . 0.0 108.462 172.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.0 t -108.91 117.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -88.8 131.61 35.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 117.716 0.235 . . . . 0.0 111.283 167.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.553 HD12 HD13 ' A' ' 33' ' ' ILE . 79.5 mt -109.19 103.69 12.72 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 124.419 1.075 . . . . 0.0 109.105 167.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 53.9 mt -76.44 99.87 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 171.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.1 p -89.77 166.69 19.69 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 124.313 1.045 . . . . 0.0 109.48 172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -69.18 -25.85 30.87 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.086 2.524 . . . . 0.0 111.182 166.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.96 -46.11 78.7 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.169 0.988 . . . . 0.0 109.662 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.83 64.94 0.08 OUTLIER Glycine 0 CA--C 1.522 0.505 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 67.55 147.35 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.522 1.929 . . . . 0.0 113.643 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 p -154.43 105.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.398 165.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.99 142.35 41.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.411 166.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -152.41 169.24 23.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.182 177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 123.5 44.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.5 t -116.4 124.72 50.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.734 0.646 . . . . 0.0 109.832 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -65.03 151.55 45.7 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 123.524 1.63 . . . . 0.0 109.008 171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -76.99 -14.56 59.83 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 129.333 3.053 . . . . 0.0 110.566 -177.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -114.4 20.04 15.75 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.533 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.58 148.91 29.39 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 119.087 0.858 . . . . 0.0 109.227 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -67.76 146.07 54.1 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.069 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.2 t -51.09 -51.53 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 173.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -57.32 12.06 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.486 -0.769 . . . . 0.0 112.305 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.94 -63.08 1.06 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.21 0.914 . . . . 0.0 110.611 -174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -69.69 -34.67 74.26 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.41 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 33' ' ' ILE . . . -51.18 -57.4 8.87 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.676 -0.64 . . . . 0.0 110.911 170.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -55.39 -41.7 73.03 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.01 -38.59 65.28 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -75.22 -25.89 58.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.275 0.56 . . . . 0.0 109.794 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.63 13.65 6.09 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 125.385 1.469 . . . . 0.0 110.946 175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.553 HD13 HD12 ' A' ' 7' ' ' LEU . 93.7 mt -75.63 121.6 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-N 117.624 0.712 . . . . 0.0 110.496 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.04 80.74 8.74 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 173.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.99 155.33 86.59 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 170.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -64.81 133.69 37.36 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 173.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -169.19 156.8 7.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -168.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -168.75 -51.93 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.615 0.766 . . . . 0.0 110.05 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 p -94.11 -150.17 0.29 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.241 2.216 . . . . 0.0 110.557 -172.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 168.52 176.29 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.506 2.322 . . . . 0.0 108.683 172.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 103.55 -42.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 128.472 2.709 . . . . 0.0 110.398 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.68 -21.88 7.89 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.131 169.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.66 59.13 0.74 Allowed 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 125.774 1.629 . . . . 0.0 107.776 168.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.8 p -119.57 -137.83 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.327 1.051 . . . . 0.0 109.505 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -72.01 -93.55 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.234 1.379 . . . . 0.0 111.603 -172.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 -57.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.377 0.535 . . . . 0.0 111.662 174.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . 0.47 0.0 OUTLIER 26.23 43.91 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 129.63 3.172 . . . . 0.0 117.481 172.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 95' ' ' ILE . . . -82.45 177.89 8.51 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 120.47 -1.394 . . . . 0.0 113.069 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.692 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -139.04 165.78 25.58 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 126.151 1.834 . . . . 0.0 110.335 172.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -102.95 111.1 23.27 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.006 1.722 . . . . 0.0 110.977 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.7 t -61.27 117.38 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.938 0.79 . . . . 0.0 109.341 173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.2 t -91.7 -47.68 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.294 1.038 . . . . 0.0 109.013 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.451 ' O ' HG23 ' A' ' 85' ' ' VAL . 8.2 t -161.12 175.35 12.49 Favored 'General case' 0 N--CA 1.458 -0.064 0 O-C-N 122.075 -0.391 . . . . 0.0 110.417 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.22 -160.83 52.72 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.559 1.076 . . . . 0.0 110.762 -169.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 t -151.48 169.86 21.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.681 ' CD1' HG21 ' A' ' 74' ' ' VAL . 8.6 pt -161.46 160.01 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 127.234 2.214 . . . . 0.0 107.593 -167.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -114.82 110.55 19.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.417 ' CD ' HG23 ' A' ' 74' ' ' VAL . 9.8 pt20 -106.58 37.16 2.39 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.631 0.772 . . . . 0.0 111.264 170.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -44.21 -40.32 5.02 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.951 0.796 . . . . 0.0 111.113 171.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.05 -2.83 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.693 1.997 . . . . 0.0 113.427 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -69.19 162.78 26.36 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.433 1.015 . . . . 0.0 111.11 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -153.0 53.3 0.76 Allowed 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 160.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.69 -65.97 0.18 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 117.72 -1.133 . . . . 0.0 111.897 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.11 141.31 54.46 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.993 1.27 . . . . 0.0 111.349 -166.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -86.23 166.38 15.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 124.065 0.853 . . . . 0.0 109.893 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.95 -43.88 70.24 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -51.25 -61.97 1.91 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.234 1.014 . . . . 0.0 109.563 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -54.38 -50.95 66.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 122.979 0.511 . . . . 0.0 111.466 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.6 mtm -53.98 -58.06 8.69 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 121.455 -0.778 . . . . 0.0 111.51 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -53.85 -44.33 70.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.714 1.206 . . . . 0.0 110.56 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.51 -22.64 67.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.811 1.645 . . . . 0.0 111.945 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.93 32.86 0.96 Allowed Glycine 0 C--O 1.223 -0.569 0 CA-C-O 117.601 -1.666 . . . . 0.0 111.774 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.544 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.8 m-85 -121.02 163.66 17.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.557 2.179 . . . . 0.0 113.635 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.681 HG21 ' CD1' ' A' ' 56' ' ' ILE . 13.2 p -157.25 143.1 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 123.759 0.824 . . . . 0.0 108.906 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.4 tp -50.58 -46.09 57.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.001 0.92 . . . . 0.0 111.652 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m 74.39 -56.28 0.64 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.339 1.055 . . . . 0.0 111.183 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 29.0 p -60.71 -23.99 65.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.164 0.986 . . . . 0.0 112.437 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 82.56 1.96 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.417 1.487 . . . . 0.0 107.381 172.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.95 142.81 20.0 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.877 0.871 . . . . 0.0 110.436 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -106.66 131.46 21.68 Favored Pre-proline 0 C--O 1.234 0.271 0 C-N-CA 126.558 1.943 . . . . 0.0 109.357 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.551 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.3 Cg_endo -78.27 121.37 5.24 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.799 2.333 . . . . 0.0 111.725 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -97.29 -12.88 22.37 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.713 -0.617 . . . . 0.0 112.333 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -157.11 -175.23 5.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 125.563 1.545 . . . . 0.0 106.835 170.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -55.2 140.11 39.87 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 164.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 56' ' ' ILE . 3.3 p -156.33 146.23 11.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.754 0.788 . . . . 0.0 110.311 -168.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.84 126.8 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.692 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -143.14 147.93 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.878 0.871 . . . . 0.0 109.103 -177.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' N ' HD13 ' A' ' 87' ' ' ILE . 30.5 mt-10 -104.22 116.74 32.72 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.283 1.033 . . . . 0.0 110.813 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.1 p -79.11 176.25 9.84 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.244 0.929 . . . . 0.0 109.742 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.9 m80 67.62 52.38 0.77 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.602 1.161 . . . . 0.0 111.082 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -123.6 43.98 2.82 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.683 0.793 . . . . 0.0 110.841 -176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.3 -71.6 0.2 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -79.82 50.64 1.2 Allowed 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.696 -0.627 . . . . 0.0 111.846 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -132.73 -28.05 1.64 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.594 2.358 . . . . 0.0 111.618 165.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.544 HG22 ' CG ' ' A' ' 73' ' ' TYR . 26.0 pt -91.85 -42.19 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 119.184 0.902 . . . . 0.0 112.552 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.254 1.292 0 CA-C-O 117.351 -1.309 . . . . 0.0 109.254 -177.396 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m 80.8 123.38 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.771 2.029 . . . . 0.0 111.321 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -128.81 156.1 44.13 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.195 0.598 . . . . 0.0 111.222 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -71.09 102.11 2.4 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.842 2.457 . . . . 0.0 108.469 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.64 120.81 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -90.53 131.94 35.98 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 123.165 0.291 . . . . 0.0 111.004 166.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 61.0 mt -109.21 103.26 12.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.388 1.075 . . . . 0.0 108.285 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 36.3 mt -74.2 90.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 172.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -88.45 154.38 51.15 Favored Pre-proline 0 N--CA 1.444 -0.741 0 C-N-CA 124.102 0.961 . . . . 0.0 109.09 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -57.3 -31.95 92.36 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.87 3.046 . . . . 0.0 112.12 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.84 -33.76 37.49 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.916 2.086 . . . . 0.0 111.087 173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.46 61.53 0.27 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 124.898 1.237 . . . . 0.0 110.145 174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 68.57 153.79 0.1 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.152 2.181 . . . . 0.0 114.043 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.4 p -157.04 98.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-N 114.298 -1.319 . . . . 0.0 108.825 169.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.36 145.48 45.89 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.341 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -157.24 172.79 18.0 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.47 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.09 122.61 44.46 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.9 t -122.94 127.86 49.47 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -69.32 141.88 54.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.738 1.256 . . . . 0.0 109.951 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -58.69 -21.75 55.43 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 129.886 3.274 . . . . 0.0 111.52 173.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -107.6 12.85 27.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.809 1.644 . . . . 0.0 110.606 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.44 157.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 CA-C-N 119.261 0.937 . . . . 0.0 110.61 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -76.12 149.07 37.45 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.219 0.608 . . . . 0.0 110.806 -177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.3 t -72.54 66.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 121.84 0.829 . . . . 0.0 111.226 173.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 26' ' ' ASP . 1.4 pt? -163.34 -43.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.583 1.553 . . . . 0.0 108.723 168.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' H ' HD23 ' A' ' 25' ' ' LEU . 4.9 t70 -57.92 -57.76 11.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 -170.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -63.08 -35.06 78.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.645 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -56.43 -56.73 17.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.637 -0.665 . . . . 0.0 109.713 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.86 -39.75 74.87 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.046 0.938 . . . . 0.0 109.767 177.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -52.15 -42.15 63.15 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.869 0.759 . . . . 0.0 112.765 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.07 -23.26 55.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.048 0.451 . . . . 0.0 109.974 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.26 12.88 7.27 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.91 1.719 . . . . 0.0 111.369 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.53 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 64.2 mt -80.42 129.66 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.542 0.671 . . . . 0.0 111.1 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -93.32 127.6 38.99 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.132 0.973 . . . . 0.0 108.436 164.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.7 pt -140.73 153.26 67.66 Favored Pre-proline 0 N--CA 1.45 -0.463 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 165.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -66.31 91.25 0.27 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.204 2.603 . . . . 0.0 110.663 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -86.36 -48.88 8.08 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 123.553 0.741 . . . . 0.0 111.346 171.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t 56.56 -161.85 0.19 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.295 0.638 . . . . 0.0 112.332 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m 34.55 -136.03 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 129.031 2.932 . . . . 0.0 113.278 167.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 179.08 137.89 0.1 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.801 2.44 . . . . 0.0 107.966 156.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 70.9 83.32 0.15 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.682 1.193 . . . . 0.0 114.167 169.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -7.95 81.39 0.0 OUTLIER Glycine 0 CA--C 1.53 1.007 0 C-N-CA 128.649 3.023 . . . . 0.0 116.119 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 t -171.14 42.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.158 1.783 . . . . 0.0 107.36 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.2 p -161.87 168.52 22.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.275 1.43 . . . . 0.0 107.884 -159.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.9 m -140.9 90.88 2.36 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.175 0.59 . . . . 0.0 111.399 -167.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.2 t -169.71 -157.03 0.15 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.272 2.229 . . . . 0.0 105.688 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . 0.292 0.7 OUTLIER 32.53 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 117.509 2.411 . . . . 0.0 117.509 162.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.31 172.63 16.15 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 120.652 -1.28 . . . . 0.0 110.999 -173.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -142.54 166.09 26.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 126.004 1.764 . . . . 0.0 110.99 175.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -102.73 110.2 22.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.761 2.024 . . . . 0.0 110.873 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.04 114.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 119.14 0.882 . . . . 0.0 109.062 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.9 t -87.98 -44.89 15.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.3 t -161.54 177.64 9.85 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.99 -168.77 43.93 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -169.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -142.71 151.2 41.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.707 HG23 HG21 ' A' ' 85' ' ' VAL . 28.7 pt -142.35 157.2 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 173.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -99.74 107.63 19.75 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.3 39.88 1.64 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.676 0.79 . . . . 0.0 111.442 170.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.2 m -48.71 -38.87 22.67 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.492 1.042 . . . . 0.0 111.589 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -76.67 50.91 0.72 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.586 1.154 . . . . 0.0 110.321 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.741 ' HA ' HD22 ' A' ' 75' ' ' LEU . 6.5 pt20 -99.79 -65.64 0.95 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.17 1.388 . . . . 0.0 111.546 175.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 m 43.89 44.82 6.09 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.622 0.769 . . . . 0.0 111.515 -168.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -154.88 -72.42 0.12 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.159 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.49 143.85 52.6 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.126 0.876 . . . . 0.0 110.642 -168.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -87.9 164.83 15.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 123.729 0.643 . . . . 0.0 110.104 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.59 -43.19 68.39 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.163 0.985 . . . . 0.0 108.543 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -52.3 -61.63 2.15 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.089 0.956 . . . . 0.0 109.421 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -52.52 -52.28 55.45 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.17 0.588 . . . . 0.0 111.332 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 13.7 mtt -52.33 -59.88 3.88 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.765 -0.584 . . . . 0.0 111.317 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -54.76 -44.0 73.26 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 124.954 1.302 . . . . 0.0 110.677 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.18 -20.84 64.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.744 1.618 . . . . 0.0 111.769 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.69 32.94 1.49 Allowed Glycine 0 N--CA 1.446 -0.667 0 CA-C-O 117.972 -1.46 . . . . 0.0 111.149 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.478 ' CG ' HG22 ' A' ' 95' ' ' ILE . 93.6 m-85 -118.35 165.88 13.32 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.963 1.882 . . . . 0.0 113.049 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.634 HG21 HD11 ' A' ' 56' ' ' ILE . 7.6 p -161.69 149.92 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -175.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 61' ' ' GLN . 29.2 tp -57.57 -52.47 65.28 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.969 0.908 . . . . 0.0 110.26 176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m 73.37 -55.14 0.68 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.565 1.146 . . . . 0.0 110.129 -170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 m -31.38 -63.49 0.17 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 127.574 2.349 . . . . 0.0 111.777 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -121.35 60.43 0.94 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.122 1.769 . . . . 0.0 108.25 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 24' ' ' VAL . . . -111.22 138.49 47.61 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 121.725 -0.609 . . . . 0.0 109.89 172.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -101.4 125.44 37.67 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.215 1.406 . . . . 0.0 109.416 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.8 Cg_endo -74.25 114.99 4.17 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.858 2.372 . . . . 0.0 110.811 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.4 p -94.71 -9.8 33.67 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.144 0.884 . . . . 0.0 112.129 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -156.9 -177.7 6.81 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.479 1.512 . . . . 0.0 107.491 169.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -55.58 139.25 44.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 163.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.707 HG21 HG23 ' A' ' 56' ' ' ILE . 3.5 p -157.56 146.43 10.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.483 -165.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.7 t -122.87 124.89 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.423 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -139.11 152.21 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 123.885 0.874 . . . . 0.0 108.86 178.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 91' ' ' LYS . 17.0 mt-10 -103.99 117.23 33.81 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.138 0.975 . . . . 0.0 109.854 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.1 p -80.32 174.63 11.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.381 -0.824 . . . . 0.0 111.301 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 69.96 55.63 0.33 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.654 1.582 . . . . 0.0 111.281 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 88' ' ' GLU . 20.6 mmtt -126.33 25.81 6.53 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.429 0.692 . . . . 0.0 112.668 -174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.13 -70.56 0.09 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.19 0.996 . . . . 0.0 108.725 172.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -79.77 39.12 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.557 -0.714 . . . . 0.0 112.373 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -114.92 -43.5 3.11 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.632 1.173 . . . . 0.0 109.275 161.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.478 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.3 pt -75.89 -41.48 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--O 1.251 1.179 0 CA-C-O 117.314 -1.327 . . . . 0.0 109.559 -177.741 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m 76.11 85.04 0.09 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.216 0.607 . . . . 0.0 112.384 164.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -102.81 156.96 17.29 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.129 0.572 . . . . 0.0 112.394 -167.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -83.07 89.59 6.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.145 1.778 . . . . 0.0 109.8 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG13 HG13 ' A' ' 85' ' ' VAL . 85.2 t -87.31 127.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -96.69 131.32 43.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.139 0.427 . . . . 0.0 111.772 166.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.466 HD12 HG21 ' A' ' 33' ' ' ILE . 37.6 mt -108.8 105.14 14.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 124.34 1.025 . . . . 0.0 108.396 166.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 34.1 mt -75.19 94.0 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.4 p -93.16 155.24 41.31 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.083 0.953 . . . . 0.0 108.778 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -56.5 -32.42 89.48 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.938 3.092 . . . . 0.0 112.147 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.91 48.95 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 126.541 1.936 . . . . 0.0 111.215 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.49 60.08 0.35 Allowed Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 124.861 1.219 . . . . 0.0 110.935 171.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 67.89 141.68 0.04 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.263 2.225 . . . . 0.0 114.127 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG21 HG23 ' A' ' 33' ' ' ILE . 34.2 m -139.64 98.42 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 125.059 1.343 . . . . 0.0 107.864 169.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -82.18 133.31 35.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.696 1.599 . . . . 0.0 109.687 171.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -156.73 172.46 18.56 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.16 124.4 46.81 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 122.809 0.443 . . . . 0.0 110.224 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 48.6 t -125.43 128.21 47.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.98 140.06 50.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 123.832 1.777 . . . . 0.0 110.38 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -24.16 28.71 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 129.203 3.001 . . . . 0.0 111.335 173.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.36 7.24 38.18 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.574 1.549 . . . . 0.0 112.036 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.0 157.32 43.24 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 CA-C-N 119.796 1.18 . . . . 0.0 110.302 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -74.53 147.35 41.89 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 122.013 -0.429 . . . . 0.0 110.804 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -53.96 -57.03 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.659 0.383 . . . . 0.0 110.137 174.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -52.54 -51.03 61.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.331 0.652 . . . . 0.0 111.089 -178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.28 -65.59 0.54 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.611 0.764 . . . . 0.0 110.64 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -56.57 -42.46 78.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.616 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -53.58 -59.92 3.97 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.965 -0.46 . . . . 0.0 111.176 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -58.87 -36.4 74.57 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.897 -0.573 . . . . 0.0 110.212 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -54.42 -38.31 66.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.959 0.799 . . . . 0.0 112.695 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.11 -26.53 53.39 Favored 'General case' 0 N--CA 1.462 0.169 0 O-C-N 121.807 -0.558 . . . . 0.0 109.991 177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 12.64 8.36 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.747 1.641 . . . . 0.0 111.133 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.512 HG23 HG21 ' A' ' 14' ' ' VAL . 91.5 mt -74.34 125.53 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 117.602 0.701 . . . . 0.0 111.02 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -90.47 119.7 30.96 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.44 1.096 . . . . 0.0 109.041 167.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 HD13 HD13 ' A' ' 7' ' ' LEU . 14.2 pt -137.67 156.07 74.83 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 168.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.89 125.54 13.85 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 121.872 1.715 . . . . 0.0 109.921 -173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -148.94 64.28 1.05 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 123.233 1.492 . . . . 0.0 108.934 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -58.96 -23.75 61.94 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.657 -1.277 . . . . 0.0 112.664 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -120.94 168.03 11.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.658 1.983 . . . . 0.0 108.688 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.63 67.35 0.7 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.99 -63.19 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.839 1.655 . . . . 0.0 108.798 -178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 137.1 55.48 0.05 OUTLIER Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.728 0.68 . . . . 0.0 111.505 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.8 m -167.61 85.98 0.23 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.877 0.871 . . . . 0.0 109.227 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 7.3 p -148.04 -168.65 3.13 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.19 0.996 . . . . 0.0 108.637 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.9 p -151.93 62.95 0.85 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -163.33 -177.39 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 128.67 2.788 . . . . 0.0 104.719 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 74.89 176.86 0.22 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.676 1.591 . . . . 0.0 112.122 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 140.21 167.4 0.0 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 128.809 2.843 . . . . 0.0 112.985 168.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.689 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -142.98 161.59 27.54 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.65 1.595 . . . . 0.0 111.096 167.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -96.48 111.17 23.38 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 126.506 1.923 . . . . 0.0 110.728 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 19.8 t -61.06 111.01 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 125.211 1.405 . . . . 0.0 108.675 175.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -83.81 -47.67 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.015 0.926 . . . . 0.0 108.979 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -161.36 172.67 16.15 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.54 -162.38 50.24 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.374 0.988 . . . . 0.0 110.667 -170.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -155.88 155.58 33.15 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 121.679 -0.895 . . . . 0.0 109.193 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.659 HG22 ' HA ' ' A' ' 81' ' ' PRO . 29.7 pt -135.3 165.95 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.99 1.716 . . . . 0.0 107.416 174.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -105.83 111.32 23.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.56 31.45 5.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.77 -0.633 . . . . 0.0 111.752 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.8 m -76.21 57.99 1.2 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.016 1.28 . . . . 0.0 112.175 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -141.29 -40.25 0.39 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.789 1.636 . . . . 0.0 111.318 -173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.406 ' CB ' HD13 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -74.48 -177.51 3.14 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.106 -0.996 . . . . 0.0 112.625 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.6 p -146.6 75.4 1.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 169.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -154.28 -76.57 0.11 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.85 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.1 mp -56.6 137.3 53.99 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.303 0.956 . . . . 0.0 111.022 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.66 164.35 17.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 124.092 0.87 . . . . 0.0 109.983 -176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.17 -44.11 64.48 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.613 1.165 . . . . 0.0 108.482 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -51.32 -62.43 1.63 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.538 1.135 . . . . 0.0 109.671 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -53.97 -50.18 67.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.283 0.633 . . . . 0.0 111.294 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 29.8 mtt -52.78 -59.98 3.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.933 -0.479 . . . . 0.0 111.343 177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.63 -43.29 72.15 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.855 1.262 . . . . 0.0 110.618 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.63 -21.26 65.53 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.629 1.572 . . . . 0.0 111.948 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 33.66 1.32 Allowed Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 118.028 -1.429 . . . . 0.0 110.832 173.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.517 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.1 m-85 -118.75 166.43 12.79 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.965 1.882 . . . . 0.0 112.806 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.51 HG21 HD11 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -162.57 158.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.173 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -175.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.591 HD12 ' S1 ' ' A' ' 97' ' ' FES . 2.1 pt? -70.24 -52.95 19.25 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.86 1.209 . . . . 0.0 111.962 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.461 ' O ' HG22 ' A' ' 76' ' ' THR . 21.4 m 60.6 56.61 3.0 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.563 1.173 . . . . 0.0 110.484 -170.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.406 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 67.4 m -134.56 -93.37 0.3 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 102.798 -3.038 . . . . 0.0 102.798 172.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.5 49.85 1.77 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.632 1.573 . . . . 0.0 110.456 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.625 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -116.36 146.62 42.33 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 121.619 -0.676 . . . . 0.0 109.714 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -109.28 122.77 38.63 Favored Pre-proline 0 C--N 1.332 -0.192 0 C-N-CA 124.522 1.129 . . . . 0.0 109.553 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.659 ' HA ' HG22 ' A' ' 56' ' ' ILE . 10.8 Cg_endo -71.24 119.6 6.4 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.543 2.162 . . . . 0.0 111.102 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.9 p -93.7 -13.97 26.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.006 -0.434 . . . . 0.0 111.864 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.0 m -158.66 -177.69 6.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.803 1.641 . . . . 0.0 107.217 172.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -60.77 95.25 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.581 1.552 . . . . 0.0 109.337 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.546 HG11 ' CG2' ' A' ' 56' ' ' ILE . 4.2 p -99.24 148.75 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.673 1.189 . . . . 0.0 110.236 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -119.38 125.97 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.689 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -144.77 144.39 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.756 0.822 . . . . 0.0 109.32 -176.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -100.93 113.39 26.32 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.99 0.814 . . . . 0.0 110.538 176.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.2 p -79.46 175.69 10.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.979 0.809 . . . . 0.0 110.988 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 71.29 53.78 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.318 1.447 . . . . 0.0 111.326 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -124.73 24.67 7.68 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.528 0.731 . . . . 0.0 112.837 -173.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -50.46 -70.17 0.09 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.197 0.999 . . . . 0.0 109.252 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -78.07 42.37 0.4 Allowed 'General case' 0 CA--C 1.551 0.993 0 O-C-N 121.854 -0.529 . . . . 0.0 112.037 175.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -130.33 -27.46 2.2 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.343 1.457 . . . . 0.0 111.29 163.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.517 HG22 ' CG ' ' A' ' 73' ' ' TYR . 25.0 pt -82.52 -42.89 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 119.468 1.031 . . . . 0.0 113.197 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.567 -1.206 . . . . 0.0 109.933 -176.057 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.591 ' S1 ' HD12 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 m 52.97 75.16 0.25 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.301 1.04 . . . . 0.0 113.686 167.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -96.02 157.74 15.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.305 0.642 . . . . 0.0 112.455 -169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -81.63 88.65 6.22 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.702 1.601 . . . . 0.0 109.737 -177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 85' ' ' VAL . 59.3 t -86.85 123.55 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -95.03 131.82 40.58 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 117.714 0.234 . . . . 0.0 111.499 170.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.1 mt -111.99 105.0 13.3 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.073 1.349 . . . . 0.0 108.493 169.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.2 mt -75.55 87.19 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -83.52 154.77 65.88 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 124.423 1.089 . . . . 0.0 108.881 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.1 -27.33 78.91 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 123.716 2.944 . . . . 0.0 112.31 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.64 -31.55 57.56 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 125.666 1.586 . . . . 0.0 110.899 171.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.51 61.89 0.3 Allowed Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 125.144 1.354 . . . . 0.0 110.571 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 65.82 163.15 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.692 1.997 . . . . 0.0 112.687 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.604 HG23 ' H ' ' A' ' 15' ' ' GLU . 14.1 m -132.21 -67.61 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.088 0.955 . . . . 0.0 111.16 170.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.2 tt0 75.9 128.58 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.125 0 C-N-CA 126.438 1.895 . . . . 0.0 111.594 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.427 ' HB3' HD11 ' A' ' 33' ' ' ILE . 5.6 p90 -162.43 172.5 15.45 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.246 -0.284 . . . . 0.0 111.389 -170.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.43 127.47 45.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 26.7 t -124.75 124.99 43.32 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.277 0.631 . . . . 0.0 111.332 176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -64.33 147.9 51.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 122.271 1.034 . . . . 0.0 110.588 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -65.35 -14.71 61.44 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.212 1.005 . . . . 0.0 112.295 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -107.37 4.05 25.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.851 1.66 . . . . 0.0 111.652 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -130.59 156.36 42.48 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 CA-C-N 119.27 0.941 . . . . 0.0 108.859 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -75.85 153.74 36.59 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 118.579 -1.248 . . . . 0.0 110.46 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.1 t -52.68 -53.87 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.361 172.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -58.67 -43.02 89.76 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.033 -176.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.577 ' N ' HD13 ' A' ' 25' ' ' LEU . 78.4 m-20 -51.04 -66.54 0.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.57 1.176 . . . . 0.0 107.943 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -70.26 -34.11 72.42 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.941 -167.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -59.3 4.65 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.98 -0.45 . . . . 0.0 111.961 171.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.7 -38.62 75.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -54.84 -39.34 68.49 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -74.75 -26.03 59.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.126 0.489 . . . . 0.0 109.688 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.57 13.32 7.47 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 125.427 1.489 . . . . 0.0 110.936 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.632 HG22 HG23 ' A' ' 35' ' ' ILE . 76.4 mt -76.61 128.81 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 117.757 0.779 . . . . 0.0 110.173 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -90.83 119.48 31.07 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.996 1.318 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.632 HG23 HG22 ' A' ' 33' ' ' ILE . 8.5 pt -138.4 159.82 66.26 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 124.577 1.151 . . . . 0.0 107.946 173.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -70.56 107.17 1.95 Allowed 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 122.1 1.867 . . . . 0.0 109.104 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -133.66 95.05 3.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.1 t -80.85 -163.3 0.57 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 162.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . 0.253 10.2 p 32.22 -142.38 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.706 2.002 . . . . 0.0 113.517 -172.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 177.27 42.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.059 2.543 . . . . 0.0 108.749 157.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.12 93.46 0.17 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -168.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -35.98 94.02 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 126.353 1.93 . . . . 0.0 113.008 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.7 t -173.28 -40.83 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.995 0.918 . . . . 0.0 110.11 -170.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 176.19 2.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 175.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.7 m -131.91 69.48 1.48 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.729 0.812 . . . . 0.0 110.462 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.5 p -153.81 -178.63 7.18 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 166.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 0.7 OUTLIER 71.46 146.81 0.07 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 127.621 2.368 . . . . 0.0 112.354 -170.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 47' ' ' CYS . . . 174.4 166.54 0.23 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.446 1.098 . . . . 0.0 111.426 170.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.91 170.98 24.68 Favored Glycine 0 N--CA 1.439 -1.144 0 C-N-CA 126.041 1.781 . . . . 0.0 110.539 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -102.13 111.21 23.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.194 1.798 . . . . 0.0 110.347 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.51 111.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.959 0.903 . . . . 0.0 108.888 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -83.69 -47.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -161.94 175.79 11.47 Favored 'General case' 0 C--N 1.339 0.129 0 O-C-N 122.076 -0.39 . . . . 0.0 110.707 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.97 -160.19 53.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 m -155.16 156.2 35.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.944 HD11 HG21 ' A' ' 74' ' ' VAL . 38.0 pt -140.21 166.21 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 107.85 175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -104.29 109.16 20.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 175.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -113.43 58.7 0.66 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.997 0.919 . . . . 0.0 108.684 164.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -94.5 49.99 1.32 Allowed 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.605 -0.684 . . . . 0.0 110.283 173.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.88 -55.27 1.3 Allowed 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 123.833 0.853 . . . . 0.0 109.924 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -65.29 163.58 15.14 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 t -126.27 28.69 5.96 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 159.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -77.45 -73.31 0.31 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.326 174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.58 143.25 54.26 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.027 -173.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -93.23 167.46 11.74 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.614 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.15 -43.22 74.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.024 1.33 . . . . 0.0 108.633 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.9 -61.28 2.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 123.99 0.916 . . . . 0.0 109.423 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -55.45 -51.29 67.41 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.614 0.766 . . . . 0.0 111.011 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 63.1 mtt -50.54 -61.25 2.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.903 -0.498 . . . . 0.0 111.421 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -54.76 -44.24 73.47 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.709 1.204 . . . . 0.0 110.649 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.28 -22.84 65.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.872 1.669 . . . . 0.0 112.033 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.31 29.02 1.53 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-O 117.778 -1.568 . . . . 0.0 111.998 174.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.6 m-85 -117.5 165.04 14.01 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 120.156 1.978 . . . . 0.0 112.85 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 56' ' ' ILE . 8.4 p -158.82 146.61 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 124.09 0.956 . . . . 0.0 109.435 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HG ' ' H ' ' A' ' 77' ' ' CYS . 0.0 OUTLIER -82.88 145.2 29.57 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.347 0.522 . . . . 0.0 109.777 173.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.4 p -114.43 35.14 4.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.74 1.216 . . . . 0.0 111.304 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.485 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 1.3 m -97.79 -99.07 0.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 164.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -92.05 90.91 7.58 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.455 1.502 . . . . 0.0 109.139 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -142.3 137.88 30.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -110.09 125.72 30.47 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 125.145 1.378 . . . . 0.0 110.041 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.639 ' HA ' HG22 ' A' ' 56' ' ' ILE . 12.7 Cg_endo -73.13 117.77 5.25 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.627 2.218 . . . . 0.0 111.323 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -89.56 -19.03 25.48 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 119.078 -0.487 . . . . 0.0 111.744 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.4 m -154.37 -176.21 5.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.474 1.91 . . . . 0.0 107.403 174.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -57.09 113.25 1.63 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.623 1.169 . . . . 0.0 108.276 163.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG13 HG13 ' A' ' 5' ' ' VAL . 1.7 p -120.33 143.36 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 125.611 1.564 . . . . 0.0 109.134 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.99 126.93 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.82 155.31 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 124.641 1.176 . . . . 0.0 108.087 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -106.01 114.64 28.9 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.431 1.093 . . . . 0.0 109.268 171.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 p -75.18 176.94 6.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 119.211 0.914 . . . . 0.0 110.839 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 m80 68.95 53.4 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.96 1.304 . . . . 0.0 110.682 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -126.64 28.24 5.94 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.587 0.755 . . . . 0.0 111.727 -177.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.87 -64.46 0.87 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -74.73 14.14 0.53 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 -18.37 14.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.789 1.236 . . . . 0.0 109.782 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.469 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -100.34 -40.49 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.419 0.554 . . . . 0.0 111.308 -174.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.912 -1.518 . . . . 0.0 110.072 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 m 76.99 117.46 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.428 1.491 . . . . 0.0 111.837 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -134.84 160.05 39.44 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.412 0.685 . . . . 0.0 111.169 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -87.88 87.21 7.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.842 1.657 . . . . 0.0 109.645 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 85' ' ' VAL . 57.7 t -83.93 123.04 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 25.4 ttmt -93.37 134.38 35.66 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 168.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.464 HD23 HG23 ' A' ' 87' ' ' ILE . 39.8 mt -113.61 105.89 13.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.884 1.274 . . . . 0.0 107.757 169.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.1 mt -75.19 93.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 170.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -90.18 155.41 46.93 Favored Pre-proline 0 N--CA 1.443 -0.787 0 C-N-CA 125.215 1.406 . . . . 0.0 108.347 174.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.27 -30.22 92.35 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.687 2.925 . . . . 0.0 112.476 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.98 -32.02 61.26 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.439 1.896 . . . . 0.0 111.063 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.98 61.66 0.29 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 124.969 1.271 . . . . 0.0 110.782 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 24.1 mt-10 66.42 162.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.015 2.126 . . . . 0.0 112.368 176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.536 HG23 ' H ' ' A' ' 15' ' ' GLU . 16.7 m -135.84 -63.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.184 0.593 . . . . 0.0 111.143 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.536 ' H ' HG23 ' A' ' 14' ' ' VAL . 6.7 tt0 76.28 132.56 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.177 1.791 . . . . 0.0 112.04 177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 33' ' ' ILE . 2.6 p90 -162.27 173.83 13.67 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.29 126.81 41.76 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 16.0 t -129.26 130.87 46.77 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -76.09 139.29 41.3 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 123.571 1.653 . . . . 0.0 108.905 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -51.13 -27.65 9.02 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 130.019 3.328 . . . . 0.0 111.793 172.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -102.01 8.72 40.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.495 1.518 . . . . 0.0 111.569 -177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.74 158.05 43.17 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-N 119.488 1.04 . . . . 0.0 110.509 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -76.11 147.75 38.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.805 0.336 . . . . 0.0 110.72 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.7 t -55.93 -54.36 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tt -78.9 46.4 0.68 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.569 1.148 . . . . 0.0 111.899 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -137.9 -68.73 0.46 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.352 1.461 . . . . 0.0 107.661 172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.99 -10.27 47.82 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.845 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -77.64 -54.15 6.72 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.625 -1.297 . . . . 0.0 112.291 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.62 -39.15 67.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.158 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.333 0.3 OUTLIER -58.17 -30.18 66.2 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 177.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -78.87 -28.27 44.14 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.0 12.8 4.71 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.026 1.298 . . . . 0.0 111.293 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 16' ' ' PHE . 72.0 mt -73.77 123.46 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.177 0.988 . . . . 0.0 110.139 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -89.34 115.24 26.66 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 168.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.496 HG12 HG22 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -131.87 159.83 70.29 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 124.114 0.965 . . . . 0.0 109.216 172.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.38 101.31 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.59 2.193 . . . . 0.0 109.933 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -50.37 20.13 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.375 -0.821 . . . . 0.0 110.799 -174.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . 0.316 1.3 m 41.55 -10.81 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 131.68 3.992 . . . . 0.0 121.002 173.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.7 p -169.15 -151.33 0.09 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.963 2.905 . . . . 0.0 105.031 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -166.7 72.46 0.13 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 146.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 167.99 108.15 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.669 1.987 . . . . 0.0 108.421 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -27.21 83.78 0.0 OUTLIER Glycine 0 CA--C 1.533 1.163 0 C-N-CA 127.697 2.57 . . . . 0.0 115.383 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.1 t -164.24 -56.1 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 117.785 0.792 . . . . 0.0 109.644 -172.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -46.3 -40.95 12.52 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.7 1.2 . . . . 0.0 111.711 -177.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 20.4 m 71.11 63.86 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.044 1.738 . . . . 0.0 111.22 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.1 p -143.33 -137.53 0.1 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.529 173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.2 p 44.92 -75.47 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 129.08 2.952 . . . . 0.0 115.04 -172.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 48.39 176.38 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.754 2.822 . . . . 0.0 114.468 -171.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -167.84 161.14 34.91 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -98.91 110.68 23.25 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.229 1.412 . . . . 0.0 110.302 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.69 109.58 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.935 0.894 . . . . 0.0 108.729 173.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.44 -49.26 17.37 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.043 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.9 t -160.35 173.07 16.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.67 -167.95 32.6 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -165.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -140.94 159.22 42.68 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.044 HD11 HG21 ' A' ' 74' ' ' VAL . 45.1 pt -146.07 166.82 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.239 1.416 . . . . 0.0 107.653 173.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -110.43 110.02 20.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.99 24.56 11.16 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.962 0.905 . . . . 0.0 112.135 171.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.7 t -74.94 42.15 0.17 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.838 1.199 . . . . 0.0 112.634 -176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -130.38 6.64 4.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.26 1.824 . . . . 0.0 110.155 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -176.48 2.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.426 1.09 . . . . 0.0 112.597 -171.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -156.16 77.5 0.94 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 169.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.51 ' CE2' HD11 ' A' ' 95' ' ' ILE . 2.0 t80 -152.08 -80.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 117.878 -1.058 . . . . 0.0 110.005 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 mp -54.17 138.52 38.06 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.99 0.814 . . . . 0.0 111.06 -168.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -83.87 165.06 19.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 124.183 0.927 . . . . 0.0 109.65 177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -42.79 72.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.061 0.944 . . . . 0.0 108.687 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -51.76 -61.13 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.11 0.964 . . . . 0.0 109.497 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -53.76 -51.43 63.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.342 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 25.1 mtt -51.19 -60.05 3.53 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.325 0.511 . . . . 0.0 111.402 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -54.92 -43.17 73.05 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.783 1.233 . . . . 0.0 110.652 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -20.25 64.16 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.672 1.589 . . . . 0.0 112.058 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.5 28.88 2.03 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-O 118.037 -1.424 . . . . 0.0 111.129 172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.49 ' CG ' HG22 ' A' ' 95' ' ' ILE . 92.8 m-85 -112.44 168.52 9.57 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.736 1.768 . . . . 0.0 112.931 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.044 HG21 HD11 ' A' ' 56' ' ' ILE . 10.5 p -161.22 159.85 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 125.307 1.443 . . . . 0.0 109.334 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tp -87.08 113.71 23.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.009 1.324 . . . . 0.0 110.721 177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.7 m -85.01 46.24 1.25 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.128 -0.983 . . . . 0.0 111.607 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.99 -99.5 0.44 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 165.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -83.68 68.79 10.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.791 1.237 . . . . 0.0 109.63 -173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.659 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -116.41 134.35 54.98 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.327 1.051 . . . . 0.0 109.343 175.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -105.53 125.3 33.75 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.807 1.243 . . . . 0.0 109.492 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.634 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.6 Cg_endo -76.05 115.63 4.19 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.742 2.294 . . . . 0.0 111.874 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 p -93.52 -9.57 37.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.279 0.945 . . . . 0.0 112.102 -177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.9 m -161.96 -177.06 5.55 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.204 1.802 . . . . 0.0 107.177 171.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.04 92.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.532 1.533 . . . . 0.0 109.696 168.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 56' ' ' ILE . 5.7 p -96.42 146.76 6.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.963 1.305 . . . . 0.0 110.26 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.8 t -113.85 125.4 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 167.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.464 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -134.52 153.69 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 124.287 1.035 . . . . 0.0 108.222 176.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -103.74 125.73 50.41 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.073 0.949 . . . . 0.0 109.403 170.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 p -91.65 175.8 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.157 0.889 . . . . 0.0 110.7 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.13 60.39 0.65 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.292 1.037 . . . . 0.0 109.288 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -126.01 16.03 7.93 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.879 0.872 . . . . 0.0 112.499 -175.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -41.31 -70.69 0.1 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.361 1.465 . . . . 0.0 109.777 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -80.99 32.85 0.32 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -132.22 -29.37 1.62 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.93 2.092 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.51 HD11 ' CE2' ' A' ' 63' ' ' PHE . 39.6 pt -81.7 -41.97 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 118.694 -0.669 . . . . 0.0 112.584 169.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.486 -1.245 . . . . 0.0 110.007 -179.176 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m 54.6 71.22 0.54 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.009 1.324 . . . . 0.0 113.176 161.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -93.56 164.35 13.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.975 0.91 . . . . 0.0 111.443 -172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -87.56 89.33 7.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.145 1.378 . . . . 0.0 108.905 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.642 HG13 HG13 ' A' ' 85' ' ' VAL . 50.4 t -87.01 122.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -93.81 125.58 38.51 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.269 0.356 . . . . 0.0 110.668 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.648 HD12 HD13 ' A' ' 33' ' ' ILE . 17.1 mt -106.34 98.58 8.23 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 124.955 1.409 . . . . 0.0 108.022 174.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.429 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 35.6 mt -73.92 89.95 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 174.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.6 p -90.25 155.71 46.54 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 125.564 1.545 . . . . 0.0 108.316 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.96 -21.3 68.67 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.777 2.985 . . . . 0.0 112.681 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.54 -29.01 69.73 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.329 1.452 . . . . 0.0 110.862 172.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.8 61.95 0.35 Allowed Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 65.6 173.16 0.22 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.505 1.522 . . . . 0.0 112.571 175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.498 HG21 HG12 ' A' ' 33' ' ' ILE . 5.4 p -147.5 -55.59 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.651 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 71.1 132.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.718 1.607 . . . . 0.0 111.236 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -159.68 167.02 29.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 121.874 -0.516 . . . . 0.0 111.567 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 127.55 37.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.097 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 5.5 t -132.03 117.96 19.07 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.622 0.369 . . . . 0.0 110.696 -176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.76 148.88 19.28 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.629 1.972 . . . . 0.0 108.87 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -75.96 -6.79 52.57 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.769 -0.582 . . . . 0.0 112.328 176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -117.26 36.25 4.32 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.457 1.503 . . . . 0.0 110.082 173.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.6 163.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 121.043 -1.035 . . . . 0.0 111.116 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -81.82 140.11 34.37 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.595 0.758 . . . . 0.0 111.894 -177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 79' ' ' ALA . 2.0 t -63.84 -7.44 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.19 -34.93 10.93 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.604 1.161 . . . . 0.0 110.715 172.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -68.36 -69.46 0.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 122.17 0.986 . . . . 0.0 110.165 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.259 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -49.11 -62.16 1.68 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.775 0.83 . . . . 0.0 112.328 170.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -55.18 -40.69 71.0 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.064 -0.493 . . . . 0.0 109.727 177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -52.3 -36.23 52.56 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -81.22 -30.32 34.26 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.508 0.595 . . . . 0.0 110.707 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.69 8.54 4.73 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.538 1.066 . . . . 0.0 112.076 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.648 HD13 HD12 ' A' ' 7' ' ' LEU . 21.1 mt -70.02 118.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.732 1.266 . . . . 0.0 110.906 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -91.15 77.85 5.94 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.319 1.048 . . . . 0.0 109.634 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.88 157.7 89.04 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 120.764 -1.21 . . . . 0.0 108.837 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -75.66 60.47 5.92 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.705 2.937 . . . . 0.0 111.65 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -78.46 167.98 20.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 111.338 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 m -175.45 9.11 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.701 2.0 . . . . 0.0 114.5 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.8 p -143.86 -55.34 0.37 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.622 1.556 . . . . 0.0 111.201 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 ttm105 69.74 50.99 0.46 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.354 1.462 . . . . 0.0 111.478 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -159.55 76.14 0.66 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.753 0.706 . . . . 0.0 112.251 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.59 ' O ' HD21 ' A' ' 75' ' ' LEU . . . 63.91 -83.3 0.05 OUTLIER Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.447 ' HA ' ' S2 ' ' A' ' 97' ' ' FES . 51.0 p -164.02 163.29 23.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 119.104 1.452 . . . . 0.0 111.715 170.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 17.8 p -137.04 23.63 3.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.501 1.52 . . . . 0.0 112.117 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t 77.27 36.1 0.31 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.944 1.298 . . . . 0.0 111.485 -175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.1 p -156.65 -172.21 3.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 78.5 m 62.62 126.16 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 126.898 2.079 . . . . 0.0 112.977 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 95' ' ' ILE . . . -169.11 169.26 9.52 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.86 163.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.527 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -138.39 169.54 24.25 Favored Glycine 0 N--CA 1.431 -1.645 0 C-N-CA 126.016 1.769 . . . . 0.0 109.547 169.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -98.76 110.65 23.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.476 1.511 . . . . 0.0 108.424 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.42 103.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 t -77.03 -44.49 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 173.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 85' ' ' VAL . 9.0 t -163.46 172.3 14.68 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.64 -171.98 54.86 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.775 1.178 . . . . 0.0 111.151 -172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.3 m -137.38 157.61 46.21 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 74' ' ' VAL . 31.6 pt -148.15 168.45 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.274 1.829 . . . . 0.0 107.417 174.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -111.43 110.43 20.87 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -104.52 35.29 2.78 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.074 0.55 . . . . 0.0 112.078 172.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 t -54.02 -25.56 21.84 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.623 1.101 . . . . 0.0 113.551 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.28 -23.07 65.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.129 0.972 . . . . 0.0 112.48 175.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -53.66 158.88 1.73 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.865 1.266 . . . . 0.0 113.222 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.54 49.46 0.54 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.73 -71.7 0.1 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.531 -176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -57.08 142.1 43.53 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 119.488 1.04 . . . . 0.0 110.94 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.19 168.61 11.48 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 124.031 0.832 . . . . 0.0 109.736 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -54.38 -42.48 70.43 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.71 -61.25 2.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.581 0.752 . . . . 0.0 109.521 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -55.66 -52.03 65.21 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.314 0.646 . . . . 0.0 111.283 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 22.2 mtm -51.81 -58.09 7.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.676 -0.64 . . . . 0.0 111.573 177.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -55.95 -42.93 76.97 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.332 1.053 . . . . 0.0 110.555 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.67 -21.27 64.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.56 1.544 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.83 28.58 2.23 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 118.355 -1.247 . . . . 0.0 110.859 174.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.0 m-85 -111.56 169.62 8.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.5 1.65 . . . . 0.0 111.564 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.027 HG21 HD11 ' A' ' 56' ' ' ILE . 8.5 p -162.17 150.67 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 123.657 0.783 . . . . 0.0 109.103 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.59 HD21 ' O ' ' A' ' 42' ' ' GLY . 67.2 tp -64.2 135.02 55.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.637 0.775 . . . . 0.0 110.325 169.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -89.95 -36.81 14.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.531 0.732 . . . . 0.0 111.545 170.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -50.91 66.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.271 1.028 . . . . 0.0 111.517 -170.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.518 ' CD2' ' H ' ' A' ' 42' ' ' GLY . 1.7 m-70 -132.52 132.1 42.29 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.053 1.341 . . . . 0.0 109.372 170.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.646 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -171.74 141.13 1.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.69 1.596 . . . . 0.0 107.744 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -108.14 119.67 49.14 Favored Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 125.793 1.637 . . . . 0.0 108.863 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.786 ' HA ' HG22 ' A' ' 56' ' ' ILE . 18.4 Cg_endo -76.51 116.72 4.37 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.855 2.37 . . . . 0.0 111.341 -177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 p -91.77 -12.96 32.38 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 122.002 -0.436 . . . . 0.0 111.404 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 28.6 m -160.82 -178.28 6.72 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.301 1.84 . . . . 0.0 107.474 173.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -57.17 96.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.875 1.67 . . . . 0.0 109.251 167.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG13 HG13 ' A' ' 5' ' ' VAL . 9.1 p -103.0 147.35 9.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 C-N-CA 124.727 1.211 . . . . 0.0 110.163 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.5 t -116.92 119.46 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 173.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.527 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -136.93 142.36 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -178.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 16.4 mt-10 -98.34 119.51 37.15 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.047 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 p -80.15 177.34 9.02 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.209 1.368 . . . . 0.0 110.007 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.2 m80 67.61 47.94 1.14 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.847 1.259 . . . . 0.0 111.11 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -121.38 41.1 3.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 123.124 0.57 . . . . 0.0 110.22 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -79.04 -60.06 2.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -76.31 51.86 0.73 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.427 0.691 . . . . 0.0 112.354 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.32 -12.03 0.05 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.443 1.497 . . . . 0.0 113.431 163.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.468 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.7 pt -79.87 -40.56 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 119.916 1.235 . . . . 0.0 111.198 170.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.021 -1.466 . . . . 0.0 109.675 177.746 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.447 ' S2 ' ' HA ' ' A' ' 43' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.0 m 84.4 88.22 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.925 1.693 . . . . 0.0 113.97 160.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -117.16 158.8 23.64 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 125.321 1.448 . . . . 0.0 111.526 -170.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.35 101.52 1.95 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.46 2.304 . . . . 0.0 108.833 175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 18' ' ' CYS . 18.9 t -107.25 124.96 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.3 0.375 . . . . 0.0 110.164 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -96.67 133.84 40.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 165.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 33' ' ' ILE . 40.8 mt -108.86 106.48 16.49 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.3 1.04 . . . . 0.0 108.848 167.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.15 99.77 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 168.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -99.27 155.24 36.76 Favored Pre-proline 0 N--CA 1.445 -0.705 0 C-N-CA 124.929 1.291 . . . . 0.0 108.67 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.34 -34.54 89.1 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.995 3.13 . . . . 0.0 112.243 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.8 -34.75 28.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.438 2.295 . . . . 0.0 111.147 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.83 64.62 0.34 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 69.8 151.92 0.1 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.221 2.208 . . . . 0.0 114.045 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 p -151.94 111.55 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.176 161.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -90.03 138.19 31.71 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.705 1.202 . . . . 0.0 109.489 174.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -155.02 170.2 22.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.55 0.74 . . . . 0.0 111.992 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.1 121.97 38.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.495 ' HB3' HG21 ' A' ' 5' ' ' VAL . 9.6 t -120.35 127.36 52.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -67.9 135.27 52.21 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -48.51 -39.45 23.33 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 123.183 1.468 . . . . 0.0 108.537 166.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -8.85 56.54 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 126.315 1.846 . . . . 0.0 111.954 -173.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 27' ' ' GLN . 1.5 p -128.62 155.68 40.61 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 124.11 0.964 . . . . 0.0 109.815 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -75.49 148.25 39.16 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.781 -0.575 . . . . 0.0 110.639 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.11 50.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.945 0.898 . . . . 0.0 111.152 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 2.3 pt? -150.02 -47.65 0.13 Allowed 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 165.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.97 -66.61 0.36 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.277 1.031 . . . . 0.0 111.019 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.463 ' HB2' HG11 ' A' ' 22' ' ' VAL . 27.2 tt0 -69.03 -16.62 63.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.895 -0.503 . . . . 0.0 111.243 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.684 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -69.76 -51.32 35.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -56.6 -39.28 73.28 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.002 0.921 . . . . 0.0 109.638 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -50.87 -36.19 36.62 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.78 -28.73 27.94 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 121.966 -0.459 . . . . 0.0 110.214 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.83 12.89 4.76 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.518 1.532 . . . . 0.0 111.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.684 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 80.4 mt -73.81 112.18 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 118.334 1.067 . . . . 0.0 110.777 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.65 71.91 10.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.559 0.743 . . . . 0.0 110.414 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.23 152.63 95.92 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.76 -1.213 . . . . 0.0 109.469 175.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.03 74.12 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.647 2.898 . . . . 0.0 110.268 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -61.25 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.709 1.204 . . . . 0.0 109.863 172.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.05 13.62 14.41 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.855 1.262 . . . . 0.0 111.426 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.527 ' HB2' ' S2 ' ' A' ' 97' ' ' FES . 86.8 m -154.0 -107.58 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.63 0.772 . . . . 0.0 109.948 -159.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 174.64 -71.78 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 129.181 2.992 . . . . 0.0 108.915 -169.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 174.73 104.12 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.602 0.761 . . . . 0.0 111.823 -172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.08 -57.19 3.99 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.479 1.038 . . . . 0.0 114.762 154.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.3 p -81.53 65.42 6.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.366 1.466 . . . . 0.0 107.394 174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.02 -76.28 0.56 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -162.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 81.51 44.77 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.096 1.358 . . . . 0.0 111.019 -171.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 m -167.61 177.3 5.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.837 2.455 . . . . 0.0 106.168 173.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 39' ' ' CYS 0.648 0.8 OUTLIER 43.66 157.13 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 129.361 3.064 . . . . 0.0 118.348 -166.338 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.93 167.65 0.73 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 110.254 -173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.14 165.72 27.71 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.554 2.026 . . . . 0.0 110.458 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -102.0 114.96 29.53 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.853 1.661 . . . . 0.0 110.704 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 57.3 t -64.5 112.18 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.1 0.96 . . . . 0.0 108.562 175.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.8 t -85.82 -42.37 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -157.02 -171.88 3.82 Favored 'General case' 0 C--O 1.227 -0.115 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.13 -155.21 22.51 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.71 1.148 . . . . 0.0 111.851 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.1 m -153.98 156.78 38.06 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.775 HG23 HG21 ' A' ' 85' ' ' VAL . 17.7 pt -136.29 149.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 172.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.8 112.73 24.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 177.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -107.84 42.11 1.41 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.468 0.707 . . . . 0.0 111.593 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.29 11.76 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.929 -1.107 . . . . 0.0 112.791 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -104.42 14.99 29.1 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.279 1.032 . . . . 0.0 112.45 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -113.31 179.85 3.84 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.166 -0.959 . . . . 0.0 112.905 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 t -145.02 68.8 1.24 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 161.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.404 ' CE2' HD11 ' A' ' 95' ' ' ILE . 2.4 t80 -137.22 -82.54 0.35 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 117.511 -1.233 . . . . 0.0 111.73 175.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.1 mp -53.79 138.0 36.81 Favored 'General case' 0 C--N 1.344 0.365 0 CA-C-N 119.529 1.059 . . . . 0.0 111.137 -165.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -85.92 168.54 14.11 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 124.086 0.866 . . . . 0.0 109.942 176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -55.86 -42.66 76.17 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.358 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.1 -60.54 3.07 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.802 0.841 . . . . 0.0 109.614 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -54.62 -51.1 66.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 43.4 mtt -51.74 -59.68 4.02 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.26 0.482 . . . . 0.0 111.344 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.08 -42.12 72.43 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.916 1.286 . . . . 0.0 110.795 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.44 -20.2 64.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.412 1.485 . . . . 0.0 111.812 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.88 3.18 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-O 118.613 -1.104 . . . . 0.0 110.528 174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.528 ' CG ' HG22 ' A' ' 95' ' ' ILE . 93.2 m-85 -109.76 169.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 119.077 1.439 . . . . 0.0 111.642 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 56' ' ' ILE . 12.4 p -161.14 156.91 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 N-CA-C 106.457 -1.682 . . . . 0.0 106.457 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.402 HD11 ' S1 ' ' A' ' 97' ' ' FES . 6.4 tp -64.76 128.53 36.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 166.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.5 t -68.23 -40.0 82.18 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 21.6 m -81.51 -177.66 6.61 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.445 1.898 . . . . 0.0 109.254 175.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 33.52 50.88 0.31 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.429 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.634 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -139.89 133.32 30.07 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.132 1.373 . . . . 0.0 108.428 -174.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -107.32 124.12 36.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.213 1.405 . . . . 0.0 111.126 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.758 ' HA ' HG22 ' A' ' 56' ' ' ILE . 19.2 Cg_endo -76.49 100.78 1.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.943 3.095 . . . . 0.0 112.806 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.4 p -81.78 -18.06 45.46 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.06 -0.4 . . . . 0.0 110.89 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.1 m -151.98 179.59 8.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.304 . . . . 0.0 107.702 175.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.38 136.29 53.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 168.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.775 HG21 HG23 ' A' ' 56' ' ' ILE . 2.8 p -155.43 144.52 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.833 0.825 . . . . 0.0 111.662 -164.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -125.42 123.81 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 151.52 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -99.03 127.03 44.88 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 118.056 -0.973 . . . . 0.0 108.943 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.2 p -86.57 178.44 7.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.682 1.128 . . . . 0.0 109.073 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 65.5 53.9 1.19 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.436 1.094 . . . . 0.0 111.555 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -122.22 18.64 10.71 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.2 -67.19 0.3 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.001 0.92 . . . . 0.0 109.005 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -81.29 23.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.599 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.39 -21.37 9.87 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 124.541 1.136 . . . . 0.0 110.854 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.528 HG22 ' CG ' ' A' ' 73' ' ' TYR . 18.3 pt -88.47 -42.7 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 119.478 1.035 . . . . 0.0 112.562 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.251 1.143 0 CA-C-O 116.879 -1.534 . . . . 0.0 110.068 -177.01 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.527 ' S2 ' ' HB2' ' A' ' 39' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.4 m 55.48 75.21 0.33 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.485 1.114 . . . . 0.0 113.194 166.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -98.39 163.44 12.7 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 124.054 0.942 . . . . 0.0 112.853 -171.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.44 81.87 8.17 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 126.98 2.112 . . . . 0.0 109.484 -174.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 85' ' ' VAL . 95.5 t -88.04 99.0 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -170.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -68.76 127.76 34.22 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.834 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.544 HD12 HD13 ' A' ' 33' ' ' ILE . 66.9 mt -107.95 109.53 21.05 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.2 mt -78.58 91.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 169.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.1 p -88.29 155.07 51.87 Favored Pre-proline 0 N--CA 1.443 -0.822 0 C-N-CA 124.023 0.929 . . . . 0.0 108.57 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -53.05 -37.03 78.54 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.468 3.446 . . . . 0.0 112.696 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.5 -36.63 15.59 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 127.852 2.461 . . . . 0.0 111.159 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.06 65.08 0.29 Allowed Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 69.54 165.31 0.26 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 127.02 2.128 . . . . 0.0 112.765 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.87 -59.95 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.201 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 70.63 145.47 0.06 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.128 1.371 . . . . 0.0 110.966 -172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.526 ' HB3' HD11 ' A' ' 33' ' ' ILE . 3.1 p90 -169.54 158.94 8.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.93 0.892 . . . . 0.0 110.39 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.29 121.71 27.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.8 t -120.49 120.43 35.86 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 122.58 0.352 . . . . 0.0 110.427 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.57 141.97 58.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 0.4 OUTLIER -55.35 -31.1 61.47 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 125.531 1.532 . . . . 0.0 110.901 169.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -88.31 -5.32 58.4 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.257 1.023 . . . . 0.0 112.083 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -119.23 149.01 21.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 CA-C-N 119.725 1.148 . . . . 0.0 110.086 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -72.18 150.38 43.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.185 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 56.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.745 0.783 . . . . 0.0 111.528 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 25' ' ' LEU . 5.4 tt -163.9 -52.75 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 175.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.22 -56.62 13.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.572 0.701 . . . . 0.0 110.159 -175.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -71.29 -23.58 61.99 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.079 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -63.16 -54.09 43.04 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.549 -0.719 . . . . 0.0 110.226 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -48.75 -46.87 41.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.901 0.88 . . . . 0.0 108.894 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -53.87 -38.74 65.06 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -79.3 -25.59 42.4 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.882 -0.511 . . . . 0.0 109.863 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 122.03 12.75 5.22 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.827 1.68 . . . . 0.0 111.529 176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.688 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 98.7 mt -76.23 108.84 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 118.167 0.984 . . . . 0.0 111.318 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -78.87 68.61 4.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.742 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.13 156.42 80.98 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 120.944 -1.097 . . . . 0.0 108.247 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.19 72.01 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.198 3.265 . . . . 0.0 110.374 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -77.23 161.73 27.92 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.698 1.999 . . . . 0.0 111.865 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.1 t -156.99 -61.15 0.09 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.214 1.806 . . . . 0.0 108.379 175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.15 162.08 17.97 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 128.758 2.823 . . . . 0.0 110.417 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -150.28 71.52 1.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.46 1.104 . . . . 0.0 108.828 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.0 44.26 0.15 Allowed 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.391 -0.818 . . . . 0.0 110.766 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' H ' ' CD2' ' A' ' 78' ' ' HIS . . . 67.1 -67.93 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.919 1.247 . . . . 0.0 112.923 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.1 t -67.77 76.02 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.128 1.371 . . . . 0.0 111.256 -172.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.2 t -59.3 159.16 8.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.108 0.963 . . . . 0.0 112.774 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.28 -34.68 4.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.002 2.521 . . . . 0.0 110.443 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.4 m -159.52 86.87 0.81 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 117.485 -1.245 . . . . 0.0 112.656 -175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.429 ' HB3' ' S2 ' ' A' ' 97' ' ' FES . 1.4 p -175.89 165.27 2.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.841 2.057 . . . . 0.0 110.925 169.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 163.95 169.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.692 2.397 . . . . 0.0 109.592 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -139.68 167.33 25.35 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 126.135 1.826 . . . . 0.0 110.684 171.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -103.83 112.39 25.33 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.964 1.706 . . . . 0.0 110.26 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.3 t -58.97 113.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 124.389 1.076 . . . . 0.0 109.132 172.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.7 t -85.78 -46.28 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.9 t -162.71 174.84 11.98 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.064 -0.398 . . . . 0.0 110.388 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.5 -173.2 54.44 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 124.599 1.095 . . . . 0.0 110.928 -170.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -141.44 147.7 38.34 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 74' ' ' VAL . 28.7 pt -145.47 169.97 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 125.784 1.633 . . . . 0.0 107.408 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -112.24 111.72 22.8 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -114.09 48.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 109.56 168.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 t -88.99 48.54 1.64 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.526 -1.359 . . . . 0.0 109.585 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -129.87 -50.15 1.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 124.138 0.975 . . . . 0.0 110.954 -171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.6 pm0 -58.5 -35.04 71.62 Favored 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -170.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.1 m 54.32 53.23 11.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.802 0.441 . . . . 0.0 109.917 -172.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -143.91 -68.08 0.33 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 117.347 -1.311 . . . . 0.0 109.478 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp -55.22 137.43 47.23 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.887 1.221 . . . . 0.0 110.279 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.81 167.49 13.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 124.05 0.844 . . . . 0.0 109.763 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -52.16 -43.37 64.05 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.926 1.29 . . . . 0.0 108.58 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -52.11 -60.81 2.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.45 1.1 . . . . 0.0 109.674 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -58.12 -48.34 80.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.211 0.604 . . . . 0.0 111.044 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 57.7 mtt -51.98 -60.57 3.04 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.912 -0.493 . . . . 0.0 110.839 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -53.97 -45.1 71.28 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.777 1.231 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.37 -20.96 63.59 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.019 1.728 . . . . 0.0 112.059 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.55 30.95 1.74 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-O 117.802 -1.554 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.57 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.6 m-85 -118.25 158.39 25.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.981 1.89 . . . . 0.0 113.747 -175.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.04 HG21 HD11 ' A' ' 56' ' ' ILE . 12.2 p -154.65 144.68 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 123.536 0.734 . . . . 0.0 110.671 -175.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.71 147.77 43.29 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 175.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.9 p -120.65 38.5 4.0 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.002 0.921 . . . . 0.0 112.325 -170.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 64.6 m -146.01 -43.08 0.2 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.708 1.603 . . . . 0.0 109.846 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.407 ' CD2' ' H ' ' A' ' 42' ' ' GLY . 16.0 m-70 -118.86 84.87 2.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.629 1.571 . . . . 0.0 108.234 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -158.54 135.94 10.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.147 1.379 . . . . 0.0 107.439 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -116.96 118.65 36.02 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.768 1.627 . . . . 0.0 109.337 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.436 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.2 Cg_endo -74.34 117.85 5.14 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.587 2.192 . . . . 0.0 111.666 -175.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.0 p -89.88 -16.03 30.91 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.731 -0.606 . . . . 0.0 111.2 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 23.8 m -156.6 -177.49 6.64 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.877 1.671 . . . . 0.0 107.112 175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.72 133.67 42.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 161.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 5' ' ' VAL . 2.5 p -140.75 148.84 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 107.622 -175.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.72 121.12 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 173.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.41 153.62 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -103.32 126.16 50.34 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 124.296 1.038 . . . . 0.0 109.29 171.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.9 p -83.8 177.24 8.43 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.781 1.173 . . . . 0.0 109.263 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.2 m80 70.37 56.23 0.28 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.672 1.189 . . . . 0.0 111.54 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -129.04 31.47 4.89 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 123.614 0.765 . . . . 0.0 112.582 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -59.77 -66.23 0.55 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -80.23 47.55 0.92 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.649 0.738 . . . . 0.0 111.547 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -140.32 -41.29 0.42 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 131.453 3.901 . . . . 0.0 108.949 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.57 HG22 ' CG ' ' A' ' 73' ' ' TYR . 21.5 pt -75.49 -47.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.061 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.058 -1.448 . . . . 0.0 109.758 -173.616 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.429 ' S2 ' ' HB3' ' A' ' 47' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.3 m 80.85 103.81 0.06 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.443 1.497 . . . . 0.0 112.502 169.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -118.68 154.93 31.92 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 121.552 0.691 . . . . 0.0 112.736 -173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.73 100.67 0.56 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 128.557 2.743 . . . . 0.0 108.65 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG13 HG13 ' A' ' 85' ' ' VAL . 58.6 t -107.04 125.67 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 27.8 ttmt -97.18 135.72 38.72 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 165.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.439 HD22 HG23 ' A' ' 89' ' ' THR . 28.5 mt -112.14 106.89 15.62 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 124.505 1.128 . . . . 0.0 108.447 169.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.1 mt -78.42 91.61 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' HG1' ' A' ' 89' ' ' THR . 62.1 p -94.7 155.86 38.92 Favored Pre-proline 0 N--CA 1.442 -0.834 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.745 176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 68.6 Cg_exo -53.43 -37.11 81.6 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 125.133 3.889 . . . . 0.0 112.431 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -46.64 -38.06 9.13 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 128.444 2.698 . . . . 0.0 111.106 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 119.8 61.9 0.26 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 24.4 mt-10 70.7 152.01 0.1 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 127.558 2.343 . . . . 0.0 112.905 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG11 HG23 ' A' ' 33' ' ' ILE . 13.7 p -152.65 90.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-O 122.861 1.315 . . . . 0.0 108.361 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -83.22 140.21 32.67 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.538 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.03 170.58 21.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.188 0.595 . . . . 0.0 112.224 -166.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 124.42 47.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.2 t -122.32 130.47 53.16 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -73.25 131.28 41.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.159 0.981 . . . . 0.0 108.988 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -44.48 -28.6 0.59 Allowed 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.864 2.066 . . . . 0.0 111.833 160.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.57 -14.3 58.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.263 1.825 . . . . 0.0 112.489 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -131.9 154.4 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.767 1.227 . . . . 0.0 110.078 -166.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -74.94 153.01 38.77 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 120.516 -1.365 . . . . 0.0 110.053 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -49.27 -51.3 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.815 -0.553 . . . . 0.0 110.866 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.75 72.88 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.82 -67.78 0.39 Allowed 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.95 -38.54 82.75 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.44 -61.88 1.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.424 0.556 . . . . 0.0 111.918 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -55.33 -40.09 70.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.95 -40.27 72.94 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.99 -19.9 56.73 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.481 -0.762 . . . . 0.0 109.039 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.26 15.08 7.3 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 125.237 1.399 . . . . 0.0 110.686 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.426 HG23 HG11 ' A' ' 14' ' ' VAL . 48.9 mt -81.81 133.12 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 117.302 0.551 . . . . 0.0 110.043 -175.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -93.17 115.2 27.84 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.487 1.115 . . . . 0.0 108.832 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 35' ' ' ILE . 5.5 pt -137.05 157.92 73.68 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 173.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.63 131.69 13.84 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.474 2.116 . . . . 0.0 109.75 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -172.85 136.59 0.7 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.0 t -155.6 22.69 0.4 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.802 1.183 . . . . 0.0 112.211 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.35 -172.04 1.2 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -159.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.418 ' HA ' ' S1 ' ' A' ' 97' ' ' FES . 2.7 ttt85 -169.47 84.44 0.13 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.517 1.053 . . . . 0.0 110.778 176.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.66 -60.96 0.09 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.265 0.484 . . . . 0.0 111.768 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 155.96 -54.58 0.41 Allowed Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 p -106.09 73.2 0.98 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.807 -0.82 . . . . 0.0 109.053 173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . 0.329 0.1 OUTLIER -121.46 -109.88 0.34 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 116.494 -1.717 . . . . 0.0 108.581 175.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 p -163.24 151.35 13.61 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 122.985 2.63 . . . . 0.0 115.09 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.433 ' H ' ' CD ' ' A' ' 92' ' ' GLU . 19.8 m 71.56 52.03 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.402 2.281 . . . . 0.0 112.442 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 87.6 m -154.2 81.9 1.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.476 0.71 . . . . 0.0 110.636 -173.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.21 154.67 29.59 Favored 'General case' 0 CA--C 1.521 -0.153 0 O-C-N 119.582 -1.948 . . . . 0.0 110.537 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.11 167.12 27.9 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.546 1.546 . . . . 0.0 111.066 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -105.23 112.57 25.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.516 1.926 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.9 110.15 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 99.2 t -83.67 -45.48 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 85' ' ' VAL . 7.7 t -160.96 174.41 13.85 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 121.977 -0.452 . . . . 0.0 110.292 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.39 -162.8 54.25 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 m -155.17 155.86 34.68 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.742 HD11 HG21 ' A' ' 74' ' ' VAL . 30.2 pt -144.22 160.73 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.724 1.61 . . . . 0.0 107.801 -177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -101.38 108.14 19.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -104.55 38.67 1.83 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.711 0.804 . . . . 0.0 111.463 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.1 m -46.56 -38.75 9.9 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.328 0.967 . . . . 0.0 112.414 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -75.26 31.68 0.1 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.934 0.894 . . . . 0.0 112.375 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -91.88 -65.25 1.02 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.321 1.448 . . . . 0.0 113.231 -170.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m 43.49 33.85 0.7 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.924 0.89 . . . . 0.0 113.35 -167.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -137.97 -76.47 0.39 Allowed 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.226 -0.893 . . . . 0.0 110.467 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.5 mp -55.99 141.73 38.67 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.956 0.798 . . . . 0.0 110.174 -173.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -85.38 164.86 17.68 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 123.812 0.695 . . . . 0.0 109.548 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.48 -40.42 74.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.444 1.097 . . . . 0.0 108.683 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.29 -61.64 2.17 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 123.947 0.899 . . . . 0.0 109.402 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.41 -53.11 31.76 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.628 0.771 . . . . 0.0 111.332 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.3 mtm -50.54 -62.15 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 0.0 111.857 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -53.94 -43.46 69.84 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.667 1.187 . . . . 0.0 110.72 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.53 64.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.766 1.626 . . . . 0.0 112.112 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.86 26.39 2.11 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-O 117.922 -1.488 . . . . 0.0 111.842 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.8 m-85 -113.68 166.25 11.73 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 120.018 1.909 . . . . 0.0 112.88 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.742 HG21 HD11 ' A' ' 56' ' ' ILE . 8.6 p -160.72 153.75 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 77' ' ' CYS . 0.3 OUTLIER -74.46 132.74 42.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 173.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 m -72.08 -49.99 31.89 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.719 -0.613 . . . . 0.0 110.448 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.419 ' SG ' HD22 ' A' ' 75' ' ' LEU . 3.4 p -74.34 176.85 6.33 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.2 m170 50.23 46.57 24.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.817 0.818 . . . . 0.0 111.602 166.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -147.91 125.26 11.59 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.409 1.084 . . . . 0.0 108.952 -170.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -108.4 125.22 32.36 Favored Pre-proline 0 CA--C 1.53 0.187 0 C-N-CA 125.547 1.539 . . . . 0.0 109.678 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.454 ' HA ' HG22 ' A' ' 56' ' ' ILE . 9.9 Cg_endo -71.98 119.36 6.14 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.194 1.93 . . . . 0.0 111.757 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -91.3 -17.19 26.33 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.257 -0.902 . . . . 0.0 112.039 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.5 m -156.21 -173.99 4.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -55.53 140.17 41.53 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 163.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 53' ' ' SER . 2.5 p -150.66 148.09 15.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.354 0.597 . . . . 0.0 109.853 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.54 124.2 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.53 151.98 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 123.795 0.838 . . . . 0.0 108.966 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -100.26 121.23 41.14 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.067 0.947 . . . . 0.0 108.605 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.439 HG23 HD22 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -74.34 179.81 4.35 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 119.163 0.892 . . . . 0.0 110.712 176.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.565 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 3.5 m-70 65.46 50.47 1.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.761 1.224 . . . . 0.0 112.86 169.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -122.01 15.5 10.78 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -172.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 46' ' ' SER . 27.1 tp10 -45.39 -63.43 0.95 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.795 0.807 . . . . 0.0 109.125 174.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -82.86 21.89 0.98 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.732 0.813 . . . . 0.0 113.142 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -110.2 -26.14 9.79 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.352 1.061 . . . . 0.0 110.495 162.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.535 HG22 ' CG ' ' A' ' 73' ' ' TYR . 34.6 pt -82.4 -48.85 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 119.478 1.035 . . . . 0.0 112.09 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--O 1.253 1.283 0 CA-C-O 117.498 -1.239 . . . . 0.0 109.693 -176.145 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.418 ' S1 ' ' HA ' ' A' ' 40' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 119.469 -0.3 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m 55.43 68.08 0.92 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.051 1.34 . . . . 0.0 113.844 151.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -98.4 158.25 15.7 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 111.424 -168.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -84.82 90.21 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.837 1.655 . . . . 0.0 109.135 -177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG13 HG13 ' A' ' 85' ' ' VAL . 39.4 t -87.0 120.56 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -88.97 131.08 35.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.878 0.308 . . . . 0.0 111.346 167.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.8 mt -109.29 103.87 12.89 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.418 1.487 . . . . 0.0 107.508 166.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.4 mt -74.17 86.38 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 172.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.8 p -79.34 154.17 76.77 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.691 173.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -57.83 -32.43 94.93 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.949 3.1 . . . . 0.0 112.194 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -32.18 33.82 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 126.429 1.892 . . . . 0.0 110.907 173.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.01 62.62 0.32 Allowed Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 125.255 1.407 . . . . 0.0 109.931 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 67.69 161.72 0.18 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.728 2.011 . . . . 0.0 112.883 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' H ' ' A' ' 15' ' ' GLU . 19.7 m -132.4 -61.73 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.072 170.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 14' ' ' VAL . 4.6 tt0 73.67 129.06 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.121 1.768 . . . . 0.0 111.987 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -163.73 171.37 15.69 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -94.29 127.88 40.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.404 0.682 . . . . 0.0 111.524 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.463 ' HB3' ' HG3' ' A' ' 81' ' ' PRO . 34.6 t -131.51 130.27 42.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 175.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -74.3 150.99 39.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.065 0.946 . . . . 0.0 110.108 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.29 -7.38 46.62 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -115.26 21.01 14.51 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.767 1.627 . . . . 0.0 110.703 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.42 158.12 27.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.28 0 O-C-N 121.024 -1.048 . . . . 0.0 110.589 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.408 ' CE1' ' HB2' ' A' ' 78' ' ' HIS . 41.2 m-85 -77.94 143.45 37.64 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.566 0.346 . . . . 0.0 110.99 -177.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 79' ' ' ALA . 5.6 t -49.07 -62.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.474 0.71 . . . . 0.0 111.523 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 tp -49.86 -52.5 32.21 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.537 0.735 . . . . 0.0 111.475 -178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -54.45 43.33 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -170.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -58.64 -44.91 90.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.581 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -50.87 -56.06 14.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.361 -0.837 . . . . 0.0 110.793 178.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -59.26 -38.95 81.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.674 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -51.7 -38.24 54.24 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.227 0.921 . . . . 0.0 112.301 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.96 -25.86 43.5 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.934 -0.479 . . . . 0.0 110.616 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.92 11.32 10.21 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.82 1.676 . . . . 0.0 111.31 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.589 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 97.1 mt -78.24 123.41 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.7 0.75 . . . . 0.0 111.075 -178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.59 119.37 30.78 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.703 1.601 . . . . 0.0 109.986 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.9 pt -136.16 148.33 64.13 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.02 129.46 27.37 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 123.023 2.482 . . . . 0.0 111.088 -174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -166.27 143.38 5.16 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -171.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.0 p -155.62 15.62 0.37 Allowed 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.08 -175.68 1.77 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.88 2.872 . . . . 0.0 105.833 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -160.67 79.88 0.64 Allowed 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.658 1.572 . . . . 0.0 109.736 162.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.21 -71.0 0.42 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 122.703 0.401 . . . . 0.0 110.624 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.69 79.04 0.07 OUTLIER Glycine 0 C--N 1.334 0.458 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.6 p -175.41 -40.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.326 0.651 . . . . 0.0 110.933 -172.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.01 155.36 31.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 110.254 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.8 p -109.07 72.91 0.83 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.7 m -152.43 -154.16 0.52 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.436 1.094 . . . . 0.0 108.32 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.1 p 46.82 88.31 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 160.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.88 163.74 38.58 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.595 -1.941 . . . . 0.0 113.056 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.59 160.68 28.45 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.175 1.845 . . . . 0.0 111.085 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.9 tttt -98.26 112.94 24.75 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.026 1.73 . . . . 0.0 111.166 -177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.9 t -58.16 116.2 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 119.073 0.851 . . . . 0.0 109.474 173.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.9 t -90.98 -48.49 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 122.998 0.519 . . . . 0.0 109.876 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 t -160.33 174.06 14.73 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.08 -169.37 43.14 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -170.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.2 m -142.54 149.48 39.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.071 0.948 . . . . 0.0 108.817 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.768 HG23 HG21 ' A' ' 85' ' ' VAL . 24.9 pt -132.89 165.52 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.027 1.731 . . . . 0.0 107.035 169.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -107.13 110.73 22.89 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -109.45 46.17 1.02 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.112 0.565 . . . . 0.0 110.168 168.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.2 t -52.83 -44.83 67.0 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.539 -0.726 . . . . 0.0 109.751 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -78.64 41.99 0.43 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.549 1.54 . . . . 0.0 111.823 -173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -105.86 -72.05 0.73 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.212 1.805 . . . . 0.0 111.672 -172.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.0 t 53.53 61.11 3.28 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.742 -0.599 . . . . 0.0 111.367 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -160.51 -67.43 0.07 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.606 173.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.1 mp -58.84 147.41 33.76 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.516 1.053 . . . . 0.0 110.877 -172.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -85.85 160.62 19.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.966 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -55.36 -41.22 72.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.57 -61.01 2.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.981 0.912 . . . . 0.0 109.559 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -51.44 -51.07 57.99 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.51 0.724 . . . . 0.0 111.202 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.1 mtt -52.18 -60.45 3.19 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.626 -0.671 . . . . 0.0 111.558 177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.94 -42.68 76.54 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.379 1.072 . . . . 0.0 110.854 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.99 -19.93 63.34 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.8 1.64 . . . . 0.0 111.749 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.28 34.63 1.31 Allowed Glycine 0 N--CA 1.443 -0.845 0 CA-C-O 117.559 -1.689 . . . . 0.0 110.949 171.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -116.48 162.27 17.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 120.48 2.14 . . . . 0.0 113.802 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -159.08 161.34 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 125.285 1.434 . . . . 0.0 108.729 -169.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.26 -55.42 4.54 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.217 1.407 . . . . 0.0 110.383 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 80.19 -56.92 0.35 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.003 1.321 . . . . 0.0 110.487 -177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -41.04 -39.21 1.15 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.102 1.761 . . . . 0.0 112.72 -178.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -143.89 52.84 1.3 Allowed 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.575 0.75 . . . . 0.0 111.821 173.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' CB ' HD12 ' A' ' 56' ' ' ILE . . . -103.75 151.42 23.05 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 169.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -105.84 126.16 31.39 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 124.58 1.152 . . . . 0.0 109.215 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.716 ' HA ' HG22 ' A' ' 56' ' ' ILE . 16.4 Cg_endo -75.87 119.1 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.659 2.24 . . . . 0.0 110.899 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.3 p -91.31 -15.04 29.72 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.099 -0.376 . . . . 0.0 111.709 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.1 m -156.94 -174.71 5.05 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -53.49 134.81 40.58 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.768 HG21 HG23 ' A' ' 56' ' ' ILE . 3.6 p -151.87 148.04 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 123.617 0.767 . . . . 0.0 109.769 -171.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.71 123.73 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.09 153.05 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -100.63 119.32 38.39 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 124.024 0.93 . . . . 0.0 109.477 170.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.7 p -79.91 175.89 10.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 119.411 1.005 . . . . 0.0 111.202 177.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 69.42 56.94 0.36 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.747 1.619 . . . . 0.0 111.814 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.2 mmtt -126.96 12.68 7.25 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.84 -63.73 0.98 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.283 1.033 . . . . 0.0 109.075 173.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -79.87 26.63 0.32 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -110.12 -45.33 3.61 Favored 'General case' 0 C--N 1.344 0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.8 pt -71.62 -41.61 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -170.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.996 -1.478 . . . . 0.0 110.325 -178.583 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.448 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.8 m 77.09 100.78 0.07 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.065 1.746 . . . . 0.0 111.498 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -109.17 158.98 17.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 123.591 0.756 . . . . 0.0 112.055 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -74.96 104.54 5.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.018 2.127 . . . . 0.0 109.123 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.592 HG13 HG13 ' A' ' 85' ' ' VAL . 30.2 t -110.19 111.77 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 122.898 0.479 . . . . 0.0 110.557 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -84.6 128.33 34.54 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 117.937 0.335 . . . . 0.0 111.456 168.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 55.1 mt -106.55 112.13 25.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mt -84.22 86.32 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p -83.32 153.69 65.9 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 118.134 -0.936 . . . . 0.0 109.097 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.25 -36.92 69.51 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.654 3.569 . . . . 0.0 113.063 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -46.95 -38.68 11.0 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 127.526 2.33 . . . . 0.0 111.099 173.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.23 64.22 0.22 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.9 166.88 0.27 Allowed 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 127.215 2.206 . . . . 0.0 112.158 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.72 -59.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.732 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 70.55 142.36 0.05 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 125.988 1.715 . . . . 0.0 113.086 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -164.34 178.93 7.13 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.811 0.844 . . . . 0.0 111.264 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.86 124.38 48.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.818 1.247 . . . . 0.0 109.086 175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.5 t -121.05 128.3 52.51 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.51 0.324 . . . . 0.0 110.325 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.52 141.06 53.95 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.782 1.277 . . . . 0.0 108.23 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -65.07 -18.83 65.63 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 128.895 2.878 . . . . 0.0 110.786 -179.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -107.59 17.52 22.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.811 1.244 . . . . 0.0 111.292 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -134.35 151.78 32.64 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.59 1.086 . . . . 0.0 111.501 177.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -65.05 138.74 58.52 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.905 0.882 . . . . 0.0 110.327 177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 5' ' ' VAL . 1.9 t -68.68 4.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -109.46 -52.07 2.81 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -45.8 -62.3 1.36 Allowed 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.394 1.478 . . . . 0.0 111.246 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.444 ' HB2' HG11 ' A' ' 22' ' ' VAL . 19.3 tt0 -65.07 -28.17 69.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.913 -0.492 . . . . 0.0 111.198 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.621 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -60.45 -52.22 66.14 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.532 -0.73 . . . . 0.0 109.542 173.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -56.67 -41.4 77.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.037 0.935 . . . . 0.0 109.892 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -51.72 -37.72 52.17 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.73 -25.31 41.13 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.848 -0.532 . . . . 0.0 110.578 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.15 11.34 9.04 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.805 1.669 . . . . 0.0 111.284 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.621 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 41.2 mt -82.16 126.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 118.208 1.004 . . . . 0.0 110.124 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -90.24 110.98 22.01 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 124.419 1.088 . . . . 0.0 109.447 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 33' ' ' ILE . 5.8 pt -136.75 155.28 76.7 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 170.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -58.32 110.52 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.598 2.198 . . . . 0.0 112.487 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -148.68 -20.39 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.173 1.389 . . . . 0.0 113.255 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 p -71.81 74.94 0.87 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.151 0.98 . . . . 0.0 111.506 -165.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 -77.11 0.08 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.942 2.097 . . . . 0.0 107.119 -166.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 59.84 96.5 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 128.134 2.574 . . . . 0.0 113.961 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 150.98 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.821 2.448 . . . . 0.0 113.092 155.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 31.56 -65.28 0.0 OUTLIER Glycine 0 CA--C 1.549 2.187 0 C-N-CA 129.763 3.554 . . . . 0.0 117.55 173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.2 t -82.64 62.16 6.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.109 -1.818 . . . . 0.0 109.99 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.1 p -114.78 -67.29 1.01 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.538 1.135 . . . . 0.0 112.47 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.2 m -147.28 -106.85 0.09 Allowed 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.024 -1.048 . . . . 0.0 110.705 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 t -153.76 129.99 10.45 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.5 p -162.11 150.76 15.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.357 1.463 . . . . 0.0 108.031 168.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . -173.32 174.64 3.28 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.585 1.154 . . . . 0.0 110.231 -176.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.699 ' HA3' HD11 ' A' ' 87' ' ' ILE . . . -143.4 156.05 26.36 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.092 1.806 . . . . 0.0 111.263 171.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.98 126.61 34.84 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 125.5 1.52 . . . . 0.0 110.028 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 17.3 t -73.73 128.34 36.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 120.11 1.323 . . . . 0.0 108.969 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.4 t -108.25 -44.21 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 123.297 0.639 . . . . 0.0 109.953 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.5 t -158.93 172.54 18.02 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.599 0.636 . . . . 0.0 109.715 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.97 -161.76 46.85 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.471 1.034 . . . . 0.0 111.407 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 m -156.24 158.55 37.75 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.65 -0.912 . . . . 0.0 108.757 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.712 HG22 ' HA ' ' A' ' 81' ' ' PRO . 8.9 pt -130.58 179.67 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 125.565 1.546 . . . . 0.0 107.498 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -113.44 118.99 36.05 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 165.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.417 ' NE2' HG23 ' A' ' 74' ' ' VAL . 8.7 pt20 -108.39 34.64 3.52 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.818 0.847 . . . . 0.0 111.721 169.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.1 t -80.39 36.21 0.36 Allowed 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.631 -1.293 . . . . 0.0 113.173 -166.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -161.28 43.08 0.16 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.242 1.017 . . . . 0.0 109.619 176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -105.38 -33.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.644 1.978 . . . . 0.0 110.363 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.1 t 52.55 46.86 25.91 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.607 0.763 . . . . 0.0 109.792 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -155.12 -72.12 0.12 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.57 -1.205 . . . . 0.0 110.748 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.92 136.32 57.03 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 120.063 1.301 . . . . 0.0 110.973 -170.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.75 164.45 20.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 123.641 0.588 . . . . 0.0 110.253 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -52.6 -44.01 65.72 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.94 -61.2 2.45 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.286 1.034 . . . . 0.0 109.766 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -54.34 -49.53 69.55 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.227 0.611 . . . . 0.0 111.139 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 12.2 mtt -54.59 -58.55 7.05 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.635 -0.666 . . . . 0.0 111.66 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.33 -43.16 70.98 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.403 1.081 . . . . 0.0 110.697 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.52 -19.82 65.09 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.842 1.657 . . . . 0.0 111.727 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.58 51.33 0.98 Allowed Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.453 ' CG ' HG22 ' A' ' 95' ' ' ILE . 94.1 m-85 -125.31 146.47 49.55 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.393 1.097 . . . . 0.0 111.915 169.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.526 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -170.0 -175.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 87' ' ' ILE . 3.6 tp 76.0 167.06 0.27 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.742 1.217 . . . . 0.0 107.769 171.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.576 ' HA ' HD21 ' A' ' 25' ' ' LEU . 2.2 p 64.09 170.69 0.18 Allowed 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 124.681 1.238 . . . . 0.0 111.088 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 52.52 21.69 1.88 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.8 t60 103.14 117.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 129.492 3.117 . . . . 0.0 110.897 -170.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -162.41 114.1 1.61 Allowed 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.886 -0.509 . . . . 0.0 111.991 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -106.08 123.01 40.43 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 125.277 1.431 . . . . 0.0 110.938 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.712 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.6 Cg_endo -74.38 120.16 6.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.716 2.277 . . . . 0.0 111.29 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 p -99.34 -13.0 19.81 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.685 -0.635 . . . . 0.0 112.176 -174.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.1 m -156.28 -173.52 4.54 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 172.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.35 143.85 32.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 163.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG13 HG13 ' A' ' 5' ' ' VAL . 2.6 p -153.89 151.9 10.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 121.281 0.562 . . . . 0.0 111.687 -172.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.5 t -135.56 127.15 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.699 HD11 ' HA3' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -156.07 141.73 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -167.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.532 ' N ' HD13 ' A' ' 87' ' ' ILE . 23.9 mt-10 -94.98 118.16 31.34 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.418 -0.801 . . . . 0.0 110.81 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.0 p -77.3 176.03 9.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.932 0.493 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 66.23 55.35 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.116 1.366 . . . . 0.0 111.472 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -123.28 33.29 5.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 122.939 0.496 . . . . 0.0 111.967 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -55.96 -71.93 0.08 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -80.35 45.0 0.72 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.498 0.666 . . . . 0.0 110.902 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.32 -46.13 2.06 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.134 1.374 . . . . 0.0 108.296 164.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.453 HG22 ' CG ' ' A' ' 73' ' ' TYR . 6.9 pt -72.5 -38.81 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -171.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 CA--C 1.564 1.516 1 CA-C-O 81.463 -18.399 . . . . 0.0 111.435 -174.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' H1 ' ' CG ' ' A' ' 20' ' ' ASP . . . . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.4 m 54.6 72.99 0.43 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 144.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -99.8 155.4 17.67 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.03 101.74 0.42 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.309 2.244 . . . . 0.0 109.314 168.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.2 109.79 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -81.76 134.25 35.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.101 166.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.42 HD22 ' CG2' ' A' ' 89' ' ' THR . 75.4 mt -112.13 106.86 15.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 167.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.1 mt -76.66 96.28 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.1 p -92.42 156.23 41.69 Favored Pre-proline 0 N--CA 1.444 -0.765 0 C-N-CA 124.623 1.169 . . . . 0.0 108.882 174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -53.55 -36.85 81.94 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.49 3.46 . . . . 0.0 112.505 178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.89 -34.84 21.49 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 127.423 2.289 . . . . 0.0 111.084 174.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 118.37 64.21 0.3 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 125.225 1.393 . . . . 0.0 109.693 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 67.9 161.59 0.18 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.996 2.118 . . . . 0.0 112.293 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.75 -58.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.786 173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 72.21 143.46 0.06 Allowed 'General case' 0 C--O 1.229 0.017 0 C-N-CA 126.032 1.733 . . . . 0.0 112.79 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.502 ' HB3' HD11 ' A' ' 33' ' ' ILE . 1.7 p90 -163.43 169.95 18.15 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.998 0.519 . . . . 0.0 112.012 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 126.35 36.34 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.4 t -119.86 125.11 47.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 123.653 0.596 . . . . 0.0 110.531 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -69.11 146.27 52.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 123.003 1.383 . . . . 0.0 110.015 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' CG ' ' H1 ' ' A' ' 1' ' ' ALA . 6.8 p-10 -77.0 -1.65 29.87 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.257 1.023 . . . . 0.0 111.88 -173.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.06 23.05 10.8 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.789 1.636 . . . . 0.0 111.207 171.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -130.88 149.04 33.1 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-N 119.465 1.03 . . . . 0.0 110.367 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.3 m-30 -64.25 142.83 58.27 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.9 t -49.12 -58.87 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 O-C-N 123.07 0.231 . . . . 0.0 110.554 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 26' ' ' ASP . 2.7 pp -58.6 -36.26 73.74 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -176.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.635 ' N ' HD12 ' A' ' 25' ' ' LEU . 20.1 t0 -61.49 -62.15 2.02 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 122.398 1.094 . . . . 0.0 108.337 -169.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -62.12 -38.15 87.81 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.589 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.77 -58.21 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.203 -0.935 . . . . 0.0 112.084 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -58.88 -38.49 78.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.24 0.616 . . . . 0.0 109.573 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -52.1 -40.81 61.8 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.886 0.766 . . . . 0.0 112.384 171.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -76.02 -24.07 55.24 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.886 -0.509 . . . . 0.0 109.948 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.31 15.34 7.73 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 125.386 1.47 . . . . 0.0 110.669 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 16' ' ' PHE . 61.4 mt -77.88 125.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 117.557 0.678 . . . . 0.0 109.496 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -89.43 119.53 29.96 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.74 0.816 . . . . 0.0 109.166 174.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.467 HG23 HG22 ' A' ' 33' ' ' ILE . 8.4 pt -140.76 162.16 50.31 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.755 1.222 . . . . 0.0 107.955 175.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.3 138.23 70.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.637 2.225 . . . . 0.0 109.8 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -164.92 -101.1 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.3 p 50.64 49.66 20.45 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.144 0.978 . . . . 0.0 111.742 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 14.8 t -150.27 175.0 12.2 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 127.729 2.411 . . . . 0.0 106.023 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -165.07 148.66 8.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 151.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 81.89 101.95 0.06 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.772 2.029 . . . . 0.0 111.212 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -44.67 134.24 7.02 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.309 1.433 . . . . 0.0 112.729 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t 117.47 75.19 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 129.202 3.001 . . . . 0.0 107.803 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 12.2 p -143.99 -155.84 0.64 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.905 1.282 . . . . 0.0 109.665 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.7 t -153.99 167.01 31.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 169.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.7 m 62.89 57.38 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.618 1.167 . . . . 0.0 112.549 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.52 121.13 2.91 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.844 0.858 . . . . 0.0 109.649 175.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.66 162.2 3.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.288 0.635 . . . . 0.0 111.03 176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.09 166.39 25.19 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.959 1.742 . . . . 0.0 109.977 167.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -100.24 114.27 27.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.63 1.572 . . . . 0.0 110.802 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.422 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 47.0 t -64.17 109.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.425 1.09 . . . . 0.0 108.519 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.8 t -83.47 -40.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.8 t -155.81 -169.74 3.19 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.24 -159.46 14.92 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.333 0.968 . . . . 0.0 112.012 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -155.25 151.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 81' ' ' PRO . 31.2 pt -136.57 154.84 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.17 107.17 19.64 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -105.0 27.16 8.42 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.247 0.619 . . . . 0.0 111.772 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.3 m -78.75 58.21 2.25 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.074 1.307 . . . . 0.0 111.764 -177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -142.05 -36.98 0.41 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.028 2.131 . . . . 0.0 110.987 -173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.575 ' CB ' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -77.29 -169.76 1.5 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.856 2.062 . . . . 0.0 114.12 -174.341 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.9 m -158.13 77.68 0.8 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.242 1.417 . . . . 0.0 108.727 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -149.57 -65.3 0.22 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 118.011 -0.995 . . . . 0.0 111.253 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mp -59.74 145.12 46.28 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.077 1.308 . . . . 0.0 110.639 -176.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.54 164.81 14.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.044 0.84 . . . . 0.0 110.243 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -52.23 -44.4 64.81 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.968 1.307 . . . . 0.0 108.59 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -53.6 -60.97 2.62 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.309 1.044 . . . . 0.0 109.41 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -53.96 -50.09 67.29 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 123.279 0.632 . . . . 0.0 111.431 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 64.4 mtt -50.38 -60.51 2.92 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.381 -0.825 . . . . 0.0 111.362 175.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.04 -43.33 73.69 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.416 1.086 . . . . 0.0 110.759 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.32 -21.69 64.22 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.725 1.61 . . . . 0.0 111.875 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.21 35.07 1.25 Allowed Glycine 0 N--CA 1.446 -0.659 0 CA-C-O 118.498 -1.168 . . . . 0.0 110.332 173.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -116.58 164.46 14.56 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 119.212 1.506 . . . . 0.0 111.476 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 56' ' ' ILE . 11.1 p -156.92 148.74 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 123.796 0.839 . . . . 0.0 108.77 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 ' CB ' ' A' ' 61' ' ' GLN . 4.7 tp -66.28 141.41 58.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 169.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 t -81.94 -38.51 25.12 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.594 0.634 . . . . 0.0 110.316 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.431 ' SG ' HD23 ' A' ' 25' ' ' LEU . 3.8 m -79.39 179.23 7.55 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.557 1.143 . . . . 0.0 108.787 171.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 72.1 m80 42.7 51.14 5.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.505 1.122 . . . . 0.0 111.222 168.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -153.05 123.74 7.29 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.399 1.08 . . . . 0.0 108.563 -166.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.85 126.52 28.14 Favored Pre-proline 0 N--CA 1.454 -0.247 0 C-N-CA 124.811 1.244 . . . . 0.0 110.215 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.645 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.2 Cg_endo -73.36 121.03 6.85 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.361 2.041 . . . . 0.0 111.648 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -95.68 -16.19 22.17 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.7 m -156.64 -173.97 4.72 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 171.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -55.5 142.58 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 165.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 p -152.74 149.53 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.857 0.837 . . . . 0.0 109.9 -173.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.6 t -122.7 123.7 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.404 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -135.63 153.11 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -102.1 128.84 48.4 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.742 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.42 ' CG2' HD22 ' A' ' 7' ' ' LEU . 43.4 p -85.44 178.6 7.38 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.071 0.85 . . . . 0.0 110.04 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.8 m80 63.43 58.22 1.39 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.838 1.255 . . . . 0.0 110.877 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mmtt -126.51 6.15 6.89 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.914 0.885 . . . . 0.0 111.413 -176.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -45.72 -55.53 6.37 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 127.867 2.467 . . . . 0.0 110.808 176.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -93.06 33.01 1.21 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 111.956 176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.37 -39.59 2.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.615 1.166 . . . . 0.0 108.204 169.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.2 pt -67.92 -38.92 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.252 1.198 0 CA-C-O 117.45 -1.262 . . . . 0.0 110.25 -177.567 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.429 ' S2 ' HD21 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.1 m 75.25 73.51 0.09 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.19 0.995 . . . . 0.0 111.639 137.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -107.09 158.84 16.76 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.553 1.141 . . . . 0.0 111.629 -159.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -69.97 102.8 2.08 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 127.058 2.143 . . . . 0.0 108.025 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG21 ' HB3' ' A' ' 18' ' ' CYS . 21.7 t -108.57 122.24 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -93.02 132.01 37.5 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.508 0.14 . . . . 0.0 110.691 168.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.5 mt -108.17 104.64 14.09 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mt -73.71 95.15 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -94.85 152.94 40.03 Favored Pre-proline 0 N--CA 1.441 -0.909 0 C-N-CA 124.934 1.293 . . . . 0.0 108.705 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -52.81 -37.33 76.52 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 124.461 3.441 . . . . 0.0 112.236 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.81 -39.57 8.56 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 128.819 2.848 . . . . 0.0 111.088 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.16 62.75 0.23 Allowed Glycine 0 N--CA 1.437 -1.298 0 C-N-CA 125.348 1.451 . . . . 0.0 109.555 174.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 71.2 157.1 0.17 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 127.597 2.359 . . . . 0.0 114.669 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 p -159.22 108.9 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.826 163.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.67 143.53 42.13 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.073 0.549 . . . . 0.0 110.856 164.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -157.92 162.71 38.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.401 1.08 . . . . 0.0 110.443 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -84.14 131.16 34.8 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' HG21 ' A' ' 5' ' ' VAL . 22.0 t -127.4 129.35 47.38 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 121.385 -0.126 . . . . 0.0 111.019 170.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.76 136.71 47.25 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-O 121.669 0.747 . . . . 0.0 110.298 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -49.29 -32.75 11.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 125.655 1.582 . . . . 0.0 112.316 165.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.68 -10.99 59.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.84 1.256 . . . . 0.0 112.285 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.418 HG11 ' HG2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -130.22 148.45 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 119.141 0.882 . . . . 0.0 109.172 -167.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -74.92 150.44 39.11 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.686 -1.258 . . . . 0.0 109.576 -174.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -49.96 -40.55 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.284 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.426 ' C ' HD22 ' A' ' 25' ' ' LEU 0.269 0.0 OUTLIER -66.12 -32.22 73.55 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 179.252 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -65.65 -66.71 0.51 Allowed 'General case' 0 C--N 1.339 0.142 0 CA-C-O 121.458 0.647 . . . . 0.0 109.537 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.418 ' HG2' HG11 ' A' ' 22' ' ' VAL . 36.0 mm-40 -56.83 -36.16 69.64 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.956 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.726 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -49.96 -58.93 4.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 122.02 -0.425 . . . . 0.0 111.028 172.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.08 -36.68 75.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 118.767 -0.635 . . . . 0.0 111.642 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -52.82 -39.58 62.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.7 0.682 . . . . 0.0 111.961 171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -81.46 -29.17 33.84 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.2 14.35 7.78 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.977 1.751 . . . . 0.0 111.601 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.726 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 72.7 mt -76.36 112.28 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-N 117.754 0.777 . . . . 0.0 109.588 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -84.7 98.09 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.032 1.333 . . . . 0.0 109.159 175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG22 ' CE1' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -87.29 156.9 53.98 Favored Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 121.592 -0.692 . . . . 0.0 109.848 174.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 35' ' ' ILE . 39.5 Cg_endo -75.67 92.92 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.86 2.373 . . . . 0.0 110.894 -173.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.557 ' CE1' HG22 ' A' ' 35' ' ' ILE . 16.7 m-85 -82.89 149.94 26.79 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.554 0.742 . . . . 0.0 111.463 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.25 -37.85 2.19 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.39 1.076 . . . . 0.0 111.104 168.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -149.98 -34.93 0.17 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.817 1.647 . . . . 0.0 112.118 -161.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . 0.429 0.0 OUTLIER 22.61 98.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.835 3.254 . . . . 0.0 116.565 -165.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.69 -44.22 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.875 1.27 . . . . 0.0 112.052 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 102.7 58.99 0.75 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.736 1.16 . . . . 0.0 110.5 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.2 m 174.96 85.21 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 127.343 2.257 . . . . 0.0 108.22 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 21.6 p -152.4 -164.59 1.99 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.384 1.074 . . . . 0.0 109.45 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 t -139.69 47.65 1.84 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.88 177.24 10.02 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -165.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 63.35 132.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 127.182 2.193 . . . . 0.0 114.836 171.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 95' ' ' ILE . . . -174.73 169.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.826 166.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -134.14 164.59 24.49 Favored Glycine 0 N--CA 1.436 -1.323 0 C-N-CA 125.969 1.747 . . . . 0.0 109.208 162.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -98.24 109.25 22.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 125.796 1.638 . . . . 0.0 109.636 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.619 HG23 ' HB ' ' A' ' 74' ' ' VAL . 61.7 t -62.32 111.38 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 87.6 t -84.6 -42.08 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 122.852 0.461 . . . . 0.0 109.857 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.6 t -155.73 -166.75 2.3 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 58.48 -158.24 18.33 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 123.795 0.712 . . . . 0.0 111.929 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.9 m -145.58 154.91 42.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 168.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.654 HG23 HG21 ' A' ' 85' ' ' VAL . 28.3 pt -135.99 165.5 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -106.6 116.36 31.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 171.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -111.36 54.12 0.69 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.3 p -50.28 -45.86 54.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.509 -0.744 . . . . 0.0 109.494 169.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.6 42.83 0.54 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.251 1.42 . . . . 0.0 110.679 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.4 ' HA ' HD13 ' A' ' 75' ' ' LEU . 6.9 pt20 -76.98 160.8 28.86 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.619 -1.3 . . . . 0.0 114.176 -175.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.4 m -67.69 -71.48 0.21 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.473 1.109 . . . . 0.0 110.896 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -160.06 8.55 0.1 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 118.069 -0.967 . . . . 0.0 111.562 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.24 140.22 57.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 119.52 1.055 . . . . 0.0 109.921 -165.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -87.05 165.34 15.87 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.992 0.808 . . . . 0.0 109.641 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.17 -39.49 69.6 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.924 0.89 . . . . 0.0 108.757 176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -52.87 -62.38 1.69 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.654 0.782 . . . . 0.0 109.519 176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -51.93 -51.41 57.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.215 0.606 . . . . 0.0 111.573 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 21.0 mtm -51.56 -60.39 3.2 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.711 -0.618 . . . . 0.0 111.487 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -56.1 -43.39 78.06 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.704 1.202 . . . . 0.0 110.708 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.61 -22.13 66.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.733 1.613 . . . . 0.0 111.37 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 126.71 27.61 1.03 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 116.921 -2.044 . . . . 0.0 112.569 169.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CG ' HG22 ' A' ' 95' ' ' ILE . 90.9 m-85 -120.44 167.02 12.79 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 121.245 2.523 . . . . 0.0 114.953 -172.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.619 ' HB ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -164.69 146.59 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -171.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 77' ' ' CYS . 0.1 OUTLIER -66.98 148.55 51.82 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.805 1.639 . . . . 0.0 109.299 174.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.5 t -106.32 35.97 2.76 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.038 -1.039 . . . . 0.0 112.107 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.408 ' H ' ' HG ' ' A' ' 75' ' ' LEU . 68.5 m -134.89 -105.08 0.22 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.638 1.975 . . . . 0.0 106.44 -174.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -76.4 68.76 2.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.99 0.916 . . . . 0.0 112.053 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.65 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -123.14 138.23 54.71 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.979 0.912 . . . . 0.0 109.434 173.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -108.95 124.4 34.29 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 126.123 1.769 . . . . 0.0 109.603 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.471 ' HA ' HG22 ' A' ' 56' ' ' ILE . 10.8 Cg_endo -74.3 111.39 3.3 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.726 2.284 . . . . 0.0 111.673 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 p -82.07 -18.93 41.38 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 121.354 -0.841 . . . . 0.0 110.93 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.6 m -155.8 -177.12 6.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.225 1.41 . . . . 0.0 107.736 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -56.48 140.55 45.7 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 163.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.654 HG21 HG23 ' A' ' 56' ' ' ILE . 2.7 p -160.61 140.31 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 121.648 0.737 . . . . 0.0 111.938 -166.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.12 127.28 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.87 153.09 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 124.233 1.013 . . . . 0.0 108.921 176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -103.17 125.94 50.1 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 124.42 1.088 . . . . 0.0 109.232 172.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.1 p -83.56 177.14 8.55 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.536 1.516 . . . . 0.0 109.237 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' CG ' ' HG3' ' A' ' 36' ' ' PRO . 2.9 m80 69.38 57.0 0.36 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.582 1.153 . . . . 0.0 112.106 174.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -128.05 32.74 4.86 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -175.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -60.47 -68.66 0.28 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 172.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -81.75 52.64 1.96 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.669 0.747 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.52 -40.43 0.34 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 130.293 3.437 . . . . 0.0 109.363 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.566 HG22 ' CG ' ' A' ' 73' ' ' TYR . 35.1 pt -75.58 -43.28 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-O 119.007 -0.521 . . . . 0.0 112.278 175.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.076 -1.44 . . . . 0.0 109.569 176.164 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.415 ' N ' ' OD1' ' A' ' 20' ' ' ASP . . . . . . . . 0 C--O 1.226 -0.143 0 CA-C-O 121.69 0.757 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 m 61.92 69.68 0.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.166 -1.379 . . . . 0.0 112.884 160.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -98.8 158.48 15.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.518 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -81.21 84.65 6.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.982 1.713 . . . . 0.0 109.116 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 85' ' ' VAL . 60.8 t -84.19 127.59 39.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.425 ' HD3' ' OE2' ' A' ' 13' ' ' GLU . 8.8 ttmt -97.9 131.83 44.02 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 169.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD12 HG21 ' A' ' 33' ' ' ILE . 47.7 mt -109.41 110.93 22.21 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.732 1.27 . . . . 0.0 108.023 169.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 mt -80.53 86.06 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.6 p -86.55 154.92 56.69 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.418 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HD3' ' CD2' ' A' ' 90' ' ' HIS . 51.3 Cg_exo -55.07 -35.73 91.1 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.738 3.625 . . . . 0.0 112.411 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -48.39 -38.22 18.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 128.018 2.527 . . . . 0.0 111.212 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.34 61.86 0.21 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 125.593 1.568 . . . . 0.0 110.423 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.425 ' OE2' ' HD3' ' A' ' 6' ' ' LYS . 26.8 mt-10 68.2 160.41 0.17 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.12 2.168 . . . . 0.0 111.997 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -129.18 -64.1 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.386 0.674 . . . . 0.0 111.53 172.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 75.54 127.89 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.068 1.747 . . . . 0.0 112.353 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -163.53 168.99 19.39 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.63 119.56 35.35 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.869 0.868 . . . . 0.0 112.12 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.0 t -125.98 129.42 49.19 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.743 0.817 . . . . 0.0 111.585 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -79.24 149.06 31.97 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 123.756 0.822 . . . . 0.0 110.284 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 9.5 p-10 -65.34 -19.27 65.88 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 121.94 -0.475 . . . . 0.0 111.997 176.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -89.05 -3.28 58.74 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.615 1.166 . . . . 0.0 111.8 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 p -134.24 153.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.52 1.055 . . . . 0.0 110.667 -170.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -76.89 156.23 32.26 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.126 0.489 . . . . 0.0 112.001 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.78 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 123.954 0.902 . . . . 0.0 111.596 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.46 -51.14 0.1 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -48.59 -60.48 2.67 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.956 0.903 . . . . 0.0 110.929 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -72.22 -5.12 33.61 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -89.35 -49.07 6.93 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.396 -0.815 . . . . 0.0 109.618 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -53.63 -38.84 64.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.672 0.789 . . . . 0.0 110.541 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . 0.258 0.4 OUTLIER -58.25 -35.52 71.85 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 176.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -79.89 -25.77 40.49 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.61 11.7 6.45 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 125.811 1.672 . . . . 0.0 111.24 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.668 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 54.9 mt -75.44 121.35 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 118.279 1.039 . . . . 0.0 110.566 -178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -96.39 113.53 25.12 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 166.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.8 mt -107.33 137.62 19.67 Favored Pre-proline 0 N--CA 1.439 -1.022 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 163.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.92 114.92 4.17 Favored 'Trans proline' 0 N--CA 1.439 -1.694 0 C-N-CA 122.733 2.289 . . . . 0.0 106.916 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 38' ' ' SER . 12.4 m-85 -63.63 -97.21 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 167.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 37' ' ' TYR . 36.7 t 115.24 -66.31 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.347 2.659 . . . . 0.0 106.643 -164.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 p -113.5 -175.31 2.64 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.358 1.463 . . . . 0.0 110.868 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -161.29 150.86 16.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.872 2.069 . . . . 0.0 107.383 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 83.81 91.86 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.725 2.41 . . . . 0.0 111.371 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -35.8 142.8 0.13 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 126.428 1.966 . . . . 0.0 113.99 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t 89.96 46.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.878 2.471 . . . . 0.0 108.178 -160.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 5.8 p -143.25 137.0 28.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.798 1.639 . . . . 0.0 108.01 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 m -107.81 77.29 1.11 Allowed 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.2 1.0 . . . . 0.0 111.193 -168.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.86 -170.37 2.52 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 170.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 1.8 m 62.29 175.69 0.13 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.648 1.179 . . . . 0.0 110.992 175.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 47' ' ' CYS . . . 153.91 170.17 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.514 1.926 . . . . 0.0 111.83 165.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.75 165.25 27.66 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 124.834 1.207 . . . . 0.0 111.054 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -101.62 111.04 23.15 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.175 1.79 . . . . 0.0 110.308 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.462 HG23 ' HB ' ' A' ' 74' ' ' VAL . 78.2 t -58.8 116.91 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.016 0.927 . . . . 0.0 109.306 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 76.9 t -93.05 -47.02 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.216 0.606 . . . . 0.0 109.911 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 85' ' ' VAL . 23.3 t -158.31 170.71 21.62 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.26 -161.37 54.17 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -168.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.3 t -155.88 168.68 26.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 168.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 81' ' ' PRO . 29.1 pt -147.08 162.26 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 127.581 2.352 . . . . 0.0 107.999 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -105.22 113.48 27.09 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -116.61 28.21 8.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.27 1.028 . . . . 0.0 111.772 174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.1 p -57.43 -34.04 68.54 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.323 -0.86 . . . . 0.0 113.17 -172.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.74 -34.08 57.79 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.841 1.257 . . . . 0.0 113.054 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.548 ' HB2' HD13 ' A' ' 75' ' ' LEU . 14.0 pt20 -55.59 -32.09 62.77 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -160.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 p 39.53 58.35 2.0 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.069 1.348 . . . . 0.0 113.12 -172.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -149.51 -71.43 0.19 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 117.691 -1.147 . . . . 0.0 110.753 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' CD1' HD12 ' A' ' 75' ' ' LEU . 7.6 mp -55.69 139.33 45.23 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.785 1.175 . . . . 0.0 111.766 -168.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -80.43 164.91 22.7 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.05 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.95 -44.44 67.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.6 -61.71 2.11 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 123.886 0.875 . . . . 0.0 109.569 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -53.05 -52.09 59.63 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.346 0.658 . . . . 0.0 111.433 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 14.8 mtt -53.87 -58.17 8.26 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.566 -0.709 . . . . 0.0 111.665 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -53.79 -43.63 69.43 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.62 1.168 . . . . 0.0 110.557 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.97 65.03 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.17 28.75 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-O 117.913 -1.493 . . . . 0.0 111.072 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.503 ' CG ' HG22 ' A' ' 95' ' ' ILE . 86.2 m-85 -110.79 163.57 13.64 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 120.067 1.934 . . . . 0.0 113.939 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -158.38 167.58 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.683 1.593 . . . . 0.0 108.885 -168.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 61' ' ' GLN . 1.3 tt -118.73 105.47 11.59 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.821 1.648 . . . . 0.0 110.16 -173.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.9 p -79.94 48.67 0.99 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.358 1.463 . . . . 0.0 112.412 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.72 -59.05 0.2 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 123.229 0.612 . . . . 0.0 109.798 -164.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.425 ' H ' HD23 ' A' ' 75' ' ' LEU . 3.3 m80 -120.64 64.26 0.85 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.278 1.831 . . . . 0.0 106.718 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.609 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -139.94 133.9 30.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.15 123.68 36.18 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 125.822 1.649 . . . . 0.0 109.409 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.792 ' HA ' HG22 ' A' ' 56' ' ' ILE . 15.7 Cg_endo -72.84 114.83 4.14 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.193 2.596 . . . . 0.0 111.063 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 p -88.34 -17.02 31.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.944 0.498 . . . . 0.0 110.834 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 m -157.08 -178.74 7.59 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 125.543 1.537 . . . . 0.0 108.116 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -53.58 121.4 7.68 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 161.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.544 HG13 HG13 ' A' ' 5' ' ' VAL . 7.2 p -135.25 144.51 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.748 1.219 . . . . 0.0 108.995 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.2 t -115.59 125.28 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.17 154.02 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 C-N-CA 123.999 0.92 . . . . 0.0 108.669 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.57 121.87 41.82 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.199 1.0 . . . . 0.0 108.643 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -178.23 3.47 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.917 1.235 . . . . 0.0 110.999 176.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.582 ' CD2' ' HD3' ' A' ' 10' ' ' PRO . 5.1 m-70 65.88 48.45 1.83 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.968 1.307 . . . . 0.0 112.931 169.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -119.31 15.39 13.05 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -40.65 -68.44 0.18 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.116 0.967 . . . . 0.0 109.68 170.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.81 17.51 0.71 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.991 -176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -113.14 -17.48 12.37 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 117.888 -1.054 . . . . 0.0 110.904 169.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.503 HG22 ' CG ' ' A' ' 73' ' ' TYR . 28.8 pt -89.82 -45.48 15.15 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 119.98 1.264 . . . . 0.0 111.673 177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.252 1.227 0 CA-C-O 117.728 -1.13 . . . . 0.0 110.157 -176.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.51 ' S1 ' HD11 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.277 0 CA-C-O 121.051 0.453 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.0 m 57.8 75.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.876 1.271 . . . . 0.0 112.695 169.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -98.39 158.75 15.39 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.56 0.744 . . . . 0.0 112.704 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -81.93 83.77 7.13 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.992 1.717 . . . . 0.0 109.181 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 85' ' ' VAL . 94.7 t -81.66 121.68 35.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -89.55 132.34 35.13 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.733 -0.787 . . . . 0.0 112.675 167.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.436 HD12 HD13 ' A' ' 33' ' ' ILE . 71.8 mt -111.26 106.95 16.08 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 125.429 1.492 . . . . 0.0 107.238 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 23.1 mt -76.39 94.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 169.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -89.88 156.29 47.11 Favored Pre-proline 0 N--CA 1.444 -0.735 0 C-N-CA 124.618 1.167 . . . . 0.0 108.689 174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -52.12 -38.69 71.17 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.524 3.483 . . . . 0.0 112.422 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.69 -39.49 11.55 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 128.222 2.609 . . . . 0.0 111.237 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.05 66.19 0.28 Allowed Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 125.585 1.564 . . . . 0.0 109.803 175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 68.7 164.16 0.23 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 127.221 2.208 . . . . 0.0 112.565 177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.71 -60.64 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.311 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 74.27 131.26 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.41 1.484 . . . . 0.0 111.598 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -162.44 167.86 22.94 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -170.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.54 124.44 39.57 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.914 0.486 . . . . 0.0 110.797 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 7.4 t -131.78 123.99 28.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.187 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.79 138.7 56.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.41 1.484 . . . . 0.0 109.637 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 20' ' ' ASP . 1.8 p-10 -56.17 -27.29 53.85 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.691 1.597 . . . . 0.0 111.916 169.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -87.0 1.18 53.67 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.459 1.104 . . . . 0.0 111.865 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -133.41 156.53 41.83 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 CA-C-N 119.639 1.109 . . . . 0.0 110.677 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -78.42 149.07 33.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 121.83 -0.543 . . . . 0.0 111.241 -174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -72.23 63.09 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 122.073 0.94 . . . . 0.0 110.423 171.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' C ' HD13 ' A' ' 25' ' ' LEU . 1.9 tm? -166.32 -51.87 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.44 -63.07 1.28 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.397 0.617 . . . . 0.0 110.98 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -58.02 -32.58 68.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.357 0.599 . . . . 0.0 110.243 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.734 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -58.06 -58.26 9.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.513 -0.742 . . . . 0.0 110.105 177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.49 -41.51 63.44 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -53.59 -44.07 69.09 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 173.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -77.87 -24.53 48.46 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.77 -0.581 . . . . 0.0 110.073 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 119.61 12.1 6.86 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.924 1.726 . . . . 0.0 111.736 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.734 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 86.7 mt -76.24 111.49 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 117.826 0.813 . . . . 0.0 111.017 -177.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -89.17 73.1 8.18 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 159.43 29.44 Favored Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 121.112 -0.992 . . . . 0.0 108.739 175.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 59.7 Cg_endo -78.6 60.51 7.64 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.313 2.675 . . . . 0.0 110.989 -174.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CB ' ' HD2' ' A' ' 40' ' ' ARG . 39.3 p90 -83.43 161.07 21.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.29 0.566 . . . . 0.0 111.219 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.96 8.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 162.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 -72.96 0.18 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.945 0.793 . . . . 0.0 111.597 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HD2' ' CB ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER 71.35 70.08 0.17 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.948 2.099 . . . . 0.0 112.454 -163.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 173.8 72.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.902 2.481 . . . . 0.0 111.36 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.8 -98.78 0.02 OUTLIER Glycine 0 CA--C 1.537 1.451 0 N-CA-C 116.569 1.388 . . . . 0.0 116.569 172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.4 t -72.25 73.35 0.95 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -152.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 47' ' ' CYS . 16.7 p -137.48 -151.56 0.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.368 1.467 . . . . 0.0 111.444 -172.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 t -157.33 66.0 0.5 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.116 1.366 . . . . 0.0 109.049 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.3 m -158.03 62.64 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.452 -0.78 . . . . 0.0 110.724 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 3.7 m -141.26 -148.07 0.23 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.264 0.554 . . . . 0.0 109.564 -168.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 81.91 127.01 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.628 1.971 . . . . 0.0 113.206 157.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.51 27.34 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 125.737 1.637 . . . . 0.0 109.848 174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -92.77 111.04 22.51 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.834 1.254 . . . . 0.0 109.965 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -59.93 110.89 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.46 -42.43 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.6 t -157.24 -167.88 2.45 Favored 'General case' 0 C--O 1.228 -0.069 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.65 -153.64 14.18 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.01 0.814 . . . . 0.0 111.644 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.6 m -157.28 154.99 29.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.617 HG22 ' HA ' ' A' ' 81' ' ' PRO . 26.9 pt -141.75 166.31 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 126.43 1.892 . . . . 0.0 106.381 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -109.44 119.71 40.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -108.36 46.31 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.678 0.791 . . . . 0.0 111.295 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 t -63.23 -10.69 16.68 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -60.13 -61.64 2.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.302 0.955 . . . . 0.0 108.999 167.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 73.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.655 2.382 . . . . 0.0 112.636 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 51.8 p -83.75 -81.84 0.17 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 122.709 0.403 . . . . 0.0 111.231 -173.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 95' ' ' ILE . 36.3 p90 -145.26 8.47 1.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.186 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.0 142.89 55.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.167 0.894 . . . . 0.0 109.194 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.85 167.23 11.76 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.865 0.728 . . . . 0.0 109.67 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.88 -41.91 75.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.966 0.907 . . . . 0.0 109.029 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -60.16 3.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.853 0.861 . . . . 0.0 109.545 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -55.1 -50.32 69.49 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.647 0.779 . . . . 0.0 110.999 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 20.2 mtm -51.29 -59.83 3.79 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.829 -0.544 . . . . 0.0 112.182 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.04 -43.19 73.53 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.239 1.016 . . . . 0.0 110.511 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.03 -22.89 67.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.585 1.554 . . . . 0.0 111.797 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.42 35.55 0.8 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-O 118.33 -1.261 . . . . 0.0 111.019 170.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.443 ' CG ' HG22 ' A' ' 95' ' ' ILE . 91.0 m-85 -116.46 161.77 18.59 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.789 1.794 . . . . 0.0 112.777 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -160.3 146.0 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.423 1.089 . . . . 0.0 108.74 -177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' CD1' ' H ' ' A' ' 78' ' ' HIS . 3.9 pp -70.27 165.7 21.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.611 1.096 . . . . 0.0 110.897 171.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 p -134.99 41.94 2.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.231 0.613 . . . . 0.0 110.854 -171.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 78.0 m -137.44 -54.08 0.68 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.425 1.09 . . . . 0.0 110.271 -166.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.426 ' H ' ' CD1' ' A' ' 75' ' ' LEU . 0.6 OUTLIER -128.72 57.71 1.6 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.978 1.711 . . . . 0.0 109.484 174.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -115.95 137.95 51.64 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -106.15 120.72 47.9 Favored Pre-proline 0 C--O 1.234 0.267 0 C-N-CA 126.105 1.762 . . . . 0.0 109.275 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.617 ' HA ' HG22 ' A' ' 56' ' ' ILE . 13.0 Cg_endo -75.4 116.08 4.41 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.675 2.25 . . . . 0.0 112.031 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 p -90.41 -15.42 30.99 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 122.027 -0.421 . . . . 0.0 111.385 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.8 m -158.48 -177.31 6.45 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.088 1.355 . . . . 0.0 108.524 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -64.36 84.46 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.116 1.766 . . . . 0.0 109.941 168.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 5' ' ' VAL . 2.1 p -85.82 155.32 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 124.822 1.249 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.8 t -121.71 125.09 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -139.62 153.21 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.509 1.124 . . . . 0.0 108.642 178.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 29.3 mt-10 -101.39 129.09 47.34 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.787 170.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 p -88.51 176.89 6.96 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.083 1.311 . . . . 0.0 109.463 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.405 ' CE1' ' HD3' ' A' ' 36' ' ' PRO . 2.9 m80 66.11 55.21 0.92 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 0.0 111.487 176.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -122.0 13.86 10.61 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -46.06 -62.76 1.19 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.475 1.11 . . . . 0.0 108.794 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.99 28.08 0.62 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.306 0.642 . . . . 0.0 112.302 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -125.77 -12.35 6.56 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.819 1.248 . . . . 0.0 111.836 168.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.443 HG22 ' CG ' ' A' ' 73' ' ' TYR . 46.7 pt -91.21 -40.37 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.352 0 CA-C-N 119.876 1.216 . . . . 0.0 111.924 172.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.964 -1.494 . . . . 0.0 110.173 178.096 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.8 m 80.97 112.15 0.07 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.228 1.411 . . . . 0.0 111.901 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.4 155.21 37.83 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 123.75 0.82 . . . . 0.0 111.298 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -76.97 99.65 5.34 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 128.044 2.537 . . . . 0.0 108.038 175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.89 118.47 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -85.94 129.95 34.68 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 123.126 0.266 . . . . 0.0 110.372 168.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 33' ' ' ILE . 77.4 mt -108.92 102.88 11.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 167.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 88' ' ' GLU . 39.0 mt -71.37 94.73 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 171.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -93.52 155.21 40.95 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.66 -32.61 76.25 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.745 2.963 . . . . 0.0 112.244 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -52.4 -33.91 45.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 127.679 2.392 . . . . 0.0 111.392 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.91 60.52 0.34 Allowed Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 125.212 1.387 . . . . 0.0 110.489 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 71.47 145.27 0.07 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 127.868 2.467 . . . . 0.0 114.262 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.456 HG21 HG23 ' A' ' 33' ' ' ILE . 35.3 m -143.23 97.13 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 167.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -69.14 135.91 51.39 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.847 161.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' A' ' 33' ' ' ILE . 4.8 p90 -151.19 170.33 19.71 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.595 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 119.51 39.17 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -175.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 81' ' ' PRO . 9.2 t -122.01 126.22 48.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.959 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.59 145.73 45.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.725 1.726 . . . . 0.0 110.936 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -56.74 -24.64 51.14 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 127.198 2.199 . . . . 0.0 112.119 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -103.78 10.06 36.75 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.456 1.502 . . . . 0.0 111.332 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.432 HG11 ' CG ' ' A' ' 27' ' ' GLN . 1.7 p -134.53 158.36 41.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.52 1.054 . . . . 0.0 110.943 -175.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -77.91 138.08 38.69 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.4 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 t -49.0 -48.93 16.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.612 0.244 . . . . 0.0 110.916 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.66 -37.81 74.02 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -67.03 -64.07 0.93 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.718 0.77 . . . . 0.0 108.939 -167.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.432 ' CG ' HG11 ' A' ' 22' ' ' VAL . 20.4 mm100 -57.17 -40.92 78.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.301 177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 33' ' ' ILE . . . -50.1 -59.54 3.81 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.753 -0.592 . . . . 0.0 111.454 175.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -56.69 -39.71 74.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.112 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -53.03 -40.95 64.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 172.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -75.22 -24.85 57.8 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 121.849 -0.532 . . . . 0.0 109.749 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.88 12.88 6.86 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.615 1.578 . . . . 0.0 111.057 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 28' ' ' ALA . 89.1 mt -75.77 116.38 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 117.672 0.736 . . . . 0.0 110.785 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -80.38 63.93 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.9 156.26 87.77 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 174.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -71.67 76.39 1.94 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.33 2.686 . . . . 0.0 109.512 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -56.32 -63.93 1.03 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.705 1.202 . . . . 0.0 110.561 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t 66.0 -134.14 0.19 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.327 1.051 . . . . 0.0 110.882 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.64 173.24 0.3 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.523 1.056 . . . . 0.0 110.157 165.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.63 101.42 1.99 Allowed 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 161.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -158.35 -36.47 0.07 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.824 0.849 . . . . 0.0 112.904 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.88 77.09 1.14 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 -26.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.715 1.606 . . . . 0.0 111.71 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.04 -179.59 0.96 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.779 0.718 . . . . 0.0 111.091 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.2 t -128.93 69.1 1.39 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 85.2 p -163.08 168.33 21.06 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.344 1.458 . . . . 0.0 107.178 172.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 75' ' ' LEU . 0.1 OUTLIER 66.83 147.81 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.008 1.723 . . . . 0.0 111.506 -177.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 47' ' ' CYS . . . 168.29 169.27 0.04 OUTLIER 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.49 1.516 . . . . 0.0 111.122 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.22 166.0 26.16 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 125.478 1.513 . . . . 0.0 110.574 168.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -101.35 107.68 19.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.284 1.834 . . . . 0.0 110.087 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.9 t -59.56 109.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 172.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.19 -46.67 25.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -162.76 177.71 9.1 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . 95.39 -161.96 23.37 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -174.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.518 ' H ' HG22 ' A' ' 85' ' ' VAL . 6.6 m -156.71 144.83 19.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 168.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.946 HD11 HG21 ' A' ' 74' ' ' VAL . 49.1 pt -143.93 164.08 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.817 1.647 . . . . 0.0 106.741 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -108.96 109.9 21.07 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -104.75 25.08 10.81 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.372 0.669 . . . . 0.0 111.928 170.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.8 m -77.24 31.4 0.14 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.371 -1.456 . . . . 0.0 113.301 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -125.6 12.94 8.06 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.828 1.651 . . . . 0.0 109.653 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.618 ' HB2' HD23 ' A' ' 75' ' ' LEU . 10.2 pt20 -115.91 -36.31 4.19 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -161.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.9 m 41.86 64.39 1.09 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -142.9 -74.38 0.28 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.873 168.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' A' ' 75' ' ' LEU . 7.1 mp -52.22 141.13 19.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.069 0.85 . . . . 0.0 112.244 -168.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -83.94 169.06 15.43 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 124.424 1.078 . . . . 0.0 109.881 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -54.17 -44.86 71.85 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.64 -62.37 1.69 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.133 0.973 . . . . 0.0 109.482 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -53.39 -49.3 67.51 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.017 0.527 . . . . 0.0 111.359 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 33.3 mtt -54.18 -60.63 3.07 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.544 -0.722 . . . . 0.0 111.483 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.88 -42.19 68.39 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.248 1.019 . . . . 0.0 110.701 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.64 -20.25 65.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.872 1.669 . . . . 0.0 112.32 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.83 30.64 1.93 Allowed Glycine 0 C--O 1.221 -0.715 0 CA-C-O 117.554 -1.692 . . . . 0.0 111.527 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.526 ' CG ' HG22 ' A' ' 95' ' ' ILE . 96.4 m-85 -118.12 161.44 19.85 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 120.52 2.16 . . . . 0.0 113.514 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.946 HG21 HD11 ' A' ' 56' ' ' ILE . 7.1 p -146.69 140.76 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 176.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 61' ' ' GLN . 0.9 OUTLIER -78.46 136.39 37.6 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 169.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.42 ' N ' HD12 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -60.18 -57.01 14.64 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.882 0.873 . . . . 0.0 110.886 -178.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 62.8 m -61.56 125.05 22.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.433 0.693 . . . . 0.0 109.648 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 74.04 69.8 0.1 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.279 1.032 . . . . 0.0 112.791 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -141.19 128.4 20.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.214 1.406 . . . . 0.0 109.562 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -112.19 123.01 35.25 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 126.222 1.809 . . . . 0.0 109.096 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.618 ' HA ' HG22 ' A' ' 56' ' ' ILE . 16.8 Cg_endo -75.38 129.69 12.23 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.788 2.325 . . . . 0.0 111.595 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.3 p -104.05 -12.49 16.74 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.5 m -157.16 -174.93 5.14 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -58.13 127.77 33.75 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.607 HG21 HG23 ' A' ' 56' ' ' ILE . 25.1 t -135.91 153.76 32.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.674 0.79 . . . . 0.0 109.569 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.63 121.15 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.452 HG23 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -136.27 152.83 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 21.6 mt-10 -101.13 131.2 47.18 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 124.347 1.059 . . . . 0.0 109.284 168.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.6 p -88.74 177.46 6.72 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 120.153 1.342 . . . . 0.0 109.434 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 m80 69.1 54.46 0.44 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.915 1.286 . . . . 0.0 111.437 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -125.32 22.37 7.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.74 0.816 . . . . 0.0 112.895 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -45.75 -72.67 0.05 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.173 1.389 . . . . 0.0 108.91 170.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.09 37.57 0.44 Allowed 'General case' 0 CA--C 1.548 0.885 0 O-C-N 121.935 -0.478 . . . . 0.0 111.812 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -122.06 -29.54 4.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.452 1.501 . . . . 0.0 110.647 163.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.526 HG22 ' CG ' ' A' ' 73' ' ' TYR . 26.1 pt -83.68 -45.59 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 119.347 0.976 . . . . 0.0 112.608 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.251 1.136 0 CA-C-O 116.981 -1.485 . . . . 0.0 109.803 -175.662 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.577 ' S2 ' HD11 ' A' ' 75' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.489 ' N ' ' OD1' ' A' ' 21' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 117.252 2.315 . . . . 0.0 117.252 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 m 97.41 105.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.767 2.427 . . . . 0.0 112.305 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -131.63 155.61 47.26 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.97 0.908 . . . . 0.0 112.54 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.29 96.93 0.06 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.277 2.631 . . . . 0.0 109.651 169.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -104.38 118.59 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -85.82 130.24 34.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.471 0.176 . . . . 0.0 111.238 167.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.41 ' CD1' HD11 ' A' ' 35' ' ' ILE . 64.2 mt -110.06 105.25 14.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 124.483 1.114 . . . . 0.0 108.603 169.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.5 mt -78.3 86.86 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.5 p -87.11 153.53 54.27 Favored Pre-proline 0 N--CA 1.443 -0.778 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.99 176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -55.09 -35.05 89.56 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.951 3.101 . . . . 0.0 112.397 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.27 -38.8 13.13 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 127.485 2.314 . . . . 0.0 111.14 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.69 62.12 0.19 Allowed Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 125.283 1.421 . . . . 0.0 110.197 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 67.43 162.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.111 2.164 . . . . 0.0 111.921 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.49 -59.85 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 C-N-CA 123.438 0.695 . . . . 0.0 110.15 170.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 69.26 137.45 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 126.354 1.862 . . . . 0.0 112.464 -174.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -163.64 174.65 11.46 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 122.725 0.41 . . . . 0.0 111.722 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.79 122.77 42.45 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 176.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.9 t -120.6 126.58 50.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.21 133.64 49.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -52.35 -30.87 30.8 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 122.766 1.27 . . . . 0.0 109.315 166.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -70.1 -14.1 62.51 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.949 1.3 . . . . 0.0 112.136 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.52 160.84 42.3 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 124.341 1.056 . . . . 0.0 111.657 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -74.34 147.05 42.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 122.032 -0.417 . . . . 0.0 111.86 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.2 62.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 122.174 0.987 . . . . 0.0 110.335 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.8 tp -166.21 -60.83 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -49.59 -58.25 5.6 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.757 1.265 . . . . 0.0 109.823 -172.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -74.93 -20.13 59.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.925 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 33' ' ' ILE . . . -65.72 -52.05 54.38 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.25 -40.86 68.15 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.213 0.605 . . . . 0.0 109.976 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -53.56 -39.61 64.9 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 173.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.42 -24.74 46.03 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.704 -0.622 . . . . 0.0 109.763 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.11 10.1 6.97 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.87 1.7 . . . . 0.0 111.37 175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.609 ' HB ' ' HB1' ' A' ' 28' ' ' ALA . 71.4 mt -78.02 129.47 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 118.119 0.96 . . . . 0.0 111.012 -176.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -87.2 125.41 34.16 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 165.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' A' ' 7' ' ' LEU . 17.8 mt -123.04 148.41 54.25 Favored Pre-proline 0 N--CA 1.441 -0.878 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 164.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' HD3' ' CE1' ' A' ' 90' ' ' HIS . 36.6 Cg_endo -78.17 64.53 8.39 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 124.126 3.217 . . . . 0.0 110.859 -171.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -68.73 -31.08 69.89 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 124.097 0.959 . . . . 0.0 113.488 -165.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 t 57.86 -84.65 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.72 -159.9 0.77 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.268 3.027 . . . . 0.0 108.56 -174.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.45 ' HA ' ' S1 ' ' A' ' 97' ' ' FES . 2.1 ttp180 -166.99 59.7 0.08 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.024 1.284 . . . . 0.0 112.592 169.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -142.38 10.02 1.86 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.13 -69.05 0.34 Allowed Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.474 1.034 . . . . 0.0 111.988 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 p -75.45 65.64 1.74 Allowed 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.244 1.018 . . . . 0.0 110.19 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.6 p -158.16 147.08 19.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.267 1.827 . . . . 0.0 106.1 -170.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.2 m -102.14 85.01 2.58 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.674 -166.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 88.8 p -159.99 -145.87 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.795 0.725 . . . . 0.0 111.668 167.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 60.2 m 56.55 -114.92 0.87 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 125.932 1.693 . . . . 0.0 111.313 165.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 64.05 149.48 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.595 2.358 . . . . 0.0 113.574 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.01 158.31 27.6 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.001 175.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -95.43 109.81 21.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.074 1.35 . . . . 0.0 109.584 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' A' ' 74' ' ' VAL . 40.7 t -61.14 107.33 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.436 1.094 . . . . 0.0 108.225 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 91.7 t -80.29 -37.9 17.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -157.7 -163.21 1.3 Allowed 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . 73.53 -171.28 51.8 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.033 0.349 . . . . 0.0 113.168 172.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.425 ' H ' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -150.92 129.94 12.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.66 HG23 HG21 ' A' ' 85' ' ' VAL . 16.7 pt -139.1 152.28 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -100.72 112.97 25.47 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -105.68 41.94 1.31 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.249 0.62 . . . . 0.0 110.765 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -49.79 -37.44 30.04 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.413 1.006 . . . . 0.0 111.495 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.2 6.27 3.69 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.607 0.763 . . . . 0.0 112.455 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -59.33 -62.17 2.08 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.343 1.457 . . . . 0.0 111.858 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.6 m 37.86 39.37 0.22 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.616 1.166 . . . . 0.0 113.355 -165.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -143.85 -70.43 0.31 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.34 1.056 . . . . 0.0 110.484 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.41 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 6.9 mp -56.9 144.32 34.03 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.987 0.812 . . . . 0.0 110.156 -172.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -89.19 165.58 14.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.618 0.723 . . . . 0.0 110.233 174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.16 -41.35 71.73 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.818 1.247 . . . . 0.0 108.683 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.54 -60.63 2.93 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.129 0.972 . . . . 0.0 109.465 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -54.41 -48.26 71.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.462 0.705 . . . . 0.0 111.39 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 15.0 mtt -53.98 -60.18 3.67 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.521 -0.737 . . . . 0.0 111.106 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -53.67 -44.72 69.9 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.747 1.219 . . . . 0.0 110.558 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.18 64.03 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.741 1.617 . . . . 0.0 112.254 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.88 32.59 1.4 Allowed Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 117.553 -1.693 . . . . 0.0 111.415 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.54 ' CG ' HG22 ' A' ' 95' ' ' ILE . 95.0 m-85 -120.24 159.38 25.06 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.343 2.072 . . . . 0.0 113.184 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.423 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 5.1 p -154.26 150.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.552 1.141 . . . . 0.0 108.73 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.626 HD22 ' SG ' ' A' ' 77' ' ' CYS . 0.4 OUTLIER -79.24 119.9 22.97 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 172.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.7 p -70.76 -45.81 64.09 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.465 -0.772 . . . . 0.0 110.817 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.626 ' SG ' HD22 ' A' ' 75' ' ' LEU . 26.3 p -59.12 -33.58 71.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.503 1.521 . . . . 0.0 112.326 -177.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -128.58 72.24 1.43 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.137 0.975 . . . . 0.0 110.181 175.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -138.33 141.47 39.73 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 124.263 1.025 . . . . 0.0 109.282 168.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -112.66 118.44 45.08 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 126.006 1.723 . . . . 0.0 109.281 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.536 ' HA ' HG22 ' A' ' 56' ' ' ILE . 11.8 Cg_endo -75.85 108.79 2.76 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.339 2.693 . . . . 0.0 112.707 -174.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -88.43 -12.98 41.59 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.865 -0.522 . . . . 0.0 111.366 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.8 m -152.62 -177.27 6.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.167 1.387 . . . . 0.0 108.103 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.16 124.21 20.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 166.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.66 HG21 HG23 ' A' ' 56' ' ' ILE . 53.5 t -133.62 156.09 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.558 0.694 . . . . 0.0 111.282 -173.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.7 t -123.3 118.77 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.39 152.24 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.165 0.986 . . . . 0.0 108.939 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -100.53 127.55 46.86 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.077 0.951 . . . . 0.0 108.833 170.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.4 p -83.33 179.49 7.67 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.042 1.292 . . . . 0.0 110.139 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.455 ' CE1' ' HD3' ' A' ' 36' ' ' PRO . 1.3 m80 69.73 55.33 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.153 1.381 . . . . 0.0 111.122 173.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -123.54 13.59 9.43 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -34.88 -76.29 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.855 2.062 . . . . 0.0 110.767 166.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -82.77 40.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.002 0.819 . . . . 0.0 112.426 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -120.37 -28.78 4.94 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.311 1.044 . . . . 0.0 111.047 158.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.54 HG22 ' CG ' ' A' ' 73' ' ' TYR . 34.8 pt -81.42 -48.52 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 119.296 0.953 . . . . 0.0 112.896 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.253 1.239 0 CA-C-O 117.546 -1.216 . . . . 0.0 110.044 -173.306 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' FES . . . . . 0.45 ' S1 ' ' HA ' ' A' ' 40' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_